 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0004666	prostaglandin-endoperoxide synthase activity	1	1.974408e-4	7.281617e-1	7.281617e-1	5.064810e+3	1.974408e-4	1	1.974408e-4	1.000000e+0	1	2.217111e-4	8.176705e-1	8.176705e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	PTGS2
GO Molecular Function	GO:0050473	arachidonate 15-lipoxygenase activity	2	2.020903e-4	7.453090e-1	3.726545e-1	4.948282e+3	2.020903e-4	1	2.020903e-4	1.000000e+0	2	3.325574e-4	1.000000e+0	6.132358e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	PTGS2
GO Molecular Function	GO:0047498	calcium-dependent phospholipase A2 activity	3	6.616246e-4	1.000000e+0	8.133572e-1	1.511431e+3	6.616246e-4	1	6.616246e-4	1.000000e+0	3	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	PLA2G4A
GO Molecular Function	GO:0004623	phospholipase A2 activity	4	1.434459e-3	1.000000e+0	1.000000e+0	6.971268e+2	1.434459e-3	1	1.434459e-3	1.000000e+0	8	3.212404e-3	1.000000e+0	1.000000e+0	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	PLA2G4A
GO Molecular Function	GO:0016702	oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen	5	1.463528e-3	1.000000e+0	1.000000e+0	6.832805e+2	1.463528e-3	1	1.463528e-3	1.000000e+0	6	2.769621e-3	1.000000e+0	1.000000e+0	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	PTGS2
GO Molecular Function	GO:0016701	oxidoreductase activity, acting on single donors with incorporation of molecular oxygen	6	1.471019e-3	1.000000e+0	9.041863e-1	6.798007e+2	1.471019e-3	1	1.471019e-3	1.000000e+0	7	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	PTGS2
GO Molecular Function	GO:0004622	lysophospholipase activity	7	1.639950e-3	1.000000e+0	8.640194e-1	6.097745e+2	1.639950e-3	1	1.639950e-3	1.000000e+0	4	1.440682e-3	1.000000e+0	1.000000e+0	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	PLA2G4A
GO Molecular Function	GO:0004601	peroxidase activity	8	2.725406e-3	1.000000e+0	1.000000e+0	3.669178e+2	2.725406e-3	1	2.725406e-3	1.000000e+0	10	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	PTGS2
GO Molecular Function	GO:0016209	antioxidant activity	9	3.982005e-3	1.000000e+0	1.000000e+0	2.511297e+2	3.982005e-3	1	3.982005e-3	1.000000e+0	11	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	PTGS2
GO Molecular Function	GO:0005544	calcium-dependent phospholipid binding	10	4.309211e-3	1.000000e+0	1.000000e+0	2.320610e+2	4.309211e-3	1	4.309211e-3	1.000000e+0	8	3.212404e-3	1.000000e+0	1.000000e+0	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	PLA2G4A
GO Molecular Function	GO:0052689	carboxylic ester hydrolase activity	11	6.575470e-3	1.000000e+0	1.000000e+0	1.520804e+2	6.575470e-3	1	6.575470e-3	1.000000e+0	14	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	PLA2G4A
GO Molecular Function	GO:0051213	dioxygenase activity	12	8.072355e-3	1.000000e+0	1.000000e+0	1.238796e+2	8.072355e-3	1	8.072355e-3	1.000000e+0	12	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	PTGS2
GO Molecular Function	GO:0004620	phospholipase activity	13	8.606222e-3	1.000000e+0	1.000000e+0	1.161950e+2	8.606222e-3	1	8.606222e-3	1.000000e+0	13	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	PLA2G4A
GO Molecular Function	GO:0020037	heme binding	14	8.778443e-3	1.000000e+0	1.000000e+0	1.139154e+2	8.778443e-3	1	8.778443e-3	1.000000e+0	16	1.425002e-2	1.000000e+0	1.000000e+0	6.992636e+1	1.430076e-2	1	129	5.000000e-1	7.751938e-3	unnamed	PTGS2
GO Molecular Function	GO:0016298	lipase activity	15	9.695674e-3	1.000000e+0	1.000000e+0	1.031388e+2	9.695674e-3	1	9.695674e-3	1.000000e+0	15	1.171681e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	PLA2G4A
GO Molecular Function	GO:0046906	tetrapyrrole binding	16	9.836374e-3	1.000000e+0	1.000000e+0	1.016635e+2	9.836374e-3	1	9.836374e-3	1.000000e+0	17	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	PTGS2
GO Molecular Function	GO:0016705	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	17	1.379212e-2	1.000000e+0	1.000000e+0	7.250518e+1	1.379212e-2	1	1.379212e-2	1.000000e+0	18	1.743944e-2	1.000000e+0	1.000000e+0	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	PTGS2
GO Molecular Function	GO:0016491	oxidoreductase activity	18	6.045513e-2	1.000000e+0	1.000000e+0	1.654119e+1	6.045513e-2	1	6.045513e-2	1.000000e+0	24	7.769532e-2	1.000000e+0	1.000000e+0	1.261608e+1	7.926390e-2	1	715	5.000000e-1	1.398601e-3	unnamed	PTGS2
GO Molecular Function	GO:0042803	protein homodimerization activity	19	6.175957e-2	1.000000e+0	1.000000e+0	1.619182e+1	6.175957e-2	1	6.175957e-2	1.000000e+0	22	6.294423e-2	1.000000e+0	1.000000e+0	1.563345e+1	6.396541e-2	1	577	5.000000e-1	1.733102e-3	unnamed	PTGS2
GO Molecular Function	GO:0005543	phospholipid binding	20	6.199769e-2	1.000000e+0	1.000000e+0	1.612963e+1	6.199769e-2	1	6.199769e-2	1.000000e+0	21	5.530932e-2	1.000000e+0	1.000000e+0	1.782708e+1	5.609445e-2	1	506	5.000000e-1	1.976285e-3	unnamed	PLA2G4A
GO Molecular Function	GO:0016788	hydrolase activity, acting on ester bonds	21	6.759571e-2	1.000000e+0	1.000000e+0	1.479384e+1	6.759571e-2	1	6.759571e-2	1.000000e+0	25	8.226776e-2	1.000000e+0	1.000000e+0	1.190040e+1	8.403082e-2	1	758	5.000000e-1	1.319261e-3	unnamed	PLA2G4A
GO Molecular Function	GO:0008289	lipid binding	22	8.303762e-2	1.000000e+0	1.000000e+0	1.204273e+1	8.303762e-2	1	8.303762e-2	1.000000e+0	5	1.749126e-3	1.000000e+0	1.000000e+0	2.389536e+1	8.369824e-2	2	755	1.000000e+0	2.649007e-3	unnamed	PLA2G4A,PTGS2
GO Molecular Function	GO:0005509	calcium ion binding	23	8.363577e-2	1.000000e+0	1.000000e+0	1.195661e+1	8.363577e-2	1	8.363577e-2	1.000000e+0	23	7.396518e-2	1.000000e+0	1.000000e+0	1.326544e+1	7.538385e-2	1	680	5.000000e-1	1.470588e-3	unnamed	PLA2G4A
GO Molecular Function	GO:0042802	identical protein binding	24	9.800114e-2	1.000000e+0	1.000000e+0	1.020396e+1	9.800114e-2	1	9.800114e-2	1.000000e+0	27	1.043301e-1	1.000000e+0	1.000000e+0	9.328335e+0	1.072003e-1	1	967	5.000000e-1	1.034126e-3	unnamed	PTGS2
GO Molecular Function	GO:0046983	protein dimerization activity	25	1.038803e-1	1.000000e+0	1.000000e+0	9.626466e+0	1.038803e-1	1	1.038803e-1	1.000000e+0	28	1.064273e-1	1.000000e+0	1.000000e+0	9.139311e+0	1.094174e-1	1	987	5.000000e-1	1.013171e-3	unnamed	PTGS2
GO Molecular Function	GO:0019899	enzyme binding	26	1.157271e-1	1.000000e+0	1.000000e+0	8.641016e+0	1.157271e-1	1	1.157271e-1	1.000000e+0	30	1.255021e-1	1.000000e+0	1.000000e+0	7.709829e+0	1.297046e-1	1	1170	5.000000e-1	8.547009e-4	unnamed	PTGS2
GO Molecular Function	GO:0016787	hydrolase activity	27	1.965374e-1	1.000000e+0	1.000000e+0	5.088091e+0	1.965374e-1	1	1.965374e-1	1.000000e+0	31	2.486583e-1	1.000000e+0	1.000000e+0	3.753849e+0	2.663932e-1	1	2403	5.000000e-1	4.161465e-4	unnamed	PLA2G4A
GO Molecular Function	GO:0043168	anion binding	28	2.579088e-1	1.000000e+0	1.000000e+0	3.877340e+0	2.579088e-1	1	2.579088e-1	1.000000e+0	32	2.792822e-1	1.000000e+0	1.000000e+0	3.310275e+0	3.020897e-1	1	2725	5.000000e-1	3.669725e-4	unnamed	PLA2G4A
GO Molecular Function	GO:0046872	metal ion binding	29	3.527991e-1	1.000000e+0	1.000000e+0	2.834474e+0	3.527991e-1	1	3.527991e-1	1.000000e+0	19	4.826814e-2	1.000000e+0	1.000000e+0	4.551211e+0	4.394435e-1	2	3964	1.000000e+0	5.045409e-4	unnamed	PLA2G4A,PTGS2
GO Molecular Function	GO:0043169	cation binding	30	3.606111e-1	1.000000e+0	1.000000e+0	2.773071e+0	3.606111e-1	1	3.606111e-1	1.000000e+0	20	4.988904e-2	1.000000e+0	1.000000e+0	4.476675e+0	4.467602e-1	2	4030	1.000000e+0	4.962779e-4	unnamed	PLA2G4A,PTGS2
GO Molecular Function	GO:1901363	heterocyclic compound binding	31	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	34	5.012582e-1	1.000000e+0	1.000000e+0	1.701981e+0	5.875506e-1	1	5300	5.000000e-1	1.886792e-4	unnamed	PTGS2
GO Molecular Function	GO:0097159	organic cyclic compound binding	32	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	35	5.069571e-1	1.000000e+0	1.000000e+0	1.678857e+0	5.956433e-1	1	5373	5.000000e-1	1.861158e-4	unnamed	PTGS2
GO Molecular Function	GO:0003824	catalytic activity	33	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	26	9.272591e-2	1.000000e+0	1.000000e+0	3.283764e+0	6.090571e-1	2	5494	1.000000e+0	3.640335e-4	unnamed	PLA2G4A,PTGS2
GO Molecular Function	GO:0043167	ion binding	34	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	29	1.118514e-1	1.000000e+0	1.000000e+0	2.989891e+0	6.689208e-1	2	6034	1.000000e+0	3.314551e-4	unnamed	PLA2G4A,PTGS2
GO Molecular Function	GO:0005515	protein binding	35	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	36	6.900633e-1	1.000000e+0	1.000000e+0	1.127985e+0	8.865362e-1	1	7997	5.000000e-1	1.250469e-4	unnamed	PTGS2
GO Molecular Function	GO:0005488	binding	36	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	33	4.553379e-1	1.000000e+0	1.000000e+0	1.481929e+0	1.349593e+0	2	12174	1.000000e+0	1.642845e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0090362	positive regulation of platelet-derived growth factor production	1	1.250564e-4	1.000000e+0	1.000000e+0	7.996393e+3	1.250564e-4	1	1.250564e-4	1.000000e+0	6	1.108586e-4	1.000000e+0	1.928940e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	PTGS2
GO Biological Process	GO:0035633	maintenance of blood-brain barrier	1	1.250564e-4	1.000000e+0	1.000000e+0	7.996393e+3	1.250564e-4	1	1.250564e-4	1.000000e+0	6	1.108586e-4	1.000000e+0	1.928940e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	PTGS2
GO Biological Process	GO:0090271	positive regulation of fibroblast growth factor production	1	1.250564e-4	1.000000e+0	1.000000e+0	7.996393e+3	1.250564e-4	1	1.250564e-4	1.000000e+0	6	1.108586e-4	1.000000e+0	1.928940e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	PTGS2
GO Biological Process	GO:0090361	regulation of platelet-derived growth factor production	4	1.354274e-4	1.000000e+0	3.534655e-1	7.384032e+3	1.354274e-4	1	1.354274e-4	1.000000e+0	10	2.217111e-4	1.000000e+0	2.314664e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	PTGS2
GO Biological Process	GO:0090336	positive regulation of brown fat cell differentiation	5	1.524026e-4	1.000000e+0	3.182166e-1	6.561569e+3	1.524026e-4	1	1.524026e-4	1.000000e+0	13	3.325574e-4	1.000000e+0	2.670692e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	PTGS2
GO Biological Process	GO:0032227	negative regulation of synaptic transmission, dopaminergic	6	1.855922e-4	1.000000e+0	3.229304e-1	5.388158e+3	1.855922e-4	1	1.855922e-4	1.000000e+0	10	2.217111e-4	1.000000e+0	2.314664e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	PTGS2
GO Biological Process	GO:0031915	positive regulation of synaptic plasticity	7	3.038165e-4	1.000000e+0	4.531206e-1	3.291461e+3	3.038165e-4	1	3.038165e-4	1.000000e+0	19	5.542315e-4	1.000000e+0	3.045356e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	PTGS2
GO Biological Process	GO:0009750	response to fructose stimulus	8	3.703323e-4	1.000000e+0	4.832837e-1	2.700278e+3	3.703323e-4	1	3.703323e-4	1.000000e+0	19	5.542315e-4	1.000000e+0	3.045356e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	PTGS2
GO Biological Process	GO:0006663	platelet activating factor biosynthetic process	9	5.245316e-4	1.000000e+0	6.084567e-1	1.906463e+3	5.245316e-4	1	5.245316e-4	1.000000e+0	15	4.433975e-4	1.000000e+0	3.086047e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	PLA2G4A
GO Biological Process	GO:0071318	cellular response to ATP	10	5.381486e-4	1.000000e+0	5.618271e-1	1.858223e+3	5.381486e-4	1	5.381486e-4	1.000000e+0	23	6.650594e-4	1.000000e+0	3.018791e-1	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	PTGS2
GO Biological Process	GO:0090270	regulation of fibroblast growth factor production	11	5.485122e-4	1.000000e+0	5.205879e-1	1.823113e+3	5.485122e-4	1	5.485122e-4	1.000000e+0	13	3.325574e-4	1.000000e+0	2.670692e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	PTGS2
GO Biological Process	GO:0046469	platelet activating factor metabolic process	12	5.923786e-4	1.000000e+0	5.153694e-1	1.688110e+3	5.923786e-4	1	5.923786e-4	1.000000e+0	19	5.542315e-4	1.000000e+0	3.045356e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	PLA2G4A
GO Biological Process	GO:0010042	response to manganese ion	13	6.173801e-4	1.000000e+0	4.958037e-1	1.619748e+3	6.173801e-4	1	6.173801e-4	1.000000e+0	29	8.866967e-4	1.000000e+0	3.192108e-1	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	PTGS2
GO Biological Process	GO:0019372	lipoxygenase pathway	14	7.275659e-4	1.000000e+0	5.425563e-1	1.374446e+3	7.275659e-4	1	7.275659e-4	1.000000e+0	35	1.329898e-3	1.000000e+0	3.966896e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	PTGS2
GO Biological Process	GO:0090050	positive regulation of cell migration involved in sprouting angiogenesis	15	7.357239e-4	1.000000e+0	5.120638e-1	1.359206e+3	7.357239e-4	1	7.357239e-4	1.000000e+0	23	6.650594e-4	1.000000e+0	3.018791e-1	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	PTGS2
GO Biological Process	GO:0035965	cardiolipin acyl-chain remodeling	16	7.572819e-4	1.000000e+0	4.941264e-1	1.320512e+3	7.572819e-4	1	7.572819e-4	1.000000e+0	27	7.758812e-4	1.000000e+0	3.000074e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	PLA2G4A
GO Biological Process	GO:0019371	cyclooxygenase pathway	17	8.781644e-4	1.000000e+0	5.392963e-1	1.138739e+3	8.781644e-4	1	8.781644e-4	1.000000e+0	39	1.440682e-3	1.000000e+0	3.856595e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	PTGS2
GO Biological Process	GO:0031394	positive regulation of prostaglandin biosynthetic process	18	9.017718e-4	1.000000e+0	5.230276e-1	1.108928e+3	9.017718e-4	1	9.017718e-4	1.000000e+0	19	5.542315e-4	1.000000e+0	3.045356e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	PTGS2
GO Biological Process	GO:0036149	phosphatidylinositol acyl-chain remodeling	19	9.022481e-4	1.000000e+0	4.957616e-1	1.108343e+3	9.022481e-4	1	9.022481e-4	1.000000e+0	45	1.773000e-3	1.000000e+0	4.113360e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	PLA2G4A
GO Biological Process	GO:0032048	cardiolipin metabolic process	20	9.352759e-4	1.000000e+0	4.882140e-1	1.069203e+3	9.352759e-4	1	9.352759e-4	1.000000e+0	35	1.329898e-3	1.000000e+0	3.966896e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	PLA2G4A
GO Biological Process	GO:0036148	phosphatidylglycerol acyl-chain remodeling	21	1.027223e-3	1.000000e+0	5.106766e-1	9.734983e+2	1.027223e-3	1	1.027223e-3	1.000000e+0	49	1.883760e-3	1.000000e+0	4.013562e-1	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	PLA2G4A
GO Biological Process	GO:0036150	phosphatidylserine acyl-chain remodeling	22	1.031335e-3	1.000000e+0	4.894153e-1	9.696172e+2	1.031335e-3	1	1.031335e-3	1.000000e+0	49	1.883760e-3	1.000000e+0	4.013562e-1	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	PLA2G4A
GO Biological Process	GO:0031392	regulation of prostaglandin biosynthetic process	23	1.032169e-3	1.000000e+0	4.685150e-1	9.688332e+2	1.032169e-3	1	1.032169e-3	1.000000e+0	23	6.650594e-4	1.000000e+0	3.018791e-1	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	PTGS2
GO Biological Process	GO:0031622	positive regulation of fever generation	24	1.097362e-3	1.000000e+0	4.773525e-1	9.112763e+2	1.097362e-3	1	1.097362e-3	1.000000e+0	27	7.758812e-4	1.000000e+0	3.000074e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	PTGS2
GO Biological Process	GO:0031652	positive regulation of heat generation	25	1.179118e-3	1.000000e+0	4.923997e-1	8.480919e+2	1.179118e-3	1	1.179118e-3	1.000000e+0	30	9.975062e-4	1.000000e+0	3.471322e-1	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	PTGS2
GO Biological Process	GO:0042640	anagen	26	1.300309e-3	1.000000e+0	5.221241e-1	7.690480e+2	1.300309e-3	1	1.300309e-3	1.000000e+0	32	1.219107e-3	1.000000e+0	3.977337e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	PTGS2
GO Biological Process	GO:0032225	regulation of synaptic transmission, dopaminergic	27	1.329654e-3	1.000000e+0	5.141329e-1	7.520756e+2	1.329654e-3	1	1.329654e-3	1.000000e+0	35	1.329898e-3	1.000000e+0	3.966896e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	PTGS2
GO Biological Process	GO:0036152	phosphatidylethanolamine acyl-chain remodeling	28	1.387906e-3	1.000000e+0	5.174907e-1	7.205098e+2	1.387906e-3	1	1.387906e-3	1.000000e+0	66	2.548193e-3	1.000000e+0	4.030778e-1	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	PLA2G4A
GO Biological Process	GO:0046697	decidualization	29	1.403718e-3	1.000000e+0	5.053385e-1	7.123939e+2	1.403718e-3	1	1.403718e-3	1.000000e+0	49	1.883760e-3	1.000000e+0	4.013562e-1	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	PTGS2
GO Biological Process	GO:0045723	positive regulation of fatty acid biosynthetic process	30	1.420555e-3	1.000000e+0	4.943531e-1	7.039502e+2	1.420555e-3	1	1.420555e-3	1.000000e+0	39	1.440682e-3	1.000000e+0	3.856595e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	PTGS2
GO Biological Process	GO:0001516	prostaglandin biosynthetic process	31	1.461491e-3	1.000000e+0	4.921925e-1	6.842326e+2	1.461491e-3	1	1.461491e-3	1.000000e+0	58	2.216004e-3	1.000000e+0	3.988807e-1	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	PTGS2
GO Biological Process	GO:0036151	phosphatidylcholine acyl-chain remodeling	32	1.465451e-3	1.000000e+0	4.781034e-1	6.823839e+2	1.465451e-3	1	1.465451e-3	1.000000e+0	72	2.769621e-3	1.000000e+0	4.015950e-1	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	PLA2G4A
GO Biological Process	GO:0071236	cellular response to antibiotic	33	1.487166e-3	1.000000e+0	4.704852e-1	6.724198e+2	1.487166e-3	1	1.487166e-3	1.000000e+0	32	1.219107e-3	1.000000e+0	3.977337e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	PLA2G4A
GO Biological Process	GO:0097237	cellular response to toxic substance	34	1.511826e-3	1.000000e+0	4.642195e-1	6.614518e+2	1.511826e-3	1	1.511826e-3	1.000000e+0	35	1.329898e-3	1.000000e+0	3.966896e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	PLA2G4A
GO Biological Process	GO:0071636	positive regulation of transforming growth factor beta production	35	1.533683e-3	1.000000e+0	4.574757e-1	6.520253e+2	1.533683e-3	1	1.533683e-3	1.000000e+0	32	1.219107e-3	1.000000e+0	3.977337e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	PTGS2
GO Biological Process	GO:0090049	regulation of cell migration involved in sprouting angiogenesis	36	1.582113e-3	1.000000e+0	4.588128e-1	6.320662e+2	1.582113e-3	1	1.582113e-3	1.000000e+0	42	1.551461e-3	1.000000e+0	3.856489e-1	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	PTGS2
GO Biological Process	GO:0006693	prostaglandin metabolic process	37	1.599916e-3	1.000000e+0	4.514358e-1	6.250327e+2	1.599916e-3	1	1.599916e-3	1.000000e+0	72	2.769621e-3	1.000000e+0	4.015950e-1	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	PTGS2
GO Biological Process	GO:0006658	phosphatidylserine metabolic process	38	1.747932e-3	1.000000e+0	4.802213e-1	5.721046e+2	1.747932e-3	1	1.747932e-3	1.000000e+0	72	2.769621e-3	1.000000e+0	4.015950e-1	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	PLA2G4A
GO Biological Process	GO:0050482	arachidonic acid secretion	39	1.797373e-3	1.000000e+0	4.811429e-1	5.563674e+2	1.797373e-3	1	1.797373e-3	1.000000e+0	42	1.551461e-3	1.000000e+0	3.856489e-1	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	PLA2G4A
GO Biological Process	GO:0031650	regulation of heat generation	40	1.801381e-3	1.000000e+0	4.701604e-1	5.551298e+2	1.801381e-3	1	1.801381e-3	1.000000e+0	31	1.108309e-3	1.000000e+0	3.732499e-1	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	PTGS2
GO Biological Process	GO:0033280	response to vitamin D	41	1.823402e-3	1.000000e+0	4.643004e-1	5.484254e+2	1.823402e-3	1	1.823402e-3	1.000000e+0	45	1.773000e-3	1.000000e+0	4.113360e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	PTGS2
GO Biological Process	GO:0046471	phosphatidylglycerol metabolic process	42	1.878382e-3	1.000000e+0	4.669121e-1	5.323732e+2	1.878382e-3	1	1.878382e-3	1.000000e+0	88	3.655089e-3	1.000000e+0	4.336265e-1	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	PLA2G4A
GO Biological Process	GO:0042346	positive regulation of NF-kappaB import into nucleus	43	1.904327e-3	1.000000e+0	4.623529e-1	5.251198e+2	1.904327e-3	1	1.904327e-3	1.000000e+0	69	2.658910e-3	1.000000e+0	4.023046e-1	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	PTGS2
GO Biological Process	GO:0009395	phospholipid catabolic process	44	1.937291e-3	1.000000e+0	4.596663e-1	5.161846e+2	1.937291e-3	1	1.937291e-3	1.000000e+0	64	2.437470e-3	1.000000e+0	3.976123e-1	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	PLA2G4A
GO Biological Process	GO:0071715	icosanoid transport	45	2.014283e-3	1.000000e+0	4.673137e-1	4.964547e+2	2.014283e-3	1	2.014283e-3	1.000000e+0	45	1.773000e-3	1.000000e+0	4.113360e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	PLA2G4A
GO Biological Process	GO:0033198	response to ATP	46	2.016336e-3	1.000000e+0	4.576206e-1	4.959492e+2	2.016336e-3	1	2.016336e-3	1.000000e+0	59	2.326740e-3	1.000000e+0	4.117147e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	PTGS2
GO Biological Process	GO:0048820	hair follicle maturation	47	2.044675e-3	1.000000e+0	4.541789e-1	4.890752e+2	2.044675e-3	1	2.044675e-3	1.000000e+0	44	1.662234e-3	1.000000e+0	3.944028e-1	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	PTGS2
GO Biological Process	GO:0045986	negative regulation of smooth muscle contraction	48	2.052219e-3	1.000000e+0	4.463576e-1	4.872774e+2	2.052219e-3	1	2.052219e-3	1.000000e+0	39	1.440682e-3	1.000000e+0	3.856595e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	PTGS2
GO Biological Process	GO:0051926	negative regulation of calcium ion transport	49	2.086493e-3	1.000000e+0	4.445508e-1	4.792731e+2	2.086493e-3	1	2.086493e-3	1.000000e+0	59	2.326740e-3	1.000000e+0	4.117147e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	PTGS2
GO Biological Process	GO:0030728	ovulation	50	2.202863e-3	1.000000e+0	4.599578e-1	4.539546e+2	2.202863e-3	1	2.202863e-3	1.000000e+0	49	1.883760e-3	1.000000e+0	4.013562e-1	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	PTGS2
GO Biological Process	GO:0045907	positive regulation of vasoconstriction	51	2.313065e-3	1.000000e+0	4.734980e-1	4.323267e+2	2.313065e-3	1	2.313065e-3	1.000000e+0	59	2.326740e-3	1.000000e+0	4.117147e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	PTGS2
GO Biological Process	GO:0071634	regulation of transforming growth factor beta production	52	2.404331e-3	1.000000e+0	4.827157e-1	4.159161e+2	2.404331e-3	1	2.404331e-3	1.000000e+0	49	1.883760e-3	1.000000e+0	4.013562e-1	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	PTGS2
GO Biological Process	GO:0002675	positive regulation of acute inflammatory response	53	2.544536e-3	1.000000e+0	5.012256e-1	3.929990e+2	2.544536e-3	1	2.544536e-3	1.000000e+0	59	2.326740e-3	1.000000e+0	4.117147e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	PTGS2
GO Biological Process	GO:0010226	response to lithium ion	54	2.621833e-3	1.000000e+0	5.068877e-1	3.814126e+2	2.621833e-3	1	2.621833e-3	1.000000e+0	69	2.658910e-3	1.000000e+0	4.023046e-1	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	PTGS2
GO Biological Process	GO:0052646	alditol phosphate metabolic process	55	2.654436e-3	1.000000e+0	5.038602e-1	3.767279e+2	2.654436e-3	1	2.654436e-3	1.000000e+0	84	3.433759e-3	1.000000e+0	4.267672e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	PLA2G4A
GO Biological Process	GO:0045932	negative regulation of muscle contraction	56	2.682041e-3	1.000000e+0	5.000091e-1	3.728504e+2	2.682041e-3	1	2.682041e-3	1.000000e+0	56	2.105263e-3	1.000000e+0	3.924812e-1	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	PTGS2
GO Biological Process	GO:0010575	positive regulation vascular endothelial growth factor production	57	2.691328e-3	1.000000e+0	4.929380e-1	3.715638e+2	2.691328e-3	1	2.691328e-3	1.000000e+0	56	2.105263e-3	1.000000e+0	3.924812e-1	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	PTGS2
GO Biological Process	GO:0042304	regulation of fatty acid biosynthetic process	58	2.759132e-3	1.000000e+0	4.966438e-1	3.624328e+2	2.759132e-3	1	2.759132e-3	1.000000e+0	79	3.212404e-3	1.000000e+0	4.245253e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	PTGS2
GO Biological Process	GO:0042993	positive regulation of transcription factor import into nucleus	59	2.816052e-3	1.000000e+0	4.982980e-1	3.551070e+2	2.816052e-3	1	2.816052e-3	1.000000e+0	93	4.097676e-3	1.000000e+0	4.599972e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	PTGS2
GO Biological Process	GO:0001893	maternal placenta development	60	2.845005e-3	1.000000e+0	4.950309e-1	3.514932e+2	2.845005e-3	1	2.845005e-3	1.000000e+0	75	2.880326e-3	1.000000e+0	4.009414e-1	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	PTGS2
GO Biological Process	GO:0050873	brown fat cell differentiation	61	3.049057e-3	1.000000e+0	5.218386e-1	3.279703e+2	3.049057e-3	1	3.049057e-3	1.000000e+0	81	3.323085e-3	1.000000e+0	4.283087e-1	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	PTGS2
GO Biological Process	GO:0006654	phosphatidic acid biosynthetic process	62	3.161019e-3	1.000000e+0	5.322748e-1	3.163537e+2	3.161019e-3	1	3.161019e-3	1.000000e+0	84	3.433759e-3	1.000000e+0	4.267672e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	PLA2G4A
GO Biological Process	GO:0010574	regulation of vascular endothelial growth factor production	63	3.192847e-3	1.000000e+0	5.291004e-1	3.132001e+2	3.192847e-3	1	3.192847e-3	1.000000e+0	66	2.548193e-3	1.000000e+0	4.030778e-1	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	PTGS2
GO Biological Process	GO:0045987	positive regulation of smooth muscle contraction	64	3.255893e-3	1.000000e+0	5.311175e-1	3.071354e+2	3.255893e-3	1	3.255893e-3	1.000000e+0	64	2.437470e-3	1.000000e+0	3.976123e-1	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	PTGS2
GO Biological Process	GO:0015909	long-chain fatty acid transport	65	3.284386e-3	1.000000e+0	5.275229e-1	3.044709e+2	3.284386e-3	1	3.284386e-3	1.000000e+0	93	4.097676e-3	1.000000e+0	4.599972e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	PLA2G4A
GO Biological Process	GO:0019369	arachidonic acid metabolic process	66	3.329049e-3	1.000000e+0	5.265950e-1	3.003860e+2	3.329049e-3	1	3.329049e-3	1.000000e+0	2	8.468024e-6	8.840617e-2	4.420309e-2	3.403962e+2	5.875506e-3	2	53	1.000000e+0	3.773585e-2	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0007566	embryo implantation	67	3.562812e-3	1.000000e+0	5.551606e-1	2.806772e+2	3.562812e-3	1	3.562812e-3	1.000000e+0	91	3.987038e-3	1.000000e+0	4.574140e-1	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	PTGS2
GO Biological Process	GO:0046717	acid secretion	68	3.608291e-3	1.000000e+0	5.539788e-1	2.771395e+2	3.608291e-3	1	3.608291e-3	1.000000e+0	77	3.101718e-3	1.000000e+0	4.205446e-1	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	PLA2G4A
GO Biological Process	GO:0042345	regulation of NF-kappaB import into nucleus	69	3.634144e-3	1.000000e+0	5.498618e-1	2.751679e+2	3.634144e-3	1	3.634144e-3	1.000000e+0	98	4.540164e-3	1.000000e+0	4.836665e-1	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	PTGS2
GO Biological Process	GO:0051968	positive regulation of synaptic transmission, glutamatergic	70	3.656181e-3	1.000000e+0	5.452933e-1	2.735094e+2	3.656181e-3	1	3.656181e-3	1.000000e+0	45	1.773000e-3	1.000000e+0	4.113360e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	PTGS2
GO Biological Process	GO:0045429	positive regulation of nitric oxide biosynthetic process	71	3.696598e-3	1.000000e+0	5.435561e-1	2.705190e+2	3.696598e-3	1	3.696598e-3	1.000000e+0	81	3.323085e-3	1.000000e+0	4.283087e-1	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	PTGS2
GO Biological Process	GO:0046456	icosanoid biosynthetic process	72	3.742760e-3	1.000000e+0	5.427002e-1	2.671825e+2	3.742760e-3	1	3.742760e-3	1.000000e+0	1	6.083704e-6	6.351387e-2	6.351387e-2	4.009111e+2	4.988637e-3	2	45	1.000000e+0	4.444444e-2	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0043536	positive regulation of blood vessel endothelial cell migration	73	3.774375e-3	1.000000e+0	5.397873e-1	2.649445e+2	3.774375e-3	1	3.774375e-3	1.000000e+0	59	2.326740e-3	1.000000e+0	4.117147e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	PTGS2
GO Biological Process	GO:0006636	unsaturated fatty acid biosynthetic process	74	3.848629e-3	1.000000e+0	5.429687e-1	2.598328e+2	3.848629e-3	1	3.848629e-3	1.000000e+0	111	5.867038e-3	1.000000e+0	5.518187e-1	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	PTGS2
GO Biological Process	GO:0045600	positive regulation of fat cell differentiation	75	3.900260e-3	1.000000e+0	5.429162e-1	2.563932e+2	3.900260e-3	1	3.900260e-3	1.000000e+0	88	3.655089e-3	1.000000e+0	4.336265e-1	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	PTGS2
GO Biological Process	GO:0045923	positive regulation of fatty acid metabolic process	76	3.972897e-3	1.000000e+0	5.457506e-1	2.517055e+2	3.972897e-3	1	3.972897e-3	1.000000e+0	76	2.991025e-3	1.000000e+0	4.108724e-1	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	PTGS2
GO Biological Process	GO:0034644	cellular response to UV	77	3.980578e-3	1.000000e+0	5.397043e-1	2.512198e+2	3.980578e-3	1	3.980578e-3	1.000000e+0	95	4.208307e-3	1.000000e+0	4.624708e-1	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	PTGS2
GO Biological Process	GO:0070542	response to fatty acid	78	4.103494e-3	1.000000e+0	5.492369e-1	2.436948e+2	4.103494e-3	1	4.103494e-3	1.000000e+0	101	4.650770e-3	1.000000e+0	4.807331e-1	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	PTGS2
GO Biological Process	GO:0046470	phosphatidylcholine metabolic process	79	4.278699e-3	1.000000e+0	5.654382e-1	2.337159e+2	4.278699e-3	1	4.278699e-3	1.000000e+0	116	6.640639e-3	1.000000e+0	5.976575e-1	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	PLA2G4A
GO Biological Process	GO:0045933	positive regulation of muscle contraction	80	4.330215e-3	1.000000e+0	5.650931e-1	2.309354e+2	4.330215e-3	1	4.330215e-3	1.000000e+0	81	3.323085e-3	1.000000e+0	4.283087e-1	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	PTGS2
GO Biological Process	GO:0015908	fatty acid transport	81	4.425742e-3	1.000000e+0	5.704290e-1	2.259508e+2	4.425742e-3	1	4.425742e-3	1.000000e+0	106	5.203711e-3	1.000000e+0	5.125164e-1	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	PLA2G4A
GO Biological Process	GO:0045428	regulation of nitric oxide biosynthetic process	82	4.487372e-3	1.000000e+0	5.713191e-1	2.228476e+2	4.487372e-3	1	4.487372e-3	1.000000e+0	101	4.650770e-3	1.000000e+0	4.807331e-1	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	PTGS2
GO Biological Process	GO:0046677	response to antibiotic	83	4.535799e-3	1.000000e+0	5.705270e-1	2.204683e+2	4.535799e-3	1	4.535799e-3	1.000000e+0	96	4.318932e-3	1.000000e+0	4.696839e-1	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	PLA2G4A
GO Biological Process	GO:0048661	positive regulation of smooth muscle cell proliferation	84	4.805238e-3	1.000000e+0	5.972224e-1	2.081062e+2	4.805238e-3	1	4.805238e-3	1.000000e+0	98	4.540164e-3	1.000000e+0	4.836665e-1	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	PTGS2
GO Biological Process	GO:0046889	positive regulation of lipid biosynthetic process	85	4.919144e-3	1.000000e+0	6.041866e-1	2.032874e+2	4.919144e-3	1	4.919144e-3	1.000000e+0	105	5.093135e-3	1.000000e+0	5.064031e-1	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	PTGS2
GO Biological Process	GO:0050805	negative regulation of synaptic transmission	86	4.948800e-3	1.000000e+0	6.007613e-1	2.020692e+2	4.948800e-3	1	4.948800e-3	1.000000e+0	79	3.212404e-3	1.000000e+0	4.245253e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	PTGS2
GO Biological Process	GO:0030282	bone mineralization	87	5.100484e-3	1.000000e+0	6.120581e-1	1.960598e+2	5.100484e-3	1	5.100484e-3	1.000000e+0	91	3.987038e-3	1.000000e+0	4.574140e-1	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	PTGS2
GO Biological Process	GO:0071695	anatomical structure maturation	88	5.299460e-3	1.000000e+0	6.287087e-1	1.886985e+2	5.299460e-3	1	5.299460e-3	1.000000e+0	104	4.982553e-3	1.000000e+0	5.001717e-1	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	PTGS2
GO Biological Process	GO:0002673	regulation of acute inflammatory response	89	5.366371e-3	1.000000e+0	6.294934e-1	1.863457e+2	5.366371e-3	1	5.366371e-3	1.000000e+0	116	6.640639e-3	1.000000e+0	5.976575e-1	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	PTGS2
GO Biological Process	GO:0051970	negative regulation of transmission of nerve impulse	90	5.455312e-3	1.000000e+0	6.328162e-1	1.833076e+2	5.455312e-3	1	5.455312e-3	1.000000e+0	88	3.655089e-3	1.000000e+0	4.336265e-1	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	PTGS2
GO Biological Process	GO:0006690	icosanoid metabolic process	91	5.508572e-3	1.000000e+0	6.319724e-1	1.815352e+2	5.508572e-3	1	5.508572e-3	1.000000e+0	3	1.941869e-5	2.027311e-1	6.757704e-2	2.255125e+2	8.868688e-3	2	80	1.000000e+0	2.500000e-2	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0043535	regulation of blood vessel endothelial cell migration	92	5.635547e-3	1.000000e+0	6.395121e-1	1.774451e+2	5.635547e-3	1	5.635547e-3	1.000000e+0	98	4.540164e-3	1.000000e+0	4.836665e-1	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	PTGS2
GO Biological Process	GO:0071260	cellular response to mechanical stimulus	93	5.639954e-3	1.000000e+0	6.331303e-1	1.773064e+2	5.639954e-3	1	5.639954e-3	1.000000e+0	113	6.198618e-3	1.000000e+0	5.726865e-1	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	PTGS2
GO Biological Process	GO:0060135	maternal process involved in female pregnancy	94	5.814320e-3	1.000000e+0	6.457606e-1	1.719892e+2	5.814320e-3	1	5.814320e-3	1.000000e+0	106	5.203711e-3	1.000000e+0	5.125164e-1	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	PTGS2
GO Biological Process	GO:0001676	long-chain fatty acid metabolic process	95	5.861454e-3	1.000000e+0	6.441429e-1	1.706061e+2	5.861454e-3	1	5.861454e-3	1.000000e+0	4	2.091196e-5	2.183209e-1	5.458022e-2	2.173614e+2	9.201264e-3	2	83	1.000000e+0	2.409639e-2	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0031645	negative regulation of neurological system process	96	6.073322e-3	1.000000e+0	6.604738e-1	1.646545e+2	6.073322e-3	1	6.073322e-3	1.000000e+0	97	4.429551e-3	1.000000e+0	4.767476e-1	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	PTGS2
GO Biological Process	GO:0042990	regulation of transcription factor import into nucleus	97	6.117862e-3	1.000000e+0	6.584585e-1	1.634558e+2	6.117862e-3	1	6.117862e-3	1.000000e+0	129	8.297342e-3	1.000000e+0	6.715058e-1	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	PTGS2
GO Biological Process	GO:0042439	ethanolamine-containing compound metabolic process	98	6.164129e-3	1.000000e+0	6.566684e-1	1.622289e+2	6.164129e-3	1	6.164129e-3	1.000000e+0	134	8.738896e-3	1.000000e+0	6.808513e-1	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	PLA2G4A
GO Biological Process	GO:0033559	unsaturated fatty acid metabolic process	99	6.219924e-3	1.000000e+0	6.559193e-1	1.607737e+2	6.219924e-3	1	6.219924e-3	1.000000e+0	5	2.572362e-5	2.685546e-1	5.371092e-2	1.960978e+2	1.019899e-2	2	92	1.000000e+0	2.173913e-2	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0006940	regulation of smooth muscle contraction	100	6.611384e-3	1.000000e+0	6.902285e-1	1.512543e+2	6.611384e-3	1	6.611384e-3	1.000000e+0	106	5.203711e-3	1.000000e+0	5.125164e-1	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	PTGS2
GO Biological Process	GO:0051966	regulation of synaptic transmission, glutamatergic	101	6.769607e-3	1.000000e+0	6.997495e-1	1.477191e+2	6.769607e-3	1	6.769607e-3	1.000000e+0	84	3.433759e-3	1.000000e+0	4.267672e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	PTGS2
GO Biological Process	GO:0019229	regulation of vasoconstriction	102	6.910433e-3	1.000000e+0	7.073031e-1	1.447087e+2	6.910433e-3	1	6.910433e-3	1.000000e+0	110	5.314281e-3	1.000000e+0	5.043736e-1	1.879271e+2	5.321213e-3	1	48	5.000000e-1	2.083333e-2	unnamed	PTGS2
GO Biological Process	GO:0019217	regulation of fatty acid metabolic process	103	7.371381e-3	1.000000e+0	7.471575e-1	1.356598e+2	7.371381e-3	1	7.371381e-3	1.000000e+0	125	7.745261e-3	1.000000e+0	6.468842e-1	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	PTGS2
GO Biological Process	GO:0071482	cellular response to light stimulus	104	7.391235e-3	1.000000e+0	7.419663e-1	1.352954e+2	7.391235e-3	1	7.391235e-3	1.000000e+0	133	8.628517e-3	1.000000e+0	6.773061e-1	1.156474e+2	8.646971e-3	1	78	5.000000e-1	1.282051e-2	unnamed	PTGS2
GO Biological Process	GO:0033273	response to vitamin	105	7.728759e-3	1.000000e+0	7.684595e-1	1.293869e+2	7.728759e-3	1	7.728759e-3	1.000000e+0	115	6.530143e-3	1.000000e+0	5.928234e-1	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	PTGS2
GO Biological Process	GO:0071456	cellular response to hypoxia	106	7.759905e-3	1.000000e+0	7.642774e-1	1.288675e+2	7.759905e-3	1	7.759905e-3	1.000000e+0	138	9.511379e-3	1.000000e+0	7.195565e-1	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	PTGS2
GO Biological Process	GO:0031214	biomineral tissue development	107	7.851129e-3	1.000000e+0	7.660354e-1	1.273702e+2	7.851129e-3	1	7.851129e-3	1.000000e+0	123	7.303486e-3	1.000000e+0	6.199056e-1	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	PTGS2
GO Biological Process	GO:0036294	cellular response to decreased oxygen levels	108	7.906320e-3	1.000000e+0	7.642776e-1	1.264811e+2	7.906320e-3	1	7.906320e-3	1.000000e+0	139	9.621709e-3	1.000000e+0	7.226665e-1	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	PTGS2
GO Biological Process	GO:0032846	positive regulation of homeostatic process	109	7.943270e-3	1.000000e+0	7.608049e-1	1.258927e+2	7.943270e-3	1	7.943270e-3	1.000000e+0	119	6.861613e-3	1.000000e+0	6.019768e-1	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	PTGS2
GO Biological Process	GO:0050729	positive regulation of inflammatory response	110	7.955556e-3	1.000000e+0	7.550546e-1	1.256983e+2	7.955556e-3	1	7.955556e-3	1.000000e+0	128	8.076528e-3	1.000000e+0	6.587418e-1	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	PTGS2
GO Biological Process	GO:0043271	negative regulation of ion transport	111	8.119842e-3	1.000000e+0	7.637041e-1	1.231551e+2	8.119842e-3	1	8.119842e-3	1.000000e+0	118	6.751129e-3	1.000000e+0	5.973033e-1	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	PTGS2
GO Biological Process	GO:0015718	monocarboxylic acid transport	112	8.433010e-3	1.000000e+0	7.860770e-1	1.185816e+2	8.433010e-3	1	8.433010e-3	1.000000e+0	140	9.732033e-3	1.000000e+0	7.257316e-1	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	PLA2G4A
GO Biological Process	GO:0042307	positive regulation of protein import into nucleus	113	8.564936e-3	1.000000e+0	7.913091e-1	1.167551e+2	8.564936e-3	1	8.564936e-3	1.000000e+0	126	7.855690e-3	1.000000e+0	6.509000e-1	1.270493e+2	7.870961e-3	1	71	5.000000e-1	1.408451e-2	unnamed	PTGS2
GO Biological Process	GO:0046165	alcohol biosynthetic process	114	8.603659e-3	1.000000e+0	7.879140e-1	1.162296e+2	8.603659e-3	1	8.603659e-3	1.000000e+0	151	1.127592e-2	1.000000e+0	7.796067e-1	8.843627e+1	1.130758e-2	1	102	5.000000e-1	9.803922e-3	unnamed	PLA2G4A
GO Biological Process	GO:0050806	positive regulation of synaptic transmission	115	8.645036e-3	1.000000e+0	7.848189e-1	1.156733e+2	8.645036e-3	1	8.645036e-3	1.000000e+0	112	5.977571e-3	1.000000e+0	5.571950e-1	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	PTGS2
GO Biological Process	GO:0071453	cellular response to oxygen levels	116	8.912916e-3	1.000000e+0	8.021624e-1	1.121967e+2	8.912916e-3	1	8.912916e-3	1.000000e+0	144	1.039385e-2	1.000000e+0	7.535541e-1	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	PTGS2
GO Biological Process	GO:0051971	positive regulation of transmission of nerve impulse	117	8.938266e-3	1.000000e+0	7.975684e-1	1.118785e+2	8.938266e-3	1	8.938266e-3	1.000000e+0	114	6.309133e-3	1.000000e+0	5.777838e-1	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	PTGS2
GO Biological Process	GO:0019233	sensory perception of pain	118	8.954777e-3	1.000000e+0	7.922701e-1	1.116722e+2	8.954777e-3	1	8.954777e-3	1.000000e+0	119	6.861613e-3	1.000000e+0	6.019768e-1	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	PTGS2
GO Biological Process	GO:0034612	response to tumor necrosis factor	119	9.003188e-3	1.000000e+0	7.898595e-1	1.110718e+2	9.003188e-3	1	9.003188e-3	1.000000e+0	145	1.061440e-2	1.000000e+0	7.642368e-1	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	PTGS2
GO Biological Process	GO:0010595	positive regulation of endothelial cell migration	120	9.047773e-3	1.000000e+0	7.871563e-1	1.105244e+2	9.047773e-3	1	9.047773e-3	1.000000e+0	106	5.203711e-3	1.000000e+0	5.125164e-1	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	PTGS2
GO Biological Process	GO:0048660	regulation of smooth muscle cell proliferation	121	9.235438e-3	1.000000e+0	7.968427e-1	1.082786e+2	9.235438e-3	1	9.235438e-3	1.000000e+0	124	7.524386e-3	1.000000e+0	6.335048e-1	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	PTGS2
GO Biological Process	GO:0006633	fatty acid biosynthetic process	122	9.579437e-3	1.000000e+0	8.197485e-1	1.043903e+2	9.579437e-3	1	9.579437e-3	1.000000e+0	158	1.237796e-2	1.000000e+0	8.178855e-1	8.054018e+1	1.241616e-2	1	112	5.000000e-1	8.928571e-3	unnamed	PTGS2
GO Biological Process	GO:0006576	cellular biogenic amine metabolic process	123	9.594717e-3	1.000000e+0	8.143809e-1	1.042240e+2	9.594717e-3	1	9.594717e-3	1.000000e+0	163	1.336928e-2	1.000000e+0	8.562901e-1	7.454959e+1	1.341389e-2	1	121	5.000000e-1	8.264463e-3	unnamed	PLA2G4A
GO Biological Process	GO:0001816	cytokine production	124	9.726380e-3	1.000000e+0	8.188984e-1	1.028132e+2	9.726380e-3	1	9.726380e-3	1.000000e+0	147	1.083493e-2	1.000000e+0	7.695012e-1	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	PTGS2
GO Biological Process	GO:0007292	female gamete generation	125	9.763386e-3	1.000000e+0	8.154380e-1	1.024235e+2	9.763386e-3	1	9.763386e-3	1.000000e+0	140	9.732033e-3	1.000000e+0	7.257316e-1	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	PTGS2
GO Biological Process	GO:0009411	response to UV	126	9.876412e-3	1.000000e+0	8.183313e-1	1.012513e+2	9.876412e-3	1	9.876412e-3	1.000000e+0	156	1.193722e-2	1.000000e+0	7.988755e-1	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	PTGS2
GO Biological Process	GO:0009308	amine metabolic process	127	9.927184e-3	1.000000e+0	8.160614e-1	1.007335e+2	9.927184e-3	1	9.927184e-3	1.000000e+0	168	1.436009e-2	1.000000e+0	8.923770e-1	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	PLA2G4A
GO Biological Process	GO:0046824	positive regulation of nucleocytoplasmic transport	128	9.948065e-3	1.000000e+0	8.113891e-1	1.005221e+2	9.948065e-3	1	9.948065e-3	1.000000e+0	137	9.401043e-3	1.000000e+0	7.164006e-1	1.061235e+2	9.422981e-3	1	85	5.000000e-1	1.176471e-2	unnamed	PTGS2
GO Biological Process	GO:0045766	positive regulation of angiogenesis	129	1.005308e-2	1.000000e+0	8.135981e-1	9.947197e+1	1.005308e-2	1	1.005308e-2	1.000000e+0	143	1.017327e-2	1.000000e+0	7.427199e-1	9.804891e+1	1.019899e-2	1	92	5.000000e-1	1.086957e-2	unnamed	PTGS2
GO Biological Process	GO:0031646	positive regulation of neurological system process	130	1.005679e-2	1.000000e+0	8.076376e-1	9.943532e+1	1.005679e-2	1	1.005679e-2	1.000000e+0	121	6.972090e-3	1.000000e+0	6.015588e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	PTGS2
GO Biological Process	GO:0044242	cellular lipid catabolic process	131	1.025236e-2	1.000000e+0	8.170583e-1	9.753854e+1	1.025236e-2	1	1.025236e-2	1.000000e+0	165	1.380970e-2	1.000000e+0	8.737774e-1	7.216400e+1	1.385732e-2	1	125	5.000000e-1	8.000000e-3	unnamed	PLA2G4A
GO Biological Process	GO:0046683	response to organophosphorus	132	1.030301e-2	1.000000e+0	8.148744e-1	9.705900e+1	1.030301e-2	1	1.030301e-2	1.000000e+0	153	1.149638e-2	1.000000e+0	7.844589e-1	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	PTGS2
GO Biological Process	GO:0032355	response to estradiol stimulus	133	1.035433e-2	1.000000e+0	8.127760e-1	9.657796e+1	1.035433e-2	1	1.035433e-2	1.000000e+0	131	8.518131e-3	1.000000e+0	6.788495e-1	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	PTGS2
GO Biological Process	GO:0046488	phosphatidylinositol metabolic process	134	1.046233e-2	1.000000e+0	8.151248e-1	9.558100e+1	1.046233e-2	1	1.046233e-2	1.000000e+0	167	1.425002e-2	1.000000e+0	8.908396e-1	6.992636e+1	1.430076e-2	1	129	5.000000e-1	7.751938e-3	unnamed	PLA2G4A
GO Biological Process	GO:0045598	regulation of fat cell differentiation	135	1.077995e-2	1.000000e+0	8.336495e-1	9.276480e+1	1.077995e-2	1	1.077995e-2	1.000000e+0	127	7.966112e-3	1.000000e+0	6.548520e-1	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	PTGS2
GO Biological Process	GO:0045834	positive regulation of lipid metabolic process	136	1.124900e-2	1.000000e+0	8.635262e-1	8.889678e+1	1.124900e-2	1	1.124900e-2	1.000000e+0	150	1.094519e-2	1.000000e+0	7.617852e-1	9.111616e+1	1.097500e-2	1	99	5.000000e-1	1.010101e-2	unnamed	PTGS2
GO Biological Process	GO:0014074	response to purine-containing compound	137	1.141315e-2	1.000000e+0	8.697320e-1	8.761825e+1	1.141315e-2	1	1.141315e-2	1.000000e+0	162	1.292876e-2	1.000000e+0	8.331868e-1	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	PTGS2
GO Biological Process	GO:0046890	regulation of lipid biosynthetic process	138	1.142551e-2	1.000000e+0	8.643647e-1	8.752346e+1	1.142551e-2	1	1.142551e-2	1.000000e+0	155	1.160660e-2	1.000000e+0	7.817607e-1	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	PTGS2
GO Biological Process	GO:0009746	response to hexose stimulus	139	1.156889e-2	1.000000e+0	8.689152e-1	8.643871e+1	1.156889e-2	1	1.156889e-2	1.000000e+0	153	1.149638e-2	1.000000e+0	7.844589e-1	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	PTGS2
GO Biological Process	GO:0007613	memory	140	1.161419e-2	1.000000e+0	8.660867e-1	8.610158e+1	1.161419e-2	1	1.161419e-2	1.000000e+0	129	8.297342e-3	1.000000e+0	6.715058e-1	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	PTGS2
GO Biological Process	GO:0009636	response to toxic substance	141	1.165947e-2	1.000000e+0	8.632969e-1	8.576717e+1	1.165947e-2	1	1.165947e-2	1.000000e+0	169	1.458020e-2	1.000000e+0	9.006940e-1	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	PLA2G4A
GO Biological Process	GO:0001942	hair follicle development	142	1.168927e-2	1.000000e+0	8.594083e-1	8.554853e+1	1.168927e-2	1	1.168927e-2	1.000000e+0	131	8.518131e-3	1.000000e+0	6.788495e-1	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	PTGS2
GO Biological Process	GO:0042633	hair cycle	143	1.186122e-2	1.000000e+0	8.659520e-1	8.430837e+1	1.186122e-2	1	1.186122e-2	1.000000e+0	136	8.959636e-3	1.000000e+0	6.877838e-1	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	PTGS2
GO Biological Process	GO:0034284	response to monosaccharide stimulus	144	1.200441e-2	1.000000e+0	8.703197e-1	8.330272e+1	1.200441e-2	1	1.200441e-2	1.000000e+0	156	1.193722e-2	1.000000e+0	7.988755e-1	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	PTGS2
GO Biological Process	GO:0071478	cellular response to radiation	145	1.210647e-2	1.000000e+0	8.716658e-1	8.260045e+1	1.210647e-2	1	1.210647e-2	1.000000e+0	161	1.281861e-2	1.000000e+0	8.312192e-1	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	PTGS2
GO Biological Process	GO:0010634	positive regulation of epithelial cell migration	146	1.253016e-2	1.000000e+0	8.959923e-1	7.980744e+1	1.253016e-2	1	1.253016e-2	1.000000e+0	122	7.193027e-3	1.000000e+0	6.155344e-1	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	PTGS2
GO Biological Process	GO:0090316	positive regulation of intracellular protein transport	147	1.278808e-2	1.000000e+0	9.082147e-1	7.819781e+1	1.278808e-2	1	1.278808e-2	1.000000e+0	158	1.237796e-2	1.000000e+0	8.178855e-1	8.054018e+1	1.241616e-2	1	112	5.000000e-1	8.928571e-3	unnamed	PTGS2
GO Biological Process	GO:0048167	regulation of synaptic plasticity	148	1.286865e-2	1.000000e+0	9.077615e-1	7.770822e+1	1.286865e-2	1	1.286865e-2	1.000000e+0	147	1.083493e-2	1.000000e+0	7.695012e-1	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	PTGS2
GO Biological Process	GO:0045444	fat cell differentiation	149	1.330619e-2	1.000000e+0	9.323263e-1	7.515298e+1	1.330619e-2	1	1.330619e-2	1.000000e+0	142	9.952663e-3	1.000000e+0	7.317310e-1	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	PTGS2
GO Biological Process	GO:0051384	response to glucocorticoid stimulus	150	1.330693e-2	1.000000e+0	9.261623e-1	7.514884e+1	1.330693e-2	1	1.330693e-2	1.000000e+0	160	1.259830e-2	1.000000e+0	8.220391e-1	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	PTGS2
GO Biological Process	GO:1901617	organic hydroxy compound biosynthetic process	151	1.407648e-2	1.000000e+0	9.732348e-1	7.104051e+1	1.407648e-2	1	1.407648e-2	1.000000e+0	174	1.546041e-2	1.000000e+0	9.276246e-1	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	PLA2G4A
GO Biological Process	GO:0009743	response to carbohydrate stimulus	152	1.420967e-2	1.000000e+0	9.759800e-1	7.037461e+1	1.420967e-2	1	1.420967e-2	1.000000e+0	166	1.391979e-2	1.000000e+0	8.754374e-1	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	PTGS2
GO Biological Process	GO:0031960	response to corticosteroid stimulus	153	1.421704e-2	1.000000e+0	9.701039e-1	7.033815e+1	1.421704e-2	1	1.421704e-2	1.000000e+0	163	1.336928e-2	1.000000e+0	8.562901e-1	7.454959e+1	1.341389e-2	1	121	5.000000e-1	8.264463e-3	unnamed	PTGS2
GO Biological Process	GO:0010594	regulation of endothelial cell migration	154	1.424670e-2	1.000000e+0	9.658152e-1	7.019169e+1	1.424670e-2	1	1.424670e-2	1.000000e+0	135	8.849269e-3	1.000000e+0	6.843435e-1	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	PTGS2
GO Biological Process	GO:0007612	learning	155	1.446113e-2	1.000000e+0	9.740271e-1	6.915089e+1	1.446113e-2	1	1.446113e-2	1.000000e+0	147	1.083493e-2	1.000000e+0	7.695012e-1	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	PTGS2
GO Biological Process	GO:0072330	monocarboxylic acid biosynthetic process	156	1.463305e-2	1.000000e+0	9.792887e-1	6.833847e+1	1.463305e-2	1	1.463305e-2	1.000000e+0	186	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	PTGS2
GO Biological Process	GO:0001890	placenta development	157	1.531248e-2	1.000000e+0	1.000000e+0	6.530620e+1	1.531248e-2	1	1.531248e-2	1.000000e+0	173	1.513038e-2	1.000000e+0	9.130703e-1	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	PTGS2
GO Biological Process	GO:0006575	cellular modified amino acid metabolic process	158	1.535626e-2	1.000000e+0	1.000000e+0	6.512003e+1	1.535626e-2	1	1.535626e-2	1.000000e+0	196	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	PLA2G4A
GO Biological Process	GO:0007584	response to nutrient	159	1.535652e-2	1.000000e+0	1.000000e+0	6.511893e+1	1.535652e-2	1	1.535652e-2	1.000000e+0	170	1.469025e-2	1.000000e+0	9.021542e-1	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	PTGS2
GO Biological Process	GO:0010565	regulation of cellular ketone metabolic process	160	1.559418e-2	1.000000e+0	1.000000e+0	6.412651e+1	1.559418e-2	1	1.559418e-2	1.000000e+0	184	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	PTGS2
GO Biological Process	GO:0042306	regulation of protein import into nucleus	161	1.575768e-2	1.000000e+0	1.000000e+0	6.346113e+1	1.575768e-2	1	1.575768e-2	1.000000e+0	174	1.546041e-2	1.000000e+0	9.276246e-1	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	PTGS2
GO Biological Process	GO:0046474	glycerophospholipid biosynthetic process	162	1.596888e-2	1.000000e+0	1.000000e+0	6.262179e+1	1.596888e-2	1	1.596888e-2	1.000000e+0	195	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	PLA2G4A
GO Biological Process	GO:1900180	regulation of protein localization to nucleus	163	1.609175e-2	1.000000e+0	1.000000e+0	6.214366e+1	1.609175e-2	1	1.609175e-2	1.000000e+0	177	1.590037e-2	1.000000e+0	9.378523e-1	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	PTGS2
GO Biological Process	GO:0032388	positive regulation of intracellular transport	164	1.641483e-2	1.000000e+0	1.000000e+0	6.092053e+1	1.641483e-2	1	1.641483e-2	1.000000e+0	182	1.743944e-2	1.000000e+0	1.000000e+0	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	PTGS2
GO Biological Process	GO:0071496	cellular response to external stimulus	165	1.655194e-2	1.000000e+0	1.000000e+0	6.041588e+1	1.655194e-2	1	1.655194e-2	1.000000e+0	192	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	PTGS2
GO Biological Process	GO:0006869	lipid transport	166	1.655307e-2	1.000000e+0	1.000000e+0	6.041176e+1	1.655307e-2	1	1.655307e-2	1.000000e+0	191	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	PLA2G4A
GO Biological Process	GO:0016042	lipid catabolic process	167	1.659167e-2	1.000000e+0	1.000000e+0	6.027120e+1	1.659167e-2	1	1.659167e-2	1.000000e+0	217	2.445986e-2	1.000000e+0	1.000000e+0	4.063288e+1	2.461061e-2	1	222	5.000000e-1	4.504505e-3	unnamed	PLA2G4A
GO Biological Process	GO:0043627	response to estrogen stimulus	168	1.670796e-2	1.000000e+0	1.000000e+0	5.985171e+1	1.670796e-2	1	1.670796e-2	1.000000e+0	172	1.491033e-2	1.000000e+0	9.050224e-1	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	PTGS2
GO Biological Process	GO:0007565	female pregnancy	169	1.682907e-2	1.000000e+0	1.000000e+0	5.942101e+1	1.682907e-2	1	1.682907e-2	1.000000e+0	180	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	PTGS2
GO Biological Process	GO:0051924	regulation of calcium ion transport	170	1.698978e-2	1.000000e+0	1.000000e+0	5.885891e+1	1.698978e-2	1	1.698978e-2	1.000000e+0	178	1.612031e-2	1.000000e+0	9.454834e-1	6.178425e+1	1.618536e-2	1	146	5.000000e-1	6.849315e-3	unnamed	PTGS2
GO Biological Process	GO:0043122	regulation of I-kappaB kinase/NF-kappaB cascade	171	1.716352e-2	1.000000e+0	1.000000e+0	5.826311e+1	1.716352e-2	1	1.716352e-2	1.000000e+0	206	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	PTGS2
GO Biological Process	GO:0008654	phospholipid biosynthetic process	172	1.725729e-2	1.000000e+0	1.000000e+0	5.794653e+1	1.725729e-2	1	1.725729e-2	1.000000e+0	209	2.292630e-2	1.000000e+0	1.000000e+0	4.336779e+1	2.305859e-2	1	208	5.000000e-1	4.807692e-3	unnamed	PLA2G4A
GO Biological Process	GO:0010876	lipid localization	173	1.764264e-2	1.000000e+0	1.000000e+0	5.668085e+1	1.764264e-2	1	1.764264e-2	1.000000e+0	201	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PLA2G4A
GO Biological Process	GO:0009612	response to mechanical stimulus	174	1.774157e-2	1.000000e+0	1.000000e+0	5.636480e+1	1.774157e-2	1	1.774157e-2	1.000000e+0	176	1.579039e-2	1.000000e+0	9.366572e-1	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	PTGS2
GO Biological Process	GO:0045017	glycerolipid biosynthetic process	175	1.798737e-2	1.000000e+0	1.000000e+0	5.559457e+1	1.798737e-2	1	1.798737e-2	1.000000e+0	211	2.314545e-2	1.000000e+0	1.000000e+0	4.295476e+1	2.328031e-2	1	210	5.000000e-1	4.761905e-3	unnamed	PLA2G4A
GO Biological Process	GO:0008217	regulation of blood pressure	176	1.837522e-2	1.000000e+0	1.000000e+0	5.442112e+1	1.837522e-2	1	1.837522e-2	1.000000e+0	179	1.699983e-2	1.000000e+0	9.914985e-1	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	PTGS2
GO Biological Process	GO:0010632	regulation of epithelial cell migration	177	1.863232e-2	1.000000e+0	1.000000e+0	5.367019e+1	1.863232e-2	1	1.863232e-2	1.000000e+0	152	1.138616e-2	1.000000e+0	7.820494e-1	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	PTGS2
GO Biological Process	GO:0006937	regulation of muscle contraction	178	1.867020e-2	1.000000e+0	1.000000e+0	5.356128e+1	1.867020e-2	1	1.867020e-2	1.000000e+0	170	1.469025e-2	1.000000e+0	9.021542e-1	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	PTGS2
GO Biological Process	GO:0045765	regulation of angiogenesis	179	1.889313e-2	1.000000e+0	1.000000e+0	5.292928e+1	1.889313e-2	1	1.889313e-2	1.000000e+0	186	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	PTGS2
GO Biological Process	GO:0006650	glycerophospholipid metabolic process	180	1.897883e-2	1.000000e+0	1.000000e+0	5.269028e+1	1.897883e-2	1	1.897883e-2	1.000000e+0	220	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	PLA2G4A
GO Biological Process	GO:0046942	carboxylic acid transport	181	1.899186e-2	1.000000e+0	1.000000e+0	5.265415e+1	1.899186e-2	1	1.899186e-2	1.000000e+0	207	2.248791e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	PLA2G4A
GO Biological Process	GO:0071214	cellular response to abiotic stimulus	182	1.933309e-2	1.000000e+0	1.000000e+0	5.172478e+1	1.933309e-2	1	1.933309e-2	1.000000e+0	203	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PTGS2
GO Biological Process	GO:0032103	positive regulation of response to external stimulus	183	1.935916e-2	1.000000e+0	1.000000e+0	5.165514e+1	1.935916e-2	1	1.935916e-2	1.000000e+0	182	1.743944e-2	1.000000e+0	1.000000e+0	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	PTGS2
GO Biological Process	GO:0050727	regulation of inflammatory response	184	1.980554e-2	1.000000e+0	1.000000e+0	5.049091e+1	1.980554e-2	1	1.980554e-2	1.000000e+0	212	2.336458e-2	1.000000e+0	1.000000e+0	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	PTGS2
GO Biological Process	GO:0046822	regulation of nucleocytoplasmic transport	185	1.990459e-2	1.000000e+0	1.000000e+0	5.023968e+1	1.990459e-2	1	1.990459e-2	1.000000e+0	189	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	PTGS2
GO Biological Process	GO:0021700	developmental maturation	186	2.000053e-2	1.000000e+0	1.000000e+0	4.999869e+1	2.000053e-2	1	2.000053e-2	1.000000e+0	190	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	PTGS2
GO Biological Process	GO:0051222	positive regulation of protein transport	187	2.010013e-2	1.000000e+0	1.000000e+0	4.975093e+1	2.010013e-2	1	2.010013e-2	1.000000e+0	199	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PTGS2
GO Biological Process	GO:0030168	platelet activation	188	2.162078e-2	1.000000e+0	1.000000e+0	4.625181e+1	2.162078e-2	1	2.162078e-2	1.000000e+0	214	2.358369e-2	1.000000e+0	1.000000e+0	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	PLA2G4A
GO Biological Process	GO:0001819	positive regulation of cytokine production	189	2.182804e-2	1.000000e+0	1.000000e+0	4.581263e+1	2.182804e-2	1	2.182804e-2	1.000000e+0	232	2.730472e-2	1.000000e+0	1.000000e+0	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	PTGS2
GO Biological Process	GO:0044703	multi-organism reproductive process	190	2.193353e-2	1.000000e+0	1.000000e+0	4.559230e+1	2.193353e-2	1	2.193353e-2	1.000000e+0	203	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PTGS2
GO Biological Process	GO:1901342	regulation of vasculature development	191	2.200511e-2	1.000000e+0	1.000000e+0	4.544399e+1	2.200511e-2	1	2.200511e-2	1.000000e+0	192	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	PTGS2
GO Biological Process	GO:0010038	response to metal ion	192	2.200656e-2	1.000000e+0	1.000000e+0	4.544100e+1	2.200656e-2	1	2.200656e-2	1.000000e+0	222	2.500727e-2	1.000000e+0	1.000000e+0	3.973789e+1	2.516490e-2	1	227	5.000000e-1	4.405286e-3	unnamed	PTGS2
GO Biological Process	GO:0001666	response to hypoxia	193	2.203591e-2	1.000000e+0	1.000000e+0	4.538047e+1	2.203591e-2	1	2.203591e-2	1.000000e+0	216	2.435036e-2	1.000000e+0	1.000000e+0	4.081674e+1	2.449975e-2	1	221	5.000000e-1	4.524887e-3	unnamed	PTGS2
GO Biological Process	GO:0033157	regulation of intracellular protein transport	194	2.216024e-2	1.000000e+0	1.000000e+0	4.512586e+1	2.216024e-2	1	2.216024e-2	1.000000e+0	198	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	PTGS2
GO Biological Process	GO:0044706	multi-multicellular organism process	195	2.216275e-2	1.000000e+0	1.000000e+0	4.512076e+1	2.216275e-2	1	2.216275e-2	1.000000e+0	199	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PTGS2
GO Biological Process	GO:0006631	fatty acid metabolic process	196	2.242543e-2	1.000000e+0	1.000000e+0	4.459223e+1	2.242543e-2	1	2.242543e-2	1.000000e+0	9	2.215083e-4	1.000000e+0	2.569496e-1	6.706691e+1	2.982096e-2	2	269	1.000000e+0	7.434944e-3	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0036293	response to decreased oxygen levels	197	2.246863e-2	1.000000e+0	1.000000e+0	4.450649e+1	2.246863e-2	1	2.246863e-2	1.000000e+0	219	2.467884e-2	1.000000e+0	1.000000e+0	4.027009e+1	2.483233e-2	1	224	5.000000e-1	4.464286e-3	unnamed	PTGS2
GO Biological Process	GO:0032496	response to lipopolysaccharide	198	2.269987e-2	1.000000e+0	1.000000e+0	4.405311e+1	2.269987e-2	1	2.269987e-2	1.000000e+0	209	2.292630e-2	1.000000e+0	1.000000e+0	4.336779e+1	2.305859e-2	1	208	5.000000e-1	4.807692e-3	unnamed	PTGS2
GO Biological Process	GO:0090257	regulation of muscle system process	199	2.283758e-2	1.000000e+0	1.000000e+0	4.378747e+1	2.283758e-2	1	2.283758e-2	1.000000e+0	180	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	PTGS2
GO Biological Process	GO:0006644	phospholipid metabolic process	200	2.293343e-2	1.000000e+0	1.000000e+0	4.360446e+1	2.293343e-2	1	2.293343e-2	1.000000e+0	241	3.058208e-2	1.000000e+0	1.000000e+0	3.244784e+1	3.081869e-2	1	278	5.000000e-1	3.597122e-3	unnamed	PLA2G4A
GO Biological Process	GO:0002237	response to molecule of bacterial origin	201	2.314656e-2	1.000000e+0	1.000000e+0	4.320297e+1	2.314656e-2	1	2.314656e-2	1.000000e+0	215	2.413134e-2	1.000000e+0	1.000000e+0	4.118950e+1	2.427803e-2	1	219	5.000000e-1	4.566210e-3	unnamed	PTGS2
GO Biological Process	GO:0006979	response to oxidative stress	202	2.345031e-2	1.000000e+0	1.000000e+0	4.264336e+1	2.345031e-2	1	2.345031e-2	1.000000e+0	234	2.752338e-2	1.000000e+0	1.000000e+0	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	PTGS2
GO Biological Process	GO:0031349	positive regulation of defense response	203	2.353253e-2	1.000000e+0	1.000000e+0	4.249436e+1	2.353253e-2	1	2.353253e-2	1.000000e+0	225	2.588281e-2	1.000000e+0	1.000000e+0	3.838511e+1	2.605177e-2	1	235	5.000000e-1	4.255319e-3	unnamed	PTGS2
GO Biological Process	GO:0070482	response to oxygen levels	204	2.365938e-2	1.000000e+0	1.000000e+0	4.226654e+1	2.365938e-2	1	2.365938e-2	1.000000e+0	226	2.610163e-2	1.000000e+0	1.000000e+0	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	PTGS2
GO Biological Process	GO:0046486	glycerolipid metabolic process	205	2.379859e-2	1.000000e+0	1.000000e+0	4.201929e+1	2.379859e-2	1	2.379859e-2	1.000000e+0	246	3.200056e-2	1.000000e+0	1.000000e+0	3.099828e+1	3.225985e-2	1	291	5.000000e-1	3.436426e-3	unnamed	PLA2G4A
GO Biological Process	GO:0007611	learning or memory	206	2.388569e-2	1.000000e+0	1.000000e+0	4.186607e+1	2.388569e-2	1	2.388569e-2	1.000000e+0	188	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	PTGS2
GO Biological Process	GO:0046394	carboxylic acid biosynthetic process	207	2.519210e-2	1.000000e+0	1.000000e+0	3.969498e+1	2.519210e-2	1	2.519210e-2	1.000000e+0	12	2.281573e-4	1.000000e+0	1.984969e-1	6.608425e+1	3.026440e-2	2	273	1.000000e+0	7.326007e-3	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0010959	regulation of metal ion transport	208	2.558306e-2	1.000000e+0	1.000000e+0	3.908837e+1	2.558306e-2	1	2.558306e-2	1.000000e+0	208	2.281671e-2	1.000000e+0	1.000000e+0	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	PTGS2
GO Biological Process	GO:0019216	regulation of lipid metabolic process	209	2.565442e-2	1.000000e+0	1.000000e+0	3.897964e+1	2.565442e-2	1	2.565442e-2	1.000000e+0	224	2.511674e-2	1.000000e+0	1.000000e+0	3.956360e+1	2.527576e-2	1	228	5.000000e-1	4.385965e-3	unnamed	PTGS2
GO Biological Process	GO:0001503	ossification	210	2.567877e-2	1.000000e+0	1.000000e+0	3.894267e+1	2.567877e-2	1	2.567877e-2	1.000000e+0	202	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PTGS2
GO Biological Process	GO:0006066	alcohol metabolic process	211	2.594421e-2	1.000000e+0	1.000000e+0	3.854425e+1	2.594421e-2	1	2.594421e-2	1.000000e+0	252	3.472547e-2	1.000000e+0	1.000000e+0	2.854589e+1	3.503132e-2	1	316	5.000000e-1	3.164557e-3	unnamed	PLA2G4A
GO Biological Process	GO:0050890	cognition	212	2.624730e-2	1.000000e+0	1.000000e+0	3.809916e+1	2.624730e-2	1	2.624730e-2	1.000000e+0	194	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	PTGS2
GO Biological Process	GO:0050804	regulation of synaptic transmission	213	2.655285e-2	1.000000e+0	1.000000e+0	3.766074e+1	2.655285e-2	1	2.655285e-2	1.000000e+0	197	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	PTGS2
GO Biological Process	GO:0009416	response to light stimulus	214	2.717639e-2	1.000000e+0	1.000000e+0	3.679665e+1	2.717639e-2	1	2.717639e-2	1.000000e+0	247	3.254585e-2	1.000000e+0	1.000000e+0	3.047466e+1	3.281415e-2	1	296	5.000000e-1	3.378378e-3	unnamed	PTGS2
GO Biological Process	GO:0031667	response to nutrient levels	215	2.798141e-2	1.000000e+0	1.000000e+0	3.573801e+1	2.798141e-2	1	2.798141e-2	1.000000e+0	238	2.883484e-2	1.000000e+0	1.000000e+0	3.442939e+1	2.904495e-2	1	262	5.000000e-1	3.816794e-3	unnamed	PTGS2
GO Biological Process	GO:0097305	response to alcohol	216	2.811304e-2	1.000000e+0	1.000000e+0	3.557069e+1	2.811304e-2	1	2.811304e-2	1.000000e+0	221	2.489780e-2	1.000000e+0	1.000000e+0	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	PTGS2
GO Biological Process	GO:0015711	organic anion transport	217	2.827900e-2	1.000000e+0	1.000000e+0	3.536193e+1	2.827900e-2	1	2.827900e-2	1.000000e+0	248	3.319999e-2	1.000000e+0	1.000000e+0	2.986921e+1	3.347930e-2	1	302	5.000000e-1	3.311258e-3	unnamed	PLA2G4A
GO Biological Process	GO:0045786	negative regulation of cell cycle	218	2.832384e-2	1.000000e+0	1.000000e+0	3.530595e+1	2.832384e-2	1	2.832384e-2	1.000000e+0	232	2.730472e-2	1.000000e+0	1.000000e+0	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	PTGS2
GO Biological Process	GO:0008544	epidermis development	219	2.845698e-2	1.000000e+0	1.000000e+0	3.514076e+1	2.845698e-2	1	2.845698e-2	1.000000e+0	230	2.708603e-2	1.000000e+0	1.000000e+0	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	PTGS2
GO Biological Process	GO:0051969	regulation of transmission of nerve impulse	220	2.995129e-2	1.000000e+0	1.000000e+0	3.338754e+1	2.995129e-2	1	2.995129e-2	1.000000e+0	212	2.336458e-2	1.000000e+0	1.000000e+0	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	PTGS2
GO Biological Process	GO:0009991	response to extracellular stimulus	221	3.014307e-2	1.000000e+0	1.000000e+0	3.317512e+1	3.014307e-2	1	3.014307e-2	1.000000e+0	245	3.167331e-2	1.000000e+0	1.000000e+0	3.132118e+1	3.192728e-2	1	288	5.000000e-1	3.472222e-3	unnamed	PTGS2
GO Biological Process	GO:0010035	response to inorganic substance	222	3.091140e-2	1.000000e+0	1.000000e+0	3.235052e+1	3.091140e-2	1	3.091140e-2	1.000000e+0	253	3.581436e-2	1.000000e+0	1.000000e+0	2.767025e+1	3.613990e-2	1	326	5.000000e-1	3.067485e-3	unnamed	PTGS2
GO Biological Process	GO:0009617	response to bacterium	223	3.164494e-2	1.000000e+0	1.000000e+0	3.160062e+1	3.164494e-2	1	3.164494e-2	1.000000e+0	261	3.983792e-2	1.000000e+0	1.000000e+0	2.484986e+1	4.024167e-2	1	363	5.000000e-1	2.754821e-3	unnamed	PTGS2
GO Biological Process	GO:0031644	regulation of neurological system process	224	3.183877e-2	1.000000e+0	1.000000e+0	3.140824e+1	3.183877e-2	1	3.183877e-2	1.000000e+0	222	2.500727e-2	1.000000e+0	1.000000e+0	3.973789e+1	2.516490e-2	1	227	5.000000e-1	4.405286e-3	unnamed	PTGS2
GO Biological Process	GO:0048589	developmental growth	225	3.197468e-2	1.000000e+0	1.000000e+0	3.127475e+1	3.197468e-2	1	3.197468e-2	1.000000e+0	205	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	PTGS2
GO Biological Process	GO:0006954	inflammatory response	226	3.203906e-2	1.000000e+0	1.000000e+0	3.121190e+1	3.203906e-2	1	3.203906e-2	1.000000e+0	266	4.233480e-2	1.000000e+0	1.000000e+0	2.336917e+1	4.279142e-2	1	386	5.000000e-1	2.590674e-3	unnamed	PTGS2
GO Biological Process	GO:0043588	skin development	227	3.249392e-2	1.000000e+0	1.000000e+0	3.077499e+1	3.249392e-2	1	3.249392e-2	1.000000e+0	243	3.069123e-2	1.000000e+0	1.000000e+0	3.233154e+1	3.092955e-2	1	279	5.000000e-1	3.584229e-3	unnamed	PTGS2
GO Biological Process	GO:0071407	cellular response to organic cyclic compound	228	3.296315e-2	1.000000e+0	1.000000e+0	3.033690e+1	3.296315e-2	1	3.296315e-2	1.000000e+0	227	2.642982e-2	1.000000e+0	1.000000e+0	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	PTGS2
GO Biological Process	GO:0006520	cellular amino acid metabolic process	229	3.348268e-2	1.000000e+0	1.000000e+0	2.986619e+1	3.348268e-2	1	3.348268e-2	1.000000e+0	271	4.515346e-2	1.000000e+0	1.000000e+0	2.189442e+1	4.567374e-2	1	412	5.000000e-1	2.427184e-3	unnamed	PLA2G4A
GO Biological Process	GO:0008015	blood circulation	230	3.353044e-2	1.000000e+0	1.000000e+0	2.982364e+1	3.353044e-2	1	3.353044e-2	1.000000e+0	241	3.058208e-2	1.000000e+0	1.000000e+0	3.244784e+1	3.081869e-2	1	278	5.000000e-1	3.597122e-3	unnamed	PTGS2
GO Biological Process	GO:0003013	circulatory system process	231	3.378328e-2	1.000000e+0	1.000000e+0	2.960044e+1	3.378328e-2	1	3.378328e-2	1.000000e+0	244	3.080038e-2	1.000000e+0	1.000000e+0	3.221607e+1	3.104041e-2	1	280	5.000000e-1	3.571429e-3	unnamed	PTGS2
GO Biological Process	GO:0051223	regulation of protein transport	232	3.428315e-2	1.000000e+0	1.000000e+0	2.916884e+1	3.428315e-2	1	3.428315e-2	1.000000e+0	254	3.614091e-2	1.000000e+0	1.000000e+0	2.741793e+1	3.647248e-2	1	329	5.000000e-1	3.039514e-3	unnamed	PTGS2
GO Biological Process	GO:0044283	small molecule biosynthetic process	233	3.466661e-2	1.000000e+0	1.000000e+0	2.884620e+1	3.466661e-2	1	3.466661e-2	1.000000e+0	16	4.733490e-4	1.000000e+0	3.088602e-1	4.590585e+1	4.356743e-2	2	393	1.000000e+0	5.089059e-3	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0006820	anion transport	234	3.528482e-2	1.000000e+0	1.000000e+0	2.834080e+1	3.528482e-2	1	3.528482e-2	1.000000e+0	268	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	PLA2G4A
GO Biological Process	GO:0051051	negative regulation of transport	235	3.529688e-2	1.000000e+0	1.000000e+0	2.833112e+1	3.529688e-2	1	3.529688e-2	1.000000e+0	248	3.319999e-2	1.000000e+0	1.000000e+0	2.986921e+1	3.347930e-2	1	302	5.000000e-1	3.311258e-3	unnamed	PTGS2
GO Biological Process	GO:0030335	positive regulation of cell migration	236	3.546913e-2	1.000000e+0	1.000000e+0	2.819353e+1	3.546913e-2	1	3.546913e-2	1.000000e+0	228	2.664858e-2	1.000000e+0	1.000000e+0	3.727479e+1	2.682778e-2	1	242	5.000000e-1	4.132231e-3	unnamed	PTGS2
GO Biological Process	GO:2000147	positive regulation of cell motility	237	3.559044e-2	1.000000e+0	1.000000e+0	2.809743e+1	3.559044e-2	1	3.559044e-2	1.000000e+0	231	2.719538e-2	1.000000e+0	1.000000e+0	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	PTGS2
GO Biological Process	GO:0032787	monocarboxylic acid metabolic process	238	3.578238e-2	1.000000e+0	1.000000e+0	2.794672e+1	3.578238e-2	1	3.578238e-2	1.000000e+0	18	5.304498e-4	1.000000e+0	3.076609e-1	4.336779e+1	4.611718e-2	2	416	1.000000e+0	4.807692e-3	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0051272	positive regulation of cellular component movement	239	3.598197e-2	1.000000e+0	1.000000e+0	2.779170e+1	3.598197e-2	1	3.598197e-2	1.000000e+0	235	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	PTGS2
GO Biological Process	GO:0032844	regulation of homeostatic process	240	3.631679e-2	1.000000e+0	1.000000e+0	2.753547e+1	3.631679e-2	1	3.631679e-2	1.000000e+0	240	3.047293e-2	1.000000e+0	1.000000e+0	3.256498e+1	3.070783e-2	1	277	5.000000e-1	3.610108e-3	unnamed	PTGS2
GO Biological Process	GO:0044711	single-organism biosynthetic process	241	3.645402e-2	1.000000e+0	1.000000e+0	2.743181e+1	3.645402e-2	1	3.645402e-2	1.000000e+0	17	5.027351e-4	1.000000e+0	3.087385e-1	4.454568e+1	4.489773e-2	2	405	1.000000e+0	4.938272e-3	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0032386	regulation of intracellular transport	242	3.683590e-2	1.000000e+0	1.000000e+0	2.714743e+1	3.683590e-2	1	3.683590e-2	1.000000e+0	255	3.733778e-2	1.000000e+0	1.000000e+0	2.653088e+1	3.769192e-2	1	340	5.000000e-1	2.941176e-3	unnamed	PTGS2
GO Biological Process	GO:0001817	regulation of cytokine production	243	3.717052e-2	1.000000e+0	1.000000e+0	2.690304e+1	3.717052e-2	1	3.717052e-2	1.000000e+0	278	4.785978e-2	1.000000e+0	1.000000e+0	2.064188e+1	4.844521e-2	1	437	5.000000e-1	2.288330e-3	unnamed	PTGS2
GO Biological Process	GO:1901615	organic hydroxy compound metabolic process	244	3.732400e-2	1.000000e+0	1.000000e+0	2.679241e+1	3.732400e-2	1	3.732400e-2	1.000000e+0	269	4.472009e-2	1.000000e+0	1.000000e+0	2.210907e+1	4.523031e-2	1	408	5.000000e-1	2.450980e-3	unnamed	PLA2G4A
GO Biological Process	GO:0040017	positive regulation of locomotion	245	3.734381e-2	1.000000e+0	1.000000e+0	2.677820e+1	3.734381e-2	1	3.734381e-2	1.000000e+0	236	2.817922e-2	1.000000e+0	1.000000e+0	3.523633e+1	2.837980e-2	1	256	5.000000e-1	3.906250e-3	unnamed	PTGS2
GO Biological Process	GO:0090407	organophosphate biosynthetic process	246	3.780305e-2	1.000000e+0	1.000000e+0	2.645289e+1	3.780305e-2	1	3.780305e-2	1.000000e+0	274	4.688595e-2	1.000000e+0	1.000000e+0	2.107593e+1	4.744748e-2	1	428	5.000000e-1	2.336449e-3	unnamed	PLA2G4A
GO Biological Process	GO:0009314	response to radiation	247	3.804926e-2	1.000000e+0	1.000000e+0	2.628172e+1	3.804926e-2	1	3.804926e-2	1.000000e+0	270	4.482844e-2	1.000000e+0	1.000000e+0	2.205501e+1	4.534117e-2	1	409	5.000000e-1	2.444988e-3	unnamed	PTGS2
GO Biological Process	GO:0001525	angiogenesis	248	3.913882e-2	1.000000e+0	1.000000e+0	2.555008e+1	3.913882e-2	1	3.913882e-2	1.000000e+0	239	3.014542e-2	1.000000e+0	1.000000e+0	3.292153e+1	3.037526e-2	1	274	5.000000e-1	3.649635e-3	unnamed	PTGS2
GO Biological Process	GO:0048545	response to steroid hormone stimulus	249	3.932564e-2	1.000000e+0	1.000000e+0	2.542870e+1	3.932564e-2	1	3.932564e-2	1.000000e+0	251	3.439869e-2	1.000000e+0	1.000000e+0	2.881949e+1	3.469874e-2	1	313	5.000000e-1	3.194888e-3	unnamed	PTGS2
GO Biological Process	GO:0031347	regulation of defense response	250	3.939165e-2	1.000000e+0	1.000000e+0	2.538609e+1	3.939165e-2	1	3.939165e-2	1.000000e+0	284	5.099431e-2	1.000000e+0	1.000000e+0	1.935730e+1	5.166011e-2	1	466	5.000000e-1	2.145923e-3	unnamed	PTGS2
GO Biological Process	GO:0046434	organophosphate catabolic process	251	3.976893e-2	1.000000e+0	1.000000e+0	2.514526e+1	3.976893e-2	1	3.976893e-2	1.000000e+0	286	5.282939e-2	1.000000e+0	1.000000e+0	1.867598e+1	5.354470e-2	1	483	5.000000e-1	2.070393e-3	unnamed	PLA2G4A
GO Biological Process	GO:0051241	negative regulation of multicellular organismal process	252	4.104697e-2	1.000000e+0	1.000000e+0	2.436234e+1	4.104697e-2	1	4.104697e-2	1.000000e+0	264	4.081535e-2	1.000000e+0	1.000000e+0	2.424866e+1	4.123940e-2	1	372	5.000000e-1	2.688172e-3	unnamed	PTGS2
GO Biological Process	GO:0042493	response to drug	253	4.125969e-2	1.000000e+0	1.000000e+0	2.423673e+1	4.125969e-2	1	4.125969e-2	1.000000e+0	258	3.929468e-2	1.000000e+0	1.000000e+0	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	PTGS2
GO Biological Process	GO:0070201	regulation of establishment of protein localization	254	4.131349e-2	1.000000e+0	1.000000e+0	2.420517e+1	4.131349e-2	1	4.131349e-2	1.000000e+0	265	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	PTGS2
GO Biological Process	GO:0043065	positive regulation of apoptotic process	255	4.149734e-2	1.000000e+0	1.000000e+0	2.409793e+1	4.149734e-2	1	4.149734e-2	1.000000e+0	256	3.766407e-2	1.000000e+0	1.000000e+0	2.629883e+1	3.802450e-2	1	343	5.000000e-1	2.915452e-3	unnamed	PTGS2
GO Biological Process	GO:0043068	positive regulation of programmed cell death	256	4.177005e-2	1.000000e+0	1.000000e+0	2.394060e+1	4.177005e-2	1	4.177005e-2	1.000000e+0	257	3.842519e-2	1.000000e+0	1.000000e+0	2.577286e+1	3.880051e-2	1	350	5.000000e-1	2.857143e-3	unnamed	PTGS2
GO Biological Process	GO:0071417	cellular response to organonitrogen compound	257	4.299231e-2	1.000000e+0	1.000000e+0	2.325998e+1	4.299231e-2	1	4.299231e-2	1.000000e+0	267	4.266025e-2	1.000000e+0	1.000000e+0	2.318895e+1	4.312400e-2	1	389	5.000000e-1	2.570694e-3	unnamed	PTGS2
GO Biological Process	GO:0010942	positive regulation of cell death	258	4.327902e-2	1.000000e+0	1.000000e+0	2.310588e+1	4.327902e-2	1	4.327902e-2	1.000000e+0	262	4.059818e-2	1.000000e+0	1.000000e+0	2.437973e+1	4.101768e-2	1	370	5.000000e-1	2.702703e-3	unnamed	PTGS2
GO Biological Process	GO:1901699	cellular response to nitrogen compound	259	4.470909e-2	1.000000e+0	1.000000e+0	2.236681e+1	4.470909e-2	1	4.470909e-2	1.000000e+0	272	4.580333e-2	1.000000e+0	1.000000e+0	2.158014e+1	4.633889e-2	1	418	5.000000e-1	2.392344e-3	unnamed	PTGS2
GO Biological Process	GO:0034097	response to cytokine stimulus	260	4.481356e-2	1.000000e+0	1.000000e+0	2.231468e+1	4.481356e-2	1	4.481356e-2	1.000000e+0	295	5.735550e-2	1.000000e+0	1.000000e+0	1.718190e+1	5.820076e-2	1	525	5.000000e-1	1.904762e-3	unnamed	PTGS2
GO Biological Process	GO:0008610	lipid biosynthetic process	261	4.482047e-2	1.000000e+0	1.000000e+0	2.231123e+1	4.482047e-2	1	4.482047e-2	1.000000e+0	26	7.452721e-4	1.000000e+0	2.992554e-1	3.659432e+1	5.465329e-2	2	493	1.000000e+0	4.056795e-3	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0051707	response to other organism	262	4.714268e-2	1.000000e+0	1.000000e+0	2.121220e+1	4.714268e-2	1	4.714268e-2	1.000000e+0	304	6.530370e-2	1.000000e+0	1.000000e+0	1.505927e+1	6.640430e-2	1	599	5.000000e-1	1.669449e-3	unnamed	PTGS2
GO Biological Process	GO:0032880	regulation of protein localization	263	4.731536e-2	1.000000e+0	1.000000e+0	2.113479e+1	4.731536e-2	1	4.731536e-2	1.000000e+0	280	4.840059e-2	1.000000e+0	1.000000e+0	2.040837e+1	4.899950e-2	1	442	5.000000e-1	2.262443e-3	unnamed	PTGS2
GO Biological Process	GO:0007596	blood coagulation	264	4.808184e-2	1.000000e+0	1.000000e+0	2.079787e+1	4.808184e-2	1	4.808184e-2	1.000000e+0	291	5.477048e-2	1.000000e+0	1.000000e+0	1.800499e+1	5.554016e-2	1	501	5.000000e-1	1.996008e-3	unnamed	PLA2G4A
GO Biological Process	GO:0007599	hemostasis	265	4.832719e-2	1.000000e+0	1.000000e+0	2.069229e+1	4.832719e-2	1	4.832719e-2	1.000000e+0	292	5.530932e-2	1.000000e+0	1.000000e+0	1.782708e+1	5.609445e-2	1	506	5.000000e-1	1.976285e-3	unnamed	PLA2G4A
GO Biological Process	GO:0032101	regulation of response to external stimulus	266	4.860355e-2	1.000000e+0	1.000000e+0	2.057463e+1	4.860355e-2	1	4.860355e-2	1.000000e+0	279	4.807612e-2	1.000000e+0	1.000000e+0	2.054784e+1	4.866693e-2	1	439	5.000000e-1	2.277904e-3	unnamed	PTGS2
GO Biological Process	GO:0009607	response to biotic stimulus	267	4.908367e-2	1.000000e+0	1.000000e+0	2.037337e+1	4.908367e-2	1	4.908367e-2	1.000000e+0	309	6.798130e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	624	5.000000e-1	1.602564e-3	unnamed	PTGS2
GO Biological Process	GO:0040007	growth	268	5.170662e-2	1.000000e+0	1.000000e+0	1.933988e+1	5.170662e-2	1	5.170662e-2	1.000000e+0	260	3.962064e-2	1.000000e+0	1.000000e+0	2.498753e+1	4.001995e-2	1	361	5.000000e-1	2.770083e-3	unnamed	PTGS2
GO Biological Process	GO:0046903	secretion	269	5.307229e-2	1.000000e+0	1.000000e+0	1.884223e+1	5.307229e-2	1	5.307229e-2	1.000000e+0	290	5.444710e-2	1.000000e+0	1.000000e+0	1.811345e+1	5.520758e-2	1	498	5.000000e-1	2.008032e-3	unnamed	PLA2G4A
GO Biological Process	GO:0044708	single-organism behavior	270	5.490503e-2	1.000000e+0	1.000000e+0	1.821327e+1	5.490503e-2	1	5.490503e-2	1.000000e+0	262	4.059818e-2	1.000000e+0	1.000000e+0	2.437973e+1	4.101768e-2	1	370	5.000000e-1	2.702703e-3	unnamed	PTGS2
GO Biological Process	GO:0048514	blood vessel morphogenesis	271	5.515746e-2	1.000000e+0	1.000000e+0	1.812991e+1	5.515746e-2	1	5.515746e-2	1.000000e+0	258	3.929468e-2	1.000000e+0	1.000000e+0	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	PTGS2
GO Biological Process	GO:0043269	regulation of ion transport	272	5.622673e-2	1.000000e+0	1.000000e+0	1.778513e+1	5.622673e-2	1	5.622673e-2	1.000000e+0	277	4.753523e-2	1.000000e+0	1.000000e+0	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	PTGS2
GO Biological Process	GO:0007276	gamete generation	273	5.686474e-2	1.000000e+0	1.000000e+0	1.758559e+1	5.686474e-2	1	5.686474e-2	1.000000e+0	295	5.735550e-2	1.000000e+0	1.000000e+0	1.718190e+1	5.820076e-2	1	525	5.000000e-1	1.904762e-3	unnamed	PTGS2
GO Biological Process	GO:0003006	developmental process involved in reproduction	274	5.715290e-2	1.000000e+0	1.000000e+0	1.749692e+1	5.715290e-2	1	5.715290e-2	1.000000e+0	276	4.721062e-2	1.000000e+0	1.000000e+0	2.092923e+1	4.778006e-2	1	431	5.000000e-1	2.320186e-3	unnamed	PTGS2
GO Biological Process	GO:0050878	regulation of body fluid levels	275	5.804318e-2	1.000000e+0	1.000000e+0	1.722855e+1	5.804318e-2	1	5.804318e-2	1.000000e+0	305	6.573237e-2	1.000000e+0	1.000000e+0	1.495937e+1	6.684774e-2	1	603	5.000000e-1	1.658375e-3	unnamed	PLA2G4A
GO Biological Process	GO:0001775	cell activation	276	5.914753e-2	1.000000e+0	1.000000e+0	1.690688e+1	5.914753e-2	1	5.914753e-2	1.000000e+0	301	6.176339e-2	1.000000e+0	1.000000e+0	1.593728e+1	6.274597e-2	1	566	5.000000e-1	1.766784e-3	unnamed	PLA2G4A
GO Biological Process	GO:1901566	organonitrogen compound biosynthetic process	277	5.924039e-2	1.000000e+0	1.000000e+0	1.688038e+1	5.924039e-2	1	5.924039e-2	1.000000e+0	300	6.111898e-2	1.000000e+0	1.000000e+0	1.610804e+1	6.208082e-2	1	560	5.000000e-1	1.785714e-3	unnamed	PLA2G4A
GO Biological Process	GO:0007600	sensory perception	278	5.978826e-2	1.000000e+0	1.000000e+0	1.672569e+1	5.978826e-2	1	5.978826e-2	1.000000e+0	330	9.032149e-2	1.000000e+0	1.000000e+0	1.081595e+1	9.245607e-2	1	834	5.000000e-1	1.199041e-3	unnamed	PTGS2
GO Biological Process	GO:0030334	regulation of cell migration	279	6.141275e-2	1.000000e+0	1.000000e+0	1.628326e+1	6.141275e-2	1	6.141275e-2	1.000000e+0	275	4.710240e-2	1.000000e+0	1.000000e+0	2.097791e+1	4.766920e-2	1	430	5.000000e-1	2.325581e-3	unnamed	PTGS2
GO Biological Process	GO:0051050	positive regulation of transport	280	6.143757e-2	1.000000e+0	1.000000e+0	1.627669e+1	6.143757e-2	1	6.143757e-2	1.000000e+0	297	5.821639e-2	1.000000e+0	1.000000e+0	1.692402e+1	5.908763e-2	1	533	5.000000e-1	1.876173e-3	unnamed	PTGS2
GO Biological Process	GO:0042060	wound healing	281	6.218622e-2	1.000000e+0	1.000000e+0	1.608073e+1	6.218622e-2	1	6.218622e-2	1.000000e+0	307	6.658942e-2	1.000000e+0	1.000000e+0	1.476350e+1	6.773460e-2	1	611	5.000000e-1	1.636661e-3	unnamed	PLA2G4A
GO Biological Process	GO:2000145	regulation of cell motility	282	6.359747e-2	1.000000e+0	1.000000e+0	1.572390e+1	6.359747e-2	1	6.359747e-2	1.000000e+0	283	4.969789e-2	1.000000e+0	1.000000e+0	1.986894e+1	5.032980e-2	1	454	5.000000e-1	2.202643e-3	unnamed	PTGS2
GO Biological Process	GO:0001568	blood vessel development	283	6.483130e-2	1.000000e+0	1.000000e+0	1.542465e+1	6.483130e-2	1	6.483130e-2	1.000000e+0	273	4.623645e-2	1.000000e+0	1.000000e+0	2.137559e+1	4.678233e-2	1	422	5.000000e-1	2.369668e-3	unnamed	PTGS2
GO Biological Process	GO:0019953	sexual reproduction	284	6.533147e-2	1.000000e+0	1.000000e+0	1.530656e+1	6.533147e-2	1	6.533147e-2	1.000000e+0	308	6.691072e-2	1.000000e+0	1.000000e+0	1.469137e+1	6.806718e-2	1	614	5.000000e-1	1.628664e-3	unnamed	PTGS2
GO Biological Process	GO:0019752	carboxylic acid metabolic process	285	6.544102e-2	1.000000e+0	1.000000e+0	1.528093e+1	6.544102e-2	1	6.544102e-2	1.000000e+0	54	1.993581e-3	1.000000e+0	3.854257e-1	2.238337e+1	8.935203e-2	2	806	1.000000e+0	2.481390e-3	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0007610	behavior	286	6.544758e-2	1.000000e+0	1.000000e+0	1.527940e+1	6.544758e-2	1	6.544758e-2	1.000000e+0	281	4.872500e-2	1.000000e+0	1.000000e+0	2.027079e+1	4.933208e-2	1	445	5.000000e-1	2.247191e-3	unnamed	PTGS2
GO Biological Process	GO:0044057	regulation of system process	287	6.822429e-2	1.000000e+0	1.000000e+0	1.465754e+1	6.822429e-2	1	6.822429e-2	1.000000e+0	288	5.390802e-2	1.000000e+0	1.000000e+0	1.829716e+1	5.465329e-2	1	493	5.000000e-1	2.028398e-3	unnamed	PTGS2
GO Biological Process	GO:0001944	vasculature development	288	6.845513e-2	1.000000e+0	1.000000e+0	1.460811e+1	6.845513e-2	1	6.845513e-2	1.000000e+0	282	4.937365e-2	1.000000e+0	1.000000e+0	2.000111e+1	4.999723e-2	1	451	5.000000e-1	2.217295e-3	unnamed	PTGS2
GO Biological Process	GO:0010243	response to organonitrogen compound	289	6.859350e-2	1.000000e+0	1.000000e+0	1.457864e+1	6.859350e-2	1	6.859350e-2	1.000000e+0	310	6.894429e-2	1.000000e+0	1.000000e+0	1.425039e+1	7.017349e-2	1	633	5.000000e-1	1.579779e-3	unnamed	PTGS2
GO Biological Process	GO:0040012	regulation of locomotion	290	6.930090e-2	1.000000e+0	1.000000e+0	1.442983e+1	6.930090e-2	1	6.930090e-2	1.000000e+0	287	5.369234e-2	1.000000e+0	1.000000e+0	1.837169e+1	5.443157e-2	1	491	5.000000e-1	2.036660e-3	unnamed	PTGS2
GO Biological Process	GO:0014070	response to organic cyclic compound	291	6.953782e-2	1.000000e+0	1.000000e+0	1.438066e+1	6.953782e-2	1	6.953782e-2	1.000000e+0	306	6.594667e-2	1.000000e+0	1.000000e+0	1.490992e+1	6.706945e-2	1	605	5.000000e-1	1.652893e-3	unnamed	PTGS2
GO Biological Process	GO:1901701	cellular response to oxygen-containing compound	292	6.966859e-2	1.000000e+0	1.000000e+0	1.435367e+1	6.966859e-2	1	6.966859e-2	1.000000e+0	312	7.012061e-2	1.000000e+0	1.000000e+0	1.400699e+1	7.139294e-2	1	644	5.000000e-1	1.552795e-3	unnamed	PTGS2
GO Biological Process	GO:0044255	cellular lipid metabolic process	293	7.113785e-2	1.000000e+0	1.000000e+0	1.405721e+1	7.113785e-2	1	7.113785e-2	1.000000e+0	55	2.068521e-3	1.000000e+0	3.926429e-1	2.197442e+1	9.101491e-2	2	821	1.000000e+0	2.436054e-3	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:1901698	response to nitrogen compound	294	7.125062e-2	1.000000e+0	1.000000e+0	1.403497e+1	7.125062e-2	1	7.125062e-2	1.000000e+0	314	7.332497e-2	1.000000e+0	1.000000e+0	1.338353e+1	7.471870e-2	1	674	5.000000e-1	1.483680e-3	unnamed	PTGS2
GO Biological Process	GO:0051270	regulation of cellular component movement	295	7.158871e-2	1.000000e+0	1.000000e+0	1.396868e+1	7.158871e-2	1	7.158871e-2	1.000000e+0	294	5.627884e-2	1.000000e+0	1.000000e+0	1.751553e+1	5.709218e-2	1	515	5.000000e-1	1.941748e-3	unnamed	PTGS2
GO Biological Process	GO:0033993	response to lipid	296	7.196408e-2	1.000000e+0	1.000000e+0	1.389582e+1	7.196408e-2	1	7.196408e-2	1.000000e+0	303	6.466050e-2	1.000000e+0	1.000000e+0	1.521164e+1	6.573915e-2	1	593	5.000000e-1	1.686341e-3	unnamed	PTGS2
GO Biological Process	GO:0051240	positive regulation of multicellular organismal process	297	7.314079e-2	1.000000e+0	1.000000e+0	1.367226e+1	7.314079e-2	1	7.314079e-2	1.000000e+0	302	6.380257e-2	1.000000e+0	1.000000e+0	1.541966e+1	6.485228e-2	1	585	5.000000e-1	1.709402e-3	unnamed	PTGS2
GO Biological Process	GO:0051726	regulation of cell cycle	298	7.419191e-2	1.000000e+0	1.000000e+0	1.347856e+1	7.419191e-2	1	7.419191e-2	1.000000e+0	318	7.705640e-2	1.000000e+0	1.000000e+0	1.272285e+1	7.859875e-2	1	709	5.000000e-1	1.410437e-3	unnamed	PTGS2
GO Biological Process	GO:0008285	negative regulation of cell proliferation	299	7.420861e-2	1.000000e+0	1.000000e+0	1.347553e+1	7.420861e-2	1	7.420861e-2	1.000000e+0	299	6.058180e-2	1.000000e+0	1.000000e+0	1.625315e+1	6.152652e-2	1	555	5.000000e-1	1.801802e-3	unnamed	PTGS2
GO Biological Process	GO:0048609	multicellular organismal reproductive process	300	7.483828e-2	1.000000e+0	1.000000e+0	1.336215e+1	7.483828e-2	1	7.483828e-2	1.000000e+0	313	7.289804e-2	1.000000e+0	1.000000e+0	1.346343e+1	7.427526e-2	1	670	5.000000e-1	1.492537e-3	unnamed	PTGS2
GO Biological Process	GO:0009725	response to hormone stimulus	301	7.546651e-2	1.000000e+0	1.000000e+0	1.325091e+1	7.546651e-2	1	7.546651e-2	1.000000e+0	317	7.673686e-2	1.000000e+0	1.000000e+0	1.277691e+1	7.826617e-2	1	706	5.000000e-1	1.416431e-3	unnamed	PTGS2
GO Biological Process	GO:0032504	multicellular organism reproduction	302	7.740256e-2	1.000000e+0	1.000000e+0	1.291947e+1	7.740256e-2	1	7.740256e-2	1.000000e+0	315	7.503170e-2	1.000000e+0	1.000000e+0	1.307319e+1	7.649243e-2	1	690	5.000000e-1	1.449275e-3	unnamed	PTGS2
GO Biological Process	GO:0044702	single organism reproductive process	303	7.805445e-2	1.000000e+0	1.000000e+0	1.281157e+1	7.805445e-2	1	7.805445e-2	1.000000e+0	319	7.812114e-2	1.000000e+0	1.000000e+0	1.254590e+1	7.970733e-2	1	719	5.000000e-1	1.390821e-3	unnamed	PTGS2
GO Biological Process	GO:0055114	oxidation-reduction process	304	7.921377e-2	1.000000e+0	1.000000e+0	1.262407e+1	7.921377e-2	1	7.921377e-2	1.000000e+0	335	9.970771e-2	1.000000e+0	1.000000e+0	9.773023e+0	1.023225e-1	1	923	5.000000e-1	1.083424e-3	unnamed	PTGS2
GO Biological Process	GO:0080134	regulation of response to stress	305	7.926357e-2	1.000000e+0	1.000000e+0	1.261614e+1	7.926357e-2	1	7.926357e-2	1.000000e+0	329	8.926381e-2	1.000000e+0	1.000000e+0	1.094721e+1	9.134749e-2	1	824	5.000000e-1	1.213592e-3	unnamed	PTGS2
GO Biological Process	GO:0043436	oxoacid metabolic process	306	8.179018e-2	1.000000e+0	1.000000e+0	1.222641e+1	8.179018e-2	1	8.179018e-2	1.000000e+0	68	2.586514e-3	1.000000e+0	3.971060e-1	1.965251e+1	1.017682e-1	2	918	1.000000e+0	2.178649e-3	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0006082	organic acid metabolic process	307	8.296012e-2	1.000000e+0	1.000000e+0	1.205398e+1	8.296012e-2	1	8.296012e-2	1.000000e+0	71	2.677512e-3	1.000000e+0	3.937074e-1	1.931585e+1	1.035419e-1	2	934	1.000000e+0	2.141328e-3	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0045597	positive regulation of cell differentiation	308	8.367595e-2	1.000000e+0	1.000000e+0	1.195087e+1	8.367595e-2	1	8.367595e-2	1.000000e+0	298	5.864668e-2	1.000000e+0	1.000000e+0	1.679795e+1	5.953107e-2	1	537	5.000000e-1	1.862197e-3	unnamed	PTGS2
GO Biological Process	GO:0008284	positive regulation of cell proliferation	309	8.541005e-2	1.000000e+0	1.000000e+0	1.170822e+1	8.541005e-2	1	8.541005e-2	1.000000e+0	316	7.609761e-2	1.000000e+0	1.000000e+0	1.288643e+1	7.760102e-2	1	700	5.000000e-1	1.428571e-3	unnamed	PTGS2
GO Biological Process	GO:0010627	regulation of intracellular protein kinase cascade	310	8.650803e-2	1.000000e+0	1.000000e+0	1.155962e+1	8.650803e-2	1	8.650803e-2	1.000000e+0	321	8.078030e-2	1.000000e+0	1.000000e+0	1.212433e+1	8.247880e-2	1	744	5.000000e-1	1.344086e-3	unnamed	PTGS2
GO Biological Process	GO:0022603	regulation of anatomical structure morphogenesis	311	8.664930e-2	1.000000e+0	1.000000e+0	1.154077e+1	8.664930e-2	1	8.664930e-2	1.000000e+0	311	6.937213e-2	1.000000e+0	1.000000e+0	1.416091e+1	7.061693e-2	1	637	5.000000e-1	1.569859e-3	unnamed	PTGS2
GO Biological Process	GO:0019637	organophosphate metabolic process	312	8.707730e-2	1.000000e+0	1.000000e+0	1.148405e+1	8.707730e-2	1	8.707730e-2	1.000000e+0	339	1.118684e-1	1.000000e+0	1.000000e+0	8.681906e+0	1.151821e-1	1	1039	5.000000e-1	9.624639e-4	unnamed	PLA2G4A
GO Biological Process	GO:0009628	response to abiotic stimulus	313	8.711487e-2	1.000000e+0	1.000000e+0	1.147910e+1	8.711487e-2	1	8.711487e-2	1.000000e+0	331	9.370191e-2	1.000000e+0	1.000000e+0	1.041628e+1	9.600355e-2	1	866	5.000000e-1	1.154734e-3	unnamed	PTGS2
GO Biological Process	GO:0060341	regulation of cellular localization	314	9.081570e-2	1.000000e+0	1.000000e+0	1.101131e+1	9.081570e-2	1	9.081570e-2	1.000000e+0	323	8.354176e-2	1.000000e+0	1.000000e+0	1.171494e+1	8.536112e-2	1	770	5.000000e-1	1.298701e-3	unnamed	PTGS2
GO Biological Process	GO:0006629	lipid metabolic process	315	9.193917e-2	1.000000e+0	1.000000e+0	1.087676e+1	9.193917e-2	1	9.193917e-2	1.000000e+0	87	3.475184e-3	1.000000e+0	4.170221e-1	1.695583e+1	1.179536e-1	2	1064	1.000000e+0	1.879699e-3	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0023057	negative regulation of signaling	316	9.292335e-2	1.000000e+0	1.000000e+0	1.076156e+1	9.292335e-2	1	9.292335e-2	1.000000e+0	325	8.492093e-2	1.000000e+0	1.000000e+0	1.152043e+1	8.680228e-2	1	783	5.000000e-1	1.277139e-3	unnamed	PTGS2
GO Biological Process	GO:0010648	negative regulation of cell communication	317	9.329424e-2	1.000000e+0	1.000000e+0	1.071878e+1	9.329424e-2	1	9.329424e-2	1.000000e+0	326	8.523905e-2	1.000000e+0	1.000000e+0	1.147646e+1	8.713486e-2	1	786	5.000000e-1	1.272265e-3	unnamed	PTGS2
GO Biological Process	GO:0071495	cellular response to endogenous stimulus	318	9.410737e-2	1.000000e+0	1.000000e+0	1.062616e+1	9.410737e-2	1	9.410737e-2	1.000000e+0	326	8.523905e-2	1.000000e+0	1.000000e+0	1.147646e+1	8.713486e-2	1	786	5.000000e-1	1.272265e-3	unnamed	PTGS2
GO Biological Process	GO:0009611	response to wounding	319	9.491742e-2	1.000000e+0	1.000000e+0	1.053547e+1	9.491742e-2	1	9.491742e-2	1.000000e+0	78	3.118838e-3	1.000000e+0	4.174445e-1	1.789782e+1	1.117455e-1	2	1008	1.000000e+0	1.984127e-3	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0006952	defense response	320	9.670708e-2	1.000000e+0	1.000000e+0	1.034051e+1	9.670708e-2	1	9.670708e-2	1.000000e+0	353	1.318147e-1	1.000000e+0	1.000000e+0	7.327782e+0	1.364669e-1	1	1231	5.000000e-1	8.123477e-4	unnamed	PTGS2
GO Biological Process	GO:0033554	cellular response to stress	321	1.003642e-1	1.000000e+0	1.000000e+0	9.963713e+0	1.003642e-1	1	1.003642e-1	1.000000e+0	345	1.229084e-1	1.000000e+0	1.000000e+0	7.878166e+0	1.269331e-1	1	1145	5.000000e-1	8.733624e-4	unnamed	PTGS2
GO Biological Process	GO:0048646	anatomical structure formation involved in morphogenesis	322	1.047361e-1	1.000000e+0	1.000000e+0	9.547802e+0	1.047361e-1	1	1.047361e-1	1.000000e+0	324	8.375400e-2	1.000000e+0	1.000000e+0	1.168459e+1	8.558284e-2	1	772	5.000000e-1	1.295337e-3	unnamed	PTGS2
GO Biological Process	GO:0072358	cardiovascular system development	323	1.056924e-1	1.000000e+0	1.000000e+0	9.461416e+0	1.056924e-1	1	1.056924e-1	1.000000e+0	320	7.854686e-2	1.000000e+0	1.000000e+0	1.247649e+1	8.015077e-2	1	723	5.000000e-1	1.383126e-3	unnamed	PTGS2
GO Biological Process	GO:0006811	ion transport	324	1.070764e-1	1.000000e+0	1.000000e+0	9.339125e+0	1.070764e-1	1	1.070764e-1	1.000000e+0	340	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	PLA2G4A
GO Biological Process	GO:0010647	positive regulation of cell communication	325	1.079245e-1	1.000000e+0	1.000000e+0	9.265740e+0	1.079245e-1	1	1.079245e-1	1.000000e+0	334	9.928690e-2	1.000000e+0	1.000000e+0	9.815560e+0	1.018791e-1	1	919	5.000000e-1	1.088139e-3	unnamed	PTGS2
GO Biological Process	GO:0051704	multi-organism process	326	1.079454e-1	1.000000e+0	1.000000e+0	9.263941e+0	1.079454e-1	1	1.079454e-1	1.000000e+0	359	1.466257e-1	1.000000e+0	1.000000e+0	6.560364e+0	1.524306e-1	1	1375	5.000000e-1	7.272727e-4	unnamed	PTGS2
GO Biological Process	GO:0023056	positive regulation of signaling	327	1.079881e-1	1.000000e+0	1.000000e+0	9.260277e+0	1.079881e-1	1	1.079881e-1	1.000000e+0	333	9.897123e-2	1.000000e+0	1.000000e+0	9.847707e+0	1.015465e-1	1	916	5.000000e-1	1.091703e-3	unnamed	PTGS2
GO Biological Process	GO:1901700	response to oxygen-containing compound	328	1.089184e-1	1.000000e+0	1.000000e+0	9.181188e+0	1.089184e-1	1	1.089184e-1	1.000000e+0	338	1.115549e-1	1.000000e+0	1.000000e+0	8.707046e+0	1.148495e-1	1	1036	5.000000e-1	9.652510e-4	unnamed	PTGS2
GO Biological Process	GO:0051094	positive regulation of developmental process	329	1.103781e-1	1.000000e+0	1.000000e+0	9.059771e+0	1.103781e-1	1	1.103781e-1	1.000000e+0	322	8.088659e-2	1.000000e+0	1.000000e+0	1.210805e+1	8.258966e-2	1	745	5.000000e-1	1.342282e-3	unnamed	PTGS2
GO Biological Process	GO:0022414	reproductive process	330	1.132946e-1	1.000000e+0	1.000000e+0	8.826548e+0	1.132946e-1	1	1.132946e-1	1.000000e+0	337	1.070559e-1	1.000000e+0	1.000000e+0	9.084089e+0	1.100826e-1	1	993	5.000000e-1	1.007049e-3	unnamed	PTGS2
GO Biological Process	GO:1901135	carbohydrate derivative metabolic process	331	1.134958e-1	1.000000e+0	1.000000e+0	8.810897e+0	1.134958e-1	1	1.134958e-1	1.000000e+0	350	1.288165e-1	1.000000e+0	1.000000e+0	7.504576e+0	1.332520e-1	1	1202	5.000000e-1	8.319468e-4	unnamed	PLA2G4A
GO Biological Process	GO:0042981	regulation of apoptotic process	332	1.200175e-1	1.000000e+0	1.000000e+0	8.332116e+0	1.200175e-1	1	1.200175e-1	1.000000e+0	346	1.243613e-1	1.000000e+0	1.000000e+0	7.783003e+0	1.284851e-1	1	1159	5.000000e-1	8.628128e-4	unnamed	PTGS2
GO Biological Process	GO:0000003	reproduction	333	1.207341e-1	1.000000e+0	1.000000e+0	8.282661e+0	1.207341e-1	1	1.207341e-1	1.000000e+0	341	1.175012e-1	1.000000e+0	1.000000e+0	8.252973e+0	1.211684e-1	1	1093	5.000000e-1	9.149131e-4	unnamed	PTGS2
GO Biological Process	GO:0043067	regulation of programmed cell death	334	1.213630e-1	1.000000e+0	1.000000e+0	8.239741e+0	1.213630e-1	1	1.213630e-1	1.000000e+0	347	1.256058e-1	1.000000e+0	1.000000e+0	7.703245e+0	1.298154e-1	1	1171	5.000000e-1	8.539710e-4	unnamed	PTGS2
GO Biological Process	GO:0044248	cellular catabolic process	335	1.236997e-1	1.000000e+0	1.000000e+0	8.084094e+0	1.236997e-1	1	1.236997e-1	1.000000e+0	365	1.690077e-1	1.000000e+0	1.000000e+0	5.655486e+0	1.768195e-1	1	1595	5.000000e-1	6.269592e-4	unnamed	PLA2G4A
GO Biological Process	GO:0010941	regulation of cell death	336	1.261875e-1	1.000000e+0	1.000000e+0	7.924714e+0	1.261875e-1	1	1.261875e-1	1.000000e+0	351	1.296441e-1	1.000000e+0	1.000000e+0	7.454959e+0	1.341389e-1	1	1210	5.000000e-1	8.264463e-4	unnamed	PTGS2
GO Biological Process	GO:0009719	response to endogenous stimulus	337	1.264308e-1	1.000000e+0	1.000000e+0	7.909468e+0	1.264308e-1	1	1.264308e-1	1.000000e+0	344	1.223892e-1	1.000000e+0	1.000000e+0	7.912719e+0	1.263788e-1	1	1140	5.000000e-1	8.771930e-4	unnamed	PTGS2
GO Biological Process	GO:1901575	organic substance catabolic process	338	1.333602e-1	1.000000e+0	1.000000e+0	7.498488e+0	1.333602e-1	1	1.333602e-1	1.000000e+0	369	1.828954e-1	1.000000e+0	1.000000e+0	5.205136e+0	1.921180e-1	1	1733	5.000000e-1	5.770340e-4	unnamed	PLA2G4A
GO Biological Process	GO:0048584	positive regulation of response to stimulus	339	1.367746e-1	1.000000e+0	1.000000e+0	7.311300e+0	1.367746e-1	1	1.367746e-1	1.000000e+0	354	1.352201e-1	1.000000e+0	1.000000e+0	7.136472e+0	1.401253e-1	1	1264	5.000000e-1	7.911392e-4	unnamed	PTGS2
GO Biological Process	GO:0009605	response to external stimulus	340	1.367883e-1	1.000000e+0	1.000000e+0	7.310566e+0	1.367883e-1	1	1.367883e-1	1.000000e+0	342	1.211425e-1	1.000000e+0	1.000000e+0	7.996897e+0	1.250485e-1	1	1128	5.000000e-1	8.865248e-4	unnamed	PTGS2
GO Biological Process	GO:1901564	organonitrogen compound metabolic process	341	1.379740e-1	1.000000e+0	1.000000e+0	7.247740e+0	1.379740e-1	1	1.379740e-1	1.000000e+0	362	1.637442e-1	1.000000e+0	1.000000e+0	5.846079e+0	1.710548e-1	1	1543	5.000000e-1	6.480881e-4	unnamed	PLA2G4A
GO Biological Process	GO:0051049	regulation of transport	342	1.390239e-1	1.000000e+0	1.000000e+0	7.193009e+0	1.390239e-1	1	1.390239e-1	1.000000e+0	352	1.304713e-1	1.000000e+0	1.000000e+0	7.405993e+0	1.350258e-1	1	1218	5.000000e-1	8.210181e-4	unnamed	PTGS2
GO Biological Process	GO:0071702	organic substance transport	343	1.396970e-1	1.000000e+0	1.000000e+0	7.158351e+0	1.396970e-1	1	1.396970e-1	1.000000e+0	367	1.786811e-1	1.000000e+0	1.000000e+0	5.334418e+0	1.874619e-1	1	1691	5.000000e-1	5.913661e-4	unnamed	PLA2G4A
GO Biological Process	GO:0042127	regulation of cell proliferation	344	1.497663e-1	1.000000e+0	1.000000e+0	6.677069e+0	1.497663e-1	1	1.497663e-1	1.000000e+0	103	4.774054e-3	1.000000e+0	4.838944e-1	1.446752e+1	1.382407e-1	2	1247	1.000000e+0	1.603849e-3	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0009056	catabolic process	345	1.498546e-1	1.000000e+0	1.000000e+0	6.673137e+0	1.498546e-1	1	1.498546e-1	1.000000e+0	371	2.035077e-1	1.000000e+0	1.000000e+0	4.649742e+0	2.150657e-1	1	1940	5.000000e-1	5.154639e-4	unnamed	PLA2G4A
GO Biological Process	GO:0033036	macromolecule localization	346	1.501784e-1	1.000000e+0	1.000000e+0	6.658748e+0	1.501784e-1	1	1.501784e-1	1.000000e+0	368	1.787816e-1	1.000000e+0	1.000000e+0	5.331265e+0	1.875728e-1	1	1692	5.000000e-1	5.910165e-4	unnamed	PLA2G4A
GO Biological Process	GO:0006928	cellular component movement	347	1.503710e-1	1.000000e+0	1.000000e+0	6.650218e+0	1.503710e-1	1	1.503710e-1	1.000000e+0	348	1.264349e-1	1.000000e+0	1.000000e+0	7.650975e+0	1.307023e-1	1	1179	5.000000e-1	8.481764e-4	unnamed	PTGS2
GO Biological Process	GO:0045595	regulation of cell differentiation	348	1.536001e-1	1.000000e+0	1.000000e+0	6.510412e+0	1.536001e-1	1	1.536001e-1	1.000000e+0	343	1.221815e-1	1.000000e+0	1.000000e+0	7.926626e+0	1.261571e-1	1	1138	5.000000e-1	8.787346e-4	unnamed	PTGS2
GO Biological Process	GO:0071310	cellular response to organic substance	349	1.544577e-1	1.000000e+0	1.000000e+0	6.474265e+0	1.544577e-1	1	1.544577e-1	1.000000e+0	361	1.591759e-1	1.000000e+0	1.000000e+0	6.021696e+0	1.660662e-1	1	1498	5.000000e-1	6.675567e-4	unnamed	PTGS2
GO Biological Process	GO:0050877	neurological system process	350	1.566250e-1	1.000000e+0	1.000000e+0	6.384679e+0	1.566250e-1	1	1.566250e-1	1.000000e+0	363	1.641497e-1	1.000000e+0	1.000000e+0	5.830963e+0	1.714983e-1	1	1547	5.000000e-1	6.464124e-4	unnamed	PTGS2
GO Biological Process	GO:0051173	positive regulation of nitrogen compound metabolic process	351	1.569956e-1	1.000000e+0	1.000000e+0	6.369604e+0	1.569956e-1	1	1.569956e-1	1.000000e+0	355	1.389275e-1	1.000000e+0	1.000000e+0	6.938846e+0	1.441162e-1	1	1300	5.000000e-1	7.692308e-4	unnamed	PTGS2
GO Biological Process	GO:0031328	positive regulation of cellular biosynthetic process	352	1.595607e-1	1.000000e+0	1.000000e+0	6.267208e+0	1.595607e-1	1	1.595607e-1	1.000000e+0	357	1.447813e-1	1.000000e+0	1.000000e+0	6.647384e+0	1.504351e-1	1	1357	5.000000e-1	7.369197e-4	unnamed	PTGS2
GO Biological Process	GO:0009891	positive regulation of biosynthetic process	353	1.621017e-1	1.000000e+0	1.000000e+0	6.168967e+0	1.621017e-1	1	1.621017e-1	1.000000e+0	360	1.471377e-1	1.000000e+0	1.000000e+0	6.536594e+0	1.529849e-1	1	1380	5.000000e-1	7.246377e-4	unnamed	PTGS2
GO Biological Process	GO:2000026	regulation of multicellular organismal development	354	1.643381e-1	1.000000e+0	1.000000e+0	6.085018e+0	1.643381e-1	1	1.643381e-1	1.000000e+0	349	1.281955e-1	1.000000e+0	1.000000e+0	7.542224e+0	1.325869e-1	1	1196	5.000000e-1	8.361204e-4	unnamed	PTGS2
GO Biological Process	GO:0009888	tissue development	355	1.692045e-1	1.000000e+0	1.000000e+0	5.910010e+0	1.692045e-1	1	1.692045e-1	1.000000e+0	356	1.422163e-1	1.000000e+0	1.000000e+0	6.772147e+0	1.476637e-1	1	1332	5.000000e-1	7.507508e-4	unnamed	PTGS2
GO Biological Process	GO:0070887	cellular response to chemical stimulus	356	1.826020e-1	1.000000e+0	1.000000e+0	5.476391e+0	1.826020e-1	1	1.826020e-1	1.000000e+0	146	1.066993e-2	1.000000e+0	7.629731e-1	9.678648e+0	2.066404e-1	2	1864	1.000000e+0	1.072961e-3	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0006796	phosphate-containing compound metabolic process	357	1.861159e-1	1.000000e+0	1.000000e+0	5.372996e+0	1.861159e-1	1	1.861159e-1	1.000000e+0	375	2.116001e-1	1.000000e+0	1.000000e+0	4.461177e+0	2.241561e-1	1	2022	5.000000e-1	4.945598e-4	unnamed	PLA2G4A
GO Biological Process	GO:0032879	regulation of localization	358	1.871404e-1	1.000000e+0	1.000000e+0	5.343583e+0	1.871404e-1	1	1.871404e-1	1.000000e+0	366	1.713304e-1	1.000000e+0	1.000000e+0	5.575093e+0	1.793692e-1	1	1618	5.000000e-1	6.180470e-4	unnamed	PTGS2
GO Biological Process	GO:0006793	phosphorus metabolic process	359	1.905359e-1	1.000000e+0	1.000000e+0	5.248354e+0	1.905359e-1	1	1.905359e-1	1.000000e+0	380	2.159254e-1	1.000000e+0	1.000000e+0	4.366167e+0	2.290339e-1	1	2066	5.000000e-1	4.840271e-4	unnamed	PLA2G4A
GO Biological Process	GO:0003008	system process	360	1.967197e-1	1.000000e+0	1.000000e+0	5.083376e+0	1.967197e-1	1	1.967197e-1	1.000000e+0	372	2.046945e-1	1.000000e+0	1.000000e+0	4.621158e+0	2.163960e-1	1	1952	5.000000e-1	5.122951e-4	unnamed	PTGS2
GO Biological Process	GO:0050793	regulation of developmental process	361	2.001040e-1	1.000000e+0	1.000000e+0	4.997401e+0	2.001040e-1	1	2.001040e-1	1.000000e+0	364	1.687044e-1	1.000000e+0	1.000000e+0	5.666143e+0	1.764869e-1	1	1592	5.000000e-1	6.281407e-4	unnamed	PTGS2
GO Biological Process	GO:0044281	small molecule metabolic process	362	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	185	1.809104e-2	1.000000e+0	1.000000e+0	7.433457e+0	2.690538e-1	2	2427	1.000000e+0	8.240626e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0010033	response to organic substance	363	2.019131e-1	1.000000e+0	1.000000e+0	4.952626e+0	2.019131e-1	1	2.019131e-1	1.000000e+0	379	2.147469e-1	1.000000e+0	1.000000e+0	4.391675e+0	2.277036e-1	1	2054	5.000000e-1	4.868549e-4	unnamed	PTGS2
GO Biological Process	GO:0009966	regulation of signal transduction	364	2.171476e-1	1.000000e+0	1.000000e+0	4.605162e+0	2.171476e-1	1	2.171476e-1	1.000000e+0	377	2.126825e-1	1.000000e+0	1.000000e+0	4.437039e+0	2.253755e-1	1	2033	5.000000e-1	4.918839e-4	unnamed	PTGS2
GO Biological Process	GO:0031325	positive regulation of cellular metabolic process	365	2.230682e-1	1.000000e+0	1.000000e+0	4.482934e+0	2.230682e-1	1	2.230682e-1	1.000000e+0	378	2.132726e-1	1.000000e+0	1.000000e+0	4.423982e+0	2.260407e-1	1	2039	5.000000e-1	4.904365e-4	unnamed	PTGS2
GO Biological Process	GO:0044765	single-organism transport	366	2.288177e-1	1.000000e+0	1.000000e+0	4.370291e+0	2.288177e-1	1	2.288177e-1	1.000000e+0	389	2.680389e-1	1.000000e+0	1.000000e+0	3.461435e+0	2.888975e-1	1	2606	5.000000e-1	3.837299e-4	unnamed	PLA2G4A
GO Biological Process	GO:0009893	positive regulation of metabolic process	367	2.357828e-1	1.000000e+0	1.000000e+0	4.241191e+0	2.357828e-1	1	2.357828e-1	1.000000e+0	381	2.244425e-1	1.000000e+0	1.000000e+0	4.189735e+0	2.386786e-1	1	2153	5.000000e-1	4.644682e-4	unnamed	PTGS2
GO Biological Process	GO:0051239	regulation of multicellular organismal process	368	2.372698e-1	1.000000e+0	1.000000e+0	4.214612e+0	2.372698e-1	1	2.372698e-1	1.000000e+0	373	2.076578e-1	1.000000e+0	1.000000e+0	4.551211e+0	2.197217e-1	1	1982	5.000000e-1	5.045409e-4	unnamed	PTGS2
GO Biological Process	GO:0006950	response to stress	369	2.428193e-1	1.000000e+0	1.000000e+0	4.118289e+0	2.428193e-1	1	2.428193e-1	1.000000e+0	229	2.694799e-2	1.000000e+0	1.000000e+0	6.090817e+0	3.283632e-1	2	2962	1.000000e+0	6.752194e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0009653	anatomical structure morphogenesis	370	2.467616e-1	1.000000e+0	1.000000e+0	4.052494e+0	2.467616e-1	1	2.467616e-1	1.000000e+0	370	1.993468e-1	1.000000e+0	1.000000e+0	4.752634e+0	2.104096e-1	1	1898	5.000000e-1	5.268704e-4	unnamed	PTGS2
GO Biological Process	GO:0010646	regulation of cell communication	371	2.469539e-1	1.000000e+0	1.000000e+0	4.049338e+0	2.469539e-1	1	2.469539e-1	1.000000e+0	384	2.372763e-1	1.000000e+0	1.000000e+0	3.947702e+0	2.533119e-1	1	2285	5.000000e-1	4.376368e-4	unnamed	PTGS2
GO Biological Process	GO:0023051	regulation of signaling	372	2.471337e-1	1.000000e+0	1.000000e+0	4.046392e+0	2.471337e-1	1	2.471337e-1	1.000000e+0	383	2.369858e-1	1.000000e+0	1.000000e+0	3.952892e+0	2.529793e-1	1	2282	5.000000e-1	4.382121e-4	unnamed	PTGS2
GO Biological Process	GO:0044710	single-organism metabolic process	373	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	237	2.877979e-2	1.000000e+0	1.000000e+0	5.893826e+0	3.393382e-1	2	3061	1.000000e+0	6.533812e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0048583	regulation of response to stimulus	374	2.696284e-1	1.000000e+0	1.000000e+0	3.708809e+0	2.696284e-1	1	2.696284e-1	1.000000e+0	391	2.749464e-1	1.000000e+0	1.000000e+0	3.367115e+0	2.969902e-1	1	2679	5.000000e-1	3.732736e-4	unnamed	PTGS2
GO Biological Process	GO:0065008	regulation of biological quality	375	2.713082e-1	1.000000e+0	1.000000e+0	3.685845e+0	2.713082e-1	1	2.713082e-1	1.000000e+0	218	2.452977e-2	1.000000e+0	1.000000e+0	6.383935e+0	3.132864e-1	2	2826	1.000000e+0	7.077141e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0006810	transport	376	2.770578e-1	1.000000e+0	1.000000e+0	3.609355e+0	2.770578e-1	1	2.770578e-1	1.000000e+0	396	3.291182e-1	1.000000e+0	1.000000e+0	2.763634e+0	3.618425e-1	1	3264	5.000000e-1	3.063725e-4	unnamed	PLA2G4A
GO Biological Process	GO:0048513	organ development	377	2.824258e-1	1.000000e+0	1.000000e+0	3.540753e+0	2.824258e-1	1	2.824258e-1	1.000000e+0	386	2.446169e-1	1.000000e+0	1.000000e+0	3.820627e+0	2.617372e-1	1	2361	5.000000e-1	4.235493e-4	unnamed	PTGS2
GO Biological Process	GO:0051234	establishment of localization	378	2.827781e-1	1.000000e+0	1.000000e+0	3.536342e+0	2.827781e-1	1	2.827781e-1	1.000000e+0	399	3.336507e-1	1.000000e+0	1.000000e+0	2.721937e+0	3.673854e-1	1	3314	5.000000e-1	3.017502e-4	unnamed	PLA2G4A
GO Biological Process	GO:0042221	response to chemical stimulus	379	2.954524e-1	1.000000e+0	1.000000e+0	3.384640e+0	2.954524e-1	1	2.954524e-1	1.000000e+0	250	3.351109e-2	1.000000e+0	1.000000e+0	5.462004e+0	3.661660e-1	2	3303	1.000000e+0	6.055101e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0048523	negative regulation of cellular process	380	3.146568e-1	1.000000e+0	1.000000e+0	3.178065e+0	3.146568e-1	1	3.146568e-1	1.000000e+0	394	3.089005e-1	1.000000e+0	1.000000e+0	2.964344e+0	3.373427e-1	1	3043	5.000000e-1	3.286231e-4	unnamed	PTGS2
GO Biological Process	GO:0030154	cell differentiation	381	3.160741e-1	1.000000e+0	1.000000e+0	3.163815e+0	3.160741e-1	1	3.160741e-1	1.000000e+0	390	2.690819e-1	1.000000e+0	1.000000e+0	3.446886e+0	2.901170e-1	1	2617	5.000000e-1	3.821169e-4	unnamed	PTGS2
GO Biological Process	GO:0048869	cellular developmental process	382	3.225257e-1	1.000000e+0	1.000000e+0	3.100528e+0	3.225257e-1	1	3.225257e-1	1.000000e+0	392	2.802231e-1	1.000000e+0	1.000000e+0	3.298172e+0	3.031983e-1	1	2735	5.000000e-1	3.656307e-4	unnamed	PTGS2
GO Biological Process	GO:0048519	negative regulation of biological process	383	3.368683e-1	1.000000e+0	1.000000e+0	2.968519e+0	3.368683e-1	1	3.368683e-1	1.000000e+0	400	3.341936e-1	1.000000e+0	1.000000e+0	2.717018e+0	3.680506e-1	1	3320	5.000000e-1	3.012048e-4	unnamed	PTGS2
GO Biological Process	GO:0048522	positive regulation of cellular process	384	3.411192e-1	1.000000e+0	1.000000e+0	2.931526e+0	3.411192e-1	1	3.411192e-1	1.000000e+0	397	3.331076e-1	1.000000e+0	1.000000e+0	2.726874e+0	3.667202e-1	1	3308	5.000000e-1	3.022975e-4	unnamed	PTGS2
GO Biological Process	GO:0031326	regulation of cellular biosynthetic process	385	3.434354e-1	1.000000e+0	1.000000e+0	2.911756e+0	3.434354e-1	1	3.434354e-1	1.000000e+0	403	3.710294e-1	1.000000e+0	1.000000e+0	2.416421e+0	4.138352e-1	1	3733	5.000000e-1	2.678811e-4	unnamed	PTGS2
GO Biological Process	GO:0009889	regulation of biosynthetic process	386	3.455319e-1	1.000000e+0	1.000000e+0	2.894089e+0	3.455319e-1	1	3.455319e-1	1.000000e+0	404	3.736643e-1	1.000000e+0	1.000000e+0	2.397157e+0	4.171609e-1	1	3763	5.000000e-1	2.657454e-4	unnamed	PTGS2
GO Biological Process	GO:0044249	cellular biosynthetic process	387	3.470471e-1	1.000000e+0	1.000000e+0	2.881453e+0	3.470471e-1	1	3.470471e-1	1.000000e+0	285	5.201600e-2	1.000000e+0	1.000000e+0	4.384204e+0	4.561831e-1	2	4115	1.000000e+0	4.860267e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:1901576	organic substance biosynthetic process	388	3.536536e-1	1.000000e+0	1.000000e+0	2.827626e+0	3.536536e-1	1	3.536536e-1	1.000000e+0	289	5.431647e-2	1.000000e+0	1.000000e+0	4.290369e+0	4.661604e-1	2	4205	1.000000e+0	4.756243e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0009058	biosynthetic process	389	3.586722e-1	1.000000e+0	1.000000e+0	2.788061e+0	3.586722e-1	1	3.586722e-1	1.000000e+0	293	5.616641e-2	1.000000e+0	1.000000e+0	4.219130e+0	4.740314e-1	2	4276	1.000000e+0	4.677268e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0051179	localization	390	3.597525e-1	1.000000e+0	1.000000e+0	2.779689e+0	3.597525e-1	1	3.597525e-1	1.000000e+0	409	3.970433e-1	1.000000e+0	1.000000e+0	2.237227e+0	4.469819e-1	1	4032	5.000000e-1	2.480159e-4	unnamed	PLA2G4A
GO Biological Process	GO:0051171	regulation of nitrogen compound metabolic process	391	3.708892e-1	1.000000e+0	1.000000e+0	2.696223e+0	3.708892e-1	1	3.708892e-1	1.000000e+0	408	3.955790e-1	1.000000e+0	1.000000e+0	2.246700e+0	4.450973e-1	1	4015	5.000000e-1	2.490660e-4	unnamed	PTGS2
GO Biological Process	GO:0048518	positive regulation of biological process	392	3.729968e-1	1.000000e+0	1.000000e+0	2.680988e+0	3.729968e-1	1	3.729968e-1	1.000000e+0	402	3.689175e-1	1.000000e+0	1.000000e+0	2.432057e+0	4.111745e-1	1	3709	5.000000e-1	2.696145e-4	unnamed	PTGS2
GO Biological Process	GO:0044767	single-organism developmental process	393	3.730678e-1	1.000000e+0	1.000000e+0	2.680478e+0	3.730678e-1	1	3.730678e-1	1.000000e+0	397	3.331076e-1	1.000000e+0	1.000000e+0	2.726874e+0	3.667202e-1	1	3308	5.000000e-1	3.022975e-4	unnamed	PTGS2
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	394	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	411	4.663767e-1	1.000000e+0	1.000000e+0	1.855306e+0	5.389945e-1	1	4862	5.000000e-1	2.056767e-4	unnamed	PLA2G4A
GO Biological Process	GO:0048731	system development	395	3.900631e-1	1.000000e+0	1.000000e+0	2.563688e+0	3.900631e-1	1	3.900631e-1	1.000000e+0	401	3.405107e-1	1.000000e+0	1.000000e+0	2.660914e+0	3.758107e-1	1	3390	5.000000e-1	2.949853e-4	unnamed	PTGS2
GO Biological Process	GO:0006807	nitrogen compound metabolic process	396	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	414	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	PLA2G4A
GO Biological Process	GO:0048856	anatomical structure development	397	4.234725e-1	1.000000e+0	1.000000e+0	2.361429e+0	4.234725e-1	1	4.234725e-1	1.000000e+0	406	3.845834e-1	1.000000e+0	1.000000e+0	2.320087e+0	4.310182e-1	1	3888	5.000000e-1	2.572016e-4	unnamed	PTGS2
GO Biological Process	GO:0007275	multicellular organismal development	398	4.357034e-1	1.000000e+0	1.000000e+0	2.295139e+0	4.357034e-1	1	4.357034e-1	1.000000e+0	407	3.919536e-1	1.000000e+0	1.000000e+0	2.270451e+0	4.404412e-1	1	3973	5.000000e-1	2.516990e-4	unnamed	PTGS2
GO Biological Process	GO:0080090	regulation of primary metabolic process	399	4.363900e-1	1.000000e+0	1.000000e+0	2.291528e+0	4.363900e-1	1	4.363900e-1	1.000000e+0	412	4.714664e-1	1.000000e+0	1.000000e+0	1.831574e+0	5.459786e-1	1	4925	5.000000e-1	2.030457e-4	unnamed	PTGS2
GO Biological Process	GO:0031323	regulation of cellular metabolic process	400	4.406599e-1	1.000000e+0	1.000000e+0	2.269324e+0	4.406599e-1	1	4.406599e-1	1.000000e+0	413	4.760505e-1	1.000000e+0	1.000000e+0	1.810618e+0	5.522975e-1	1	4982	5.000000e-1	2.007226e-4	unnamed	PTGS2
GO Biological Process	GO:0051716	cellular response to stimulus	401	4.562761e-1	1.000000e+0	1.000000e+0	2.191655e+0	4.562761e-1	1	4.562761e-1	1.000000e+0	328	8.743600e-2	1.000000e+0	1.000000e+0	3.381631e+0	5.914306e-1	2	5335	1.000000e+0	3.748828e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0032502	developmental process	402	4.657420e-1	1.000000e+0	1.000000e+0	2.147111e+0	4.657420e-1	1	4.657420e-1	1.000000e+0	410	4.306509e-1	1.000000e+0	1.000000e+0	2.037150e+0	4.908819e-1	1	4428	5.000000e-1	2.258356e-4	unnamed	PTGS2
GO Biological Process	GO:0019222	regulation of metabolic process	403	4.728179e-1	1.000000e+0	1.000000e+0	2.114979e+0	4.728179e-1	1	4.728179e-1	1.000000e+0	415	5.177180e-1	1.000000e+0	1.000000e+0	1.636520e+0	6.110526e-1	1	5512	5.000000e-1	1.814224e-4	unnamed	PTGS2
GO Biological Process	GO:0044707	single-multicellular organism process	404	5.372858e-1	1.000000e+0	1.000000e+0	1.861207e+0	5.372858e-1	1	5.372858e-1	1.000000e+0	332	9.848405e-2	1.000000e+0	1.000000e+0	3.186330e+0	6.276814e-1	2	5662	1.000000e+0	3.532321e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0050896	response to stimulus	405	5.533212e-1	1.000000e+0	1.000000e+0	1.807268e+0	5.533212e-1	1	5.533212e-1	1.000000e+0	358	1.457136e-1	1.000000e+0	1.000000e+0	2.619573e+0	7.634832e-1	2	6887	1.000000e+0	2.904022e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0032501	multicellular organismal process	406	5.539872e-1	1.000000e+0	1.000000e+0	1.805096e+0	5.539872e-1	1	5.539872e-1	1.000000e+0	336	1.064675e-1	1.000000e+0	1.000000e+0	3.064549e+0	6.526246e-1	2	5887	1.000000e+0	3.397316e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0044237	cellular metabolic process	407	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	374	2.082916e-1	1.000000e+0	1.000000e+0	2.191037e+0	9.128097e-1	2	8234	1.000000e+0	2.428953e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0044238	primary metabolic process	408	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	376	2.124101e-1	1.000000e+0	1.000000e+0	2.169693e+0	9.217893e-1	2	8315	1.000000e+0	2.405292e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0071704	organic substance metabolic process	409	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	382	2.252177e-1	1.000000e+0	1.000000e+0	2.107101e+0	9.491713e-1	2	8562	1.000000e+0	2.335903e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0008152	metabolic process	410	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	387	2.598086e-1	1.000000e+0	1.000000e+0	1.961831e+0	1.019456e+0	2	9196	1.000000e+0	2.174859e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0050794	regulation of cellular process	411	6.759845e-1	1.000000e+0	1.000000e+0	1.479324e+0	6.759845e-1	1	6.759845e-1	1.000000e+0	385	2.408423e-1	1.000000e+0	1.000000e+0	2.037610e+0	9.815420e-1	2	8854	1.000000e+0	2.258866e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0050789	regulation of biological process	412	6.921477e-1	1.000000e+0	1.000000e+0	1.444778e+0	6.921477e-1	1	6.921477e-1	1.000000e+0	388	2.673785e-1	1.000000e+0	1.000000e+0	1.933862e+0	1.034200e+0	2	9329	1.000000e+0	2.143853e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0065007	biological regulation	413	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	393	2.982605e-1	1.000000e+0	1.000000e+0	1.831016e+0	1.092290e+0	2	9853	1.000000e+0	2.029839e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0044763	single-organism cellular process	414	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	395	3.141478e-1	1.000000e+0	1.000000e+0	1.784118e+0	1.121002e+0	2	10112	1.000000e+0	1.977848e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0044699	single-organism process	415	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	405	3.800402e-1	1.000000e+0	1.000000e+0	1.622100e+0	1.232969e+0	2	11122	1.000000e+0	1.798238e-4	unnamed	PLA2G4A,PTGS2
GO Biological Process	GO:0009987	cellular process	416	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	416	5.606826e-1	1.000000e+0	1.000000e+0	1.335480e+0	1.497589e+0	2	13509	1.000000e+0	1.480494e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0005743	mitochondrial inner membrane	1	2.386818e-2	1.000000e+0	1.000000e+0	4.189679e+1	2.386818e-2	1	2.386818e-2	1.000000e+0	7	4.103249e-2	1.000000e+0	1.000000e+0	2.411898e+1	4.146112e-2	1	374	5.000000e-1	2.673797e-3	unnamed	PLA2G4A
GO Cellular Component	GO:0019866	organelle inner membrane	2	2.738529e-2	1.000000e+0	1.000000e+0	3.651595e+1	2.738529e-2	1	2.738529e-2	1.000000e+0	8	4.472009e-2	1.000000e+0	1.000000e+0	2.210907e+1	4.523031e-2	1	408	5.000000e-1	2.450980e-3	unnamed	PLA2G4A
GO Cellular Component	GO:0031966	mitochondrial membrane	3	3.702819e-2	1.000000e+0	1.000000e+0	2.700645e+1	3.702819e-2	1	3.702819e-2	1.000000e+0	9	5.800120e-2	1.000000e+0	1.000000e+0	1.698776e+1	5.886592e-2	1	531	5.000000e-1	1.883239e-3	unnamed	PLA2G4A
GO Cellular Component	GO:0005740	mitochondrial envelope	4	3.831325e-2	1.000000e+0	1.000000e+0	2.610063e+1	3.831325e-2	1	3.831325e-2	1.000000e+0	10	6.090412e-2	1.000000e+0	1.000000e+0	1.616577e+1	6.185910e-2	1	558	5.000000e-1	1.792115e-3	unnamed	PLA2G4A
GO Cellular Component	GO:0044429	mitochondrial part	5	5.499540e-2	1.000000e+0	1.000000e+0	1.818334e+1	5.499540e-2	1	5.499540e-2	1.000000e+0	12	8.598112e-2	1.000000e+0	1.000000e+0	1.137516e+1	8.791087e-2	1	793	5.000000e-1	1.261034e-3	unnamed	PLA2G4A
GO Cellular Component	GO:0005789	endoplasmic reticulum membrane	6	6.490642e-2	1.000000e+0	1.000000e+0	1.540680e+1	6.490642e-2	1	6.490642e-2	1.000000e+0	1	1.900641e-3	1.000000e+0	1.000000e+0	2.292376e+1	8.724572e-2	2	787	1.000000e+0	2.541296e-3	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0042175	nuclear outer membrane-endoplasmic reticulum membrane network	7	6.714499e-2	1.000000e+0	1.000000e+0	1.489314e+1	6.714499e-2	1	6.714499e-2	1.000000e+0	2	1.993581e-3	1.000000e+0	1.000000e+0	2.238337e+1	8.935203e-2	2	806	1.000000e+0	2.481390e-3	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0031967	organelle envelope	8	6.812257e-2	1.000000e+0	1.000000e+0	1.467942e+1	6.812257e-2	1	6.812257e-2	1.000000e+0	14	9.359637e-2	1.000000e+0	1.000000e+0	1.042832e+1	9.589269e-2	1	865	5.000000e-1	1.156069e-3	unnamed	PLA2G4A
GO Cellular Component	GO:0031975	envelope	9	6.827720e-2	1.000000e+0	1.000000e+0	1.464618e+1	6.827720e-2	1	6.827720e-2	1.000000e+0	15	9.401850e-2	1.000000e+0	1.000000e+0	1.038032e+1	9.633612e-2	1	869	5.000000e-1	1.150748e-3	unnamed	PLA2G4A
GO Cellular Component	GO:0044432	endoplasmic reticulum part	10	7.857548e-2	1.000000e+0	1.000000e+0	1.272662e+1	7.857548e-2	1	7.857548e-2	1.000000e+0	3	2.712041e-3	1.000000e+0	1.000000e+0	1.919255e+1	1.042071e-1	2	940	1.000000e+0	2.127660e-3	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0016023	cytoplasmic membrane-bounded vesicle	11	8.772555e-2	1.000000e+0	1.000000e+0	1.139919e+1	8.772555e-2	1	8.772555e-2	1.000000e+0	16	9.949731e-2	1.000000e+0	1.000000e+0	9.794245e+0	1.021008e-1	1	921	5.000000e-1	1.085776e-3	unnamed	PLA2G4A
GO Cellular Component	GO:0031988	membrane-bounded vesicle	12	9.310199e-2	1.000000e+0	1.000000e+0	1.074091e+1	9.310199e-2	1	9.310199e-2	1.000000e+0	17	1.061128e-1	1.000000e+0	1.000000e+0	9.167175e+0	1.090849e-1	1	984	5.000000e-1	1.016260e-3	unnamed	PLA2G4A
GO Cellular Component	GO:0031410	cytoplasmic vesicle	13	9.330829e-2	1.000000e+0	1.000000e+0	1.071716e+1	9.330829e-2	1	9.330829e-2	1.000000e+0	18	1.070559e-1	1.000000e+0	1.000000e+0	9.084089e+0	1.100826e-1	1	993	5.000000e-1	1.007049e-3	unnamed	PLA2G4A
GO Cellular Component	GO:0043005	neuron projection	14	9.775274e-2	1.000000e+0	1.000000e+0	1.022989e+1	9.775274e-2	1	9.775274e-2	1.000000e+0	11	7.108250e-2	1.000000e+0	1.000000e+0	1.381394e+1	7.239067e-2	1	653	5.000000e-1	1.531394e-3	unnamed	PTGS2
GO Cellular Component	GO:0031982	vesicle	15	1.007261e-1	1.000000e+0	1.000000e+0	9.927917e+0	1.007261e-1	1	1.007261e-1	1.000000e+0	19	1.159383e-1	1.000000e+0	1.000000e+0	8.367811e+0	1.195056e-1	1	1078	5.000000e-1	9.276438e-4	unnamed	PLA2G4A
GO Cellular Component	GO:0097458	neuron part	16	1.147756e-1	1.000000e+0	1.000000e+0	8.712655e+0	1.147756e-1	1	1.147756e-1	1.000000e+0	13	8.714662e-2	1.000000e+0	1.000000e+0	1.121953e+1	8.913031e-2	1	804	5.000000e-1	1.243781e-3	unnamed	PTGS2
GO Cellular Component	GO:0005783	endoplasmic reticulum	17	1.167593e-1	1.000000e+0	1.000000e+0	8.564628e+0	1.167593e-1	1	1.167593e-1	1.000000e+0	4	5.562502e-3	1.000000e+0	1.000000e+0	1.340342e+1	1.492157e-1	2	1346	1.000000e+0	1.485884e-3	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0005739	mitochondrion	18	1.171632e-1	1.000000e+0	1.000000e+0	8.535104e+0	1.171632e-1	1	1.171632e-1	1.000000e+0	26	1.680979e-1	1.000000e+0	1.000000e+0	5.687579e+0	1.758217e-1	1	1586	5.000000e-1	6.305170e-4	unnamed	PLA2G4A
GO Cellular Component	GO:0005794	Golgi apparatus	19	1.250692e-1	1.000000e+0	1.000000e+0	7.995574e+0	1.250692e-1	1	1.250692e-1	1.000000e+0	22	1.300577e-1	1.000000e+0	1.000000e+0	7.430395e+0	1.345823e-1	1	1214	5.000000e-1	8.237232e-4	unnamed	PLA2G4A
GO Cellular Component	GO:0012505	endomembrane system	20	1.513815e-1	1.000000e+0	1.000000e+0	6.605825e+0	1.513815e-1	1	1.513815e-1	1.000000e+0	5	8.319526e-3	1.000000e+0	1.000000e+0	1.096051e+1	1.824733e-1	2	1646	1.000000e+0	1.215067e-3	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0042995	cell projection	21	1.598517e-1	1.000000e+0	1.000000e+0	6.255796e+0	1.598517e-1	1	1.598517e-1	1.000000e+0	24	1.387218e-1	1.000000e+0	1.000000e+0	6.949538e+0	1.438945e-1	1	1298	5.000000e-1	7.704160e-4	unnamed	PTGS2
GO Cellular Component	GO:0005829	cytosol	22	2.084988e-1	1.000000e+0	1.000000e+0	4.796191e+0	2.084988e-1	1	2.084988e-1	1.000000e+0	28	2.663307e-1	1.000000e+0	1.000000e+0	3.485510e+0	2.869021e-1	1	2588	5.000000e-1	3.863988e-4	unnamed	PLA2G4A
GO Cellular Component	GO:0031090	organelle membrane	23	2.131131e-1	1.000000e+0	1.000000e+0	4.692344e+0	2.131131e-1	1	2.131131e-1	1.000000e+0	6	2.034938e-2	1.000000e+0	1.000000e+0	7.008936e+0	2.853500e-1	2	2574	1.000000e+0	7.770008e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0043234	protein complex	24	3.027166e-1	1.000000e+0	1.000000e+0	3.303419e+0	3.027166e-1	1	3.027166e-1	1.000000e+0	32	3.630030e-1	1.000000e+0	1.000000e+0	2.476798e+0	4.037470e-1	1	3642	5.000000e-1	2.745744e-4	unnamed	PTGS2
GO Cellular Component	GO:0032991	macromolecular complex	25	3.347910e-1	1.000000e+0	1.000000e+0	2.986938e+0	3.347910e-1	1	3.347910e-1	1.000000e+0	35	4.132884e-1	1.000000e+0	1.000000e+0	2.136547e+0	4.680450e-1	1	4222	5.000000e-1	2.368546e-4	unnamed	PTGS2
GO Cellular Component	GO:0044446	intracellular organelle part	26	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	21	1.292379e-1	1.000000e+0	1.000000e+0	2.781529e+0	7.190289e-1	2	6486	1.000000e+0	3.083565e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0005634	nucleus	27	4.766312e-1	1.000000e+0	1.000000e+0	2.098058e+0	4.766312e-1	1	4.766312e-1	1.000000e+0	38	5.600157e-1	1.000000e+0	1.000000e+0	1.485100e+0	6.733551e-1	1	6074	5.000000e-1	1.646362e-4	unnamed	PTGS2
GO Cellular Component	GO:0044422	organelle part	28	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	23	1.337401e-1	1.000000e+0	1.000000e+0	2.734313e+0	7.314450e-1	2	6598	1.000000e+0	3.031222e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0044444	cytoplasmic part	29	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	25	1.519576e-1	1.000000e+0	1.000000e+0	2.565193e+0	7.796685e-1	2	7033	1.000000e+0	2.843737e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0044425	membrane part	30	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	20	1.178243e-1	1.000000e+0	1.000000e+0	2.913128e+0	6.865473e-1	2	6193	1.000000e+0	3.229453e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0016020	membrane	31	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	27	1.895088e-1	1.000000e+0	1.000000e+0	2.297046e+0	8.706834e-1	2	7854	1.000000e+0	2.546473e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0005737	cytoplasm	32	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	29	2.746502e-1	1.000000e+0	1.000000e+0	1.908091e+0	1.048168e+0	2	9455	1.000000e+0	2.115283e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	33	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	30	3.079649e-1	1.000000e+0	1.000000e+0	1.801938e+0	1.109916e+0	2	10012	1.000000e+0	1.997603e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0043227	membrane-bounded organelle	34	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	31	3.100602e-1	1.000000e+0	1.000000e+0	1.795839e+0	1.113685e+0	2	10046	1.000000e+0	1.990842e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0043229	intracellular organelle	35	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	33	3.712075e-1	1.000000e+0	1.000000e+0	1.641285e+0	1.218558e+0	2	10992	1.000000e+0	1.819505e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0043226	organelle	36	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	34	3.733721e-1	1.000000e+0	1.000000e+0	1.636520e+0	1.222105e+0	2	11024	1.000000e+0	1.814224e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0044424	intracellular part	37	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	36	4.860618e-1	1.000000e+0	1.000000e+0	1.434330e+0	1.394379e+0	2	12578	1.000000e+0	1.590078e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0005622	intracellular	38	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	37	4.992900e-1	1.000000e+0	1.000000e+0	1.415202e+0	1.413225e+0	2	12748	1.000000e+0	1.568874e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0044464	cell part	39	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	39	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	PLA2G4A,PTGS2
GO Cellular Component	GO:0005623	cell	40	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	40	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0011383	abnormal kidney capsule morphology	1	1.250564e-4	9.901966e-1	9.901966e-1	7.996393e+3	1.250564e-4	1	1.250564e-4	1.000000e+0	20	1.108586e-4	8.777784e-1	4.388892e-2	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	PTGS2
Mouse Phenotype	MP:0004155	decreased susceptibility to induced pancreatitis	2	1.969637e-4	1.000000e+0	7.797793e-1	5.077077e+3	1.969637e-4	1	1.969637e-4	1.000000e+0	45	4.433975e-4	1.000000e+0	7.801825e-2	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	PTGS2
Mouse Phenotype	MP:0009148	pancreas necrosis	3	2.098821e-4	1.000000e+0	5.539488e-1	4.764580e+3	2.098821e-4	1	2.098821e-4	1.000000e+0	37	3.325574e-4	1.000000e+0	7.116728e-2	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	PTGS2
Mouse Phenotype	MP:0008095	abnormal memory B cell differentiation	4	2.120252e-4	1.000000e+0	4.197039e-1	4.716422e+3	2.120252e-4	1	2.120252e-4	1.000000e+0	37	3.325574e-4	1.000000e+0	7.116728e-2	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	PTGS2
Mouse Phenotype	MP:0011403	pyelonephritis	5	2.549339e-4	1.000000e+0	4.037133e-1	3.922585e+3	2.549339e-4	1	2.549339e-4	1.000000e+0	56	5.542315e-4	1.000000e+0	7.836438e-2	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	PTGS2
Mouse Phenotype	MP:0011563	increased urine prostaglandin level	6	2.840587e-4	1.000000e+0	3.748628e-1	3.520400e+3	2.840587e-4	1	2.840587e-4	1.000000e+0	45	4.433975e-4	1.000000e+0	7.801825e-2	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	PTGS2
Mouse Phenotype	MP:0004504	decreased incidence of tumors by UV induction	7	3.003227e-4	1.000000e+0	3.397079e-1	3.329752e+3	3.003227e-4	1	3.003227e-4	1.000000e+0	56	5.542315e-4	1.000000e+0	7.836438e-2	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	PTGS2
Mouse Phenotype	MP:0011564	decreased urine prostaglandin level	8	3.394570e-4	1.000000e+0	3.359776e-1	2.945881e+3	3.394570e-4	1	3.394570e-4	1.000000e+0	37	3.325574e-4	1.000000e+0	7.116728e-2	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	PTGS2
Mouse Phenotype	MP:0011408	renal tubule hypertrophy	9	4.525868e-4	1.000000e+0	3.981758e-1	2.209521e+3	4.525868e-4	1	4.525868e-4	1.000000e+0	45	4.433975e-4	1.000000e+0	7.801825e-2	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	PTGS2
Mouse Phenotype	MP:0011562	abnormal urine prostaglandin level	10	4.984593e-4	1.000000e+0	3.946801e-1	2.006182e+3	4.984593e-4	1	4.984593e-4	1.000000e+0	63	6.650594e-4	1.000000e+0	8.358635e-2	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	PTGS2
Mouse Phenotype	MP:0005462	abnormal mast cell differentiation	11	5.982978e-4	1.000000e+0	4.306656e-1	1.671408e+3	5.982978e-4	1	5.982978e-4	1.000000e+0	45	4.433975e-4	1.000000e+0	7.801825e-2	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	PLA2G4A
Mouse Phenotype	MP:0003422	abnormal thrombolysis	12	6.590629e-4	1.000000e+0	4.348717e-1	1.517306e+3	6.590629e-4	1	6.590629e-4	1.000000e+0	76	9.975062e-4	1.000000e+0	1.039244e-1	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	PTGS2
Mouse Phenotype	MP:0011308	kidney corticomedullary cysts	13	7.006366e-4	1.000000e+0	4.267416e-1	1.427273e+3	7.006366e-4	1	7.006366e-4	1.000000e+0	56	5.542315e-4	1.000000e+0	7.836438e-2	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	PTGS2
Mouse Phenotype	MP:0003426	pulmonary interstitial fibrosis	14	7.478374e-4	1.000000e+0	4.229555e-1	1.337189e+3	7.478374e-4	1	7.478374e-4	1.000000e+0	76	9.975062e-4	1.000000e+0	1.039244e-1	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	PTGS2
Mouse Phenotype	MP:0011352	proximal convoluted tubule brush border loss	15	7.493280e-4	1.000000e+0	3.955453e-1	1.334529e+3	7.493280e-4	1	7.493280e-4	1.000000e+0	76	9.975062e-4	1.000000e+0	1.039244e-1	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	PTGS2
Mouse Phenotype	MP:0011534	granular kidney	16	8.464559e-4	1.000000e+0	4.188899e-1	1.181396e+3	8.464559e-4	1	8.464559e-4	1.000000e+0	68	7.758812e-4	1.000000e+0	9.034452e-2	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	PTGS2
Mouse Phenotype	MP:0005571	decreased lactate dehydrogenase level	17	8.500214e-4	1.000000e+0	3.959100e-1	1.176441e+3	8.500214e-4	1	8.500214e-4	1.000000e+0	84	1.108309e-3	1.000000e+0	1.044713e-1	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	PTGS2
Mouse Phenotype	MP:0004867	decreased platelet calcium level	18	8.532167e-4	1.000000e+0	3.753205e-1	1.172035e+3	8.532167e-4	1	8.532167e-4	1.000000e+0	71	8.866967e-4	1.000000e+0	9.888542e-2	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	PTGS2
Mouse Phenotype	MP:0003269	colon polyps	19	8.835779e-4	1.000000e+0	3.682195e-1	1.131762e+3	8.835779e-4	1	8.835779e-4	1.000000e+0	101	1.551461e-3	1.000000e+0	1.216284e-1	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003045	fibrosis	20	9.526964e-4	1.000000e+0	3.771725e-1	1.049652e+3	9.526964e-4	1	9.526964e-4	1.000000e+0	63	6.650594e-4	1.000000e+0	8.358635e-2	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	PTGS2
Mouse Phenotype	MP:0003033	abnormal pulmonary vascular resistance	21	1.015407e-3	1.000000e+0	3.828568e-1	9.848264e+2	1.015407e-3	1	1.015407e-3	1.000000e+0	45	4.433975e-4	1.000000e+0	7.801825e-2	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	PLA2G4A
Mouse Phenotype	MP:0012008	delayed parturition	22	1.030449e-3	1.000000e+0	3.708680e-1	9.704512e+2	1.030449e-3	1	1.030449e-3	1.000000e+0	63	6.650594e-4	1.000000e+0	8.358635e-2	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	PTGS2
Mouse Phenotype	MP:0012010	parturition failure	23	1.117984e-3	1.000000e+0	3.848781e-1	8.944668e+2	1.117984e-3	1	1.117984e-3	1.000000e+0	56	5.542315e-4	1.000000e+0	7.836438e-2	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	PLA2G4A
Mouse Phenotype	MP:0010936	decreased airway resistance	24	1.173248e-3	1.000000e+0	3.870741e-1	8.523345e+2	1.173248e-3	1	1.173248e-3	1.000000e+0	68	7.758812e-4	1.000000e+0	9.034452e-2	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	PLA2G4A
Mouse Phenotype	MP:0003299	gastric polyps	25	1.216025e-3	1.000000e+0	3.851394e-1	8.223515e+2	1.216025e-3	1	1.216025e-3	1.000000e+0	68	7.758812e-4	1.000000e+0	9.034452e-2	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	PTGS2
Mouse Phenotype	MP:0003829	impaired febrile response	26	1.217264e-3	1.000000e+0	3.707037e-1	8.215148e+2	1.217264e-3	1	1.217264e-3	1.000000e+0	91	1.329898e-3	1.000000e+0	1.157157e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	PTGS2
Mouse Phenotype	MP:0009815	decreased prostaglandin level	27	1.222859e-3	1.000000e+0	3.586147e-1	8.177559e+2	1.222859e-3	1	1.222859e-3	1.000000e+0	118	1.883760e-3	1.000000e+0	1.264035e-1	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003288	intestinal edema	28	1.235030e-3	1.000000e+0	3.492488e-1	8.096972e+2	1.235030e-3	1	1.235030e-3	1.000000e+0	118	1.883760e-3	1.000000e+0	1.264035e-1	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	PTGS2
Mouse Phenotype	MP:0011377	renal glomerulus fibrosis	29	1.306415e-3	1.000000e+0	3.566963e-1	7.654534e+2	1.306415e-3	1	1.306415e-3	1.000000e+0	112	1.773000e-3	1.000000e+0	1.253448e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003626	kidney medulla hypoplasia	30	1.310192e-3	1.000000e+0	3.458033e-1	7.632471e+2	1.310192e-3	1	1.310192e-3	1.000000e+0	76	9.975062e-4	1.000000e+0	1.039244e-1	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	PTGS2
Mouse Phenotype	MP:0008764	increased mast cell degranulation	31	1.310799e-3	1.000000e+0	3.348034e-1	7.628932e+2	1.310799e-3	1	1.310799e-3	1.000000e+0	91	1.329898e-3	1.000000e+0	1.157157e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0009814	increased prostaglandin level	32	1.388483e-3	1.000000e+0	3.435628e-1	7.202102e+2	1.388483e-3	1	1.388483e-3	1.000000e+0	112	1.773000e-3	1.000000e+0	1.253448e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003303	peritoneal inflammation	33	1.392348e-3	1.000000e+0	3.340791e-1	7.182110e+2	1.392348e-3	1	1.392348e-3	1.000000e+0	122	1.994515e-3	1.000000e+0	1.294473e-1	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	PTGS2
Mouse Phenotype	MP:0011423	kidney cortex atrophy	34	1.410426e-3	1.000000e+0	3.284633e-1	7.090057e+2	1.410426e-3	1	1.410426e-3	1.000000e+0	105	1.662234e-3	1.000000e+0	1.253483e-1	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003177	allodynia	35	1.435207e-3	1.000000e+0	3.246848e-1	6.967638e+2	1.435207e-3	1	1.435207e-3	1.000000e+0	91	1.329898e-3	1.000000e+0	1.157157e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	PTGS2
Mouse Phenotype	MP:0011350	abnormal proximal convoluted tubule brush border morphology	36	1.444855e-3	1.000000e+0	3.177878e-1	6.921111e+2	1.444855e-3	1	1.444855e-3	1.000000e+0	86	1.219107e-3	1.000000e+0	1.122429e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002999	abnormal bone healing	37	1.473976e-3	1.000000e+0	3.154309e-1	6.784369e+2	1.473976e-3	1	1.473976e-3	1.000000e+0	86	1.219107e-3	1.000000e+0	1.122429e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002440	abnormal memory B cell morphology	38	1.482302e-3	1.000000e+0	3.088649e-1	6.746261e+2	1.482302e-3	1	1.482302e-3	1.000000e+0	112	1.773000e-3	1.000000e+0	1.253448e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008997	increased blood osmolality	39	1.499178e-3	1.000000e+0	3.043716e-1	6.670320e+2	1.499178e-3	1	1.499178e-3	1.000000e+0	129	2.216004e-3	1.000000e+0	1.360180e-1	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0003197	nephrocalcinosis	40	1.511099e-3	1.000000e+0	2.991220e-1	6.617700e+2	1.511099e-3	1	1.511099e-3	1.000000e+0	137	2.548193e-3	1.000000e+0	1.472744e-1	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008996	abnormal blood osmolality	41	1.568503e-3	1.000000e+0	3.029124e-1	6.375504e+2	1.568503e-3	1	1.568503e-3	1.000000e+0	131	2.326740e-3	1.000000e+0	1.406346e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0009373	abnormal cumulus expansion	42	1.652199e-3	1.000000e+0	3.114788e-1	6.052539e+2	1.652199e-3	1	1.652199e-3	1.000000e+0	96	1.440682e-3	1.000000e+0	1.188263e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008004	abnormal stomach pH	43	1.842663e-3	1.000000e+0	3.393071e-1	5.426929e+2	1.842663e-3	1	1.842663e-3	1.000000e+0	122	1.994515e-3	1.000000e+0	1.294473e-1	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004031	insulitis	44	1.929583e-3	1.000000e+0	3.472372e-1	5.182468e+2	1.929583e-3	1	1.929583e-3	1.000000e+0	149	3.212404e-3	1.000000e+0	1.707102e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0003071	decreased vascular permeability	45	2.068456e-3	1.000000e+0	3.639563e-1	4.834525e+2	2.068456e-3	1	2.068456e-3	1.000000e+0	126	2.105263e-3	1.000000e+0	1.322974e-1	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	PTGS2
Mouse Phenotype	MP:0009401	increased skeletal muscle fiber diameter	46	2.100110e-3	1.000000e+0	3.614928e-1	4.761655e+2	2.100110e-3	1	2.100110e-3	1.000000e+0	91	1.329898e-3	1.000000e+0	1.157157e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0011376	abnormal kidney corticomedullary boundary morphology	47	2.118436e-3	1.000000e+0	3.568889e-1	4.720464e+2	2.118436e-3	1	2.118436e-3	1.000000e+0	91	1.329898e-3	1.000000e+0	1.157157e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008907	decreased total fat pad weight	48	2.128592e-3	1.000000e+0	3.511290e-1	4.697940e+2	2.128592e-3	1	2.128592e-3	1.000000e+0	105	1.662234e-3	1.000000e+0	1.253483e-1	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	PTGS2
Mouse Phenotype	MP:0009660	abnormal induced retinal neovascularization	49	2.132790e-3	1.000000e+0	3.446415e-1	4.688694e+2	2.132790e-3	1	2.132790e-3	1.000000e+0	131	2.326740e-3	1.000000e+0	1.406346e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	PTGS2
Mouse Phenotype	MP:0011452	decreased susceptibility to dopaminergic neuron neurotoxicity	50	2.158203e-3	1.000000e+0	3.417730e-1	4.633485e+2	2.158203e-3	1	2.158203e-3	1.000000e+0	96	1.440682e-3	1.000000e+0	1.188263e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0011405	tubulointerstitial nephritis	51	2.235471e-3	1.000000e+0	3.470678e-1	4.473330e+2	2.235471e-3	1	2.235471e-3	1.000000e+0	131	2.326740e-3	1.000000e+0	1.406346e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	PTGS2
Mouse Phenotype	MP:0005528	decreased renal glomerular filtration rate	52	2.265639e-3	1.000000e+0	3.449871e-1	4.413766e+2	2.265639e-3	1	2.265639e-3	1.000000e+0	122	1.994515e-3	1.000000e+0	1.294473e-1	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003845	abnormal decidualization	53	2.300671e-3	1.000000e+0	3.437116e-1	4.346559e+2	2.300671e-3	1	2.300671e-3	1.000000e+0	105	1.662234e-3	1.000000e+0	1.253483e-1	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008763	abnormal mast cell degranulation	54	2.353087e-3	1.000000e+0	3.450323e-1	4.249736e+2	2.353087e-3	1	2.353087e-3	1.000000e+0	141	2.880326e-3	1.000000e+0	1.617477e-1	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0005532	abnormal vascular resistance	55	2.373078e-3	1.000000e+0	3.416369e-1	4.213936e+2	2.373078e-3	1	2.373078e-3	1.000000e+0	126	2.105263e-3	1.000000e+0	1.322974e-1	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0009648	abnormal superovulation	56	2.451787e-3	1.000000e+0	3.466652e-1	4.078658e+2	2.451787e-3	1	2.451787e-3	1.000000e+0	96	1.440682e-3	1.000000e+0	1.188263e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002328	abnormal airway resistance	57	2.462018e-3	1.000000e+0	3.420045e-1	4.061709e+2	2.462018e-3	1	2.462018e-3	1.000000e+0	122	1.994515e-3	1.000000e+0	1.294473e-1	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0003357	impaired granulosa cell differentiation	58	2.486670e-3	1.000000e+0	3.394733e-1	4.021442e+2	2.486670e-3	1	2.486670e-3	1.000000e+0	101	1.551461e-3	1.000000e+0	1.216284e-1	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	PTGS2
Mouse Phenotype	MP:0011682	renal glomerulus cysts	59	2.543527e-3	1.000000e+0	3.413499e-1	3.931548e+2	2.543527e-3	1	2.543527e-3	1.000000e+0	105	1.662234e-3	1.000000e+0	1.253483e-1	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008950	ventricular tachycardia	60	2.607116e-3	1.000000e+0	3.440524e-1	3.835656e+2	2.607116e-3	1	2.607116e-3	1.000000e+0	96	1.440682e-3	1.000000e+0	1.188263e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	PTGS2
Mouse Phenotype	MP:0011346	renal tubule atrophy	61	2.689957e-3	1.000000e+0	3.491652e-1	3.717532e+2	2.689957e-3	1	2.689957e-3	1.000000e+0	155	3.323085e-3	1.000000e+0	1.697560e-1	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002872	polycythemia	62	2.836406e-3	1.000000e+0	3.622365e-1	3.525589e+2	2.836406e-3	1	2.836406e-3	1.000000e+0	112	1.773000e-3	1.000000e+0	1.253448e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0005596	increased susceptibility to type I hypersensitivity reaction	63	2.916581e-3	1.000000e+0	3.665633e-1	3.428672e+2	2.916581e-3	1	2.916581e-3	1.000000e+0	149	3.212404e-3	1.000000e+0	1.707102e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0002943	abnormal lactate dehydrogenase level	64	3.002953e-3	1.000000e+0	3.715216e-1	3.330055e+2	3.002953e-3	1	3.002953e-3	1.000000e+0	171	4.097676e-3	1.000000e+0	1.897392e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003915	increased left ventricle weight	65	3.015506e-3	1.000000e+0	3.673350e-1	3.316193e+2	3.015506e-3	1	3.015506e-3	1.000000e+0	141	2.880326e-3	1.000000e+0	1.617477e-1	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0009811	abnormal prostaglandin level	66	3.034512e-3	1.000000e+0	3.640495e-1	3.295423e+2	3.034512e-3	1	3.034512e-3	1.000000e+0	157	3.433759e-3	1.000000e+0	1.731752e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002847	abnormal renal glomerular filtration rate	67	3.269204e-3	1.000000e+0	3.863516e-1	3.058849e+2	3.269204e-3	1	3.269204e-3	1.000000e+0	149	3.212404e-3	1.000000e+0	1.707102e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008011	intestine polyps	68	3.308763e-3	1.000000e+0	3.852763e-1	3.022277e+2	3.308763e-3	1	3.308763e-3	1.000000e+0	2	2.322869e-6	1.839248e-2	9.196238e-3	6.443214e+2	3.104041e-3	2	28	1.000000e+0	7.142857e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0004721	abnormal platelet dense granule morphology	69	3.332899e-3	1.000000e+0	3.824622e-1	3.000391e+2	3.332899e-3	1	3.332899e-3	1.000000e+0	149	3.212404e-3	1.000000e+0	1.707102e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002276	abnormal lung interstitium morphology	70	3.345196e-3	1.000000e+0	3.783895e-1	2.989361e+2	3.345196e-3	1	3.345196e-3	1.000000e+0	145	2.991025e-3	1.000000e+0	1.633306e-1	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	PTGS2
Mouse Phenotype	MP:0001728	failure of embryo implantation	71	3.412170e-3	1.000000e+0	3.805290e-1	2.930686e+2	3.412170e-3	1	3.412170e-3	1.000000e+0	145	2.991025e-3	1.000000e+0	1.633306e-1	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	PTGS2
Mouse Phenotype	MP:0006050	pulmonary fibrosis	72	3.428262e-3	1.000000e+0	3.770136e-1	2.916930e+2	3.428262e-3	1	3.428262e-3	1.000000e+0	175	4.208307e-3	1.000000e+0	1.904079e-1	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002907	abnormal parturition	73	3.627013e-3	1.000000e+0	3.934067e-1	2.757089e+2	3.627013e-3	1	3.627013e-3	1.000000e+0	1	1.997175e-6	1.581363e-2	1.581363e-2	6.938846e+2	2.882324e-3	2	26	1.000000e+0	7.692308e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002656	abnormal keratinocyte differentiation	74	3.664518e-3	1.000000e+0	3.921034e-1	2.728872e+2	3.664518e-3	1	3.664518e-3	1.000000e+0	157	3.433759e-3	1.000000e+0	1.731752e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004193	abnormal kidney papilla morphology	75	3.677249e-3	1.000000e+0	3.882194e-1	2.719424e+2	3.677249e-3	1	3.677249e-3	1.000000e+0	147	3.101718e-3	1.000000e+0	1.670708e-1	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003355	decreased ovulation rate	76	3.755467e-3	1.000000e+0	3.912604e-1	2.662785e+2	3.755467e-3	1	3.755467e-3	1.000000e+0	155	3.323085e-3	1.000000e+0	1.697560e-1	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003139	patent ductus arteriosus	77	3.829383e-3	1.000000e+0	3.937799e-1	2.611387e+2	3.829383e-3	1	3.829383e-3	1.000000e+0	112	1.773000e-3	1.000000e+0	1.253448e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	PTGS2
Mouse Phenotype	MP:0006058	decreased cerebral infarction size	78	3.900267e-3	1.000000e+0	3.959271e-1	2.563927e+2	3.900267e-3	1	3.900267e-3	1.000000e+0	4	3.047997e-6	2.413404e-2	6.033510e-3	5.637812e+2	3.547475e-3	2	32	1.000000e+0	6.250000e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0011334	abnormal nephrogenic zone morphology	79	3.975865e-3	1.000000e+0	3.984924e-1	2.515176e+2	3.975865e-3	1	3.975865e-3	1.000000e+0	105	1.662234e-3	1.000000e+0	1.253483e-1	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008852	retinal neovascularization	80	3.980517e-3	1.000000e+0	3.939717e-1	2.512236e+2	3.980517e-3	1	3.980517e-3	1.000000e+0	175	4.208307e-3	1.000000e+0	1.904079e-1	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008868	abnormal granulosa cell morphology	81	3.999434e-3	1.000000e+0	3.909570e-1	2.500354e+2	3.999434e-3	1	3.999434e-3	1.000000e+0	149	3.212404e-3	1.000000e+0	1.707102e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	PTGS2
Mouse Phenotype	MP:0012106	impaired exercise endurance	82	4.043128e-3	1.000000e+0	3.904084e-1	2.473333e+2	4.043128e-3	1	4.043128e-3	1.000000e+0	179	4.318932e-3	1.000000e+0	1.910464e-1	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004192	abnormal kidney pyramid morphology	83	4.147920e-3	1.000000e+0	3.957016e-1	2.410847e+2	4.147920e-3	1	4.147920e-3	1.000000e+0	157	3.433759e-3	1.000000e+0	1.731752e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008236	decreased susceptibility to neuronal excitotoxicity	84	4.153878e-3	1.000000e+0	3.915525e-1	2.407389e+2	4.153878e-3	1	4.153878e-3	1.000000e+0	5	3.244642e-6	2.569108e-2	5.138215e-3	5.466970e+2	3.658334e-3	2	33	1.000000e+0	6.060606e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0010352	gastrointestinal tract polyps	85	4.161266e-3	1.000000e+0	3.876342e-1	2.403115e+2	4.161266e-3	1	4.161266e-3	1.000000e+0	3	2.857497e-6	2.262566e-2	7.541887e-3	5.819677e+2	3.436617e-3	2	31	1.000000e+0	6.451613e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0000359	abnormal mast cell morphology	86	4.377678e-3	1.000000e+0	4.030518e-1	2.284316e+2	4.377678e-3	1	4.377678e-3	1.000000e+0	191	4.761371e-3	1.000000e+0	1.973850e-1	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0011294	renal glomerulus hypertrophy	87	4.392650e-3	1.000000e+0	3.997816e-1	2.276530e+2	4.392650e-3	1	4.392650e-3	1.000000e+0	162	3.655089e-3	1.000000e+0	1.786481e-1	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	PTGS2
Mouse Phenotype	MP:0006059	decreased susceptibility to ischemic brain injury	88	4.468559e-3	1.000000e+0	4.020688e-1	2.237858e+2	4.468559e-3	1	4.468559e-3	1.000000e+0	6	4.793221e-6	3.795272e-2	6.325454e-3	4.510250e+2	4.434344e-3	2	40	1.000000e+0	5.000000e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005232	abnormal mesenteric lymph node morphology	89	4.478333e-3	1.000000e+0	3.984207e-1	2.232974e+2	4.478333e-3	1	4.478333e-3	1.000000e+0	195	5.093135e-3	1.000000e+0	2.068074e-1	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008235	increased susceptibility to neuronal excitotoxicity	90	4.583351e-3	1.000000e+0	4.032330e-1	2.181810e+2	4.583351e-3	1	4.583351e-3	1.000000e+0	171	4.097676e-3	1.000000e+0	1.897392e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	PTGS2
Mouse Phenotype	MP:0009399	increased skeletal muscle fiber size	91	4.661553e-3	1.000000e+0	4.056063e-1	2.145208e+2	4.661553e-3	1	4.661553e-3	1.000000e+0	162	3.655089e-3	1.000000e+0	1.786481e-1	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0006143	increased systemic arterial diastolic blood pressure	92	4.666536e-3	1.000000e+0	4.016264e-1	2.142917e+2	4.666536e-3	1	4.666536e-3	1.000000e+0	175	4.208307e-3	1.000000e+0	1.904079e-1	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004969	pale kidney	93	4.735873e-3	1.000000e+0	4.032112e-1	2.111543e+2	4.735873e-3	1	4.735873e-3	1.000000e+0	179	4.318932e-3	1.000000e+0	1.910464e-1	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002332	abnormal exercise endurance	94	4.747380e-3	1.000000e+0	3.998910e-1	2.106425e+2	4.747380e-3	1	4.747380e-3	1.000000e+0	206	5.535402e-3	1.000000e+0	2.127637e-1	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004014	abnormal uterine environment	95	4.943569e-3	1.000000e+0	4.120335e-1	2.022830e+2	4.943569e-3	1	4.943569e-3	1.000000e+0	162	3.655089e-3	1.000000e+0	1.786481e-1	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008531	increased chemical nociceptive threshold	96	4.969088e-3	1.000000e+0	4.098462e-1	2.012442e+2	4.969088e-3	1	4.969088e-3	1.000000e+0	149	3.212404e-3	1.000000e+0	1.707102e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003718	maternal effect	97	4.987535e-3	1.000000e+0	4.071268e-1	2.004998e+2	4.987535e-3	1	4.987535e-3	1.000000e+0	221	6.972090e-3	1.000000e+0	2.497964e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0011402	renal cast	98	4.998242e-3	1.000000e+0	4.038376e-1	2.000703e+2	4.998242e-3	1	4.998242e-3	1.000000e+0	183	4.429551e-3	1.000000e+0	1.916567e-1	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	PTGS2
Mouse Phenotype	MP:0009625	abnormal abdominal lymph node morphology	99	5.003450e-3	1.000000e+0	4.001749e-1	1.998621e+2	5.003450e-3	1	5.003450e-3	1.000000e+0	204	5.424845e-3	1.000000e+0	2.105584e-1	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002899	fatigue	100	5.069027e-3	1.000000e+0	4.013656e-1	1.972765e+2	5.069027e-3	1	5.069027e-3	1.000000e+0	199	5.203711e-3	1.000000e+0	2.070502e-1	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003436	decreased susceptibility to induced arthritis	101	5.083847e-3	1.000000e+0	3.985535e-1	1.967014e+2	5.083847e-3	1	5.083847e-3	1.000000e+0	232	7.634827e-3	1.000000e+0	2.605714e-1	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008735	increased susceptibility to endotoxin shock	102	5.113674e-3	1.000000e+0	3.969615e-1	1.955541e+2	5.113674e-3	1	5.113674e-3	1.000000e+0	226	7.193027e-3	1.000000e+0	2.520106e-1	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	PTGS2
Mouse Phenotype	MP:0000522	kidney cortex cysts	103	5.195203e-3	1.000000e+0	3.993749e-1	1.924853e+2	5.195203e-3	1	5.195203e-3	1.000000e+0	171	4.097676e-3	1.000000e+0	1.897392e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	PTGS2
Mouse Phenotype	MP:0010564	abnormal fetal ductus arteriosus morphology	104	5.206467e-3	1.000000e+0	3.963924e-1	1.920688e+2	5.206467e-3	1	5.206467e-3	1.000000e+0	140	2.769621e-3	1.000000e+0	1.566419e-1	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003215	renal interstitial fibrosis	105	5.216004e-3	1.000000e+0	3.933364e-1	1.917177e+2	5.216004e-3	1	5.216004e-3	1.000000e+0	204	5.424845e-3	1.000000e+0	2.105584e-1	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008111	abnormal granulocyte differentiation	106	5.247373e-3	1.000000e+0	3.919689e-1	1.905715e+2	5.247373e-3	1	5.247373e-3	1.000000e+0	167	3.987038e-3	1.000000e+0	1.890381e-1	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0002531	abnormal type I hypersensitivity reaction	107	5.266007e-3	1.000000e+0	3.896845e-1	1.898972e+2	5.266007e-3	1	5.266007e-3	1.000000e+0	218	6.861613e-3	1.000000e+0	2.492213e-1	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0009641	kidney degeneration	108	5.322444e-3	1.000000e+0	3.902140e-1	1.878836e+2	5.322444e-3	1	5.322444e-3	1.000000e+0	199	5.203711e-3	1.000000e+0	2.070502e-1	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	PTGS2
Mouse Phenotype	MP:0001619	abnormal vascular permeability	109	5.451697e-3	1.000000e+0	3.960233e-1	1.834291e+2	5.451697e-3	1	5.451697e-3	1.000000e+0	218	6.861613e-3	1.000000e+0	2.492213e-1	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008734	decreased susceptibility to endotoxin shock	110	5.475155e-3	1.000000e+0	3.941116e-1	1.826432e+2	5.475155e-3	1	5.475155e-3	1.000000e+0	250	8.518131e-3	1.000000e+0	2.697862e-1	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004485	increased response of heart to induced stress	111	5.526300e-3	1.000000e+0	3.942094e-1	1.809529e+2	5.526300e-3	1	5.526300e-3	1.000000e+0	179	4.318932e-3	1.000000e+0	1.910464e-1	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0001750	increased circulating follicle stimulating hormone level	112	5.563724e-3	1.000000e+0	3.933354e-1	1.797357e+2	5.563724e-3	1	5.563724e-3	1.000000e+0	183	4.429551e-3	1.000000e+0	1.916567e-1	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	PTGS2
Mouse Phenotype	MP:0001751	increased circulating luteinizing hormone level	113	5.616919e-3	1.000000e+0	3.935820e-1	1.780335e+2	5.616919e-3	1	5.616919e-3	1.000000e+0	167	3.987038e-3	1.000000e+0	1.890381e-1	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002736	abnormal nociception after inflammation	114	5.639747e-3	1.000000e+0	3.917151e-1	1.773129e+2	5.639747e-3	1	5.639747e-3	1.000000e+0	179	4.318932e-3	1.000000e+0	1.910464e-1	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	PTGS2
Mouse Phenotype	MP:0005133	increased luteinizing hormone level	115	5.740025e-3	1.000000e+0	3.952132e-1	1.742153e+2	5.740025e-3	1	5.740025e-3	1.000000e+0	175	4.208307e-3	1.000000e+0	1.904079e-1	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003606	kidney failure	116	5.859894e-3	1.000000e+0	3.999883e-1	1.706515e+2	5.859894e-3	1	5.859894e-3	1.000000e+0	225	7.082562e-3	1.000000e+0	2.492432e-1	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	PTGS2
Mouse Phenotype	MP:0005131	increased follicle stimulating hormone level	117	5.896049e-3	1.000000e+0	3.990164e-1	1.696051e+2	5.896049e-3	1	5.896049e-3	1.000000e+0	188	4.650770e-3	1.000000e+0	1.958766e-1	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	PTGS2
Mouse Phenotype	MP:0011290	decreased nephron number	118	5.931956e-3	1.000000e+0	3.980443e-1	1.685785e+2	5.931956e-3	1	5.931956e-3	1.000000e+0	136	2.437470e-3	1.000000e+0	1.419109e-1	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002423	abnormal mast cell physiology	119	6.078923e-3	1.000000e+0	4.044783e-1	1.645028e+2	6.078923e-3	1	6.078923e-3	1.000000e+0	226	7.193027e-3	1.000000e+0	2.520106e-1	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0008537	increased susceptibility to induced colitis	120	6.109192e-3	1.000000e+0	4.031049e-1	1.636878e+2	6.109192e-3	1	6.109192e-3	1.000000e+0	254	8.849269e-3	1.000000e+0	2.758603e-1	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	PTGS2
Mouse Phenotype	MP:0001906	increased dopamine level	121	6.132616e-3	1.000000e+0	4.013062e-1	1.630625e+2	6.132616e-3	1	6.132616e-3	1.000000e+0	166	3.876395e-3	1.000000e+0	1.848994e-1	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0009548	abnormal platelet aggregation	122	6.156328e-3	1.000000e+0	3.995558e-1	1.624345e+2	6.156328e-3	1	6.156328e-3	1.000000e+0	239	7.966112e-3	1.000000e+0	2.639150e-1	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	PTGS2
Mouse Phenotype	MP:0011289	abnormal nephron number	123	6.165244e-3	1.000000e+0	3.968813e-1	1.621996e+2	6.165244e-3	1	6.165244e-3	1.000000e+0	137	2.548193e-3	1.000000e+0	1.472744e-1	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002988	decreased urine osmolality	124	6.199998e-3	1.000000e+0	3.958999e-1	1.612904e+2	6.199998e-3	1	6.199998e-3	1.000000e+0	226	7.193027e-3	1.000000e+0	2.520106e-1	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0004564	enlarged myocardial fiber	125	6.291336e-3	1.000000e+0	3.985184e-1	1.589488e+2	6.291336e-3	1	6.291336e-3	1.000000e+0	7	9.463539e-6	7.493230e-2	1.070461e-2	3.221607e+2	6.208082e-3	2	56	1.000000e+0	3.571429e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0006298	abnormal platelet activation	126	6.366805e-3	1.000000e+0	4.000981e-1	1.570646e+2	6.366805e-3	1	6.366805e-3	1.000000e+0	254	8.849269e-3	1.000000e+0	2.758603e-1	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003918	decreased kidney weight	127	6.557932e-3	1.000000e+0	4.088638e-1	1.524871e+2	6.557932e-3	1	6.557932e-3	1.000000e+0	207	5.645954e-3	1.000000e+0	2.159646e-1	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004800	decreased susceptibility to experimental autoimmune encephalomyelitis	128	6.639636e-3	1.000000e+0	4.107237e-1	1.506107e+2	6.639636e-3	1	6.639636e-3	1.000000e+0	260	9.511379e-3	1.000000e+0	2.896581e-1	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0004970	kidney atrophy	129	6.812864e-3	1.000000e+0	4.181725e-1	1.467812e+2	6.812864e-3	1	6.812864e-3	1.000000e+0	214	6.751129e-3	1.000000e+0	2.497918e-1	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	PTGS2
Mouse Phenotype	MP:0000242	impaired fertilization	130	6.847566e-3	1.000000e+0	4.170694e-1	1.460373e+2	6.847566e-3	1	6.847566e-3	1.000000e+0	232	7.634827e-3	1.000000e+0	2.605714e-1	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	PTGS2
Mouse Phenotype	MP:0001869	pancreas inflammation	131	7.024653e-3	1.000000e+0	4.245893e-1	1.423558e+2	7.024653e-3	1	7.024653e-3	1.000000e+0	231	7.524386e-3	1.000000e+0	2.579138e-1	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0011425	abnormal kidney interstitium morphology	132	7.137873e-3	1.000000e+0	4.281642e-1	1.400978e+2	7.137873e-3	1	7.137873e-3	1.000000e+0	210	6.198618e-3	1.000000e+0	2.337174e-1	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	PTGS2
Mouse Phenotype	MP:0000364	abnormal vascular regression	133	7.175326e-3	1.000000e+0	4.271747e-1	1.393665e+2	7.175326e-3	1	7.175326e-3	1.000000e+0	183	4.429551e-3	1.000000e+0	1.916567e-1	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	PTGS2
Mouse Phenotype	MP:0001727	abnormal embryo implantation	134	7.204455e-3	1.000000e+0	4.257080e-1	1.388030e+2	7.204455e-3	1	7.204455e-3	1.000000e+0	211	6.640639e-3	1.000000e+0	2.491971e-1	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	PTGS2
Mouse Phenotype	MP:0005658	increased susceptibility to diet-induced obesity	135	7.274275e-3	1.000000e+0	4.266497e-1	1.374707e+2	7.274275e-3	1	7.274275e-3	1.000000e+0	193	4.982553e-3	1.000000e+0	2.044138e-1	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003131	increased erythrocyte cell number	136	7.308415e-3	1.000000e+0	4.255002e-1	1.368286e+2	7.308415e-3	1	7.308415e-3	1.000000e+0	214	6.751129e-3	1.000000e+0	2.497918e-1	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0000750	abnormal muscle regeneration	137	7.350092e-3	1.000000e+0	4.248031e-1	1.360527e+2	7.350092e-3	1	7.350092e-3	1.000000e+0	211	6.640639e-3	1.000000e+0	2.491971e-1	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004816	abnormal class switch recombination	138	7.358171e-3	1.000000e+0	4.221884e-1	1.359033e+2	7.358171e-3	1	7.358171e-3	1.000000e+0	261	9.621709e-3	1.000000e+0	2.918954e-1	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004754	abnormal kidney collecting duct morphology	139	7.386172e-3	1.000000e+0	4.207461e-1	1.353881e+2	7.386172e-3	1	7.386172e-3	1.000000e+0	211	6.640639e-3	1.000000e+0	2.491971e-1	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	PTGS2
Mouse Phenotype	MP:0001777	abnormal body temperature homeostasis	140	7.396935e-3	1.000000e+0	4.183495e-1	1.351911e+2	7.396935e-3	1	7.396935e-3	1.000000e+0	214	6.751129e-3	1.000000e+0	2.497918e-1	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002735	abnormal chemical nociception	141	7.466533e-3	1.000000e+0	4.192908e-1	1.339310e+2	7.466533e-3	1	7.466533e-3	1.000000e+0	188	4.650770e-3	1.000000e+0	1.958766e-1	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	PTGS2
Mouse Phenotype	MP:0005264	glomerulosclerosis	142	7.509636e-3	1.000000e+0	4.187415e-1	1.331623e+2	7.509636e-3	1	7.509636e-3	1.000000e+0	248	8.297342e-3	1.000000e+0	2.649127e-1	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002655	abnormal keratinocyte morphology	143	7.705272e-3	1.000000e+0	4.266458e-1	1.297813e+2	7.705272e-3	1	7.705272e-3	1.000000e+0	250	8.518131e-3	1.000000e+0	2.697862e-1	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	PTGS2
Mouse Phenotype	MP:0005656	decreased aggression	144	7.720965e-3	1.000000e+0	4.245458e-1	1.295175e+2	7.720965e-3	1	7.720965e-3	1.000000e+0	188	4.650770e-3	1.000000e+0	1.958766e-1	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	PTGS2
Mouse Phenotype	MP:0001134	absent corpus luteum	145	7.789151e-3	1.000000e+0	4.253414e-1	1.283837e+2	7.789151e-3	1	7.789151e-3	1.000000e+0	239	7.966112e-3	1.000000e+0	2.639150e-1	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002987	abnormal urine osmolality	146	7.800398e-3	1.000000e+0	4.230380e-1	1.281986e+2	7.800398e-3	1	7.800398e-3	1.000000e+0	246	8.186938e-3	1.000000e+0	2.635129e-1	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0003075	altered response to CNS ischemic injury	147	7.842317e-3	1.000000e+0	4.224181e-1	1.275133e+2	7.842317e-3	1	7.842317e-3	1.000000e+0	9	1.751369e-5	1.386734e-1	1.540816e-2	2.373816e+2	8.425254e-3	2	76	1.000000e+0	2.631579e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005553	increased circulating creatinine level	148	7.889951e-3	1.000000e+0	4.221124e-1	1.267435e+2	7.889951e-3	1	7.889951e-3	1.000000e+0	232	7.634827e-3	1.000000e+0	2.605714e-1	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004502	decreased incidence of tumors by chemical induction	149	7.907466e-3	1.000000e+0	4.202102e-1	1.264628e+2	7.907466e-3	1	7.907466e-3	1.000000e+0	8	1.659806e-5	1.314234e-1	1.642793e-2	2.437973e+2	8.203536e-3	2	74	1.000000e+0	2.702703e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005666	abnormal adipose tissue physiology	150	8.115871e-3	1.000000e+0	4.284098e-1	1.232154e+2	8.115871e-3	1	8.115871e-3	1.000000e+0	244	8.076528e-3	1.000000e+0	2.620900e-1	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003014	abnormal kidney medulla morphology	151	8.188426e-3	1.000000e+0	4.293772e-1	1.221236e+2	8.188426e-3	1	8.188426e-3	1.000000e+0	221	6.972090e-3	1.000000e+0	2.497964e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004505	decreased renal glomerulus number	152	8.188443e-3	1.000000e+0	4.265532e-1	1.221233e+2	8.188443e-3	1	8.188443e-3	1.000000e+0	199	5.203711e-3	1.000000e+0	2.070502e-1	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	PTGS2
Mouse Phenotype	MP:0005410	abnormal fertilization	153	8.438447e-3	1.000000e+0	4.367034e-1	1.185052e+2	8.438447e-3	1	8.438447e-3	1.000000e+0	268	1.028356e-2	1.000000e+0	3.038255e-1	9.699462e+1	1.030985e-2	1	93	5.000000e-1	1.075269e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008496	decreased IgG2a level	154	8.463890e-3	1.000000e+0	4.351759e-1	1.181490e+2	8.463890e-3	1	8.463890e-3	1.000000e+0	264	9.842351e-3	1.000000e+0	2.951960e-1	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	PTGS2
Mouse Phenotype	MP:0010985	abnormal kidney mesenchyme morphology	155	8.609892e-3	1.000000e+0	4.398266e-1	1.161455e+2	8.609892e-3	1	8.609892e-3	1.000000e+0	171	4.097676e-3	1.000000e+0	1.897392e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003985	renal fibrosis	156	8.649340e-3	1.000000e+0	4.390094e-1	1.156158e+2	8.649340e-3	1	8.649340e-3	1.000000e+0	249	8.407740e-3	1.000000e+0	2.673594e-1	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008561	decreased tumor necrosis factor secretion	157	8.803612e-3	1.000000e+0	4.439936e-1	1.135897e+2	8.803612e-3	1	8.803612e-3	1.000000e+0	296	1.259830e-2	1.000000e+0	3.370045e-1	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0009577	abnormal developmental vascular remodeling	158	8.941743e-3	1.000000e+0	4.481058e-1	1.118350e+2	8.941743e-3	1	8.941743e-3	1.000000e+0	208	5.756499e-3	1.000000e+0	2.191344e-1	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	PTGS2
Mouse Phenotype	MP:0006144	increased systemic arterial systolic blood pressure	159	8.945795e-3	1.000000e+0	4.454893e-1	1.117844e+2	8.945795e-3	1	8.945795e-3	1.000000e+0	239	7.966112e-3	1.000000e+0	2.639150e-1	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003362	increased circulating gonadotropin level	160	9.064673e-3	1.000000e+0	4.485880e-1	1.103184e+2	9.064673e-3	1	9.064673e-3	1.000000e+0	214	6.751129e-3	1.000000e+0	2.497918e-1	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004890	decreased energy expenditure	161	9.111940e-3	1.000000e+0	4.481263e-1	1.097461e+2	9.111940e-3	1	9.111940e-3	1.000000e+0	221	6.972090e-3	1.000000e+0	2.497964e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008498	decreased IgG3 level	162	9.220685e-3	1.000000e+0	4.506752e-1	1.084518e+2	9.220685e-3	1	9.220685e-3	1.000000e+0	262	9.732033e-3	1.000000e+0	2.941154e-1	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003711	pathological neovascularization	163	9.380920e-3	1.000000e+0	4.556940e-1	1.065994e+2	9.380920e-3	1	9.380920e-3	1.000000e+0	262	9.732033e-3	1.000000e+0	2.941154e-1	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	PTGS2
Mouse Phenotype	MP:0003997	tonic-clonic seizures	164	9.416337e-3	1.000000e+0	4.546253e-1	1.061984e+2	9.416337e-3	1	9.416337e-3	1.000000e+0	232	7.634827e-3	1.000000e+0	2.605714e-1	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002053	decreased incidence of induced tumors	165	9.938530e-3	1.000000e+0	4.769290e-1	1.006185e+2	9.938530e-3	1	9.938530e-3	1.000000e+0	12	2.628897e-5	2.081561e-1	1.734634e-2	1.939892e+2	1.030985e-2	2	93	1.000000e+0	2.150538e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002626	increased heart rate	166	9.950567e-3	1.000000e+0	4.746301e-1	1.004968e+2	9.950567e-3	1	9.950567e-3	1.000000e+0	226	7.193027e-3	1.000000e+0	2.520106e-1	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002993	arthritis	167	9.999299e-3	1.000000e+0	4.740985e-1	1.000070e+2	9.999299e-3	1	9.999299e-3	1.000000e+0	308	1.413995e-2	1.000000e+0	3.635069e-1	7.047266e+1	1.418990e-2	1	128	5.000000e-1	7.812500e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002314	abnormal respiratory mechanics	168	1.004740e-2	1.000000e+0	4.735435e-1	9.952822e+1	1.004740e-2	1	1.004740e-2	1.000000e+0	246	8.186938e-3	1.000000e+0	2.635129e-1	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0005048	thrombosis	169	1.008544e-2	1.000000e+0	4.725238e-1	9.915283e+1	1.008544e-2	1	1.008544e-2	1.000000e+0	287	1.193722e-2	1.000000e+0	3.293342e-1	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005464	abnormal platelet physiology	170	1.016064e-2	1.000000e+0	4.732468e-1	9.841902e+1	1.016064e-2	1	1.016064e-2	1.000000e+0	293	1.237796e-2	1.000000e+0	3.345006e-1	8.054018e+1	1.241616e-2	1	112	5.000000e-1	8.928571e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003204	decreased neuron apoptosis	171	1.029103e-2	1.000000e+0	4.765168e-1	9.717200e+1	1.029103e-2	1	1.029103e-2	1.000000e+0	10	1.991030e-5	1.576498e-1	1.576498e-2	2.227284e+2	8.979547e-3	2	81	1.000000e+0	2.469136e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0003969	abnormal luteinizing hormone level	172	1.031555e-2	1.000000e+0	4.748751e-1	9.694106e+1	1.031555e-2	1	1.031555e-2	1.000000e+0	230	7.413939e-3	1.000000e+0	2.552329e-1	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	PTGS2
Mouse Phenotype	MP:0005328	abnormal circulating creatinine level	173	1.044036e-2	1.000000e+0	4.778426e-1	9.578215e+1	1.044036e-2	1	1.044036e-2	1.000000e+0	279	1.116569e-2	1.000000e+0	3.168815e-1	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005088	increased acute inflammation	174	1.045626e-2	1.000000e+0	4.758199e-1	9.563651e+1	1.045626e-2	1	1.045626e-2	1.000000e+0	14	4.762495e-5	3.770944e-1	2.693531e-2	1.443280e+2	1.385732e-2	2	125	1.000000e+0	1.600000e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002753	dilated heart left ventricle	175	1.058631e-2	1.000000e+0	4.789852e-1	9.446163e+1	1.058631e-2	1	1.058631e-2	1.000000e+0	268	1.028356e-2	1.000000e+0	3.038255e-1	9.699462e+1	1.030985e-2	1	93	5.000000e-1	1.075269e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008560	increased tumor necrosis factor secretion	176	1.063753e-2	1.000000e+0	4.785680e-1	9.400678e+1	1.063753e-2	1	1.063753e-2	1.000000e+0	283	1.171681e-2	1.000000e+0	3.278223e-1	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002933	joint inflammation	177	1.066118e-2	1.000000e+0	4.769222e-1	9.379828e+1	1.066118e-2	1	1.066118e-2	1.000000e+0	319	1.513038e-2	1.000000e+0	3.755560e-1	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000693	spleen hyperplasia	178	1.072298e-2	1.000000e+0	4.769919e-1	9.325767e+1	1.072298e-2	1	1.072298e-2	1.000000e+0	275	1.094519e-2	1.000000e+0	3.151419e-1	9.111616e+1	1.097500e-2	1	99	5.000000e-1	1.010101e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002816	colitis	179	1.077238e-2	1.000000e+0	4.765123e-1	9.283001e+1	1.077238e-2	1	1.077238e-2	1.000000e+0	323	1.535041e-2	1.000000e+0	3.762989e-1	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	PTGS2
Mouse Phenotype	MP:0010579	increased heart left ventricle size	180	1.102366e-2	1.000000e+0	4.849186e-1	9.071395e+1	1.102366e-2	1	1.102366e-2	1.000000e+0	270	1.039385e-2	1.000000e+0	3.048093e-1	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0001928	abnormal ovulation	181	1.122170e-2	1.000000e+0	4.909029e-1	8.911307e+1	1.122170e-2	1	1.122170e-2	1.000000e+0	253	8.738896e-3	1.000000e+0	2.734964e-1	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002945	abnormal inhibitory postsynaptic currents	182	1.138441e-2	1.000000e+0	4.952844e-1	8.783940e+1	1.138441e-2	1	1.138441e-2	1.000000e+0	244	8.076528e-3	1.000000e+0	2.620900e-1	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004756	abnormal proximal convoluted tubule morphology	183	1.142902e-2	1.000000e+0	4.945081e-1	8.749656e+1	1.142902e-2	1	1.142902e-2	1.000000e+0	265	1.006297e-2	1.000000e+0	3.006739e-1	9.912637e+1	1.008813e-2	1	91	5.000000e-1	1.098901e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004484	altered response of heart to induced stress	184	1.177259e-2	1.000000e+0	5.066053e-1	8.494304e+1	1.177259e-2	1	1.177259e-2	1.000000e+0	10	1.991030e-5	1.576498e-1	1.576498e-2	2.227284e+2	8.979547e-3	2	81	1.000000e+0	2.469136e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0003967	abnormal follicle stimulating hormone level	185	1.179674e-2	1.000000e+0	5.049005e-1	8.476917e+1	1.179674e-2	1	1.179674e-2	1.000000e+0	256	8.959636e-3	1.000000e+0	2.771187e-1	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	PTGS2
Mouse Phenotype	MP:0008396	abnormal osteoclast differentiation	186	1.187780e-2	1.000000e+0	5.056367e-1	8.419070e+1	1.187780e-2	1	1.187780e-2	1.000000e+0	259	9.401043e-3	1.000000e+0	2.874033e-1	1.061235e+2	9.422981e-3	1	85	5.000000e-1	1.176471e-2	unnamed	PTGS2
Mouse Phenotype	MP:0001905	abnormal dopamine level	187	1.193463e-2	1.000000e+0	5.053390e-1	8.378976e+1	1.193463e-2	1	1.193463e-2	1.000000e+0	258	9.290700e-3	1.000000e+0	2.851309e-1	1.073869e+2	9.312122e-3	1	84	5.000000e-1	1.190476e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0003304	large intestinal inflammation	188	1.198410e-2	1.000000e+0	5.047346e-1	8.344391e+1	1.198410e-2	1	1.198410e-2	1.000000e+0	333	1.677999e-2	1.000000e+0	3.989909e-1	5.934539e+1	1.685051e-2	1	152	5.000000e-1	6.578947e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002494	increased IgM level	189	1.202175e-2	1.000000e+0	5.036414e-1	8.318259e+1	1.202175e-2	1	1.202175e-2	1.000000e+0	307	1.402987e-2	1.000000e+0	3.618518e-1	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001973	increased thermal nociceptive threshold	190	1.214401e-2	1.000000e+0	5.060856e-1	8.234510e+1	1.214401e-2	1	1.214401e-2	1.000000e+0	265	1.006297e-2	1.000000e+0	3.006739e-1	9.912637e+1	1.008813e-2	1	91	5.000000e-1	1.098901e-2	unnamed	PTGS2
Mouse Phenotype	MP:0004231	abnormal calcium ion homeostasis	191	1.251972e-2	1.000000e+0	5.190112e-1	7.987399e+1	1.251972e-2	1	1.251972e-2	1.000000e+0	282	1.149638e-2	1.000000e+0	3.227955e-1	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002707	abnormal kidney weight	192	1.262894e-2	1.000000e+0	5.208122e-1	7.918322e+1	1.262894e-2	1	1.262894e-2	1.000000e+0	295	1.248814e-2	1.000000e+0	3.351901e-1	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002148	abnormal hypersensitivity reaction	193	1.264158e-2	1.000000e+0	5.186323e-1	7.910402e+1	1.264158e-2	1	1.264158e-2	1.000000e+0	331	1.656012e-2	1.000000e+0	3.961421e-1	6.013667e+1	1.662879e-2	1	150	5.000000e-1	6.666667e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0002679	abnormal corpus luteum morphology	194	1.280361e-2	1.000000e+0	5.225721e-1	7.810295e+1	1.280361e-2	1	1.280361e-2	1.000000e+0	292	1.226779e-2	1.000000e+0	3.326588e-1	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005598	decreased ventricle muscle contractility	195	1.290318e-2	1.000000e+0	5.239353e-1	7.750028e+1	1.290318e-2	1	1.290318e-2	1.000000e+0	270	1.039385e-2	1.000000e+0	3.048093e-1	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	PTGS2
Mouse Phenotype	MP:0000495	abnormal colon morphology	196	1.299585e-2	1.000000e+0	5.250058e-1	7.694764e+1	1.299585e-2	1	1.299585e-2	1.000000e+0	273	1.061440e-2	1.000000e+0	3.078565e-1	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	PTGS2
Mouse Phenotype	MP:0001601	abnormal myelopoiesis	197	1.302171e-2	1.000000e+0	5.233802e-1	7.679483e+1	1.302171e-2	1	1.302171e-2	1.000000e+0	304	1.347939e-2	1.000000e+0	3.510849e-1	7.393852e+1	1.352475e-2	1	122	5.000000e-1	8.196721e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0008495	decreased IgG1 level	198	1.309759e-2	1.000000e+0	5.237713e-1	7.634992e+1	1.309759e-2	1	1.309759e-2	1.000000e+0	322	1.524040e-2	1.000000e+0	3.747624e-1	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002061	abnormal aggression-related behavior	199	1.340014e-2	1.000000e+0	5.331774e-1	7.462608e+1	1.340014e-2	1	1.340014e-2	1.000000e+0	250	8.518131e-3	1.000000e+0	2.697862e-1	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	PTGS2
Mouse Phenotype	MP:0001130	abnormal ovarian folliculogenesis	200	1.346019e-2	1.000000e+0	5.328889e-1	7.429318e+1	1.346019e-2	1	1.346019e-2	1.000000e+0	275	1.094519e-2	1.000000e+0	3.151419e-1	9.111616e+1	1.097500e-2	1	99	5.000000e-1	1.010101e-2	unnamed	PTGS2
Mouse Phenotype	MP:0010578	abnormal heart left ventricle size	201	1.346334e-2	1.000000e+0	5.303618e-1	7.427577e+1	1.346334e-2	1	1.346334e-2	1.000000e+0	280	1.127592e-2	1.000000e+0	3.188669e-1	8.843627e+1	1.130758e-2	1	102	5.000000e-1	9.803922e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0002792	abnormal retinal vasculature morphology	202	1.376309e-2	1.000000e+0	5.394859e-1	7.265810e+1	1.376309e-2	1	1.376309e-2	1.000000e+0	290	1.204742e-2	1.000000e+0	3.289361e-1	8.275688e+1	1.208359e-2	1	109	5.000000e-1	9.174312e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003361	abnormal circulating gonadotropin level	203	1.384192e-2	1.000000e+0	5.399031e-1	7.224432e+1	1.384192e-2	1	1.384192e-2	1.000000e+0	278	1.105544e-2	1.000000e+0	3.148812e-1	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	PTGS2
Mouse Phenotype	MP:0005351	decreased susceptibility to autoimmune disorder	204	1.396740e-2	1.000000e+0	5.421268e-1	7.159528e+1	1.396740e-2	1	1.396740e-2	1.000000e+0	19	1.023353e-4	8.102909e-1	4.264689e-2	9.858470e+1	2.028712e-2	2	183	1.000000e+0	1.092896e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005087	decreased acute inflammation	205	1.397801e-2	1.000000e+0	5.398921e-1	7.154096e+1	1.397801e-2	1	1.397801e-2	1.000000e+0	358	2.029452e-2	1.000000e+0	4.488604e-1	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003638	abnormal response/metabolism to endogenous compounds	206	1.434182e-2	1.000000e+0	5.512550e-1	6.972614e+1	1.434182e-2	1	1.434182e-2	1.000000e+0	13	3.958094e-5	3.134019e-1	2.410784e-2	1.582544e+2	1.263788e-2	2	114	1.000000e+0	1.754386e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005455	increased susceptibility to weight gain	207	1.439556e-2	1.000000e+0	5.506476e-1	6.946584e+1	1.439556e-2	1	1.439556e-2	1.000000e+0	274	1.083493e-2	1.000000e+0	3.131058e-1	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	PTGS2
Mouse Phenotype	MP:0001858	intestinal inflammation	208	1.455485e-2	1.000000e+0	5.540640e-1	6.870564e+1	1.455485e-2	1	1.455485e-2	1.000000e+0	358	2.029452e-2	1.000000e+0	4.488604e-1	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005669	increased circulating leptin level	209	1.456181e-2	1.000000e+0	5.516766e-1	6.867278e+1	1.456181e-2	1	1.456181e-2	1.000000e+0	287	1.193722e-2	1.000000e+0	3.293342e-1	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005165	increased susceptibility to injury	210	1.476621e-2	1.000000e+0	5.567564e-1	6.772219e+1	1.476621e-2	1	1.476621e-2	1.000000e+0	313	1.458020e-2	1.000000e+0	3.688371e-1	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0001422	abnormal drinking behavior	211	1.489840e-2	1.000000e+0	5.590783e-1	6.712131e+1	1.489840e-2	1	1.489840e-2	1.000000e+0	317	1.491033e-2	1.000000e+0	3.724290e-1	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001127	small ovary	212	1.492773e-2	1.000000e+0	5.575366e-1	6.698940e+1	1.492773e-2	1	1.492773e-2	1.000000e+0	315	1.469025e-2	1.000000e+0	3.692616e-1	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002906	increased susceptibility to pharmacologically induced seizures	213	1.525134e-2	1.000000e+0	5.669489e-1	6.556800e+1	1.525134e-2	1	1.525134e-2	1.000000e+0	267	1.017327e-2	1.000000e+0	3.016927e-1	9.804891e+1	1.019899e-2	1	92	5.000000e-1	1.086957e-2	unnamed	PTGS2
Mouse Phenotype	MP:0002705	dilated renal tubules	214	1.543260e-2	1.000000e+0	5.710062e-1	6.479790e+1	1.543260e-2	1	1.543260e-2	1.000000e+0	291	1.215761e-2	1.000000e+0	3.308040e-1	8.200455e+1	1.219445e-2	1	110	5.000000e-1	9.090909e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005166	decreased susceptibility to injury	215	1.543512e-2	1.000000e+0	5.684432e-1	6.478730e+1	1.543512e-2	1	1.543512e-2	1.000000e+0	15	5.558293e-5	4.401056e-1	2.934038e-2	1.336370e+2	1.496591e-2	2	135	1.000000e+0	1.481481e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0009766	increased sensitivity to xenobiotic induced morbidity/mortality	216	1.546308e-2	1.000000e+0	5.668364e-1	6.467015e+1	1.546308e-2	1	1.546308e-2	1.000000e+0	323	1.535041e-2	1.000000e+0	3.762989e-1	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002021	increased incidence of induced tumors	217	1.567887e-2	1.000000e+0	5.720981e-1	6.378010e+1	1.567887e-2	1	1.567887e-2	1.000000e+0	319	1.513038e-2	1.000000e+0	3.755560e-1	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005565	increased blood urea nitrogen level	218	1.584203e-2	1.000000e+0	5.754000e-1	6.312321e+1	1.584203e-2	1	1.584203e-2	1.000000e+0	319	1.513038e-2	1.000000e+0	3.755560e-1	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	PTGS2
Mouse Phenotype	MP:0009398	abnormal skeletal muscle fiber size	219	1.584796e-2	1.000000e+0	5.729870e-1	6.309960e+1	1.584796e-2	1	1.584796e-2	1.000000e+0	306	1.369960e-2	1.000000e+0	3.544883e-1	7.274597e+1	1.374647e-2	1	124	5.000000e-1	8.064516e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0004853	abnormal ovary size	220	1.645908e-2	1.000000e+0	5.923773e-1	6.075672e+1	1.645908e-2	1	1.645908e-2	1.000000e+0	330	1.645017e-2	1.000000e+0	3.947044e-1	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000523	cortical renal glomerulopathies	221	1.651712e-2	1.000000e+0	5.917763e-1	6.054323e+1	1.651712e-2	1	1.651712e-2	1.000000e+0	353	1.941648e-2	1.000000e+0	4.355232e-1	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	PTGS2
Mouse Phenotype	MP:0008022	dilated heart ventricle	222	1.670710e-2	1.000000e+0	5.958866e-1	5.985481e+1	1.670710e-2	1	1.670710e-2	1.000000e+0	310	1.447015e-2	1.000000e+0	3.695956e-1	6.885878e+1	1.452248e-2	1	131	5.000000e-1	7.633588e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001364	decreased anxiety-related response	223	1.676151e-2	1.000000e+0	5.951464e-1	5.966051e+1	1.676151e-2	1	1.676151e-2	1.000000e+0	275	1.094519e-2	1.000000e+0	3.151419e-1	9.111616e+1	1.097500e-2	1	99	5.000000e-1	1.010101e-2	unnamed	PLA2G4A
Mouse Phenotype	MP:0005117	increased circulating pituitary hormone level	224	1.692720e-2	1.000000e+0	5.983463e-1	5.907653e+1	1.692720e-2	1	1.692720e-2	1.000000e+0	285	1.182702e-2	1.000000e+0	3.285837e-1	8.430374e+1	1.186187e-2	1	107	5.000000e-1	9.345794e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005311	abnormal circulating amino acid level	225	1.717418e-2	1.000000e+0	6.043785e-1	5.822695e+1	1.717418e-2	1	1.717418e-2	1.000000e+0	351	1.930669e-2	1.000000e+0	4.355281e-1	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002168	other aberrant phenotype	226	1.722366e-2	1.000000e+0	6.034378e-1	5.805965e+1	1.722366e-2	1	1.722366e-2	1.000000e+0	310	1.447015e-2	1.000000e+0	3.695956e-1	6.885878e+1	1.452248e-2	1	131	5.000000e-1	7.633588e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002833	increased heart weight	227	1.733210e-2	1.000000e+0	6.045620e-1	5.769640e+1	1.733210e-2	1	1.733210e-2	1.000000e+0	16	7.334243e-5	5.807254e-1	3.629534e-2	1.163935e+2	1.718308e-2	2	155	1.000000e+0	1.290323e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0008567	decreased interferon-gamma secretion	228	1.757636e-2	1.000000e+0	6.103931e-1	5.689461e+1	1.757636e-2	1	1.757636e-2	1.000000e+0	340	1.798882e-2	1.000000e+0	4.189279e-1	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0002842	increased systemic arterial blood pressure	229	1.768863e-2	1.000000e+0	6.116095e-1	5.653349e+1	1.768863e-2	1	1.768863e-2	1.000000e+0	318	1.502036e-2	1.000000e+0	3.739975e-1	6.632721e+1	1.507677e-2	1	136	5.000000e-1	7.352941e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005265	abnormal blood urea nitrogen level	230	1.799799e-2	1.000000e+0	6.196004e-1	5.556177e+1	1.799799e-2	1	1.799799e-2	1.000000e+0	337	1.732955e-2	1.000000e+0	4.071673e-1	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	PTGS2
Mouse Phenotype	MP:0009765	abnormal xenobiotic induced morbidity/mortality	231	1.808287e-2	1.000000e+0	6.198276e-1	5.530095e+1	1.808287e-2	1	1.808287e-2	1.000000e+0	350	1.919691e-2	1.000000e+0	4.342890e-1	5.184195e+1	1.928940e-2	1	174	5.000000e-1	5.747126e-3	unnamed	PTGS2
Mouse Phenotype	MP:0004194	abnormal kidney pelvis morphology	232	1.838303e-2	1.000000e+0	6.274001e-1	5.439800e+1	1.838303e-2	1	1.838303e-2	1.000000e+0	299	1.281861e-2	1.000000e+0	3.394574e-1	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000950	abnormal seizure response to pharmacological agent	233	1.840258e-2	1.000000e+0	6.253718e-1	5.434021e+1	1.840258e-2	1	1.840258e-2	1.000000e+0	300	1.292876e-2	1.000000e+0	3.412331e-1	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	PTGS2
Mouse Phenotype	MP:0008556	abnormal tumor necrosis factor secretion	234	1.863317e-2	1.000000e+0	6.305019e-1	5.366774e+1	1.863317e-2	1	1.863317e-2	1.000000e+0	22	1.361459e-4	1.000000e+0	4.900015e-2	8.550237e+1	2.339116e-2	2	211	1.000000e+0	9.478673e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0000208	decreased hematocrit	235	1.863756e-2	1.000000e+0	6.279668e-1	5.365510e+1	1.863756e-2	1	1.863756e-2	1.000000e+0	361	2.084310e-2	1.000000e+0	4.571625e-1	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001859	kidney inflammation	236	1.873100e-2	1.000000e+0	6.284409e-1	5.338744e+1	1.873100e-2	1	1.873100e-2	1.000000e+0	355	1.996530e-2	1.000000e+0	4.453106e-1	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002052	decreased tumor incidence	237	1.879449e-2	1.000000e+0	6.279104e-1	5.320709e+1	1.879449e-2	1	1.879449e-2	1.000000e+0	18	9.463539e-5	7.493230e-1	4.162906e-2	1.025057e+2	1.951111e-2	2	176	1.000000e+0	1.136364e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001876	decreased inflammatory response	238	1.891198e-2	1.000000e+0	6.291809e-1	5.287653e+1	1.891198e-2	1	1.891198e-2	1.000000e+0	395	2.741405e-2	1.000000e+0	5.495302e-1	3.622691e+1	2.760379e-2	1	249	5.000000e-1	4.016064e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003141	cardiac fibrosis	239	1.893141e-2	1.000000e+0	6.271921e-1	5.282226e+1	1.893141e-2	1	1.893141e-2	1.000000e+0	338	1.754933e-2	1.000000e+0	4.111112e-1	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000511	abnormal intestinal mucosa morphology	240	1.908337e-2	1.000000e+0	6.295922e-1	5.240164e+1	1.908337e-2	1	1.908337e-2	1.000000e+0	361	2.084310e-2	1.000000e+0	4.571625e-1	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005023	abnormal wound healing	241	1.914067e-2	1.000000e+0	6.288623e-1	5.224478e+1	1.914067e-2	1	1.914067e-2	1.000000e+0	348	1.897731e-2	1.000000e+0	4.317883e-1	5.244477e+1	1.906768e-2	1	172	5.000000e-1	5.813953e-3	unnamed	PTGS2
Mouse Phenotype	MP:0008272	abnormal endochondral bone ossification	242	1.927338e-2	1.000000e+0	6.306059e-1	5.188503e+1	1.927338e-2	1	1.927338e-2	1.000000e+0	298	1.270846e-2	1.000000e+0	3.376698e-1	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003043	hypoalgesia	243	1.928686e-2	1.000000e+0	6.284500e-1	5.184878e+1	1.928686e-2	1	1.928686e-2	1.000000e+0	328	1.601034e-2	1.000000e+0	3.864935e-1	6.221034e+1	1.607450e-2	1	145	5.000000e-1	6.896552e-3	unnamed	PTGS2
Mouse Phenotype	MP:0009644	uremia	244	1.932047e-2	1.000000e+0	6.269651e-1	5.175858e+1	1.932047e-2	1	1.932047e-2	1.000000e+0	343	1.820853e-2	1.000000e+0	4.203357e-1	5.466970e+1	1.829167e-2	1	165	5.000000e-1	6.060606e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003973	increased pituitary hormone level	245	1.939799e-2	1.000000e+0	6.269114e-1	5.155173e+1	1.939799e-2	1	1.939799e-2	1.000000e+0	305	1.358950e-2	1.000000e+0	3.527923e-1	7.333740e+1	1.363561e-2	1	123	5.000000e-1	8.130081e-3	unnamed	PTGS2
Mouse Phenotype	MP:0011479	abnormal catecholamine level	246	1.959175e-2	1.000000e+0	6.305995e-1	5.104190e+1	1.959175e-2	1	1.959175e-2	1.000000e+0	309	1.425002e-2	1.000000e+0	3.651510e-1	6.992636e+1	1.430076e-2	1	129	5.000000e-1	7.751938e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0011762	renal/urinary system inflammation	247	1.971468e-2	1.000000e+0	6.319872e-1	5.072363e+1	1.971468e-2	1	1.971468e-2	1.000000e+0	363	2.095280e-2	1.000000e+0	4.570366e-1	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000470	abnormal stomach morphology	248	1.989701e-2	1.000000e+0	6.352602e-1	5.025881e+1	1.989701e-2	1	1.989701e-2	1.000000e+0	326	1.590037e-2	1.000000e+0	3.861936e-1	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003203	increased neuron apoptosis	249	1.991428e-2	1.000000e+0	6.332581e-1	5.021522e+1	1.991428e-2	1	1.991428e-2	1.000000e+0	340	1.798882e-2	1.000000e+0	4.189279e-1	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003675	kidney cysts	250	2.014775e-2	1.000000e+0	6.381195e-1	4.963333e+1	2.014775e-2	1	2.014775e-2	1.000000e+0	316	1.480029e-2	1.000000e+0	3.708503e-1	6.731716e+1	1.485505e-2	1	134	5.000000e-1	7.462687e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002733	abnormal thermal nociception	251	2.027306e-2	1.000000e+0	6.395302e-1	4.932654e+1	2.027306e-2	1	2.027306e-2	1.000000e+0	326	1.590037e-2	1.000000e+0	3.861936e-1	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001625	cardiac hypertrophy	252	2.027860e-2	1.000000e+0	6.371665e-1	4.931306e+1	2.027860e-2	1	2.027860e-2	1.000000e+0	347	1.886750e-2	1.000000e+0	4.305270e-1	5.275146e+1	1.895682e-2	1	171	5.000000e-1	5.847953e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0005332	abnormal amino acid level	253	2.080263e-2	1.000000e+0	6.510483e-1	4.807084e+1	2.080263e-2	1	2.080263e-2	1.000000e+0	378	2.402182e-2	1.000000e+0	5.031872e-1	4.137844e+1	2.416717e-2	1	218	5.000000e-1	4.587156e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003920	abnormal heart right ventricle morphology	254	2.089794e-2	1.000000e+0	6.514563e-1	4.785162e+1	2.089794e-2	1	2.089794e-2	1.000000e+0	331	1.656012e-2	1.000000e+0	3.961421e-1	6.013667e+1	1.662879e-2	1	150	5.000000e-1	6.666667e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0005333	decreased heart rate	255	2.112767e-2	1.000000e+0	6.560349e-1	4.733130e+1	2.112767e-2	1	2.112767e-2	1.000000e+0	300	1.292876e-2	1.000000e+0	3.412331e-1	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000527	abnormal kidney development	256	2.114423e-2	1.000000e+0	6.539844e-1	4.729422e+1	2.114423e-2	1	2.114423e-2	1.000000e+0	285	1.182702e-2	1.000000e+0	3.285837e-1	8.430374e+1	1.186187e-2	1	107	5.000000e-1	9.345794e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000947	convulsive seizures	257	2.126932e-2	1.000000e+0	6.552937e-1	4.701608e+1	2.126932e-2	1	2.126932e-2	1.000000e+0	334	1.688991e-2	1.000000e+0	4.004021e-1	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	PTGS2
Mouse Phenotype	MP:0009661	abnormal pregnancy	258	2.138591e-2	1.000000e+0	6.563319e-1	4.675976e+1	2.138591e-2	1	2.138591e-2	1.000000e+0	17	7.429493e-5	5.882673e-1	3.460396e-2	1.156474e+2	1.729394e-2	2	156	1.000000e+0	1.282051e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002462	abnormal granulocyte physiology	259	2.162554e-2	1.000000e+0	6.611237e-1	4.624163e+1	2.162554e-2	1	2.162554e-2	1.000000e+0	394	2.708603e-2	1.000000e+0	5.443330e-1	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0002079	increased circulating insulin level	260	2.166245e-2	1.000000e+0	6.597049e-1	4.616284e+1	2.166245e-2	1	2.166245e-2	1.000000e+0	354	1.985555e-2	1.000000e+0	4.441137e-1	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	PTGS2
Mouse Phenotype	MP:0011110	partial preweaning lethality	261	2.208760e-2	1.000000e+0	6.700752e-1	4.527427e+1	2.208760e-2	1	2.208760e-2	1.000000e+0	336	1.721965e-2	1.000000e+0	4.057893e-1	5.782372e+1	1.729394e-2	1	156	5.000000e-1	6.410256e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000489	abnormal large intestine morphology	262	2.211060e-2	1.000000e+0	6.682127e-1	4.522718e+1	2.211060e-2	1	2.211060e-2	1.000000e+0	340	1.798882e-2	1.000000e+0	4.189279e-1	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	PTGS2
Mouse Phenotype	MP:0004982	abnormal osteoclast morphology	263	2.211747e-2	1.000000e+0	6.658788e-1	4.521313e+1	2.211747e-2	1	2.211747e-2	1.000000e+0	339	1.776908e-2	1.000000e+0	4.150312e-1	5.602795e+1	1.784823e-2	1	161	5.000000e-1	6.211180e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001712	abnormal placenta development	264	2.218013e-2	1.000000e+0	6.652359e-1	4.508541e+1	2.218013e-2	1	2.218013e-2	1.000000e+0	360	2.040425e-2	1.000000e+0	4.487801e-1	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002596	abnormal hematocrit	265	2.224140e-2	1.000000e+0	6.645562e-1	4.496120e+1	2.224140e-2	1	2.224140e-2	1.000000e+0	383	2.489780e-2	1.000000e+0	5.147279e-1	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003084	abnormal skeletal muscle fiber morphology	266	2.260042e-2	1.000000e+0	6.727448e-1	4.424697e+1	2.260042e-2	1	2.260042e-2	1.000000e+0	357	2.007505e-2	1.000000e+0	4.452500e-1	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0004720	abnormal platelet morphology	267	2.260848e-2	1.000000e+0	6.704642e-1	4.423119e+1	2.260848e-2	1	2.260848e-2	1.000000e+0	387	2.566396e-2	1.000000e+0	5.250833e-1	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	PTGS2
Mouse Phenotype	MP:0008772	increased heart ventricle size	268	2.266829e-2	1.000000e+0	6.697296e-1	4.411448e+1	2.266829e-2	1	2.266829e-2	1.000000e+0	349	1.908711e-2	1.000000e+0	4.330422e-1	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0005450	abnormal energy expenditure	269	2.280955e-2	1.000000e+0	6.713978e-1	4.384129e+1	2.280955e-2	1	2.280955e-2	1.000000e+0	372	2.281671e-2	1.000000e+0	4.856524e-1	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000228	abnormal thrombopoiesis	270	2.281943e-2	1.000000e+0	6.692009e-1	4.382231e+1	2.281943e-2	1	2.281943e-2	1.000000e+0	389	2.610163e-2	1.000000e+0	5.312923e-1	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000488	abnormal intestinal epithelium morphology	271	2.301048e-2	1.000000e+0	6.723136e-1	4.345846e+1	2.301048e-2	1	2.301048e-2	1.000000e+0	379	2.413134e-2	1.000000e+0	5.041476e-1	4.118950e+1	2.427803e-2	1	219	5.000000e-1	4.566210e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000351	increased cell proliferation	272	2.313721e-2	1.000000e+0	6.735310e-1	4.322042e+1	2.313721e-2	1	2.313721e-2	1.000000e+0	370	2.270712e-2	1.000000e+0	4.859324e-1	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005667	abnormal circulating leptin level	273	2.321797e-2	1.000000e+0	6.734062e-1	4.307009e+1	2.321797e-2	1	2.321797e-2	1.000000e+0	364	2.128185e-2	1.000000e+0	4.629387e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000278	abnormal myocardial fiber morphology	274	2.321830e-2	1.000000e+0	6.709580e-1	4.306948e+1	2.321830e-2	1	2.321830e-2	1.000000e+0	21	1.174339e-4	9.298416e-1	4.427817e-2	9.204592e+1	2.172829e-2	2	196	1.000000e+0	1.020408e-2	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0010155	abnormal intestine physiology	275	2.326312e-2	1.000000e+0	6.698087e-1	4.298649e+1	2.326312e-2	1	2.326312e-2	1.000000e+0	405	2.894409e-2	1.000000e+0	5.658748e-1	3.429848e+1	2.915581e-2	1	263	5.000000e-1	3.802281e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001805	decreased IgG level	276	2.347358e-2	1.000000e+0	6.734196e-1	4.260109e+1	2.347358e-2	1	2.347358e-2	1.000000e+0	393	2.697668e-2	1.000000e+0	5.435149e-1	3.681837e+1	2.716036e-2	1	245	5.000000e-1	4.081633e-3	unnamed	PTGS2
Mouse Phenotype	MP:0011117	abnormal susceptibility to weight gain	277	2.353900e-2	1.000000e+0	6.728585e-1	4.248268e+1	2.353900e-2	1	2.353900e-2	1.000000e+0	368	2.226868e-2	1.000000e+0	4.791397e-1	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002498	abnormal acute inflammation	278	2.372640e-2	1.000000e+0	6.757757e-1	4.214715e+1	2.372640e-2	1	2.372640e-2	1.000000e+0	33	2.737728e-4	1.000000e+0	6.568888e-2	6.033779e+1	3.314672e-2	2	299	1.000000e+0	6.688963e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005116	abnormal circulating pituitary hormone level	279	2.415984e-2	1.000000e+0	6.856545e-1	4.139100e+1	2.415984e-2	1	2.415984e-2	1.000000e+0	346	1.864787e-2	1.000000e+0	4.267452e-1	5.337574e+1	1.873510e-2	1	169	5.000000e-1	5.917160e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001131	abnormal ovarian follicle morphology	280	2.489271e-2	1.000000e+0	7.039303e-1	4.017241e+1	2.489271e-2	1	2.489271e-2	1.000000e+0	370	2.270712e-2	1.000000e+0	4.859324e-1	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002551	abnormal blood coagulation	281	2.494121e-2	1.000000e+0	7.027918e-1	4.009429e+1	2.494121e-2	1	2.494121e-2	1.000000e+0	400	2.785133e-2	1.000000e+0	5.513171e-1	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	PTGS2
Mouse Phenotype	MP:0009676	abnormal hemostasis	282	2.502326e-2	1.000000e+0	7.026034e-1	3.996282e+1	2.502326e-2	1	2.502326e-2	1.000000e+0	401	2.806993e-2	1.000000e+0	5.542586e-1	3.537451e+1	2.826894e-2	1	255	5.000000e-1	3.921569e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002417	abnormal megakaryocyte morphology	283	2.512167e-2	1.000000e+0	7.028741e-1	3.980628e+1	2.512167e-2	1	2.512167e-2	1.000000e+0	407	2.949024e-2	1.000000e+0	5.737192e-1	3.365858e+1	2.971010e-2	1	268	5.000000e-1	3.731343e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005448	abnormal energy balance	284	2.526486e-2	1.000000e+0	7.043914e-1	3.958066e+1	2.526486e-2	1	2.526486e-2	1.000000e+0	376	2.380277e-2	1.000000e+0	5.012509e-1	4.176157e+1	2.394546e-2	1	216	5.000000e-1	4.629630e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000534	abnormal ureter morphology	285	2.528177e-2	1.000000e+0	7.023897e-1	3.955419e+1	2.528177e-2	1	2.528177e-2	1.000000e+0	334	1.688991e-2	1.000000e+0	4.004021e-1	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003942	abnormal urinary system development	286	2.555047e-2	1.000000e+0	7.073728e-1	3.913823e+1	2.555047e-2	1	2.555047e-2	1.000000e+0	310	1.447015e-2	1.000000e+0	3.695956e-1	6.885878e+1	1.452248e-2	1	131	5.000000e-1	7.633588e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002425	altered susceptibility to autoimmune disorder	287	2.557136e-2	1.000000e+0	7.054844e-1	3.910624e+1	2.557136e-2	1	2.557136e-2	1.000000e+0	32	2.682975e-4	1.000000e+0	6.638686e-2	6.094932e+1	3.281415e-2	2	296	1.000000e+0	6.756757e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002413	abnormal megakaryocyte progenitor cell morphology	288	2.594276e-2	1.000000e+0	7.132457e-1	3.854641e+1	2.594276e-2	1	2.594276e-2	1.000000e+0	411	3.036376e-2	1.000000e+0	5.849641e-1	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	PTGS2
Mouse Phenotype	MP:0008559	abnormal interferon-gamma secretion	289	2.621844e-2	1.000000e+0	7.183308e-1	3.814109e+1	2.621844e-2	1	2.621844e-2	1.000000e+0	404	2.839779e-2	1.000000e+0	5.565686e-1	3.496318e+1	2.860152e-2	1	258	5.000000e-1	3.875969e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0005140	decreased cardiac muscle contractility	290	2.627907e-2	1.000000e+0	7.175092e-1	3.805310e+1	2.627907e-2	1	2.627907e-2	1.000000e+0	366	2.204943e-2	1.000000e+0	4.770147e-1	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001586	abnormal erythrocyte cell number	291	2.631922e-2	1.000000e+0	7.161360e-1	3.799505e+1	2.631922e-2	1	2.631922e-2	1.000000e+0	392	2.686732e-2	1.000000e+0	5.426924e-1	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0006043	decreased apoptosis	292	2.648005e-2	1.000000e+0	7.180446e-1	3.776428e+1	2.648005e-2	1	2.648005e-2	1.000000e+0	24	1.675231e-4	1.000000e+0	5.526866e-2	7.709829e+1	2.594091e-2	2	234	1.000000e+0	8.547009e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002461	increased immunoglobulin level	293	2.653139e-2	1.000000e+0	7.169814e-1	3.769120e+1	2.653139e-2	1	2.653139e-2	1.000000e+0	413	3.134601e-2	1.000000e+0	6.009630e-1	3.165088e+1	3.159470e-2	1	285	5.000000e-1	3.508772e-3	unnamed	PTGS2
Mouse Phenotype	MP:0009357	abnormal seizure response to inducing agent	294	2.667440e-2	1.000000e+0	7.183942e-1	3.748913e+1	2.667440e-2	1	2.667440e-2	1.000000e+0	343	1.820853e-2	1.000000e+0	4.203357e-1	5.466970e+1	1.829167e-2	1	165	5.000000e-1	6.060606e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000230	abnormal systemic arterial blood pressure	295	2.755926e-2	1.000000e+0	7.397092e-1	3.628545e+1	2.755926e-2	1	2.755926e-2	1.000000e+0	377	2.391230e-2	1.000000e+0	5.022217e-1	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	PTGS2
Mouse Phenotype	MP:0004857	abnormal heart weight	296	2.777528e-2	1.000000e+0	7.429887e-1	3.600323e+1	2.777528e-2	1	2.777528e-2	1.000000e+0	22	1.361459e-4	1.000000e+0	4.900015e-2	8.550237e+1	2.339116e-2	2	211	1.000000e+0	9.478673e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0008873	increased physiological sensitivity to xenobiotic	297	2.832153e-2	1.000000e+0	7.550501e-1	3.530883e+1	2.832153e-2	1	2.832153e-2	1.000000e+0	391	2.664858e-2	1.000000e+0	5.396508e-1	3.727479e+1	2.682778e-2	1	242	5.000000e-1	4.132231e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003965	abnormal pituitary hormone level	298	2.885433e-2	1.000000e+0	7.666731e-1	3.465684e+1	2.885433e-2	1	2.885433e-2	1.000000e+0	365	2.193980e-2	1.000000e+0	4.759434e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002460	decreased immunoglobulin level	299	2.899527e-2	1.000000e+0	7.678413e-1	3.448838e+1	2.899527e-2	1	2.899527e-2	1.000000e+0	424	3.363597e-2	1.000000e+0	6.281359e-1	2.947876e+1	3.392273e-2	1	306	5.000000e-1	3.267974e-3	unnamed	PTGS2
Mouse Phenotype	MP:0008555	abnormal interferon secretion	300	2.903162e-2	1.000000e+0	7.662412e-1	3.444520e+1	2.903162e-2	1	2.903162e-2	1.000000e+0	422	3.330900e-2	1.000000e+0	6.249779e-1	2.977063e+1	3.359016e-2	1	303	5.000000e-1	3.300330e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0004937	dilated heart	301	2.927139e-2	1.000000e+0	7.700029e-1	3.416305e+1	2.927139e-2	1	2.927139e-2	1.000000e+0	380	2.445986e-2	1.000000e+0	5.096662e-1	4.063288e+1	2.461061e-2	1	222	5.000000e-1	4.504505e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003202	abnormal neuron apoptosis	302	2.957524e-2	1.000000e+0	7.754197e-1	3.381206e+1	2.957524e-2	1	2.957524e-2	1.000000e+0	25	1.747744e-4	1.000000e+0	5.535455e-2	7.548536e+1	2.649521e-2	2	239	1.000000e+0	8.368201e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005395	other phenotype	303	2.967442e-2	1.000000e+0	7.754523e-1	3.369906e+1	2.967442e-2	1	2.967442e-2	1.000000e+0	31	2.417504e-4	1.000000e+0	6.174773e-2	6.420285e+1	3.115127e-2	2	281	1.000000e+0	7.117438e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002989	small kidney	304	2.994997e-2	1.000000e+0	7.800785e-1	3.338902e+1	2.994997e-2	1	2.994997e-2	1.000000e+0	368	2.226868e-2	1.000000e+0	4.791397e-1	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	PTGS2
Mouse Phenotype	MP:0008874	decreased physiological sensitivity to xenobiotic	305	2.998346e-2	1.000000e+0	7.783903e-1	3.335172e+1	2.998346e-2	1	2.998346e-2	1.000000e+0	29	2.085051e-4	1.000000e+0	5.692908e-2	6.912261e+1	2.893409e-2	2	261	1.000000e+0	7.662835e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002703	abnormal renal tubule morphology	306	3.058536e-2	1.000000e+0	7.914212e-1	3.269538e+1	3.058536e-2	1	3.058536e-2	1.000000e+0	28	1.912680e-4	1.000000e+0	5.408786e-2	7.216400e+1	2.771465e-2	2	250	1.000000e+0	8.000000e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0008713	abnormal cytokine level	307	3.072453e-2	1.000000e+0	7.924327e-1	3.254729e+1	3.072453e-2	1	3.072453e-2	1.000000e+0	440	4.070677e-2	1.000000e+0	7.325368e-1	2.431402e+1	4.112854e-2	1	371	5.000000e-1	2.695418e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0005293	impaired glucose tolerance	308	3.073714e-2	1.000000e+0	7.901840e-1	3.253393e+1	3.073714e-2	1	3.073714e-2	1.000000e+0	387	2.566396e-2	1.000000e+0	5.250833e-1	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0002972	abnormal cardiac muscle contractility	309	3.076905e-2	1.000000e+0	7.884445e-1	3.250019e+1	3.076905e-2	1	3.076905e-2	1.000000e+0	389	2.610163e-2	1.000000e+0	5.312923e-1	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001629	abnormal heart rate	310	3.082246e-2	1.000000e+0	7.872653e-1	3.244387e+1	3.082246e-2	1	3.082246e-2	1.000000e+0	355	1.996530e-2	1.000000e+0	4.453106e-1	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001216	abnormal epidermal layer morphology	311	3.084585e-2	1.000000e+0	7.853294e-1	3.241927e+1	3.084585e-2	1	3.084585e-2	1.000000e+0	425	3.374495e-2	1.000000e+0	6.286883e-1	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001463	abnormal spatial learning	312	3.098486e-2	1.000000e+0	7.863401e-1	3.227383e+1	3.098486e-2	1	3.098486e-2	1.000000e+0	372	2.281671e-2	1.000000e+0	4.856524e-1	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0005334	abnormal fat pad morphology	313	3.099156e-2	1.000000e+0	7.839974e-1	3.226685e+1	3.099156e-2	1	3.099156e-2	1.000000e+0	381	2.467884e-2	1.000000e+0	5.128794e-1	4.027009e+1	2.483233e-2	1	224	5.000000e-1	4.464286e-3	unnamed	PTGS2
Mouse Phenotype	MP:0008770	decreased survivor rate	314	3.107263e-2	1.000000e+0	7.835449e-1	3.218266e+1	3.107263e-2	1	3.107263e-2	1.000000e+0	374	2.358369e-2	1.000000e+0	4.992932e-1	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	PTGS2
Mouse Phenotype	MP:0008171	abnormal mature B cell morphology	315	3.123786e-2	1.000000e+0	7.852107e-1	3.201244e+1	3.123786e-2	1	3.123786e-2	1.000000e+0	423	3.352698e-2	1.000000e+0	6.275807e-1	2.957541e+1	3.381187e-2	1	305	5.000000e-1	3.278689e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002693	abnormal pancreas physiology	316	3.140305e-2	1.000000e+0	7.868650e-1	3.184404e+1	3.140305e-2	1	3.140305e-2	1.000000e+0	27	1.882138e-4	1.000000e+0	5.519544e-2	7.274597e+1	2.749293e-2	2	248	1.000000e+0	8.064516e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001970	abnormal pain threshold	317	3.167589e-2	1.000000e+0	7.911978e-1	3.156975e+1	3.167589e-2	1	3.167589e-2	1.000000e+0	385	2.500727e-2	1.000000e+0	5.143054e-1	3.973789e+1	2.516490e-2	1	227	5.000000e-1	4.405286e-3	unnamed	PTGS2
Mouse Phenotype	MP:0008835	abnormal intercellular signaling peptide or protein level	318	3.242466e-2	1.000000e+0	8.073536e-1	3.084072e+1	3.242466e-2	1	3.242466e-2	1.000000e+0	442	4.168376e-2	1.000000e+0	7.467240e-1	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0001844	autoimmune response	319	3.348674e-2	1.000000e+0	8.311850e-1	2.986257e+1	3.348674e-2	1	3.348674e-2	1.000000e+0	42	4.286307e-4	1.000000e+0	8.080709e-2	4.823797e+1	4.146112e-2	2	374	1.000000e+0	5.347594e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001577	anemia	320	3.352421e-2	1.000000e+0	8.295147e-1	2.982919e+1	3.352421e-2	1	3.352421e-2	1.000000e+0	428	3.635858e-2	1.000000e+0	6.726337e-1	2.725227e+1	3.669420e-2	1	331	5.000000e-1	3.021148e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005325	abnormal renal glomerulus morphology	321	3.367447e-2	1.000000e+0	8.306369e-1	2.969609e+1	3.367447e-2	1	3.367447e-2	1.000000e+0	419	3.319999e-2	1.000000e+0	6.273927e-1	2.986921e+1	3.347930e-2	1	302	5.000000e-1	3.311258e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001260	increased body weight	322	3.384562e-2	1.000000e+0	8.322659e-1	2.954592e+1	3.384562e-2	1	3.384562e-2	1.000000e+0	415	3.156421e-2	1.000000e+0	6.022299e-1	3.143031e+1	3.181642e-2	1	287	5.000000e-1	3.484321e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002339	abnormal lymph node morphology	323	3.392160e-2	1.000000e+0	8.315518e-1	2.947974e+1	3.392160e-2	1	3.392160e-2	1.000000e+0	430	3.701143e-2	1.000000e+0	6.815268e-1	2.676706e+1	3.735935e-2	1	337	5.000000e-1	2.967359e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005005	abnormal self tolerance	324	3.393888e-2	1.000000e+0	8.294076e-1	2.946473e+1	3.393888e-2	1	3.393888e-2	1.000000e+0	44	4.332334e-4	1.000000e+0	7.796232e-2	4.798138e+1	4.168283e-2	2	376	1.000000e+0	5.319149e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005000	abnormal immune tolerance	325	3.420392e-2	1.000000e+0	8.333127e-1	2.923641e+1	3.420392e-2	1	3.420392e-2	1.000000e+0	51	4.495365e-4	1.000000e+0	6.979275e-2	4.710444e+1	4.245884e-2	2	383	1.000000e+0	5.221932e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0003921	abnormal heart left ventricle morphology	326	3.426484e-2	1.000000e+0	8.322362e-1	2.918443e+1	3.426484e-2	1	3.426484e-2	1.000000e+0	26	1.821793e-4	1.000000e+0	5.548060e-2	7.393852e+1	2.704950e-2	2	244	1.000000e+0	8.196721e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001765	abnormal ion homeostasis	327	3.480497e-2	1.000000e+0	8.427699e-1	2.873153e+1	3.480497e-2	1	3.480497e-2	1.000000e+0	436	3.940334e-2	1.000000e+0	7.155863e-1	2.512674e+1	3.979824e-2	1	359	5.000000e-1	2.785515e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001126	abnormal ovary morphology	328	3.497291e-2	1.000000e+0	8.442546e-1	2.859356e+1	3.497291e-2	1	3.497291e-2	1.000000e+0	413	3.134601e-2	1.000000e+0	6.009630e-1	3.165088e+1	3.159470e-2	1	285	5.000000e-1	3.508772e-3	unnamed	PTGS2
Mouse Phenotype	MP:0010831	partial lethality	329	3.509983e-2	1.000000e+0	8.447430e-1	2.849017e+1	3.509983e-2	1	3.509983e-2	1.000000e+0	398	2.763270e-2	1.000000e+0	5.497380e-1	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001575	cyanosis	330	3.512426e-2	1.000000e+0	8.427694e-1	2.847035e+1	3.512426e-2	1	3.512426e-2	1.000000e+0	383	2.489780e-2	1.000000e+0	5.147279e-1	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001926	female infertility	331	3.525648e-2	1.000000e+0	8.433861e-1	2.836358e+1	3.525648e-2	1	3.525648e-2	1.000000e+0	419	3.319999e-2	1.000000e+0	6.273927e-1	2.986921e+1	3.347930e-2	1	302	5.000000e-1	3.311258e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002451	abnormal macrophage physiology	332	3.533810e-2	1.000000e+0	8.427924e-1	2.829807e+1	3.533810e-2	1	3.533810e-2	1.000000e+0	50	4.471891e-4	1.000000e+0	7.081687e-2	4.722775e+1	4.234799e-2	2	382	1.000000e+0	5.235602e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0000738	impaired muscle contractility	333	3.540346e-2	1.000000e+0	8.418156e-1	2.824583e+1	3.540346e-2	1	3.540346e-2	1.000000e+0	408	2.959946e-2	1.000000e+0	5.744327e-1	3.353346e+1	2.982096e-2	1	269	5.000000e-1	3.717472e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000249	abnormal blood vessel physiology	334	3.556760e-2	1.000000e+0	8.431864e-1	2.811547e+1	3.556760e-2	1	3.556760e-2	1.000000e+0	419	3.319999e-2	1.000000e+0	6.273927e-1	2.986921e+1	3.347930e-2	1	302	5.000000e-1	3.311258e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001264	increased body size	335	3.582830e-2	1.000000e+0	8.468313e-1	2.791090e+1	3.582830e-2	1	3.582830e-2	1.000000e+0	418	3.287295e-2	1.000000e+0	6.226986e-1	3.016890e+1	3.314672e-2	1	299	5.000000e-1	3.344482e-3	unnamed	PTGS2
Mouse Phenotype	MP:0009745	abnormal behavioral response to xenobiotic	336	3.671867e-2	1.000000e+0	8.652929e-1	2.723410e+1	3.671867e-2	1	3.671867e-2	1.000000e+0	403	2.828851e-2	1.000000e+0	5.558025e-1	3.509922e+1	2.849066e-2	1	257	5.000000e-1	3.891051e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002827	abnormal renal corpuscle morphology	337	3.690674e-2	1.000000e+0	8.671441e-1	2.709532e+1	3.690674e-2	1	3.690674e-2	1.000000e+0	427	3.570550e-2	1.000000e+0	6.620987e-1	2.775538e+1	3.602904e-2	1	325	5.000000e-1	3.076923e-3	unnamed	PTGS2
Mouse Phenotype	MP:0004085	abnormal heartbeat	338	3.710548e-2	1.000000e+0	8.692343e-1	2.695020e+1	3.710548e-2	1	3.710548e-2	1.000000e+0	382	2.478833e-2	1.000000e+0	5.138063e-1	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	PTGS2
Mouse Phenotype	MP:0009763	increased sensitivity to induced morbidity/mortality	339	3.731243e-2	1.000000e+0	8.715039e-1	2.680072e+1	3.731243e-2	1	3.731243e-2	1.000000e+0	441	4.114105e-2	1.000000e+0	7.386731e-1	2.405467e+1	4.157197e-2	1	375	5.000000e-1	2.666667e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001545	abnormal hematopoietic system physiology	340	3.751853e-2	1.000000e+0	8.737404e-1	2.665350e+1	3.751853e-2	1	3.751853e-2	1.000000e+0	445	4.244329e-2	1.000000e+0	7.552044e-1	2.330879e+1	4.290228e-2	1	387	5.000000e-1	2.583979e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001944	abnormal pancreas morphology	341	3.762730e-2	1.000000e+0	8.737037e-1	2.657645e+1	3.762730e-2	1	3.762730e-2	1.000000e+0	409	2.992705e-2	1.000000e+0	5.793701e-1	3.316360e+1	3.015354e-2	1	272	5.000000e-1	3.676471e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005319	abnormal enzyme/ coenzyme level	342	3.774804e-2	1.000000e+0	8.739444e-1	2.649144e+1	3.774804e-2	1	3.774804e-2	1.000000e+0	444	4.222631e-2	1.000000e+0	7.530359e-1	2.342987e+1	4.268056e-2	1	385	5.000000e-1	2.597403e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002706	abnormal kidney size	343	3.808311e-2	1.000000e+0	8.791314e-1	2.625836e+1	3.808311e-2	1	3.808311e-2	1.000000e+0	417	3.178240e-2	1.000000e+0	6.034845e-1	3.121280e+1	3.203814e-2	1	289	5.000000e-1	3.460208e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001923	reduced female fertility	344	3.818286e-2	1.000000e+0	8.788718e-1	2.618976e+1	3.818286e-2	1	3.818286e-2	1.000000e+0	30	2.149575e-4	1.000000e+0	5.673445e-2	6.807925e+1	2.937753e-2	2	265	1.000000e+0	7.547170e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001968	abnormal touch/ nociception	345	3.878092e-2	1.000000e+0	8.900502e-1	2.578588e+1	3.878092e-2	1	3.878092e-2	1.000000e+0	416	3.167331e-2	1.000000e+0	6.028588e-1	3.132118e+1	3.192728e-2	1	288	5.000000e-1	3.472222e-3	unnamed	PTGS2
Mouse Phenotype	MP:0010630	abnormal cardiac muscle tissue morphology	346	3.885933e-2	1.000000e+0	8.892722e-1	2.573385e+1	3.885933e-2	1	3.885933e-2	1.000000e+0	34	2.867637e-4	1.000000e+0	6.678221e-2	5.895752e+1	3.392273e-2	2	306	1.000000e+0	6.535948e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001954	respiratory distress	347	3.887509e-2	1.000000e+0	8.870691e-1	2.572341e+1	3.887509e-2	1	3.887509e-2	1.000000e+0	386	2.522619e-2	1.000000e+0	5.174637e-1	3.939083e+1	2.538662e-2	1	229	5.000000e-1	4.366812e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001574	abnormal oxygen level	348	3.901010e-2	1.000000e+0	8.875919e-1	2.563439e+1	3.901010e-2	1	3.901010e-2	1.000000e+0	401	2.806993e-2	1.000000e+0	5.542586e-1	3.537451e+1	2.826894e-2	1	255	5.000000e-1	3.921569e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001362	abnormal anxiety-related response	349	3.973609e-2	1.000000e+0	9.015197e-1	2.516604e+1	3.973609e-2	1	3.973609e-2	1.000000e+0	399	2.774202e-2	1.000000e+0	5.505296e-1	3.579563e+1	2.793637e-2	1	252	5.000000e-1	3.968254e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0001935	decreased litter size	350	4.020414e-2	1.000000e+0	9.095325e-1	2.487306e+1	4.020414e-2	1	4.020414e-2	1.000000e+0	35	3.039087e-4	1.000000e+0	6.875283e-2	5.727302e+1	3.492046e-2	2	315	1.000000e+0	6.349206e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0009643	abnormal urine homeostasis	351	4.033522e-2	1.000000e+0	9.098982e-1	2.479223e+1	4.033522e-2	1	4.033522e-2	1.000000e+0	55	5.228175e-4	1.000000e+0	7.526671e-2	4.368281e+1	4.578460e-2	2	413	1.000000e+0	4.842615e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0000521	abnormal kidney cortex morphology	352	4.045312e-2	1.000000e+0	9.099654e-1	2.471997e+1	4.045312e-2	1	4.045312e-2	1.000000e+0	434	3.853390e-2	1.000000e+0	7.030217e-1	2.569943e+1	3.891137e-2	1	351	5.000000e-1	2.849003e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001263	weight loss	353	4.066906e-2	1.000000e+0	9.122312e-1	2.458872e+1	4.066906e-2	1	4.066906e-2	1.000000e+0	442	4.168376e-2	1.000000e+0	7.467240e-1	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002446	abnormal macrophage morphology	354	4.095716e-2	1.000000e+0	9.160983e-1	2.441576e+1	4.095716e-2	1	4.095716e-2	1.000000e+0	448	4.309408e-2	1.000000e+0	7.616494e-1	2.295293e+1	4.356743e-2	1	393	5.000000e-1	2.544529e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001933	abnormal litter size	355	4.123688e-2	1.000000e+0	9.197567e-1	2.425014e+1	4.123688e-2	1	4.123688e-2	1.000000e+0	36	3.235424e-4	1.000000e+0	7.116135e-2	5.551077e+1	3.602904e-2	2	325	1.000000e+0	6.153846e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002441	abnormal granulocyte morphology	356	4.210603e-2	1.000000e+0	9.365043e-1	2.374957e+1	4.210603e-2	1	4.210603e-2	1.000000e+0	455	4.656123e-2	1.000000e+0	8.102677e-1	2.122471e+1	4.711490e-2	1	425	5.000000e-1	2.352941e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0000691	enlarged spleen	357	4.312302e-2	1.000000e+0	9.564372e-1	2.318947e+1	4.312302e-2	1	4.312302e-2	1.000000e+0	456	4.840059e-2	1.000000e+0	8.404295e-1	2.040837e+1	4.899950e-2	1	442	5.000000e-1	2.262443e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000274	enlarged heart	358	4.315159e-2	1.000000e+0	9.543975e-1	2.317412e+1	4.315159e-2	1	4.315159e-2	1.000000e+0	41	4.037551e-4	1.000000e+0	7.797397e-2	4.969972e+1	4.024167e-2	2	363	1.000000e+0	5.509642e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002144	abnormal B cell differentiation	359	4.316951e-2	1.000000e+0	9.521342e-1	2.316450e+1	4.316951e-2	1	4.316951e-2	1.000000e+0	453	4.461173e-2	1.000000e+0	7.797697e-1	2.216339e+1	4.511945e-2	1	407	5.000000e-1	2.457002e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001560	abnormal circulating insulin level	360	4.326502e-2	1.000000e+0	9.515901e-1	2.311336e+1	4.326502e-2	1	4.326502e-2	1.000000e+0	436	3.940334e-2	1.000000e+0	7.155863e-1	2.512674e+1	3.979824e-2	1	359	5.000000e-1	2.785515e-3	unnamed	PTGS2
Mouse Phenotype	MP:0004087	abnormal muscle fiber morphology	361	4.329978e-2	1.000000e+0	9.497165e-1	2.309480e+1	4.329978e-2	1	4.329978e-2	1.000000e+0	40	3.970999e-4	1.000000e+0	7.860593e-2	5.011389e+1	3.990910e-2	2	360	1.000000e+0	5.555556e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001711	abnormal placenta morphology	362	4.350805e-2	1.000000e+0	9.516485e-1	2.298425e+1	4.350805e-2	1	4.350805e-2	1.000000e+0	445	4.244329e-2	1.000000e+0	7.552044e-1	2.330879e+1	4.290228e-2	1	387	5.000000e-1	2.583979e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005620	abnormal muscle contractility	363	4.427201e-2	1.000000e+0	9.656908e-1	2.258763e+1	4.427201e-2	1	4.427201e-2	1.000000e+0	431	3.722900e-2	1.000000e+0	6.839425e-1	2.660914e+1	3.758107e-2	1	339	5.000000e-1	2.949853e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005291	abnormal glucose tolerance	364	4.475825e-2	1.000000e+0	9.736149e-1	2.234225e+1	4.475825e-2	1	4.475825e-2	1.000000e+0	438	3.951200e-2	1.000000e+0	7.142831e-1	2.505694e+1	3.990910e-2	1	360	5.000000e-1	2.777778e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0002065	abnormal fear/anxiety-related behavior	365	4.523741e-2	1.000000e+0	9.813420e-1	2.210560e+1	4.523741e-2	1	4.523741e-2	1.000000e+0	412	3.101865e-2	1.000000e+0	5.961303e-1	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0002136	abnormal kidney physiology	366	4.551147e-2	1.000000e+0	9.845897e-1	2.197248e+1	4.551147e-2	1	4.551147e-2	1.000000e+0	452	4.439500e-2	1.000000e+0	7.776983e-1	2.227284e+1	4.489773e-2	1	405	5.000000e-1	2.469136e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002064	seizures	367	4.591816e-2	1.000000e+0	9.906812e-1	2.177788e+1	4.591816e-2	1	4.591816e-2	1.000000e+0	431	3.722900e-2	1.000000e+0	6.839425e-1	2.660914e+1	3.758107e-2	1	339	5.000000e-1	2.949853e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002490	abnormal immunoglobulin level	368	4.625320e-2	1.000000e+0	9.951979e-1	2.162013e+1	4.625320e-2	1	4.625320e-2	1.000000e+0	458	5.218192e-2	1.000000e+0	9.021320e-1	1.891090e+1	5.287955e-2	1	477	5.000000e-1	2.096436e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005025	abnormal response to infection	369	4.712582e-2	1.000000e+0	1.000000e+0	2.121979e+1	4.712582e-2	1	4.712582e-2	1.000000e+0	476	6.315885e-2	1.000000e+0	1.000000e+0	1.557945e+1	6.418713e-2	1	579	5.000000e-1	1.727116e-3	unnamed	PTGS2
Mouse Phenotype	MP:0009209	abnormal internal female genitalia morphology	370	4.760230e-2	1.000000e+0	1.000000e+0	2.100739e+1	4.760230e-2	1	4.760230e-2	1.000000e+0	447	4.287718e-2	1.000000e+0	7.595112e-1	2.307033e+1	4.334571e-2	1	391	5.000000e-1	2.557545e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000477	abnormal intestine morphology	371	4.889648e-2	1.000000e+0	1.000000e+0	2.045137e+1	4.889648e-2	1	4.889648e-2	1.000000e+0	53	4.977760e-4	1.000000e+0	7.436586e-2	4.476675e+1	4.467602e-2	2	403	1.000000e+0	4.962779e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0000759	abnormal skeletal muscle morphology	372	4.926857e-2	1.000000e+0	1.000000e+0	2.029691e+1	4.926857e-2	1	4.926857e-2	1.000000e+0	439	4.027239e-2	1.000000e+0	7.263708e-1	2.457902e+1	4.068511e-2	1	367	5.000000e-1	2.724796e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0011088	partial neonatal lethality	373	4.935548e-2	1.000000e+0	1.000000e+0	2.026118e+1	4.935548e-2	1	4.935548e-2	1.000000e+0	433	3.766407e-2	1.000000e+0	6.887393e-1	2.629883e+1	3.802450e-2	1	343	5.000000e-1	2.915452e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001116	small gonad	374	4.956812e-2	1.000000e+0	1.000000e+0	2.017426e+1	4.956812e-2	1	4.956812e-2	1.000000e+0	459	5.272149e-2	1.000000e+0	9.094744e-1	1.871473e+1	5.343385e-2	1	482	5.000000e-1	2.074689e-3	unnamed	PTGS2
Mouse Phenotype	MP:0009208	abnormal female genitalia morphology	375	4.967210e-2	1.000000e+0	1.000000e+0	2.013202e+1	4.967210e-2	1	4.967210e-2	1.000000e+0	449	4.363624e-2	1.000000e+0	7.695139e-1	2.266457e+1	4.412172e-2	1	398	5.000000e-1	2.512563e-3	unnamed	PTGS2
Mouse Phenotype	MP:0008248	abnormal mononuclear phagocyte morphology	376	4.981952e-2	1.000000e+0	1.000000e+0	2.007245e+1	4.981952e-2	1	4.981952e-2	1.000000e+0	462	5.477048e-2	1.000000e+0	9.386854e-1	1.800499e+1	5.554016e-2	1	501	5.000000e-1	1.996008e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001119	abnormal female reproductive system morphology	377	4.984565e-2	1.000000e+0	1.000000e+0	2.006193e+1	4.984565e-2	1	4.984565e-2	1.000000e+0	451	4.396146e-2	1.000000e+0	7.718112e-1	2.249501e+1	4.445430e-2	1	401	5.000000e-1	2.493766e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005164	abnormal response to injury	378	5.017014e-2	1.000000e+0	1.000000e+0	1.993218e+1	5.017014e-2	1	5.017014e-2	1.000000e+0	62	6.629393e-4	1.000000e+0	8.466376e-2	3.879785e+1	5.154925e-2	2	465	1.000000e+0	4.301075e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001800	abnormal humoral immune response	379	5.047245e-2	1.000000e+0	1.000000e+0	1.981279e+1	5.047245e-2	1	5.047245e-2	1.000000e+0	465	5.692491e-2	1.000000e+0	9.693149e-1	1.731382e+1	5.775733e-2	1	521	5.000000e-1	1.919386e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001951	abnormal breathing pattern	380	5.059905e-2	1.000000e+0	1.000000e+0	1.976322e+1	5.059905e-2	1	5.059905e-2	1.000000e+0	426	3.439869e-2	1.000000e+0	6.393634e-1	2.881949e+1	3.469874e-2	1	313	5.000000e-1	3.194888e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001657	abnormal induced morbidity/mortality	381	5.088453e-2	1.000000e+0	1.000000e+0	1.965234e+1	5.088453e-2	1	5.088453e-2	1.000000e+0	471	6.036688e-2	1.000000e+0	1.000000e+0	1.631193e+1	6.130481e-2	1	553	5.000000e-1	1.808318e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003881	abnormal nephron morphology	382	5.265823e-2	1.000000e+0	1.000000e+0	1.899038e+1	5.265823e-2	1	5.265823e-2	1.000000e+0	60	6.070799e-4	1.000000e+0	8.011431e-2	4.054157e+1	4.933208e-2	2	445	1.000000e+0	4.494382e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002211	abnormal primary sex determination	383	5.292252e-2	1.000000e+0	1.000000e+0	1.889555e+1	5.292252e-2	1	5.292252e-2	1.000000e+0	461	5.433930e-2	1.000000e+0	9.333158e-1	1.814990e+1	5.509672e-2	1	497	5.000000e-1	2.012072e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002419	abnormal innate immunity	384	5.385019e-2	1.000000e+0	1.000000e+0	1.857003e+1	5.385019e-2	1	5.385019e-2	1.000000e+0	81	1.028275e-3	1.000000e+0	1.005171e-1	3.115889e+1	6.418713e-2	2	579	1.000000e+0	3.454231e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005266	abnormal metabolism	385	5.387393e-2	1.000000e+0	1.000000e+0	1.856186e+1	5.387393e-2	1	5.387393e-2	1.000000e+0	73	9.379227e-4	1.000000e+0	1.017325e-1	3.262387e+1	6.130481e-2	2	553	1.000000e+0	3.616637e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005329	abnormal myocardium layer morphology	386	5.442259e-2	1.000000e+0	1.000000e+0	1.837472e+1	5.442259e-2	1	5.442259e-2	1.000000e+0	52	4.903834e-4	1.000000e+0	7.467030e-2	4.510250e+1	4.434344e-2	2	400	1.000000e+0	5.000000e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0008271	abnormal bone ossification	387	5.470209e-2	1.000000e+0	1.000000e+0	1.828084e+1	5.470209e-2	1	5.470209e-2	1.000000e+0	435	3.918602e-2	1.000000e+0	7.132756e-1	2.526751e+1	3.957652e-2	1	357	5.000000e-1	2.801120e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003009	abnormal cytokine secretion	388	5.502210e-2	1.000000e+0	1.000000e+0	1.817451e+1	5.502210e-2	1	5.502210e-2	1.000000e+0	85	1.133953e-3	1.000000e+0	1.056311e-1	2.967270e+1	6.740203e-2	2	608	1.000000e+0	3.289474e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0010545	abnormal heart layer morphology	389	5.573559e-2	1.000000e+0	1.000000e+0	1.794186e+1	5.573559e-2	1	5.573559e-2	1.000000e+0	54	5.102199e-4	1.000000e+0	7.481335e-2	4.421814e+1	4.523031e-2	2	408	1.000000e+0	4.901961e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002459	abnormal B cell physiology	390	5.585276e-2	1.000000e+0	1.000000e+0	1.790422e+1	5.585276e-2	1	5.585276e-2	1.000000e+0	478	6.337345e-2	1.000000e+0	1.000000e+0	1.552582e+1	6.440885e-2	1	581	5.000000e-1	1.721170e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002327	abnormal respiratory function	391	5.609376e-2	1.000000e+0	1.000000e+0	1.782730e+1	5.609376e-2	1	5.609376e-2	1.000000e+0	43	4.309290e-4	1.000000e+0	7.935107e-2	4.810933e+1	4.157197e-2	2	375	1.000000e+0	5.333333e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0000260	abnormal angiogenesis	392	5.621105e-2	1.000000e+0	1.000000e+0	1.779009e+1	5.621105e-2	1	5.621105e-2	1.000000e+0	450	4.385306e-2	1.000000e+0	7.716190e-1	2.255125e+1	4.434344e-2	1	400	5.000000e-1	2.500000e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002210	abnormal sex determination	393	5.670465e-2	1.000000e+0	1.000000e+0	1.763524e+1	5.670465e-2	1	5.670465e-2	1.000000e+0	468	5.832397e-2	1.000000e+0	9.867718e-1	1.689232e+1	5.919849e-2	1	534	5.000000e-1	1.872659e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002447	abnormal erythrocyte morphology	394	5.809647e-2	1.000000e+0	1.000000e+0	1.721275e+1	5.809647e-2	1	5.809647e-2	1.000000e+0	83	1.049715e-3	1.000000e+0	1.001403e-1	3.083932e+1	6.485228e-2	2	585	1.000000e+0	3.418803e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001663	abnormal digestive system physiology	395	5.827484e-2	1.000000e+0	1.000000e+0	1.716006e+1	5.827484e-2	1	5.827484e-2	1.000000e+0	473	6.240758e-2	1.000000e+0	1.000000e+0	1.577010e+1	6.341112e-2	1	572	5.000000e-1	1.748252e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002164	abnormal gland physiology	396	5.844543e-2	1.000000e+0	1.000000e+0	1.710998e+1	5.844543e-2	1	5.844543e-2	1.000000e+0	66	7.362203e-4	1.000000e+0	8.832413e-2	3.681837e+1	5.432071e-2	2	490	1.000000e+0	4.081633e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001785	edema	397	5.960595e-2	1.000000e+0	1.000000e+0	1.677685e+1	5.960595e-2	1	5.960595e-2	1.000000e+0	454	4.645297e-2	1.000000e+0	8.101644e-1	2.127476e+1	4.700405e-2	1	424	5.000000e-1	2.358491e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005406	abnormal heart size	398	6.101337e-2	1.000000e+0	1.000000e+0	1.638985e+1	6.101337e-2	1	6.101337e-2	1.000000e+0	66	7.362203e-4	1.000000e+0	8.832413e-2	3.681837e+1	5.432071e-2	2	490	1.000000e+0	4.081633e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0004939	abnormal B cell morphology	399	6.254515e-2	1.000000e+0	1.000000e+0	1.598845e+1	6.254515e-2	1	6.254515e-2	1.000000e+0	481	6.744608e-2	1.000000e+0	1.000000e+0	1.457270e+1	6.862147e-2	1	619	5.000000e-1	1.615509e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003948	abnormal gas homeostasis	400	6.279835e-2	1.000000e+0	1.000000e+0	1.592398e+1	6.279835e-2	1	6.279835e-2	1.000000e+0	460	5.401585e-2	1.000000e+0	9.297772e-1	1.826012e+1	5.476415e-2	1	494	5.000000e-1	2.024291e-3	unnamed	PTGS2
Mouse Phenotype	MP:0008251	abnormal phagocyte morphology	401	6.342112e-2	1.000000e+0	1.000000e+0	1.576762e+1	6.342112e-2	1	6.342112e-2	1.000000e+0	485	6.905126e-2	1.000000e+0	1.000000e+0	1.422792e+1	7.028435e-2	1	634	5.000000e-1	1.577287e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002113	abnormal skeleton development	402	6.360798e-2	1.000000e+0	1.000000e+0	1.572130e+1	6.360798e-2	1	6.360798e-2	1.000000e+0	457	4.850873e-2	1.000000e+0	8.404642e-1	2.036230e+1	4.911036e-2	1	443	5.000000e-1	2.257336e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000245	abnormal erythropoiesis	403	6.477947e-2	1.000000e+0	1.000000e+0	1.543699e+1	6.477947e-2	1	6.477947e-2	1.000000e+0	88	1.240891e-3	1.000000e+0	1.116520e-1	2.836635e+1	7.050607e-2	2	636	1.000000e+0	3.144654e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0008872	abnormal physiological response to xenobiotic	404	6.542380e-2	1.000000e+0	1.000000e+0	1.528496e+1	6.542380e-2	1	6.542380e-2	1.000000e+0	75	9.860577e-4	1.000000e+0	1.041014e-1	3.181834e+1	6.285683e-2	2	567	1.000000e+0	3.527337e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002224	abnormal spleen size	405	6.692526e-2	1.000000e+0	1.000000e+0	1.494204e+1	6.692526e-2	1	6.692526e-2	1.000000e+0	486	6.947907e-2	1.000000e+0	1.000000e+0	1.413871e+1	7.072779e-2	1	638	5.000000e-1	1.567398e-3	unnamed	PTGS2
Mouse Phenotype	MP:0008195	abnormal professional antigen presenting cell morphology	406	6.835128e-2	1.000000e+0	1.000000e+0	1.463030e+1	6.835128e-2	1	6.835128e-2	1.000000e+0	491	7.332497e-2	1.000000e+0	1.000000e+0	1.338353e+1	7.471870e-2	1	674	5.000000e-1	1.483680e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002572	abnormal emotion/affect behavior	407	6.858016e-2	1.000000e+0	1.000000e+0	1.458148e+1	6.858016e-2	1	6.858016e-2	1.000000e+0	61	6.515708e-4	1.000000e+0	8.457603e-2	3.913449e+1	5.110581e-2	2	461	1.000000e+0	4.338395e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001325	abnormal retina morphology	408	6.912854e-2	1.000000e+0	1.000000e+0	1.446580e+1	6.912854e-2	1	6.912854e-2	1.000000e+0	464	5.649422e-2	1.000000e+0	9.640544e-1	1.744778e+1	5.731390e-2	1	517	5.000000e-1	1.934236e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005502	abnormal renal/urinary system physiology	409	6.955113e-2	1.000000e+0	1.000000e+0	1.437791e+1	6.955113e-2	1	6.955113e-2	1.000000e+0	90	1.268378e-3	1.000000e+0	1.115891e-1	2.805754e+1	7.128208e-2	2	643	1.000000e+0	3.110420e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0008469	abnormal protein level	410	6.968426e-2	1.000000e+0	1.000000e+0	1.435044e+1	6.968426e-2	1	6.968426e-2	1.000000e+0	500	8.322334e-2	1.000000e+0	1.000000e+0	1.176076e+1	8.502855e-2	1	767	5.000000e-1	1.303781e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0002020	increased tumor incidence	411	7.037685e-2	1.000000e+0	1.000000e+0	1.420922e+1	7.037685e-2	1	7.037685e-2	1.000000e+0	483	6.873033e-2	1.000000e+0	1.000000e+0	1.429556e+1	6.995178e-2	1	631	5.000000e-1	1.584786e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002864	abnormal ocular fundus morphology	412	7.069037e-2	1.000000e+0	1.000000e+0	1.414620e+1	7.069037e-2	1	7.069037e-2	1.000000e+0	466	5.789360e-2	1.000000e+0	9.836943e-1	1.701981e+1	5.875506e-2	1	530	5.000000e-1	1.886792e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003795	abnormal bone structure	413	7.209275e-2	1.000000e+0	1.000000e+0	1.387102e+1	7.209275e-2	1	7.209275e-2	1.000000e+0	472	6.165600e-2	1.000000e+0	1.000000e+0	1.596549e+1	6.263511e-2	1	565	5.000000e-1	1.769912e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001175	abnormal lung morphology	414	7.263683e-2	1.000000e+0	1.000000e+0	1.376712e+1	7.263683e-2	1	7.263683e-2	1.000000e+0	470	6.025942e-2	1.000000e+0	1.000000e+0	1.634149e+1	6.119395e-2	1	552	5.000000e-1	1.811594e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002069	abnormal consumption behavior	415	7.333329e-2	1.000000e+0	1.000000e+0	1.363637e+1	7.333329e-2	1	7.333329e-2	1.000000e+0	476	6.315885e-2	1.000000e+0	1.000000e+0	1.557945e+1	6.418713e-2	1	579	5.000000e-1	1.727116e-3	unnamed	PTGS2
Mouse Phenotype	MP:0008250	abnormal myeloid leukocyte morphology	416	7.384491e-2	1.000000e+0	1.000000e+0	1.354189e+1	7.384491e-2	1	7.384491e-2	1.000000e+0	110	1.716821e-3	1.000000e+0	1.235799e-1	2.411898e+1	8.292223e-2	2	748	1.000000e+0	2.673797e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001921	reduced fertility	417	7.391314e-2	1.000000e+0	1.000000e+0	1.352939e+1	7.391314e-2	1	7.391314e-2	1.000000e+0	80	1.000032e-3	1.000000e+0	9.897817e-2	3.159545e+1	6.330026e-2	2	571	1.000000e+0	3.502627e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001533	abnormal skeleton physiology	418	7.413401e-2	1.000000e+0	1.000000e+0	1.348909e+1	7.413401e-2	1	7.413401e-2	1.000000e+0	475	6.272959e-2	1.000000e+0	1.000000e+0	1.568783e+1	6.374369e-2	1	575	5.000000e-1	1.739130e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005195	abnormal posterior eye segment morphology	419	7.618498e-2	1.000000e+0	1.000000e+0	1.312595e+1	7.618498e-2	1	7.618498e-2	1.000000e+0	474	6.262226e-2	1.000000e+0	1.000000e+0	1.571516e+1	6.363284e-2	1	574	5.000000e-1	1.742160e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000259	abnormal vascular development	420	7.623737e-2	1.000000e+0	1.000000e+0	1.311693e+1	7.623737e-2	1	7.623737e-2	1.000000e+0	469	6.015194e-2	1.000000e+0	1.000000e+0	1.637114e+1	6.108309e-2	1	551	5.000000e-1	1.814882e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000003	abnormal adipose tissue morphology	421	7.628668e-2	1.000000e+0	1.000000e+0	1.310845e+1	7.628668e-2	1	7.628668e-2	1.000000e+0	484	6.894429e-2	1.000000e+0	1.000000e+0	1.425039e+1	7.017349e-2	1	633	5.000000e-1	1.579779e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001547	abnormal lipid level	422	7.658706e-2	1.000000e+0	1.000000e+0	1.305704e+1	7.658706e-2	1	7.658706e-2	1.000000e+0	500	8.322334e-2	1.000000e+0	1.000000e+0	1.176076e+1	8.502855e-2	1	767	5.000000e-1	1.303781e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002063	abnormal learning/memory/conditioning	423	7.681964e-2	1.000000e+0	1.000000e+0	1.301750e+1	7.681964e-2	1	7.681964e-2	1.000000e+0	467	5.821639e-2	1.000000e+0	9.870608e-1	1.692402e+1	5.908763e-2	1	533	5.000000e-1	1.876173e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0005294	abnormal heart ventricle morphology	424	7.700612e-2	1.000000e+0	1.000000e+0	1.298598e+1	7.700612e-2	1	7.700612e-2	1.000000e+0	74	9.413210e-4	1.000000e+0	1.007213e-1	3.256498e+1	6.141566e-2	2	554	1.000000e+0	3.610108e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005375	adipose tissue phenotype	425	7.725086e-2	1.000000e+0	1.000000e+0	1.294484e+1	7.725086e-2	1	7.725086e-2	1.000000e+0	487	7.001370e-2	1.000000e+0	1.000000e+0	1.402877e+1	7.128208e-2	1	643	5.000000e-1	1.555210e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002206	abnormal CNS synaptic transmission	426	7.759259e-2	1.000000e+0	1.000000e+0	1.288783e+1	7.759259e-2	1	7.759259e-2	1.000000e+0	463	5.541706e-2	1.000000e+0	9.477155e-1	1.779191e+1	5.620531e-2	1	507	5.000000e-1	1.972387e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002019	abnormal tumor incidence	427	7.769090e-2	1.000000e+0	1.000000e+0	1.287152e+1	7.769090e-2	1	7.769090e-2	1.000000e+0	100	1.542348e-3	1.000000e+0	1.221231e-1	2.544570e+1	7.859875e-2	2	709	1.000000e+0	2.820874e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001943	abnormal respiration	428	7.804211e-2	1.000000e+0	1.000000e+0	1.281360e+1	7.804211e-2	1	7.804211e-2	1.000000e+0	72	9.076148e-4	1.000000e+0	9.981242e-2	3.316360e+1	6.030708e-2	2	544	1.000000e+0	3.676471e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002086	abnormal extraembryonic tissue morphology	429	7.842157e-2	1.000000e+0	1.000000e+0	1.275159e+1	7.842157e-2	1	7.842157e-2	1.000000e+0	489	7.086879e-2	1.000000e+0	1.000000e+0	1.385637e+1	7.216895e-2	1	651	5.000000e-1	1.536098e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001924	infertility	430	7.848077e-2	1.000000e+0	1.000000e+0	1.274198e+1	7.848077e-2	1	7.848077e-2	1.000000e+0	494	7.886609e-2	1.000000e+0	1.000000e+0	1.242493e+1	8.048334e-2	1	726	5.000000e-1	1.377410e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002166	altered tumor susceptibility	431	7.903444e-2	1.000000e+0	1.000000e+0	1.265271e+1	7.903444e-2	1	7.903444e-2	1.000000e+0	103	1.603904e-3	1.000000e+0	1.232982e-1	2.495297e+1	8.015077e-2	2	723	1.000000e+0	2.766252e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0003699	abnormal female reproductive system physiology	432	7.951923e-2	1.000000e+0	1.000000e+0	1.257558e+1	7.951923e-2	1	7.951923e-2	1.000000e+0	89	1.260494e-3	1.000000e+0	1.121415e-1	2.814509e+1	7.106036e-2	2	641	1.000000e+0	3.120125e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002401	abnormal lymphopoiesis	433	7.968565e-2	1.000000e+0	1.000000e+0	1.254931e+1	7.968565e-2	1	7.968565e-2	1.000000e+0	503	8.523905e-2	1.000000e+0	1.000000e+0	1.147646e+1	8.713486e-2	1	786	5.000000e-1	1.272265e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002445	abnormal mononuclear cell differentiation	434	8.007402e-2	1.000000e+0	1.000000e+0	1.248844e+1	8.007402e-2	1	8.007402e-2	1.000000e+0	504	8.587513e-2	1.000000e+0	1.000000e+0	1.138952e+1	8.780001e-2	1	792	5.000000e-1	1.262626e-3	unnamed	PTGS2
Mouse Phenotype	MP:0004811	abnormal neuron physiology	435	8.084811e-2	1.000000e+0	1.000000e+0	1.236887e+1	8.084811e-2	1	8.084811e-2	1.000000e+0	82	1.035397e-3	1.000000e+0	9.997894e-2	3.105164e+1	6.440885e-2	2	581	1.000000e+0	3.442341e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002452	abnormal professional antigen presenting cell physiology	436	8.156256e-2	1.000000e+0	1.000000e+0	1.226053e+1	8.156256e-2	1	8.156256e-2	1.000000e+0	134	2.333660e-3	1.000000e+0	1.378949e-1	2.068922e+1	9.666870e-2	2	872	1.000000e+0	2.293578e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002118	abnormal lipid homeostasis	437	8.181450e-2	1.000000e+0	1.000000e+0	1.222277e+1	8.181450e-2	1	8.181450e-2	1.000000e+0	506	8.936961e-2	1.000000e+0	1.000000e+0	1.093394e+1	9.145834e-2	1	825	5.000000e-1	1.212121e-3	unnamed	PTGS2
Mouse Phenotype	MP:0011085	complete postnatal lethality	438	8.232293e-2	1.000000e+0	1.000000e+0	1.214728e+1	8.232293e-2	1	8.232293e-2	1.000000e+0	480	6.455328e-2	1.000000e+0	1.000000e+0	1.523733e+1	6.562829e-2	1	592	5.000000e-1	1.689189e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000653	abnormal sex gland morphology	439	8.328551e-2	1.000000e+0	1.000000e+0	1.200689e+1	8.328551e-2	1	8.328551e-2	1.000000e+0	497	8.088659e-2	1.000000e+0	1.000000e+0	1.210805e+1	8.258966e-2	1	745	5.000000e-1	1.342282e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000689	abnormal spleen morphology	440	8.333506e-2	1.000000e+0	1.000000e+0	1.199975e+1	8.333506e-2	1	8.333506e-2	1.000000e+0	507	8.979273e-2	1.000000e+0	1.000000e+0	1.088118e+1	9.190178e-2	1	829	5.000000e-1	1.206273e-3	unnamed	PTGS2
Mouse Phenotype	MP:0006042	increased apoptosis	441	8.429662e-2	1.000000e+0	1.000000e+0	1.186287e+1	8.429662e-2	1	8.429662e-2	1.000000e+0	495	7.939802e-2	1.000000e+0	1.000000e+0	1.233995e+1	8.103764e-2	1	731	5.000000e-1	1.367989e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000218	increased leukocyte cell number	442	8.449829e-2	1.000000e+0	1.000000e+0	1.183456e+1	8.449829e-2	1	8.449829e-2	1.000000e+0	512	9.296298e-2	1.000000e+0	1.000000e+0	1.050116e+1	9.522754e-2	1	859	5.000000e-1	1.164144e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002060	abnormal skin morphology	443	8.538698e-2	1.000000e+0	1.000000e+0	1.171139e+1	8.538698e-2	1	8.538698e-2	1.000000e+0	502	8.428452e-2	1.000000e+0	1.000000e+0	1.160940e+1	8.613713e-2	1	777	5.000000e-1	1.287001e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002414	abnormal myeloblast morphology/development	444	8.539083e-2	1.000000e+0	1.000000e+0	1.171086e+1	8.539083e-2	1	8.539083e-2	1.000000e+0	510	9.264620e-2	1.000000e+0	1.000000e+0	1.053797e+1	9.489496e-2	1	856	5.000000e-1	1.168224e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002006	tumorigenesis	445	8.579997e-2	1.000000e+0	1.000000e+0	1.165502e+1	8.579997e-2	1	8.579997e-2	1.000000e+0	120	1.920023e-3	1.000000e+0	1.266895e-1	2.280784e+1	8.768915e-2	2	791	1.000000e+0	2.528445e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005418	abnormal circulating hormone level	446	8.615845e-2	1.000000e+0	1.000000e+0	1.160652e+1	8.615845e-2	1	8.615845e-2	1.000000e+0	496	8.003612e-2	1.000000e+0	1.000000e+0	1.223948e+1	8.170279e-2	1	737	5.000000e-1	1.356852e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002221	abnormal lymph organ size	447	8.616517e-2	1.000000e+0	1.000000e+0	1.160562e+1	8.616517e-2	1	8.616517e-2	1.000000e+0	510	9.264620e-2	1.000000e+0	1.000000e+0	1.053797e+1	9.489496e-2	1	856	5.000000e-1	1.168224e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002128	abnormal blood circulation	448	8.674022e-2	1.000000e+0	1.000000e+0	1.152868e+1	8.674022e-2	1	8.674022e-2	1.000000e+0	488	7.065505e-2	1.000000e+0	1.000000e+0	1.389908e+1	7.194723e-2	1	649	5.000000e-1	1.540832e-3	unnamed	PLA2G4A
Mouse Phenotype	MP:0001784	abnormal fluid regulation	449	8.688736e-2	1.000000e+0	1.000000e+0	1.150915e+1	8.688736e-2	1	8.688736e-2	1.000000e+0	490	7.225746e-2	1.000000e+0	1.000000e+0	1.358509e+1	7.361011e-2	1	664	5.000000e-1	1.506024e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005460	abnormal leukopoiesis	450	8.694600e-2	1.000000e+0	1.000000e+0	1.150139e+1	8.694600e-2	1	8.694600e-2	1.000000e+0	130	2.269836e-3	1.000000e+0	1.382505e-1	2.097791e+1	9.533840e-2	2	860	1.000000e+0	2.325581e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002078	abnormal glucose homeostasis	451	8.818097e-2	1.000000e+0	1.000000e+0	1.134032e+1	8.818097e-2	1	8.818097e-2	1.000000e+0	111	1.726020e-3	1.000000e+0	1.231228e-1	2.405467e+1	8.314395e-2	2	750	1.000000e+0	2.666667e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002135	abnormal kidney morphology	452	8.823365e-2	1.000000e+0	1.000000e+0	1.133354e+1	8.823365e-2	1	8.823365e-2	1.000000e+0	104	1.612796e-3	1.000000e+0	1.227896e-1	2.488414e+1	8.037248e-2	2	725	1.000000e+0	2.758621e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001846	increased inflammatory response	453	8.879507e-2	1.000000e+0	1.000000e+0	1.126189e+1	8.879507e-2	1	8.879507e-2	1.000000e+0	139	2.569627e-3	1.000000e+0	1.463763e-1	1.971694e+1	1.014356e-1	2	915	1.000000e+0	2.185792e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0003635	abnormal synaptic transmission	454	8.890066e-2	1.000000e+0	1.000000e+0	1.124851e+1	8.890066e-2	1	8.890066e-2	1.000000e+0	479	6.412434e-2	1.000000e+0	1.000000e+0	1.534099e+1	6.518486e-2	1	588	5.000000e-1	1.700680e-3	unnamed	PTGS2
Mouse Phenotype	MP:0003945	abnormal lymphocyte physiology	455	9.054147e-2	1.000000e+0	1.000000e+0	1.104466e+1	9.054147e-2	1	9.054147e-2	1.000000e+0	516	1.016001e-1	1.000000e+0	1.000000e+0	9.586079e+0	1.043179e-1	1	941	5.000000e-1	1.062699e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002723	abnormal immune serum protein physiology	456	9.094959e-2	1.000000e+0	1.000000e+0	1.099510e+1	9.094959e-2	1	9.094959e-2	1.000000e+0	144	2.959943e-3	1.000000e+0	1.627558e-1	1.837169e+1	1.088631e-1	2	982	1.000000e+0	2.036660e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0000598	abnormal liver morphology	457	9.333181e-2	1.000000e+0	1.000000e+0	1.071446e+1	9.333181e-2	1	9.333181e-2	1.000000e+0	513	9.412402e-2	1.000000e+0	1.000000e+0	1.036839e+1	9.644698e-2	1	870	5.000000e-1	1.149425e-3	unnamed	PTGS2
Mouse Phenotype	MP:0011181	increased hematopoietic cell number	458	9.359664e-2	1.000000e+0	1.000000e+0	1.068414e+1	9.359664e-2	1	9.359664e-2	1.000000e+0	143	2.882053e-3	1.000000e+0	1.595811e-1	1.861816e+1	1.074220e-1	2	969	1.000000e+0	2.063983e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002138	abnormal hepatobiliary system morphology	459	9.450540e-2	1.000000e+0	1.000000e+0	1.058141e+1	9.450540e-2	1	9.450540e-2	1.000000e+0	514	9.549520e-2	1.000000e+0	1.000000e+0	1.021574e+1	9.788814e-2	1	883	5.000000e-1	1.132503e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002132	abnormal respiratory system morphology	460	9.499315e-2	1.000000e+0	1.000000e+0	1.052707e+1	9.499315e-2	1	9.499315e-2	1.000000e+0	492	7.780178e-2	1.000000e+0	1.000000e+0	1.259846e+1	7.937476e-2	1	716	5.000000e-1	1.396648e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000350	abnormal cell proliferation	461	9.545087e-2	1.000000e+0	1.000000e+0	1.047659e+1	9.545087e-2	1	9.545087e-2	1.000000e+0	508	9.021575e-2	1.000000e+0	1.000000e+0	1.082893e+1	9.234521e-2	1	833	5.000000e-1	1.200480e-3	unnamed	PTGS2
Mouse Phenotype	MP:0000516	abnormal renal/urinary system morphology	462	9.778842e-2	1.000000e+0	1.000000e+0	1.022616e+1	9.778842e-2	1	9.778842e-2	1.000000e+0	117	1.843086e-3	1.000000e+0	1.247312e-1	2.327871e+1	8.591541e-2	2	775	1.000000e+0	2.580645e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0011087	complete neonatal lethality	463	9.826674e-2	1.000000e+0	1.000000e+0	1.017638e+1	9.826674e-2	1	9.826674e-2	1.000000e+0	482	6.808832e-2	1.000000e+0	1.000000e+0	1.443280e+1	6.928662e-2	1	625	5.000000e-1	1.600000e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002106	abnormal muscle physiology	464	9.999719e-2	1.000000e+0	1.000000e+0	1.000028e+1	9.999719e-2	1	9.999719e-2	1.000000e+0	505	8.894639e-2	1.000000e+0	1.000000e+0	1.098721e+1	9.101491e-2	1	821	5.000000e-1	1.218027e-3	unnamed	PTGS2
Mouse Phenotype	MP:0011086	partial postnatal lethality	465	1.002907e-1	1.000000e+0	1.000000e+0	9.971019e+0	1.002907e-1	1	1.002907e-1	1.000000e+0	493	7.822758e-2	1.000000e+0	1.000000e+0	1.252847e+1	7.981819e-2	1	720	5.000000e-1	1.388889e-3	unnamed	PTGS2
Mouse Phenotype	MP:0001845	abnormal inflammatory response	466	1.012612e-1	1.000000e+0	1.000000e+0	9.875447e+0	1.012612e-1	1	1.012612e-1	1.000000e+0	161	3.613781e-3	1.000000e+0	1.777262e-1	1.662765e+1	1.202816e-1	2	1085	1.000000e+0	1.843318e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0003953	abnormal hormone level	467	1.023291e-1	1.000000e+0	1.000000e+0	9.772394e+0	1.023291e-1	1	1.023291e-1	1.000000e+0	509	9.095579e-2	1.000000e+0	1.000000e+0	1.073869e+1	9.312122e-2	1	840	5.000000e-1	1.190476e-3	unnamed	PTGS2
Mouse Phenotype	MP:0005370	liver/biliary system phenotype	468	1.044353e-1	1.000000e+0	1.000000e+0	9.575307e+0	1.044353e-1	1	1.044353e-1	1.000000e+0	517	1.082079e-1	1.000000e+0	1.000000e+0	8.984562e+0	1.113020e-1	1	1004	5.000000e-1	9.960159e-4	unnamed	PTGS2
Mouse Phenotype	MP:0002067	abnormal sensory capabilities/reflexes/nociception	469	1.044486e-1	1.000000e+0	1.000000e+0	9.574091e+0	1.044486e-1	1	1.044486e-1	1.000000e+0	499	8.216155e-2	1.000000e+0	1.000000e+0	1.191612e+1	8.391996e-2	1	757	5.000000e-1	1.321004e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002925	abnormal cardiovascular development	470	1.048053e-1	1.000000e+0	1.000000e+0	9.541504e+0	1.048053e-1	1	1.048053e-1	1.000000e+0	498	8.141793e-2	1.000000e+0	1.000000e+0	1.202733e+1	8.314395e-2	1	750	5.000000e-1	1.333333e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002108	abnormal muscle morphology	471	1.058722e-1	1.000000e+0	1.000000e+0	9.445349e+0	1.058722e-1	1	1.058722e-1	1.000000e+0	128	2.114148e-3	1.000000e+0	1.307799e-1	2.173614e+1	9.201264e-2	2	830	1.000000e+0	2.409639e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002133	abnormal respiratory system physiology	472	1.065359e-1	1.000000e+0	1.000000e+0	9.386507e+0	1.065359e-1	1	1.065359e-1	1.000000e+0	121	1.993581e-3	1.000000e+0	1.304560e-1	2.238337e+1	8.935203e-2	2	806	1.000000e+0	2.481390e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002398	abnormal bone marrow cell morphology/development	473	1.085064e-1	1.000000e+0	1.000000e+0	9.216047e+0	1.085064e-1	1	1.085064e-1	1.000000e+0	522	1.211425e-1	1.000000e+0	1.000000e+0	7.996897e+0	1.250485e-1	1	1128	5.000000e-1	8.865248e-4	unnamed	PTGS2
Mouse Phenotype	MP:0002722	abnormal immune system organ morphology	474	1.102968e-1	1.000000e+0	1.000000e+0	9.066446e+0	1.102968e-1	1	1.102968e-1	1.000000e+0	521	1.202068e-1	1.000000e+0	1.000000e+0	8.061215e+0	1.240508e-1	1	1119	5.000000e-1	8.936550e-4	unnamed	PTGS2
Mouse Phenotype	MP:0002160	abnormal reproductive system morphology	475	1.137433e-1	1.000000e+0	1.000000e+0	8.791730e+0	1.137433e-1	1	1.137433e-1	1.000000e+0	518	1.128084e-1	1.000000e+0	1.000000e+0	8.607347e+0	1.161798e-1	1	1048	5.000000e-1	9.541985e-4	unnamed	PTGS2
Mouse Phenotype	MP:0002619	abnormal lymphocyte morphology	476	1.142540e-1	1.000000e+0	1.000000e+0	8.752430e+0	1.142540e-1	1	1.142540e-1	1.000000e+0	524	1.290234e-1	1.000000e+0	1.000000e+0	7.492110e+0	1.334738e-1	1	1204	5.000000e-1	8.305648e-4	unnamed	PTGS2
Mouse Phenotype	MP:0000462	abnormal digestive system morphology	477	1.165265e-1	1.000000e+0	1.000000e+0	8.581738e+0	1.165265e-1	1	1.165265e-1	1.000000e+0	135	2.344383e-3	1.000000e+0	1.375024e-1	2.064188e+1	9.689042e-2	2	874	1.000000e+0	2.288330e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005367	renal/urinary system phenotype	478	1.190804e-1	1.000000e+0	1.000000e+0	8.397691e+0	1.190804e-1	1	1.190804e-1	1.000000e+0	148	3.156096e-3	1.000000e+0	1.688511e-1	1.779191e+1	1.124106e-1	2	1014	1.000000e+0	1.972387e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002442	abnormal leukocyte physiology	479	1.192967e-1	1.000000e+0	1.000000e+0	8.382459e+0	1.192967e-1	1	1.192967e-1	1.000000e+0	192	4.936268e-3	1.000000e+0	2.035696e-1	1.422792e+1	1.405687e-1	2	1268	1.000000e+0	1.577287e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001819	abnormal immune cell physiology	480	1.203217e-1	1.000000e+0	1.000000e+0	8.311053e+0	1.203217e-1	1	1.203217e-1	1.000000e+0	197	5.117040e-3	1.000000e+0	2.056686e-1	1.397444e+1	1.431185e-1	2	1291	1.000000e+0	1.549187e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002421	abnormal cell-mediated immunity	481	1.209554e-1	1.000000e+0	1.000000e+0	8.267508e+0	1.209554e-1	1	1.209554e-1	1.000000e+0	202	5.204645e-3	1.000000e+0	2.040118e-1	1.385637e+1	1.443379e-1	2	1302	1.000000e+0	1.536098e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001648	abnormal apoptosis	482	1.225891e-1	1.000000e+0	1.000000e+0	8.157331e+0	1.225891e-1	1	1.225891e-1	1.000000e+0	165	3.864571e-3	1.000000e+0	1.854526e-1	1.607932e+1	1.243833e-1	2	1122	1.000000e+0	1.782531e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002420	abnormal adaptive immunity	483	1.226687e-1	1.000000e+0	1.000000e+0	8.152037e+0	1.226687e-1	1	1.226687e-1	1.000000e+0	203	5.341498e-3	1.000000e+0	2.083447e-1	1.367779e+1	1.462225e-1	2	1319	1.000000e+0	1.516300e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0000217	abnormal leukocyte cell number	484	1.272684e-1	1.000000e+0	1.000000e+0	7.857411e+0	1.272684e-1	1	1.272684e-1	1.000000e+0	528	1.403671e-1	1.000000e+0	1.000000e+0	6.864916e+0	1.456682e-1	1	1314	5.000000e-1	7.610350e-4	unnamed	PTGS2
Mouse Phenotype	MP:0001614	abnormal blood vessel morphology	485	1.298506e-1	1.000000e+0	1.000000e+0	7.701161e+0	1.298506e-1	1	1.298506e-1	1.000000e+0	519	1.145827e-1	1.000000e+0	1.000000e+0	8.469953e+0	1.180644e-1	1	1065	5.000000e-1	9.389671e-4	unnamed	PTGS2
Mouse Phenotype	MP:0002058	neonatal lethality	486	1.337691e-1	1.000000e+0	1.000000e+0	7.475567e+0	1.337691e-1	1	1.337691e-1	1.000000e+0	515	9.633849e-2	1.000000e+0	1.000000e+0	1.012402e+1	9.877501e-2	1	891	5.000000e-1	1.122334e-3	unnamed	PTGS2
Mouse Phenotype	MP:0002161	abnormal fertility/fecundity	487	1.345122e-1	1.000000e+0	1.000000e+0	7.434268e+0	1.345122e-1	1	1.345122e-1	1.000000e+0	187	4.599501e-3	1.000000e+0	1.947532e-1	1.473938e+1	1.356909e-1	2	1224	1.000000e+0	1.633987e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0008247	abnormal mononuclear cell morphology	488	1.350005e-1	1.000000e+0	1.000000e+0	7.407378e+0	1.350005e-1	1	1.350005e-1	1.000000e+0	531	1.540854e-1	1.000000e+0	1.000000e+0	6.229627e+0	1.605233e-1	1	1448	5.000000e-1	6.906077e-4	unnamed	PTGS2
Mouse Phenotype	MP:0000266	abnormal heart morphology	489	1.360125e-1	1.000000e+0	1.000000e+0	7.352265e+0	1.360125e-1	1	1.360125e-1	1.000000e+0	160	3.514506e-3	1.000000e+0	1.739241e-1	1.686075e+1	1.186187e-1	2	1070	1.000000e+0	1.869159e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0000313	abnormal cell death	490	1.373532e-1	1.000000e+0	1.000000e+0	7.280503e+0	1.373532e-1	1	1.373532e-1	1.000000e+0	196	5.101192e-3	1.000000e+0	2.060777e-1	1.399612e+1	1.428967e-1	2	1289	1.000000e+0	1.551590e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005381	digestive/alimentary phenotype	491	1.385091e-1	1.000000e+0	1.000000e+0	7.219740e+0	1.385091e-1	1	1.385091e-1	1.000000e+0	169	3.989619e-3	1.000000e+0	1.869219e-1	1.582544e+1	1.263788e-1	2	1140	1.000000e+0	1.754386e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002092	abnormal eye morphology	492	1.428440e-1	1.000000e+0	1.000000e+0	7.000642e+0	1.428440e-1	1	1.428440e-1	1.000000e+0	520	1.188545e-1	1.000000e+0	1.000000e+0	8.155967e+0	1.226096e-1	1	1106	5.000000e-1	9.041591e-4	unnamed	PTGS2
Mouse Phenotype	MP:0011180	abnormal hematopoietic cell number	493	1.429801e-1	1.000000e+0	1.000000e+0	6.993980e+0	1.429801e-1	1	1.429801e-1	1.000000e+0	220	6.927132e-3	1.000000e+0	2.493138e-1	1.201132e+1	1.665096e-1	2	1502	1.000000e+0	1.331558e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0002083	premature death	494	1.449089e-1	1.000000e+0	1.000000e+0	6.900889e+0	1.449089e-1	1	1.449089e-1	1.000000e+0	527	1.369718e-1	1.000000e+0	1.000000e+0	7.041764e+0	1.420099e-1	1	1281	5.000000e-1	7.806401e-4	unnamed	PTGS2
Mouse Phenotype	MP:0005388	respiratory system phenotype	495	1.462977e-1	1.000000e+0	1.000000e+0	6.835375e+0	1.462977e-1	1	1.462977e-1	1.000000e+0	170	4.031744e-3	1.000000e+0	1.877844e-1	1.574258e+1	1.270440e-1	2	1146	1.000000e+0	1.745201e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005369	muscle phenotype	496	1.492399e-1	1.000000e+0	1.000000e+0	6.700621e+0	1.492399e-1	1	1.492399e-1	1.000000e+0	186	4.524622e-3	1.000000e+0	1.926127e-1	1.486079e+1	1.345823e-1	2	1214	1.000000e+0	1.647446e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0008246	abnormal leukocyte morphology	497	1.497188e-1	1.000000e+0	1.000000e+0	6.679189e+0	1.497188e-1	1	1.497188e-1	1.000000e+0	238	7.890398e-3	1.000000e+0	2.625049e-1	1.125452e+1	1.777063e-1	2	1603	1.000000e+0	1.247661e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0005391	vision/eye phenotype	498	1.504147e-1	1.000000e+0	1.000000e+0	6.648285e+0	1.504147e-1	1	1.504147e-1	1.000000e+0	523	1.268493e-1	1.000000e+0	1.000000e+0	7.625106e+0	1.311457e-1	1	1183	5.000000e-1	8.453085e-4	unnamed	PTGS2
Mouse Phenotype	MP:0000716	abnormal immune system cell morphology	499	1.505458e-1	1.000000e+0	1.000000e+0	6.642496e+0	1.505458e-1	1	1.505458e-1	1.000000e+0	242	8.009012e-3	1.000000e+0	2.620469e-1	1.117090e+1	1.790366e-1	2	1615	1.000000e+0	1.238390e-3	unnamed	PLA2G4A,PTGS2
Mouse Phenotype	MP:0001919	abnormal reproductive system physiology	500	1.530473e-1	1.000000e+0	1.000000e+0	6.533929e+0	1.530473e-1	1	1.530473e-1	1.000000e+0	209	6.052400e-3	1.000000e+0	2.292962e-1	1.284972e+1	1.556455e-1	2	1404	1.000000e+0	1.424501e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:6981	recurrent colorectal cancer	1	1.250564e-4	2.795011e-1	2.795011e-1	7.996393e+3	1.250564e-4	1	1.250564e-4	1.000000e+0	2	1.108586e-4	2.477690e-1	1.238845e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	PTGS2
Disease Ontology	DOID:4932	ampullary carcinoma	2	1.540829e-4	3.443753e-1	1.721876e-1	6.490013e+3	1.540829e-4	1	1.540829e-4	1.000000e+0	3	2.217111e-4	4.955243e-1	1.651748e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	PTGS2
Disease Ontology	DOID:4137	common bile duct disease	3	1.972300e-4	4.408091e-1	1.469364e-1	5.070222e+3	1.972300e-4	1	1.972300e-4	1.000000e+0	5	3.325574e-4	7.432658e-1	1.486532e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	PTGS2
Disease Ontology	DOID:1793	malignant neoplasm of pancreas	4	1.979884e-4	4.425041e-1	1.106260e-1	5.050800e+3	1.979884e-4	1	1.979884e-4	1.000000e+0	9	4.433975e-4	9.909934e-1	1.101104e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	PTGS2
Disease Ontology	DOID:3748	esophagus squamous cell carcinoma	5	2.312185e-4	5.167733e-1	1.033547e-1	4.324913e+3	2.312185e-4	1	2.312185e-4	1.000000e+0	9	4.433975e-4	9.909934e-1	1.101104e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	PTGS2
Disease Ontology	DOID:12569	Chagas cardiomyopathy	6	3.220093e-4	7.196908e-1	1.199485e-1	3.105501e+3	3.220093e-4	1	3.220093e-4	1.000000e+0	19	6.650594e-4	1.000000e+0	7.823199e-2	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	PTGS2
Disease Ontology	DOID:5746	ovarian serous cystadenocarcinoma	7	3.477800e-4	7.772883e-1	1.110412e-1	2.875381e+3	3.477800e-4	1	3.477800e-4	1.000000e+0	13	5.542315e-4	1.000000e+0	9.528518e-2	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	PTGS2
Disease Ontology	DOID:3605	ovarian cystadenocarcinoma	8	3.528982e-4	7.887275e-1	9.859093e-2	2.833678e+3	3.528982e-4	1	3.528982e-4	1.000000e+0	19	6.650594e-4	1.000000e+0	7.823199e-2	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	PTGS2
Disease Ontology	DOID:4362	cervix neoplasm	9	3.575055e-4	7.990248e-1	8.878053e-2	2.797160e+3	3.575055e-4	1	3.575055e-4	1.000000e+0	5	3.325574e-4	7.432658e-1	1.486532e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	PTGS2
Disease Ontology	DOID:12384	dysentery	10	4.066812e-4	9.089325e-1	9.089325e-2	2.458928e+3	4.066812e-4	1	4.066812e-4	1.000000e+0	26	7.758812e-4	1.000000e+0	6.669594e-2	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	PTGS2
Disease Ontology	DOID:10531	pneumococcal pneumonia	11	4.166569e-4	9.312282e-1	8.465711e-2	2.400056e+3	4.166569e-4	1	4.166569e-4	1.000000e+0	3	2.217111e-4	4.955243e-1	1.651748e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	PTGS2
Disease Ontology	DOID:1354	paranasal sinus carcinoma	12	5.149270e-4	1.000000e+0	9.590515e-2	1.942023e+3	5.149270e-4	1	5.149270e-4	1.000000e+0	13	5.542315e-4	1.000000e+0	9.528518e-2	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	PTGS2
Disease Ontology	DOID:9805	pneumococcal infectious disease	13	5.254906e-4	1.000000e+0	9.034396e-2	1.902984e+3	5.254906e-4	1	5.254906e-4	1.000000e+0	13	5.542315e-4	1.000000e+0	9.528518e-2	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	PTGS2
Disease Ontology	DOID:930	orbital disease	14	5.360087e-4	1.000000e+0	8.556996e-2	1.865641e+3	5.360087e-4	1	5.360087e-4	1.000000e+0	26	7.758812e-4	1.000000e+0	6.669594e-2	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	PTGS2
Disease Ontology	DOID:5744	serous adenocarcinoma of the ovary	15	5.727001e-4	1.000000e+0	8.533231e-2	1.746115e+3	5.727001e-4	1	5.727001e-4	1.000000e+0	26	7.758812e-4	1.000000e+0	6.669594e-2	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	PTGS2
Disease Ontology	DOID:6072	duodenal cancer	16	5.869312e-4	1.000000e+0	8.198695e-2	1.703777e+3	5.869312e-4	1	5.869312e-4	1.000000e+0	9	4.433975e-4	9.909934e-1	1.101104e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	PTGS2
Disease Ontology	DOID:1282	vulvar neoplasm	17	5.959671e-4	1.000000e+0	7.835215e-2	1.677945e+3	5.959671e-4	1	5.959671e-4	1.000000e+0	13	5.542315e-4	1.000000e+0	9.528518e-2	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	PTGS2
Disease Ontology	DOID:4907	small intestine carcinoma	18	5.997503e-4	1.000000e+0	7.446900e-2	1.667361e+3	5.997503e-4	1	5.997503e-4	1.000000e+0	13	5.542315e-4	1.000000e+0	9.528518e-2	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	PTGS2
Disease Ontology	DOID:2059	vulvar disease	19	6.663531e-4	1.000000e+0	7.838417e-2	1.500706e+3	6.663531e-4	1	6.663531e-4	1.000000e+0	19	6.650594e-4	1.000000e+0	7.823199e-2	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	PTGS2
Disease Ontology	DOID:2253	cervix disease	20	6.828052e-4	1.000000e+0	7.630348e-2	1.464547e+3	6.828052e-4	1	6.828052e-4	1.000000e+0	31	9.975062e-4	1.000000e+0	7.191698e-2	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	PTGS2
Disease Ontology	DOID:10457	Legionnaires' disease	21	8.338304e-4	1.000000e+0	8.874338e-2	1.199285e+3	8.338304e-4	1	8.338304e-4	1.000000e+0	9	4.433975e-4	9.909934e-1	1.101104e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	PTGS2
Disease Ontology	DOID:11168	anogenital venereal wart	22	8.841085e-4	1.000000e+0	8.981739e-2	1.131083e+3	8.841085e-4	1	8.841085e-4	1.000000e+0	26	7.758812e-4	1.000000e+0	6.669594e-2	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	PTGS2
Disease Ontology	DOID:9370	exophthalmos	23	9.116584e-4	1.000000e+0	8.858941e-2	1.096902e+3	9.116584e-4	1	9.116584e-4	1.000000e+0	30	8.866967e-4	1.000000e+0	6.605890e-2	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	PTGS2
Disease Ontology	DOID:10526	conjunctival pterygium	24	9.385247e-4	1.000000e+0	8.740011e-2	1.065502e+3	9.385247e-4	1	9.385247e-4	1.000000e+0	78	2.880326e-3	1.000000e+0	8.253242e-2	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	PTGS2
Disease Ontology	DOID:3010	lobular neoplasia	25	9.470861e-4	1.000000e+0	8.466950e-2	1.055870e+3	9.470861e-4	1	9.470861e-4	1.000000e+0	19	6.650594e-4	1.000000e+0	7.823199e-2	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	PTGS2
Disease Ontology	DOID:7757	childhood leukemia	26	9.708508e-4	1.000000e+0	8.345583e-2	1.030024e+3	9.708508e-4	1	9.708508e-4	1.000000e+0	41	1.329898e-3	1.000000e+0	7.249566e-2	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	PTGS2
Disease Ontology	DOID:8923	skin melanoma	27	1.080847e-3	1.000000e+0	8.947011e-2	9.252005e+2	1.080847e-3	1	1.080847e-3	1.000000e+0	50	1.883760e-3	1.000000e+0	8.420407e-2	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	PTGS2
Disease Ontology	DOID:4418	cutaneous fibrous histiocytoma	28	1.206961e-3	1.000000e+0	9.634135e-2	8.285272e+2	1.206961e-3	1	1.206961e-3	1.000000e+0	19	6.650594e-4	1.000000e+0	7.823199e-2	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	PTGS2
Disease Ontology	DOID:10747	lymphoid leukemia	29	1.270491e-3	1.000000e+0	9.791543e-2	7.870976e+2	1.270491e-3	1	1.270491e-3	1.000000e+0	34	1.219107e-3	1.000000e+0	8.013836e-2	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	PTGS2
Disease Ontology	DOID:2418	cutaneous melanocytic neoplasm	30	1.282814e-3	1.000000e+0	9.556964e-2	7.795362e+2	1.282814e-3	1	1.282814e-3	1.000000e+0	53	1.994515e-3	1.000000e+0	8.410832e-2	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	PTGS2
Disease Ontology	DOID:2089	constipation	31	1.359802e-3	1.000000e+0	9.803734e-2	7.354011e+2	1.359802e-3	1	1.359802e-3	1.000000e+0	34	1.219107e-3	1.000000e+0	8.013836e-2	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	PTGS2
Disease Ontology	DOID:3507	dermatofibrosarcoma	32	1.530954e-3	1.000000e+0	1.069276e-1	6.531876e+2	1.530954e-3	1	1.530954e-3	1.000000e+0	34	1.219107e-3	1.000000e+0	8.013836e-2	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	PTGS2
Disease Ontology	DOID:11729	Lyme disease	33	1.562511e-3	1.000000e+0	1.058246e-1	6.399954e+2	1.562511e-3	1	1.562511e-3	1.000000e+0	57	2.105263e-3	1.000000e+0	8.254847e-2	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	PTGS2
Disease Ontology	DOID:4305	giant cell tumor of bone	34	1.652449e-3	1.000000e+0	1.086242e-1	6.051623e+2	1.652449e-3	1	1.652449e-3	1.000000e+0	41	1.329898e-3	1.000000e+0	7.249566e-2	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	PTGS2
Disease Ontology	DOID:649	prion disease	35	1.677570e-3	1.000000e+0	1.071248e-1	5.961003e+2	1.677570e-3	1	1.677570e-3	1.000000e+0	58	2.216004e-3	1.000000e+0	8.539257e-2	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	PTGS2
Disease Ontology	DOID:100	intestinal infectious disease	36	1.720380e-3	1.000000e+0	1.068069e-1	5.812669e+2	1.720380e-3	1	1.720380e-3	1.000000e+0	58	2.216004e-3	1.000000e+0	8.539257e-2	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	PTGS2
Disease Ontology	DOID:4251	conjunctival disease	37	1.745352e-3	1.000000e+0	1.054287e-1	5.729503e+2	1.745352e-3	1	1.745352e-3	1.000000e+0	96	4.208307e-3	1.000000e+0	9.797465e-2	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	PTGS2
Disease Ontology	DOID:10808	gastric ulcer	38	1.766458e-3	1.000000e+0	1.038956e-1	5.661045e+2	1.766458e-3	1	1.766458e-3	1.000000e+0	44	1.551461e-3	1.000000e+0	7.880717e-2	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	PTGS2
Disease Ontology	DOID:0050374	Spirochaetaceae infectious disease	39	1.816242e-3	1.000000e+0	1.040846e-1	5.505874e+2	1.816242e-3	1	1.816242e-3	1.000000e+0	64	2.326740e-3	1.000000e+0	8.125412e-2	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	PTGS2
Disease Ontology	DOID:2257	primary Spirochaetales infectious disease	40	1.879493e-3	1.000000e+0	1.050167e-1	5.320583e+2	1.879493e-3	1	1.879493e-3	1.000000e+0	76	2.658910e-3	1.000000e+0	7.819295e-2	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	PTGS2
Disease Ontology	DOID:11426	ovarian endometriosis	41	1.926405e-3	1.000000e+0	1.050126e-1	5.191018e+2	1.926405e-3	1	1.926405e-3	1.000000e+0	46	1.662234e-3	1.000000e+0	8.076289e-2	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	PTGS2
Disease Ontology	DOID:10155	intestinal cancer	42	1.927134e-3	1.000000e+0	1.025511e-1	5.189052e+2	1.927134e-3	1	1.927134e-3	1.000000e+0	46	1.662234e-3	1.000000e+0	8.076289e-2	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	PTGS2
Disease Ontology	DOID:3907	lung squamous cell carcinoma	43	2.011377e-3	1.000000e+0	1.045448e-1	4.971717e+2	2.011377e-3	1	2.011377e-3	1.000000e+0	58	2.216004e-3	1.000000e+0	8.539257e-2	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	PTGS2
Disease Ontology	DOID:2938	Epstein-Barr virus infectious disease	44	2.091917e-3	1.000000e+0	1.062599e-1	4.780304e+2	2.091917e-3	1	2.091917e-3	1.000000e+0	80	2.991025e-3	1.000000e+0	8.356176e-2	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	PTGS2
Disease Ontology	DOID:0050424	familial adenomatous polyposis	45	2.166370e-3	1.000000e+0	1.075964e-1	4.616017e+2	2.166370e-3	1	2.166370e-3	1.000000e+0	1	4.793221e-7	1.071285e-3	1.071285e-3	1.387769e+3	1.441162e-3	2	13	1.000000e+0	1.538462e-1	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:200	giant cell tumor	46	2.224574e-3	1.000000e+0	1.080853e-1	4.495243e+2	2.224574e-3	1	2.224574e-3	1.000000e+0	68	2.437470e-3	1.000000e+0	8.011390e-2	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	PTGS2
Disease Ontology	DOID:10019	malignant tumor of extrahepatic bile duct	47	2.325232e-3	1.000000e+0	1.105722e-1	4.300645e+2	2.325232e-3	1	2.325232e-3	1.000000e+0	48	1.773000e-3	1.000000e+0	8.255531e-2	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	PTGS2
Disease Ontology	DOID:4945	malignant neoplasm of gastrointestinal tract	48	2.591909e-3	1.000000e+0	1.206858e-1	3.858160e+2	2.591909e-3	1	2.591909e-3	1.000000e+0	58	2.216004e-3	1.000000e+0	8.539257e-2	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	PTGS2
Disease Ontology	DOID:3702	cervical adenocarcinoma	49	2.592808e-3	1.000000e+0	1.182638e-1	3.856822e+2	2.592808e-3	1	2.592808e-3	1.000000e+0	53	1.994515e-3	1.000000e+0	8.410832e-2	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	PTGS2
Disease Ontology	DOID:8929	atrophic gastritis	50	2.781840e-3	1.000000e+0	1.243482e-1	3.594743e+2	2.781840e-3	1	2.781840e-3	1.000000e+0	78	2.880326e-3	1.000000e+0	8.253242e-2	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	PTGS2
Disease Ontology	DOID:12140	Chagas disease	51	2.800800e-3	1.000000e+0	1.227409e-1	3.570408e+2	2.800800e-3	1	2.800800e-3	1.000000e+0	68	2.437470e-3	1.000000e+0	8.011390e-2	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	PTGS2
Disease Ontology	DOID:10113	trypanosomiasis	52	2.808737e-3	1.000000e+0	1.207217e-1	3.560319e+2	2.808737e-3	1	2.808737e-3	1.000000e+0	73	2.548193e-3	1.000000e+0	7.801659e-2	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	PTGS2
Disease Ontology	DOID:8544	chronic fatigue syndrome	53	2.840122e-3	1.000000e+0	1.197674e-1	3.520975e+2	2.840122e-3	1	2.840122e-3	1.000000e+0	58	2.216004e-3	1.000000e+0	8.539257e-2	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	PTGS2
Disease Ontology	DOID:5418	schizoaffective disease	54	2.847004e-3	1.000000e+0	1.178343e-1	3.512464e+2	2.847004e-3	1	2.847004e-3	1.000000e+0	33	1.108309e-3	1.000000e+0	7.506275e-2	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	PLA2G4A
Disease Ontology	DOID:10532	streptococcal pneumonia	55	2.933566e-3	1.000000e+0	1.192095e-1	3.408820e+2	2.933566e-3	1	2.933566e-3	1.000000e+0	83	3.323085e-3	1.000000e+0	8.948307e-2	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	PTGS2
Disease Ontology	DOID:5659	invasive carcinoma	56	2.934379e-3	1.000000e+0	1.171132e-1	3.407876e+2	2.934379e-3	1	2.934379e-3	1.000000e+0	58	2.216004e-3	1.000000e+0	8.539257e-2	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	PTGS2
Disease Ontology	DOID:9253	gastrointestinal stromal tumor	57	2.976541e-3	1.000000e+0	1.167117e-1	3.359605e+2	2.976541e-3	1	2.976541e-3	1.000000e+0	64	2.326740e-3	1.000000e+0	8.125412e-2	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	PTGS2
Disease Ontology	DOID:4415	fibrous histiocytoma	58	3.024831e-3	1.000000e+0	1.165603e-1	3.305970e+2	3.024831e-3	1	3.024831e-3	1.000000e+0	53	1.994515e-3	1.000000e+0	8.410832e-2	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	PTGS2
Disease Ontology	DOID:4610	intestinal neoplasm	59	3.061880e-3	1.000000e+0	1.159882e-1	3.265967e+2	3.061880e-3	1	3.061880e-3	1.000000e+0	64	2.326740e-3	1.000000e+0	8.125412e-2	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	PTGS2
Disease Ontology	DOID:3686	primary Helicobacter infectious disease	60	3.229506e-3	1.000000e+0	1.202991e-1	3.096449e+2	3.229506e-3	1	3.229506e-3	1.000000e+0	98	4.650770e-3	1.000000e+0	1.060660e-1	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	PTGS2
Disease Ontology	DOID:13250	diarrhea	61	3.338837e-3	1.000000e+0	1.223328e-1	2.995055e+2	3.338837e-3	1	3.338837e-3	1.000000e+0	90	3.655089e-3	1.000000e+0	9.076804e-2	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	PTGS2
Disease Ontology	DOID:750	peptic ulcer	62	3.471072e-3	1.000000e+0	1.251265e-1	2.880955e+2	3.471072e-3	1	3.471072e-3	1.000000e+0	122	6.198618e-3	1.000000e+0	1.135566e-1	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	PTGS2
Disease Ontology	DOID:3713	ovary adenocarcinoma	63	3.476045e-3	1.000000e+0	1.233168e-1	2.876833e+2	3.476045e-3	1	3.476045e-3	1.000000e+0	85	3.433759e-3	1.000000e+0	9.028766e-2	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	PTGS2
Disease Ontology	DOID:5409	lung small cell carcinoma	64	3.747061e-3	1.000000e+0	1.308544e-1	2.668758e+2	3.747061e-3	1	3.747061e-3	1.000000e+0	81	3.212404e-3	1.000000e+0	8.863855e-2	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	PTGS2
Disease Ontology	DOID:3355	fibrosarcoma	65	3.783988e-3	1.000000e+0	1.301110e-1	2.642714e+2	3.783988e-3	1	3.783988e-3	1.000000e+0	87	3.544427e-3	1.000000e+0	9.105511e-2	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	PTGS2
Disease Ontology	DOID:5410	neuroendocrine neoplasm of lung	66	3.846471e-3	1.000000e+0	1.302555e-1	2.599785e+2	3.846471e-3	1	3.846471e-3	1.000000e+0	90	3.655089e-3	1.000000e+0	9.076804e-2	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	PTGS2
Disease Ontology	DOID:0050237	Euglenozoa infectious disease	67	3.876694e-3	1.000000e+0	1.293196e-1	2.579518e+2	3.876694e-3	1	3.876694e-3	1.000000e+0	97	4.318932e-3	1.000000e+0	9.951354e-2	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	PTGS2
Disease Ontology	DOID:3114	serous cystadenocarcinoma	68	3.908231e-3	1.000000e+0	1.284544e-1	2.558703e+2	3.908231e-3	1	3.908231e-3	1.000000e+0	92	3.765745e-3	1.000000e+0	9.148304e-2	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	PTGS2
Disease Ontology	DOID:2654	serous neoplasm	69	3.917205e-3	1.000000e+0	1.268834e-1	2.552840e+2	3.917205e-3	1	3.917205e-3	1.000000e+0	93	3.876395e-3	1.000000e+0	9.315853e-2	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	PTGS2
Disease Ontology	DOID:184	bone cancer	70	4.024023e-3	1.000000e+0	1.284813e-1	2.485075e+2	4.024023e-3	1	4.024023e-3	1.000000e+0	87	3.544427e-3	1.000000e+0	9.105511e-2	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	PTGS2
Disease Ontology	DOID:874	bacterial pneumonia	71	4.043168e-3	1.000000e+0	1.272744e-1	2.473308e+2	4.043168e-3	1	4.043168e-3	1.000000e+0	94	4.097676e-3	1.000000e+0	9.742879e-2	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	PTGS2
Disease Ontology	DOID:7693	abdominal aortic aneurysm	72	4.048122e-3	1.000000e+0	1.256605e-1	2.470281e+2	4.048122e-3	1	4.048122e-3	1.000000e+0	99	4.761371e-3	1.000000e+0	1.074916e-1	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	PTGS2
Disease Ontology	DOID:9860	malignant retroperitoneal cancer	73	4.065700e-3	1.000000e+0	1.244773e-1	2.459601e+2	4.065700e-3	1	4.065700e-3	1.000000e+0	73	2.548193e-3	1.000000e+0	7.801659e-2	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	PTGS2
Disease Ontology	DOID:9120	amyloidosis	74	4.162992e-3	1.000000e+0	1.257336e-1	2.402118e+2	4.162992e-3	1	4.162992e-3	1.000000e+0	110	5.424845e-3	1.000000e+0	1.102230e-1	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	PTGS2
Disease Ontology	DOID:5411	oat cell carcinoma	75	4.274359e-3	1.000000e+0	1.273759e-1	2.339532e+2	4.274359e-3	1	4.274359e-3	1.000000e+0	87	3.544427e-3	1.000000e+0	9.105511e-2	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	PTGS2
Disease Ontology	DOID:13315	relapsing pancreatitis	76	4.361864e-3	1.000000e+0	1.282732e-1	2.292598e+2	4.361864e-3	1	4.361864e-3	1.000000e+0	110	5.424845e-3	1.000000e+0	1.102230e-1	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	PTGS2
Disease Ontology	DOID:2870	endometrial adenocarcinoma	77	4.506054e-3	1.000000e+0	1.307926e-1	2.219237e+2	4.506054e-3	1	4.506054e-3	1.000000e+0	85	3.433759e-3	1.000000e+0	9.028766e-2	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	PTGS2
Disease Ontology	DOID:2913	acute pancreatitis	78	4.596022e-3	1.000000e+0	1.316937e-1	2.175794e+2	4.596022e-3	1	4.596022e-3	1.000000e+0	114	5.645954e-3	1.000000e+0	1.106904e-1	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	PTGS2
Disease Ontology	DOID:4358	metastatic melanoma	79	4.644886e-3	1.000000e+0	1.314091e-1	2.152905e+2	4.644886e-3	1	4.644886e-3	1.000000e+0	103	4.982553e-3	1.000000e+0	1.081166e-1	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	PTGS2
Disease Ontology	DOID:3974	medullary carcinoma	80	4.679913e-3	1.000000e+0	1.307451e-1	2.136792e+2	4.679913e-3	1	4.679913e-3	1.000000e+0	94	4.097676e-3	1.000000e+0	9.742879e-2	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	PTGS2
Disease Ontology	DOID:3627	aortic aneurysm	81	4.834343e-3	1.000000e+0	1.333921e-1	2.068534e+2	4.834343e-3	1	4.834343e-3	1.000000e+0	113	5.535402e-3	1.000000e+0	1.094834e-1	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	PTGS2
Disease Ontology	DOID:1107	esophageal carcinoma	82	4.988646e-3	1.000000e+0	1.359710e-1	2.004552e+2	4.988646e-3	1	4.988646e-3	1.000000e+0	114	5.645954e-3	1.000000e+0	1.106904e-1	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	PTGS2
Disease Ontology	DOID:7188	autoimmune thyroiditis	83	4.996576e-3	1.000000e+0	1.345464e-1	2.001370e+2	4.996576e-3	1	4.996576e-3	1.000000e+0	107	5.203711e-3	1.000000e+0	1.086943e-1	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	PTGS2
Disease Ontology	DOID:4007	bladder carcinoma	84	5.180855e-3	1.000000e+0	1.378477e-1	1.930183e+2	5.180855e-3	1	5.180855e-3	1.000000e+0	114	5.645954e-3	1.000000e+0	1.106904e-1	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	PTGS2
Disease Ontology	DOID:2898	commensal streptococcal infectious disease	85	5.204550e-3	1.000000e+0	1.368490e-1	1.921396e+2	5.204550e-3	1	5.204550e-3	1.000000e+0	122	6.198618e-3	1.000000e+0	1.135566e-1	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	PTGS2
Disease Ontology	DOID:4029	gastritis	86	5.221363e-3	1.000000e+0	1.356947e-1	1.915209e+2	5.221363e-3	1	5.221363e-3	1.000000e+0	139	7.524386e-3	1.000000e+0	1.209856e-1	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	PTGS2
Disease Ontology	DOID:520	aortic disease	87	5.329392e-3	1.000000e+0	1.369102e-1	1.876387e+2	5.329392e-3	1	5.329392e-3	1.000000e+0	131	6.640639e-3	1.000000e+0	1.132964e-1	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	PTGS2
Disease Ontology	DOID:3602	neurotoxicity syndrome	88	5.431563e-3	1.000000e+0	1.379494e-1	1.841091e+2	5.431563e-3	1	5.431563e-3	1.000000e+0	103	4.982553e-3	1.000000e+0	1.081166e-1	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	PTGS2
Disease Ontology	DOID:8090	malignant neoplasm of gallbladder	89	5.556412e-3	1.000000e+0	1.395346e-1	1.799723e+2	5.556412e-3	1	5.556412e-3	1.000000e+0	101	4.871965e-3	1.000000e+0	1.078103e-1	2.050114e+2	4.877778e-3	1	44	5.000000e-1	2.272727e-2	unnamed	PTGS2
Disease Ontology	DOID:156	fibrous tissue neoplasm	90	5.623262e-3	1.000000e+0	1.396443e-1	1.778327e+2	5.623262e-3	1	5.623262e-3	1.000000e+0	105	5.093135e-3	1.000000e+0	1.084110e-1	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	PTGS2
Disease Ontology	DOID:345	uterine disease	91	5.718930e-3	1.000000e+0	1.404594e-1	1.748579e+2	5.718930e-3	1	5.718930e-3	1.000000e+0	105	5.093135e-3	1.000000e+0	1.084110e-1	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	PTGS2
Disease Ontology	DOID:2893	cervix carcinoma	92	5.784062e-3	1.000000e+0	1.405150e-1	1.728889e+2	5.784062e-3	1	5.784062e-3	1.000000e+0	114	5.645954e-3	1.000000e+0	1.106904e-1	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	PTGS2
Disease Ontology	DOID:722	spontaneous abortion	93	5.907872e-3	1.000000e+0	1.419795e-1	1.692657e+2	5.907872e-3	1	5.907872e-3	1.000000e+0	132	6.972090e-3	1.000000e+0	1.180502e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	PTGS2
Disease Ontology	DOID:7166	thyroiditis	94	5.959834e-3	1.000000e+0	1.417046e-1	1.677899e+2	5.959834e-3	1	5.959834e-3	1.000000e+0	118	5.977571e-3	1.000000e+0	1.132192e-1	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	PTGS2
Disease Ontology	DOID:4948	gallbladder carcinoma	95	5.973413e-3	1.000000e+0	1.405324e-1	1.674085e+2	5.973413e-3	1	5.973413e-3	1.000000e+0	110	5.424845e-3	1.000000e+0	1.102230e-1	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	PTGS2
Disease Ontology	DOID:1648	primary breast cancer	96	6.036440e-3	1.000000e+0	1.405359e-1	1.656605e+2	6.036440e-3	1	6.036440e-3	1.000000e+0	101	4.871965e-3	1.000000e+0	1.078103e-1	2.050114e+2	4.877778e-3	1	44	5.000000e-1	2.272727e-2	unnamed	PTGS2
Disease Ontology	DOID:2876	laryngeal squamous cell carcinoma	97	6.126726e-3	1.000000e+0	1.411673e-1	1.632193e+2	6.126726e-3	1	6.126726e-3	1.000000e+0	153	8.518131e-3	1.000000e+0	1.244315e-1	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	PTGS2
Disease Ontology	DOID:11335	sarcoidosis	98	6.167436e-3	1.000000e+0	1.406553e-1	1.621419e+2	6.167436e-3	1	6.167436e-3	1.000000e+0	154	8.628517e-3	1.000000e+0	1.252256e-1	1.156474e+2	8.646971e-3	1	78	5.000000e-1	1.282051e-2	unnamed	PTGS2
Disease Ontology	DOID:76	stomach disease	99	6.326538e-3	1.000000e+0	1.428264e-1	1.580643e+2	6.326538e-3	1	6.326538e-3	1.000000e+0	160	8.959636e-3	1.000000e+0	1.251549e-1	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	PTGS2
Disease Ontology	DOID:2600	carcinoma of larynx	100	6.580420e-3	1.000000e+0	1.470724e-1	1.519660e+2	6.580420e-3	1	6.580420e-3	1.000000e+0	156	8.738896e-3	1.000000e+0	1.252015e-1	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	PTGS2
Disease Ontology	DOID:8567	Hodgkin's lymphoma	101	6.668731e-3	1.000000e+0	1.475704e-1	1.499536e+2	6.668731e-3	1	6.668731e-3	1.000000e+0	140	7.634827e-3	1.000000e+0	1.218846e-1	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	PTGS2
Disease Ontology	DOID:3995	transitional cell carcinoma	102	6.678953e-3	1.000000e+0	1.463476e-1	1.497241e+2	6.678953e-3	1	6.678953e-3	1.000000e+0	122	6.198618e-3	1.000000e+0	1.135566e-1	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	PTGS2
Disease Ontology	DOID:2598	laryngeal neoplasm	103	6.707173e-3	1.000000e+0	1.455391e-1	1.490941e+2	6.707173e-3	1	6.707173e-3	1.000000e+0	162	9.180352e-3	1.000000e+0	1.266549e-1	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	PTGS2
Disease Ontology	DOID:9219	pregnancy complication	104	6.843688e-3	1.000000e+0	1.470735e-1	1.461200e+2	6.843688e-3	1	6.843688e-3	1.000000e+0	144	8.076528e-3	1.000000e+0	1.253544e-1	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	PTGS2
Disease Ontology	DOID:10124	corneal disease	105	6.874041e-3	1.000000e+0	1.463189e-1	1.454748e+2	6.874041e-3	1	6.874041e-3	1.000000e+0	146	8.186938e-3	1.000000e+0	1.253274e-1	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	PTGS2
Disease Ontology	DOID:3588	pancreatic neoplasm	106	6.884410e-3	1.000000e+0	1.451571e-1	1.452557e+2	6.884410e-3	1	6.884410e-3	1.000000e+0	122	6.198618e-3	1.000000e+0	1.135566e-1	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	PTGS2
Disease Ontology	DOID:263	kidney neoplasm	107	6.920750e-3	1.000000e+0	1.445596e-1	1.444930e+2	6.920750e-3	1	6.920750e-3	1.000000e+0	122	6.198618e-3	1.000000e+0	1.135566e-1	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	PTGS2
Disease Ontology	DOID:0050156	idiopathic pulmonary fibrosis	108	6.999219e-3	1.000000e+0	1.448449e-1	1.428731e+2	6.999219e-3	1	6.999219e-3	1.000000e+0	136	7.303486e-3	1.000000e+0	1.200242e-1	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	PTGS2
Disease Ontology	DOID:786	laryngeal disease	109	7.022191e-3	1.000000e+0	1.439871e-1	1.424057e+2	7.022191e-3	1	7.022191e-3	1.000000e+0	169	1.028356e-2	1.000000e+0	1.359986e-1	9.699462e+1	1.030985e-2	1	93	5.000000e-1	1.075269e-2	unnamed	PTGS2
Disease Ontology	DOID:3565	meningioma	110	7.116613e-3	1.000000e+0	1.445966e-1	1.405163e+2	7.116613e-3	1	7.116613e-3	1.000000e+0	136	7.303486e-3	1.000000e+0	1.200242e-1	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	PTGS2
Disease Ontology	DOID:2403	aneurysm	111	7.479640e-3	1.000000e+0	1.506036e-1	1.336963e+2	7.479640e-3	1	7.479640e-3	1.000000e+0	151	8.407740e-3	1.000000e+0	1.244457e-1	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	PTGS2
Disease Ontology	DOID:3683	lung neoplasm	112	7.484677e-3	1.000000e+0	1.493594e-1	1.336063e+2	7.484677e-3	1	7.484677e-3	1.000000e+0	133	7.082562e-3	1.000000e+0	1.190190e-1	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	PTGS2
Disease Ontology	DOID:9206	Barrett's esophagus	113	7.581585e-3	1.000000e+0	1.499544e-1	1.318985e+2	7.581585e-3	1	7.581585e-3	1.000000e+0	162	9.180352e-3	1.000000e+0	1.266549e-1	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	PTGS2
Disease Ontology	DOID:12365	malaria	114	7.592749e-3	1.000000e+0	1.488578e-1	1.317046e+2	7.592749e-3	1	7.592749e-3	1.000000e+0	172	1.061440e-2	1.000000e+0	1.379255e-1	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	PTGS2
Disease Ontology	DOID:5366	pregnancy disease	115	7.627223e-3	1.000000e+0	1.482334e-1	1.311093e+2	7.627223e-3	1	7.627223e-3	1.000000e+0	160	8.959636e-3	1.000000e+0	1.251549e-1	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	PTGS2
Disease Ontology	DOID:12306	vitiligo	116	7.708449e-3	1.000000e+0	1.485205e-1	1.297278e+2	7.708449e-3	1	7.708449e-3	1.000000e+0	133	7.082562e-3	1.000000e+0	1.190190e-1	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	PTGS2
Disease Ontology	DOID:12722	liver metastasis	117	7.899212e-3	1.000000e+0	1.508952e-1	1.265949e+2	7.899212e-3	1	7.899212e-3	1.000000e+0	120	6.088097e-3	1.000000e+0	1.133908e-1	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	PTGS2
Disease Ontology	DOID:164	cystic, mucinous, and serous neoplasm	118	7.919792e-3	1.000000e+0	1.500062e-1	1.262659e+2	7.919792e-3	1	7.919792e-3	1.000000e+0	141	7.745261e-3	1.000000e+0	1.227706e-1	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	PTGS2
Disease Ontology	DOID:9779	bowel dysfunction	119	8.249465e-3	1.000000e+0	1.549374e-1	1.212200e+2	8.249465e-3	1	8.249465e-3	1.000000e+0	166	9.511379e-3	1.000000e+0	1.280598e-1	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	PTGS2
Disease Ontology	DOID:3371	chondrosarcoma	120	8.251733e-3	1.000000e+0	1.536885e-1	1.211867e+2	8.251733e-3	1	8.251733e-3	1.000000e+0	130	6.530143e-3	1.000000e+0	1.122682e-1	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	PTGS2
Disease Ontology	DOID:11259	Cytomegalovirus infectious disease	121	8.345451e-3	1.000000e+0	1.541494e-1	1.198258e+2	8.345451e-3	1	8.345451e-3	1.000000e+0	190	1.347939e-2	1.000000e+0	1.585602e-1	7.393852e+1	1.352475e-2	1	122	5.000000e-1	8.196721e-3	unnamed	PTGS2
Disease Ontology	DOID:9408	acute myocardial infarction	122	8.449918e-3	1.000000e+0	1.547997e-1	1.183443e+2	8.449918e-3	1	8.449918e-3	1.000000e+0	167	9.732033e-3	1.000000e+0	1.302461e-1	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	PTGS2
Disease Ontology	DOID:2513	basal cell carcinoma	123	8.459101e-3	1.000000e+0	1.537081e-1	1.182159e+2	8.459101e-3	1	8.459101e-3	1.000000e+0	133	7.082562e-3	1.000000e+0	1.190190e-1	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	PTGS2
Disease Ontology	DOID:3328	temporal lobe epilepsy	124	8.541498e-3	1.000000e+0	1.539536e-1	1.170755e+2	8.541498e-3	1	8.541498e-3	1.000000e+0	109	5.314281e-3	1.000000e+0	1.089671e-1	1.879271e+2	5.321213e-3	1	48	5.000000e-1	2.083333e-2	unnamed	PTGS2
Disease Ontology	DOID:0050243	Apicomplexa infectious disease	125	8.587481e-3	1.000000e+0	1.535442e-1	1.164486e+2	8.587481e-3	1	8.587481e-3	1.000000e+0	177	1.149638e-2	1.000000e+0	1.451662e-1	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	PTGS2
Disease Ontology	DOID:8947	diabetic retinopathy	126	8.613201e-3	1.000000e+0	1.527818e-1	1.161008e+2	8.613201e-3	1	8.613201e-3	1.000000e+0	154	8.628517e-3	1.000000e+0	1.252256e-1	1.156474e+2	8.646971e-3	1	78	5.000000e-1	1.282051e-2	unnamed	PTGS2
Disease Ontology	DOID:5616	intraepithelial neoplasm	127	8.618833e-3	1.000000e+0	1.516779e-1	1.160250e+2	8.618833e-3	1	8.618833e-3	1.000000e+0	158	8.849269e-3	1.000000e+0	1.251780e-1	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	PTGS2
Disease Ontology	DOID:0050339	commensal bacterial infectious disease	128	8.669785e-3	1.000000e+0	1.513826e-1	1.153431e+2	8.669785e-3	1	8.669785e-3	1.000000e+0	180	1.226779e-2	1.000000e+0	1.523251e-1	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	PTGS2
Disease Ontology	DOID:11713	diabetic angiopathy	129	8.681935e-3	1.000000e+0	1.504196e-1	1.151817e+2	8.681935e-3	1	8.681935e-3	1.000000e+0	158	8.849269e-3	1.000000e+0	1.251780e-1	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	PTGS2
Disease Ontology	DOID:1800	neuroendocrine carcinoma	130	8.756036e-3	1.000000e+0	1.505365e-1	1.142069e+2	8.756036e-3	1	8.756036e-3	1.000000e+0	156	8.738896e-3	1.000000e+0	1.252015e-1	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	PTGS2
Disease Ontology	DOID:2462	retinal vascular disease	131	8.884987e-3	1.000000e+0	1.515874e-1	1.125494e+2	8.884987e-3	1	8.884987e-3	1.000000e+0	162	9.180352e-3	1.000000e+0	1.266549e-1	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	PTGS2
Disease Ontology	DOID:2991	stromal neoplasm	132	9.226644e-3	1.000000e+0	1.562239e-1	1.083818e+2	9.226644e-3	1	9.226644e-3	1.000000e+0	138	7.413939e-3	1.000000e+0	1.200736e-1	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	PTGS2
Disease Ontology	DOID:4989	pancreatitis	133	9.337336e-3	1.000000e+0	1.569094e-1	1.070969e+2	9.337336e-3	1	9.337336e-3	1.000000e+0	183	1.270846e-2	1.000000e+0	1.552099e-1	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	PTGS2
Disease Ontology	DOID:3717	gastric adenocarcinoma	134	9.549000e-3	1.000000e+0	1.592688e-1	1.047230e+2	9.549000e-3	1	9.549000e-3	1.000000e+0	168	9.842351e-3	1.000000e+0	1.309384e-1	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	PTGS2
Disease Ontology	DOID:6432	pulmonary hypertension	135	9.556096e-3	1.000000e+0	1.582065e-1	1.046452e+2	9.556096e-3	1	9.556096e-3	1.000000e+0	146	8.186938e-3	1.000000e+0	1.253274e-1	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	PTGS2
Disease Ontology	DOID:8515	cor pulmonale	136	9.639953e-3	1.000000e+0	1.584213e-1	1.037349e+2	9.639953e-3	1	9.639953e-3	1.000000e+0	149	8.297342e-3	1.000000e+0	1.244601e-1	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	PTGS2
Disease Ontology	DOID:5517	stomach carcinoma	137	9.648058e-3	1.000000e+0	1.573972e-1	1.036478e+2	9.648058e-3	1	9.648058e-3	1.000000e+0	169	1.028356e-2	1.000000e+0	1.359986e-1	9.699462e+1	1.030985e-2	1	93	5.000000e-1	1.075269e-2	unnamed	PTGS2
Disease Ontology	DOID:0060005	autoimmune disease of endocrine system	138	9.664126e-3	1.000000e+0	1.565168e-1	1.034755e+2	9.664126e-3	1	9.664126e-3	1.000000e+0	177	1.149638e-2	1.000000e+0	1.451662e-1	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	PTGS2
Disease Ontology	DOID:2234	partial epilepsy	139	9.833196e-3	1.000000e+0	1.581093e-1	1.016963e+2	9.833196e-3	1	9.833196e-3	1.000000e+0	129	6.419641e-3	1.000000e+0	1.112240e-1	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	PTGS2
Disease Ontology	DOID:824	periodontitis	140	1.005957e-2	1.000000e+0	1.605938e-1	9.940786e+1	1.005957e-2	1	1.005957e-2	1.000000e+0	186	1.292876e-2	1.000000e+0	1.553536e-1	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	PTGS2
Disease Ontology	DOID:916	hepatic and intrahepatic bile duct neoplasm	141	1.028280e-2	1.000000e+0	1.629933e-1	9.724977e+1	1.028280e-2	1	1.028280e-2	1.000000e+0	146	8.186938e-3	1.000000e+0	1.253274e-1	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	PTGS2
Disease Ontology	DOID:2789	parasitic protozoa infectious disease	142	1.067627e-2	1.000000e+0	1.680385e-1	9.366571e+1	1.067627e-2	1	1.067627e-2	1.000000e+0	191	1.413995e-2	1.000000e+0	1.654596e-1	7.047266e+1	1.418990e-2	1	128	5.000000e-1	7.812500e-3	unnamed	PTGS2
Disease Ontology	DOID:5875	retroperitoneal neoplasm	143	1.087511e-2	1.000000e+0	1.699711e-1	9.195310e+1	1.087511e-2	1	1.087511e-2	1.000000e+0	151	8.407740e-3	1.000000e+0	1.244457e-1	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	PTGS2
Disease Ontology	DOID:2154	nephroblastoma	144	1.100626e-2	1.000000e+0	1.708263e-1	9.085741e+1	1.100626e-2	1	1.100626e-2	1.000000e+0	141	7.745261e-3	1.000000e+0	1.227706e-1	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	PTGS2
Disease Ontology	DOID:1485	cystic fibrosis	145	1.126000e-2	1.000000e+0	1.735593e-1	8.880998e+1	1.126000e-2	1	1.126000e-2	1.000000e+0	198	1.491033e-2	1.000000e+0	1.683060e-1	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	PTGS2
Disease Ontology	DOID:0050298	Adenoviridae infectious disease	146	1.139786e-2	1.000000e+0	1.744809e-1	8.773575e+1	1.139786e-2	1	1.139786e-2	1.000000e+0	180	1.226779e-2	1.000000e+0	1.523251e-1	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	PTGS2
Disease Ontology	DOID:5353	colonic disease	147	1.147821e-2	1.000000e+0	1.745156e-1	8.712159e+1	1.147821e-2	1	1.147821e-2	1.000000e+0	179	1.160660e-2	1.000000e+0	1.449204e-1	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	PTGS2
Disease Ontology	DOID:10286	prostate carcinoma	148	1.155289e-2	1.000000e+0	1.744643e-1	8.655844e+1	1.155289e-2	1	1.155289e-2	1.000000e+0	174	1.105544e-2	1.000000e+0	1.420052e-1	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	PTGS2
Disease Ontology	DOID:1398	parasitic infectious disease	149	1.157617e-2	1.000000e+0	1.736426e-1	8.638434e+1	1.157617e-2	1	1.157617e-2	1.000000e+0	202	1.656012e-2	1.000000e+0	1.832271e-1	6.013667e+1	1.662879e-2	1	150	5.000000e-1	6.666667e-3	unnamed	PTGS2
Disease Ontology	DOID:3969	papillary thyroid carcinoma	150	1.183917e-2	1.000000e+0	1.764036e-1	8.446540e+1	1.183917e-2	1	1.183917e-2	1.000000e+0	173	1.072467e-2	1.000000e+0	1.385528e-1	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	PTGS2
Disease Ontology	DOID:2645	mesothelioma	151	1.186473e-2	1.000000e+0	1.756137e-1	8.428343e+1	1.186473e-2	1	1.186473e-2	1.000000e+0	176	1.138616e-2	1.000000e+0	1.445913e-1	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	PTGS2
Disease Ontology	DOID:3451	skin carcinoma	152	1.189432e-2	1.000000e+0	1.748935e-1	8.407373e+1	1.189432e-2	1	1.189432e-2	1.000000e+0	171	1.039385e-2	1.000000e+0	1.358494e-1	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	PTGS2
Disease Ontology	DOID:6050	esophageal disease	153	1.204297e-2	1.000000e+0	1.759218e-1	8.303600e+1	1.204297e-2	1	1.204297e-2	1.000000e+0	183	1.270846e-2	1.000000e+0	1.552099e-1	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	PTGS2
Disease Ontology	DOID:4195	hyperglycemia	154	1.211475e-2	1.000000e+0	1.758212e-1	8.254399e+1	1.211475e-2	1	1.211475e-2	1.000000e+0	193	1.458020e-2	1.000000e+0	1.688432e-1	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	PTGS2
Disease Ontology	DOID:3680	malignant neoplasm of lip, oral cavity and pharynx	155	1.217861e-2	1.000000e+0	1.756077e-1	8.211115e+1	1.217861e-2	1	1.217861e-2	1.000000e+0	187	1.303889e-2	1.000000e+0	1.558391e-1	7.644492e+1	1.308131e-2	1	118	5.000000e-1	8.474576e-3	unnamed	PTGS2
Disease Ontology	DOID:4947	cholangiocarcinoma	156	1.226587e-2	1.000000e+0	1.757322e-1	8.152704e+1	1.226587e-2	1	1.226587e-2	1.000000e+0	189	1.325916e-2	1.000000e+0	1.567948e-1	7.517083e+1	1.330303e-2	1	120	5.000000e-1	8.333333e-3	unnamed	PTGS2
Disease Ontology	DOID:2797	idiopathic interstitial pneumonia	157	1.231573e-2	1.000000e+0	1.753227e-1	8.119697e+1	1.231573e-2	1	1.231573e-2	1.000000e+0	180	1.226779e-2	1.000000e+0	1.523251e-1	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	PTGS2
Disease Ontology	DOID:3112	papillary adenocarcinoma	158	1.242691e-2	1.000000e+0	1.757857e-1	8.047055e+1	1.242691e-2	1	1.242691e-2	1.000000e+0	175	1.127592e-2	1.000000e+0	1.440096e-1	8.843627e+1	1.130758e-2	1	102	5.000000e-1	9.803922e-3	unnamed	PTGS2
Disease Ontology	DOID:3388	periodontal disease	159	1.265238e-2	1.000000e+0	1.778495e-1	7.903652e+1	1.265238e-2	1	1.265238e-2	1.000000e+0	192	1.447015e-2	1.000000e+0	1.684416e-1	6.885878e+1	1.452248e-2	1	131	5.000000e-1	7.633588e-3	unnamed	PTGS2
Disease Ontology	DOID:4897	bile duct carcinoma	160	1.342514e-2	1.000000e+0	1.875324e-1	7.448712e+1	1.342514e-2	1	1.342514e-2	1.000000e+0	193	1.458020e-2	1.000000e+0	1.688432e-1	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	PTGS2
Disease Ontology	DOID:4606	bile duct cancer	161	1.345417e-2	1.000000e+0	1.867706e-1	7.432642e+1	1.345417e-2	1	1.345417e-2	1.000000e+0	195	1.469025e-2	1.000000e+0	1.683729e-1	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	PTGS2
Disease Ontology	DOID:8778	Crohn's disease	162	1.382583e-2	1.000000e+0	1.907452e-1	7.232841e+1	1.382583e-2	1	1.382583e-2	1.000000e+0	222	1.930669e-2	1.000000e+0	1.943714e-1	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	PTGS2
Disease Ontology	DOID:1091	tooth disease	163	1.399340e-2	1.000000e+0	1.918727e-1	7.146225e+1	1.399340e-2	1	1.399340e-2	1.000000e+0	201	1.645017e-2	1.000000e+0	1.829161e-1	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	PTGS2
Disease Ontology	DOID:0060031	autoimmune disease of gastrointestinal tract	164	1.484353e-2	1.000000e+0	2.022884e-1	6.736941e+1	1.484353e-2	1	1.484353e-2	1.000000e+0	234	2.128185e-2	1.000000e+0	2.032690e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	PTGS2
Disease Ontology	DOID:8577	ulcerative colitis	165	1.545289e-2	1.000000e+0	2.093164e-1	6.471283e+1	1.545289e-2	1	1.545289e-2	1.000000e+0	239	2.183015e-2	1.000000e+0	2.041439e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PTGS2
Disease Ontology	DOID:3113	papillary carcinoma	166	1.563409e-2	1.000000e+0	2.104951e-1	6.396281e+1	1.563409e-2	1	1.563409e-2	1.000000e+0	197	1.480029e-2	1.000000e+0	1.679119e-1	6.731716e+1	1.485505e-2	1	134	5.000000e-1	7.462687e-3	unnamed	PTGS2
Disease Ontology	DOID:1520	colon carcinoma	167	1.597372e-2	1.000000e+0	2.137800e-1	6.260281e+1	1.597372e-2	1	1.597372e-2	1.000000e+0	199	1.513038e-2	1.000000e+0	1.699317e-1	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	PTGS2
Disease Ontology	DOID:403	mouth disease	168	1.606891e-2	1.000000e+0	2.137739e-1	6.223199e+1	1.606891e-2	1	1.606891e-2	1.000000e+0	225	1.963603e-2	1.000000e+0	1.950512e-1	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	PTGS2
Disease Ontology	DOID:974	upper respiratory tract disease	169	1.623572e-2	1.000000e+0	2.147150e-1	6.159258e+1	1.623572e-2	1	1.623572e-2	1.000000e+0	246	2.325502e-2	1.000000e+0	2.112804e-1	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	PTGS2
Disease Ontology	DOID:235	colonic neoplasm	170	1.646855e-2	1.000000e+0	2.165130e-1	6.072181e+1	1.646855e-2	1	1.646855e-2	1.000000e+0	200	1.601034e-2	1.000000e+0	1.789155e-1	6.221034e+1	1.607450e-2	1	145	5.000000e-1	6.896552e-3	unnamed	PTGS2
Disease Ontology	DOID:3770	pulmonary fibrosis	171	1.667378e-2	1.000000e+0	2.179292e-1	5.997440e+1	1.667378e-2	1	1.667378e-2	1.000000e+0	202	1.656012e-2	1.000000e+0	1.832271e-1	6.013667e+1	1.662879e-2	1	150	5.000000e-1	6.666667e-3	unnamed	PTGS2
Disease Ontology	DOID:2871	endometrial carcinoma	172	1.675841e-2	1.000000e+0	2.177619e-1	5.967153e+1	1.675841e-2	1	1.675841e-2	1.000000e+0	195	1.469025e-2	1.000000e+0	1.683729e-1	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	PTGS2
Disease Ontology	DOID:332	amyotrophic lateral sclerosis	173	1.688990e-2	1.000000e+0	2.182019e-1	5.920698e+1	1.688990e-2	1	1.688990e-2	1.000000e+0	205	1.688991e-2	1.000000e+0	1.841412e-1	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	PTGS2
Disease Ontology	DOID:234	colon adenocarcinoma	174	1.743321e-2	1.000000e+0	2.239266e-1	5.736179e+1	1.743321e-2	1	1.743321e-2	1.000000e+0	204	1.677999e-2	1.000000e+0	1.838396e-1	5.934539e+1	1.685051e-2	1	152	5.000000e-1	6.578947e-3	unnamed	PTGS2
Disease Ontology	DOID:3169	papillary epithelial neoplasm	175	1.746725e-2	1.000000e+0	2.230817e-1	5.724999e+1	1.746725e-2	1	1.746725e-2	1.000000e+0	205	1.688991e-2	1.000000e+0	1.841412e-1	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	PTGS2
Disease Ontology	DOID:8552	chronic myeloid leukemia	176	1.764768e-2	1.000000e+0	2.241055e-1	5.666467e+1	1.764768e-2	1	1.764768e-2	1.000000e+0	218	1.864787e-2	1.000000e+0	1.911834e-1	5.337574e+1	1.873510e-2	1	169	5.000000e-1	5.917160e-3	unnamed	PTGS2
Disease Ontology	DOID:5520	head and neck squamous cell carcinoma	177	1.765121e-2	1.000000e+0	2.228839e-1	5.665335e+1	1.765121e-2	1	1.765121e-2	1.000000e+0	216	1.831837e-2	1.000000e+0	1.895442e-1	5.434036e+1	1.840253e-2	1	166	5.000000e-1	6.024096e-3	unnamed	PTGS2
Disease Ontology	DOID:1997	large Intestine adenocarcinoma	178	1.779600e-2	1.000000e+0	2.234498e-1	5.619241e+1	1.779600e-2	1	1.779600e-2	1.000000e+0	209	1.710974e-2	1.000000e+0	1.829678e-1	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	PTGS2
Disease Ontology	DOID:8719	in situ carcinoma	179	1.780717e-2	1.000000e+0	2.223409e-1	5.615714e+1	1.780717e-2	1	1.780717e-2	1.000000e+0	211	1.721965e-2	1.000000e+0	1.823977e-1	5.782372e+1	1.729394e-2	1	156	5.000000e-1	6.410256e-3	unnamed	PTGS2
Disease Ontology	DOID:4074	pancreas adenocarcinoma	180	1.811257e-2	1.000000e+0	2.248977e-1	5.521029e+1	1.811257e-2	1	1.811257e-2	1.000000e+0	207	1.699983e-2	1.000000e+0	1.835489e-1	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	PTGS2
Disease Ontology	DOID:4607	biliary tract cancer	181	1.820947e-2	1.000000e+0	2.248517e-1	5.491648e+1	1.820947e-2	1	1.820947e-2	1.000000e+0	219	1.897731e-2	1.000000e+0	1.936725e-1	5.244477e+1	1.906768e-2	1	172	5.000000e-1	5.813953e-3	unnamed	PTGS2
Disease Ontology	DOID:5119	ovarian cyst	182	1.840495e-2	1.000000e+0	2.260168e-1	5.433322e+1	1.840495e-2	1	1.840495e-2	1.000000e+0	217	1.842821e-2	1.000000e+0	1.898021e-1	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	PTGS2
Disease Ontology	DOID:2043	hepatitis B	183	1.857443e-2	1.000000e+0	2.268516e-1	5.383744e+1	1.857443e-2	1	1.857443e-2	1.000000e+0	234	2.128185e-2	1.000000e+0	2.032690e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	PTGS2
Disease Ontology	DOID:14330	Parkinson's disease	184	1.924662e-2	1.000000e+0	2.337837e-1	5.195717e+1	1.924662e-2	1	1.924662e-2	1.000000e+0	212	1.743944e-2	1.000000e+0	1.838545e-1	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	PTGS2
Disease Ontology	DOID:3910	lung adenocarcinoma	185	1.929084e-2	1.000000e+0	2.330542e-1	5.183808e+1	1.929084e-2	1	1.929084e-2	1.000000e+0	214	1.798882e-2	1.000000e+0	1.878739e-1	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	PTGS2
Disease Ontology	DOID:341	peripheral vascular disease	186	1.937384e-2	1.000000e+0	2.327986e-1	5.161599e+1	1.937384e-2	1	1.937384e-2	1.000000e+0	250	2.413134e-2	1.000000e+0	2.157342e-1	4.118950e+1	2.427803e-2	1	219	5.000000e-1	4.566210e-3	unnamed	PTGS2
Disease Ontology	DOID:552	pneumonia	187	1.942236e-2	1.000000e+0	2.321336e-1	5.148705e+1	1.942236e-2	1	1.942236e-2	1.000000e+0	233	2.106249e-2	1.000000e+0	2.020372e-1	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PTGS2
Disease Ontology	DOID:4138	bile duct disease	188	1.956557e-2	1.000000e+0	2.326013e-1	5.111019e+1	1.956557e-2	1	1.956557e-2	1.000000e+0	242	2.237830e-2	1.000000e+0	2.066756e-1	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	PTGS2
Disease Ontology	DOID:10283	malignant neoplasm of prostate	189	1.968080e-2	1.000000e+0	2.327333e-1	5.081093e+1	1.968080e-2	1	1.968080e-2	1.000000e+0	207	1.699983e-2	1.000000e+0	1.835489e-1	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	PTGS2
Disease Ontology	DOID:10284	malignant neoplasm of male genital organ or tract	190	1.969552e-2	1.000000e+0	2.316815e-1	5.077298e+1	1.969552e-2	1	1.969552e-2	1.000000e+0	209	1.710974e-2	1.000000e+0	1.829678e-1	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	PTGS2
Disease Ontology	DOID:3083	chronic obstructive pulmonary disease	191	1.974706e-2	1.000000e+0	2.310716e-1	5.064045e+1	1.974706e-2	1	1.974706e-2	1.000000e+0	244	2.303588e-2	1.000000e+0	2.110049e-1	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	PTGS2
Disease Ontology	DOID:1883	hepatitis C	192	1.976589e-2	1.000000e+0	2.300873e-1	5.059220e+1	1.976589e-2	1	1.976589e-2	1.000000e+0	255	2.555453e-2	1.000000e+0	2.239779e-1	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	PTGS2
Disease Ontology	DOID:1040	chronic lymphocytic leukemia	193	2.007416e-2	1.000000e+0	2.324650e-1	4.981528e+1	2.007416e-2	1	2.007416e-2	1.000000e+0	222	1.930669e-2	1.000000e+0	1.943714e-1	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	PTGS2
Disease Ontology	DOID:2939	Herpesviridae infectious disease	194	2.018168e-2	1.000000e+0	2.325054e-1	4.954988e+1	2.018168e-2	1	2.018168e-2	1.000000e+0	260	2.708603e-2	1.000000e+0	2.328357e-1	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	PTGS2
Disease Ontology	DOID:2370	diabetic nephropathy	195	2.028896e-2	1.000000e+0	2.325427e-1	4.928788e+1	2.028896e-2	1	2.028896e-2	1.000000e+0	213	1.787895e-2	1.000000e+0	1.876031e-1	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	PTGS2
Disease Ontology	DOID:3963	thyroid carcinoma	196	2.053944e-2	1.000000e+0	2.342125e-1	4.868683e+1	2.053944e-2	1	2.053944e-2	1.000000e+0	227	1.974579e-2	1.000000e+0	1.944134e-1	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	PTGS2
Disease Ontology	DOID:10952	nephritis	197	2.069794e-2	1.000000e+0	2.348218e-1	4.831398e+1	2.069794e-2	1	2.069794e-2	1.000000e+0	243	2.292630e-2	1.000000e+0	2.108654e-1	4.336779e+1	2.305859e-2	1	208	5.000000e-1	4.807692e-3	unnamed	PTGS2
Disease Ontology	DOID:231	motor neuron disease	198	2.074748e-2	1.000000e+0	2.341950e-1	4.819862e+1	2.074748e-2	1	2.074748e-2	1.000000e+0	232	2.095280e-2	1.000000e+0	2.018513e-1	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	PTGS2
Disease Ontology	DOID:0050338	primary bacterial infectious disease	199	2.087369e-2	1.000000e+0	2.344357e-1	4.790719e+1	2.087369e-2	1	2.087369e-2	1.000000e+0	264	2.817922e-2	1.000000e+0	2.385627e-1	3.523633e+1	2.837980e-2	1	256	5.000000e-1	3.906250e-3	unnamed	PTGS2
Disease Ontology	DOID:3082	interstitial lung disease	200	2.088558e-2	1.000000e+0	2.333964e-1	4.787992e+1	2.088558e-2	1	2.088558e-2	1.000000e+0	247	2.336458e-2	1.000000e+0	2.114163e-1	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	PTGS2
Disease Ontology	DOID:514	prostatic neoplasm	201	2.097895e-2	1.000000e+0	2.332734e-1	4.766682e+1	2.097895e-2	1	2.097895e-2	1.000000e+0	215	1.820853e-2	1.000000e+0	1.892840e-1	5.466970e+1	1.829167e-2	1	165	5.000000e-1	6.060606e-3	unnamed	PTGS2
Disease Ontology	DOID:481	hereditary degenerative disease of central nervous system	202	2.112248e-2	1.000000e+0	2.337066e-1	4.734292e+1	2.112248e-2	1	2.112248e-2	1.000000e+0	237	2.150119e-2	1.000000e+0	2.027644e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PTGS2
Disease Ontology	DOID:679	basal ganglia disease	203	2.127083e-2	1.000000e+0	2.341887e-1	4.701274e+1	2.127083e-2	1	2.127083e-2	1.000000e+0	228	1.996530e-2	1.000000e+0	1.957125e-1	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	PTGS2
Disease Ontology	DOID:1886	Flaviviridae infectious disease	204	2.129232e-2	1.000000e+0	2.332762e-1	4.696530e+1	2.129232e-2	1	2.129232e-2	1.000000e+0	261	2.763270e-2	1.000000e+0	2.366248e-1	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	PTGS2
Disease Ontology	DOID:47	prostate disease	205	2.176279e-2	1.000000e+0	2.372675e-1	4.595000e+1	2.176279e-2	1	2.176279e-2	1.000000e+0	224	1.941648e-2	1.000000e+0	1.937314e-1	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	PTGS2
Disease Ontology	DOID:9261	nasopharynx carcinoma	206	2.238691e-2	1.000000e+0	2.428871e-1	4.466897e+1	2.238691e-2	1	2.238691e-2	1.000000e+0	236	2.139152e-2	1.000000e+0	2.025849e-1	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	PTGS2
Disease Ontology	DOID:8398	osteoarthritis	207	2.244189e-2	1.000000e+0	2.423074e-1	4.455953e+1	2.244189e-2	1	2.244189e-2	1.000000e+0	230	2.051397e-2	1.000000e+0	1.993423e-1	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	PLA2G4A
Disease Ontology	DOID:3856	male genital cancer	208	2.324048e-2	1.000000e+0	2.497234e-1	4.302837e+1	2.324048e-2	1	2.324048e-2	1.000000e+0	225	1.963603e-2	1.000000e+0	1.950512e-1	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	PTGS2
Disease Ontology	DOID:9741	biliary tract disease	209	2.393130e-2	1.000000e+0	2.559161e-1	4.178628e+1	2.393130e-2	1	2.393130e-2	1.000000e+0	256	2.642982e-2	1.000000e+0	2.307447e-1	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	PTGS2
Disease Ontology	DOID:1100	ovarian disease	210	2.439417e-2	1.000000e+0	2.596237e-1	4.099340e+1	2.439417e-2	1	2.439417e-2	1.000000e+0	244	2.303588e-2	1.000000e+0	2.110049e-1	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	PTGS2
Disease Ontology	DOID:0050502	(+)ssRNA virus infectious disease	211	2.473880e-2	1.000000e+0	2.620437e-1	4.042233e+1	2.473880e-2	1	2.473880e-2	1.000000e+0	279	3.221869e-2	1.000000e+0	2.580960e-1	3.078669e+1	3.248157e-2	1	293	5.000000e-1	3.412969e-3	unnamed	PTGS2
Disease Ontology	DOID:3117	hepatobiliary neoplasm	212	2.482426e-2	1.000000e+0	2.617086e-1	4.028318e+1	2.482426e-2	1	2.482426e-2	1.000000e+0	253	2.424086e-2	1.000000e+0	2.141436e-1	4.100227e+1	2.438889e-2	1	220	5.000000e-1	4.545455e-3	unnamed	PTGS2
Disease Ontology	DOID:3007	ductal carcinoma	213	2.482786e-2	1.000000e+0	2.605177e-1	4.027733e+1	2.482786e-2	1	2.482786e-2	1.000000e+0	238	2.161085e-2	1.000000e+0	2.029422e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PTGS2
Disease Ontology	DOID:0070003	blastoma	214	2.525493e-2	1.000000e+0	2.637606e-1	3.959623e+1	2.525493e-2	1	2.525493e-2	1.000000e+0	220	1.908711e-2	1.000000e+0	1.939077e-1	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	PTGS2
Disease Ontology	DOID:9538	multiple myeloma	215	2.568490e-2	1.000000e+0	2.670035e-1	3.893338e+1	2.568490e-2	1	2.568490e-2	1.000000e+0	256	2.642982e-2	1.000000e+0	2.307447e-1	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	PTGS2
Disease Ontology	DOID:104	bacterial infectious disease	216	2.577429e-2	1.000000e+0	2.666923e-1	3.879835e+1	2.577429e-2	1	2.577429e-2	1.000000e+0	283	3.559663e-2	1.000000e+0	2.811253e-1	2.784105e+1	3.591819e-2	1	324	5.000000e-1	3.086420e-3	unnamed	PTGS2
Disease Ontology	DOID:4905	pancreatic carcinoma	217	2.590130e-2	1.000000e+0	2.667715e-1	3.860810e+1	2.590130e-2	1	2.590130e-2	1.000000e+0	248	2.391230e-2	1.000000e+0	2.155000e-1	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	PTGS2
Disease Ontology	DOID:9352	diabetes mellitus type 2	218	2.639624e-2	1.000000e+0	2.706220e-1	3.788418e+1	2.639624e-2	1	2.639624e-2	1.000000e+0	254	2.435036e-2	1.000000e+0	2.142640e-1	4.081674e+1	2.449975e-2	1	221	5.000000e-1	4.524887e-3	unnamed	PTGS2
Disease Ontology	DOID:10591	pre-eclampsia	219	2.656005e-2	1.000000e+0	2.710580e-1	3.765053e+1	2.656005e-2	1	2.656005e-2	1.000000e+0	268	2.938103e-2	1.000000e+0	2.450246e-1	3.378464e+1	2.959925e-2	1	267	5.000000e-1	3.745318e-3	unnamed	PTGS2
Disease Ontology	DOID:5844	myocardial infarction	220	2.663515e-2	1.000000e+0	2.705889e-1	3.754437e+1	2.663515e-2	1	2.663515e-2	1.000000e+0	268	2.938103e-2	1.000000e+0	2.450246e-1	3.378464e+1	2.959925e-2	1	267	5.000000e-1	3.745318e-3	unnamed	PTGS2
Disease Ontology	DOID:3721	plasmacytoma	221	2.664700e-2	1.000000e+0	2.694844e-1	3.752767e+1	2.664700e-2	1	2.664700e-2	1.000000e+0	259	2.675795e-2	1.000000e+0	2.309035e-1	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	PTGS2
Disease Ontology	DOID:3455	cerebrovascular accident	222	2.682361e-2	1.000000e+0	2.700485e-1	3.728059e+1	2.682361e-2	1	2.682361e-2	1.000000e+0	273	3.036376e-2	1.000000e+0	2.485824e-1	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	PTGS2
Disease Ontology	DOID:1826	epilepsy	223	2.703900e-2	1.000000e+0	2.709963e-1	3.698361e+1	2.703900e-2	1	2.703900e-2	1.000000e+0	239	2.183015e-2	1.000000e+0	2.041439e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PTGS2
Disease Ontology	DOID:484	vascular hemostatic disease	224	2.716118e-2	1.000000e+0	2.710055e-1	3.681725e+1	2.716118e-2	1	2.716118e-2	1.000000e+0	267	2.916257e-2	1.000000e+0	2.441136e-1	3.403962e+1	2.937753e-2	1	265	5.000000e-1	3.773585e-3	unnamed	PTGS2
Disease Ontology	DOID:706	mature B-cell lymphocytic neoplasm	225	2.720495e-2	1.000000e+0	2.702358e-1	3.675802e+1	2.720495e-2	1	2.720495e-2	1.000000e+0	261	2.763270e-2	1.000000e+0	2.366248e-1	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	PTGS2
Disease Ontology	DOID:3996	cancer of urinary tract	226	2.754903e-2	1.000000e+0	2.724428e-1	3.629892e+1	2.754903e-2	1	2.754903e-2	1.000000e+0	249	2.402182e-2	1.000000e+0	2.156175e-1	4.137844e+1	2.416717e-2	1	218	5.000000e-1	4.587156e-3	unnamed	PTGS2
Disease Ontology	DOID:289	endometriosis	227	2.762282e-2	1.000000e+0	2.719692e-1	3.620195e+1	2.762282e-2	1	2.762282e-2	1.000000e+0	264	2.817922e-2	1.000000e+0	2.385627e-1	3.523633e+1	2.837980e-2	1	256	5.000000e-1	3.906250e-3	unnamed	PTGS2
Disease Ontology	DOID:4001	epithelial ovarian cancer	228	2.825499e-2	1.000000e+0	2.769733e-1	3.539198e+1	2.825499e-2	1	2.825499e-2	1.000000e+0	274	3.047293e-2	1.000000e+0	2.485657e-1	3.256498e+1	3.070783e-2	1	277	5.000000e-1	3.610108e-3	unnamed	PTGS2
Disease Ontology	DOID:2620	ductal, lobular, and medullary neoplasm	229	2.916543e-2	1.000000e+0	2.846495e-1	3.428716e+1	2.916543e-2	1	2.916543e-2	1.000000e+0	256	2.642982e-2	1.000000e+0	2.307447e-1	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	PTGS2
Disease Ontology	DOID:5428	bladder cancer	230	2.930843e-2	1.000000e+0	2.848015e-1	3.411987e+1	2.930843e-2	1	2.930843e-2	1.000000e+0	271	2.992705e-2	1.000000e+0	2.468153e-1	3.316360e+1	3.015354e-2	1	272	5.000000e-1	3.676471e-3	unnamed	PTGS2
Disease Ontology	DOID:10008	malignant neoplasm of thyroid	231	2.959106e-2	1.000000e+0	2.863031e-1	3.379399e+1	2.959106e-2	1	2.959106e-2	1.000000e+0	270	2.970866e-2	1.000000e+0	2.459217e-1	3.340926e+1	2.993182e-2	1	270	5.000000e-1	3.703704e-3	unnamed	PTGS2
Disease Ontology	DOID:1781	thyroid neoplasm	232	2.994908e-2	1.000000e+0	2.885181e-1	3.339000e+1	2.994908e-2	1	2.994908e-2	1.000000e+0	271	2.992705e-2	1.000000e+0	2.468153e-1	3.316360e+1	3.015354e-2	1	272	5.000000e-1	3.676471e-3	unnamed	PTGS2
Disease Ontology	DOID:365	bladder disease	233	3.085662e-2	1.000000e+0	2.959852e-1	3.240796e+1	3.085662e-2	1	3.085662e-2	1.000000e+0	276	3.123689e-2	1.000000e+0	2.529509e-1	3.176232e+1	3.148384e-2	1	284	5.000000e-1	3.521127e-3	unnamed	PTGS2
Disease Ontology	DOID:1936	atherosclerosis	234	3.199454e-2	1.000000e+0	3.055889e-1	3.125533e+1	3.199454e-2	1	3.199454e-2	1.000000e+0	289	3.679384e-2	1.000000e+0	2.845475e-1	2.692687e+1	3.713763e-2	1	335	5.000000e-1	2.985075e-3	unnamed	PTGS2
Disease Ontology	DOID:2348	arteriosclerotic cardiovascular disease	235	3.203444e-2	1.000000e+0	3.046680e-1	3.121640e+1	3.203444e-2	1	3.203444e-2	1.000000e+0	290	3.690264e-2	1.000000e+0	2.844048e-1	2.684673e+1	3.724849e-2	1	336	5.000000e-1	2.976190e-3	unnamed	PTGS2
Disease Ontology	DOID:1542	neck carcinoma	236	3.222879e-2	1.000000e+0	3.052176e-1	3.102816e+1	3.222879e-2	1	3.222879e-2	1.000000e+0	281	3.287295e-2	1.000000e+0	2.614628e-1	3.016890e+1	3.314672e-2	1	299	5.000000e-1	3.344482e-3	unnamed	PTGS2
Disease Ontology	DOID:10009	malignant neoplasm of endocrine gland	237	3.234190e-2	1.000000e+0	3.049964e-1	3.091964e+1	3.234190e-2	1	3.234190e-2	1.000000e+0	275	3.101865e-2	1.000000e+0	2.520970e-1	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	PTGS2
Disease Ontology	DOID:8857	lupus erythematosus	238	3.295243e-2	1.000000e+0	3.094482e-1	3.034678e+1	3.295243e-2	1	3.295243e-2	1.000000e+0	292	3.929468e-2	1.000000e+0	3.007658e-1	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	PTGS2
Disease Ontology	DOID:6713	cerebrovascular disease	239	3.298186e-2	1.000000e+0	3.084287e-1	3.031970e+1	3.298186e-2	1	3.298186e-2	1.000000e+0	286	3.614091e-2	1.000000e+0	2.824298e-1	2.741793e+1	3.647248e-2	1	329	5.000000e-1	3.039514e-3	unnamed	PTGS2
Disease Ontology	DOID:4450	renal cell carcinoma	240	3.398104e-2	1.000000e+0	3.164484e-1	2.942817e+1	3.398104e-2	1	3.398104e-2	1.000000e+0	282	3.505220e-2	1.000000e+0	2.778073e-1	2.827743e+1	3.536389e-2	1	319	5.000000e-1	3.134796e-3	unnamed	PTGS2
Disease Ontology	DOID:3394	myocardial ischemia	241	3.417720e-2	1.000000e+0	3.169545e-1	2.925927e+1	3.417720e-2	1	3.417720e-2	1.000000e+0	291	3.842519e-2	1.000000e+0	2.951213e-1	2.577286e+1	3.880051e-2	1	350	5.000000e-1	2.857143e-3	unnamed	PTGS2
Disease Ontology	DOID:5295	intestinal disease	242	3.418180e-2	1.000000e+0	3.156873e-1	2.925534e+1	3.418180e-2	1	3.418180e-2	1.000000e+0	306	4.233480e-2	1.000000e+0	3.092101e-1	2.336917e+1	4.279142e-2	1	386	5.000000e-1	2.590674e-3	unnamed	PTGS2
Disease Ontology	DOID:12849	autism	243	3.469144e-2	1.000000e+0	3.190756e-1	2.882556e+1	3.469144e-2	1	3.469144e-2	1.000000e+0	229	2.029452e-2	1.000000e+0	1.980710e-1	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	PTGS2
Disease Ontology	DOID:2349	arteriosclerosis	244	3.511376e-2	1.000000e+0	3.216363e-1	2.847886e+1	3.511376e-2	1	3.511376e-2	1.000000e+0	294	3.962064e-2	1.000000e+0	3.011977e-1	2.498753e+1	4.001995e-2	1	361	5.000000e-1	2.770083e-3	unnamed	PTGS2
Disease Ontology	DOID:1036	chronic leukemia	245	3.514876e-2	1.000000e+0	3.206428e-1	2.845050e+1	3.514876e-2	1	3.514876e-2	1.000000e+0	283	3.559663e-2	1.000000e+0	2.811253e-1	2.784105e+1	3.591819e-2	1	324	5.000000e-1	3.086420e-3	unnamed	PTGS2
Disease Ontology	DOID:2868	arterial occlusive disease	246	3.554737e-2	1.000000e+0	3.229609e-1	2.813148e+1	3.554737e-2	1	3.554737e-2	1.000000e+0	295	4.048959e-2	1.000000e+0	3.067601e-1	2.444580e+1	4.090682e-2	1	369	5.000000e-1	2.710027e-3	unnamed	PTGS2
Disease Ontology	DOID:0060041	autism spectrum disease	247	3.567988e-2	1.000000e+0	3.228524e-1	2.802700e+1	3.567988e-2	1	3.567988e-2	1.000000e+0	231	2.084310e-2	1.000000e+0	2.016638e-1	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	PTGS2
Disease Ontology	DOID:48	male reproductive system disease	248	3.620361e-2	1.000000e+0	3.262704e-1	2.762155e+1	3.620361e-2	1	3.620361e-2	1.000000e+0	277	3.189148e-2	1.000000e+0	2.573193e-1	3.110517e+1	3.214899e-2	1	290	5.000000e-1	3.448276e-3	unnamed	PTGS2
Disease Ontology	DOID:2841	asthma	249	3.672570e-2	1.000000e+0	3.296463e-1	2.722889e+1	3.672570e-2	1	3.672570e-2	1.000000e+0	7	3.796231e-4	8.484576e-1	1.212082e-1	5.125284e+1	3.902223e-2	2	352	1.000000e+0	5.681818e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:3068	glioblastoma	250	3.687427e-2	1.000000e+0	3.296560e-1	2.711918e+1	3.687427e-2	1	3.687427e-2	1.000000e+0	280	3.265489e-2	1.000000e+0	2.606560e-1	3.037205e+1	3.292500e-2	1	297	5.000000e-1	3.367003e-3	unnamed	PTGS2
Disease Ontology	DOID:2213	hemorrhagic disease	251	3.724211e-2	1.000000e+0	3.316180e-1	2.685133e+1	3.724211e-2	1	3.724211e-2	1.000000e+0	314	4.309408e-2	1.000000e+0	3.067365e-1	2.295293e+1	4.356743e-2	1	393	5.000000e-1	2.544529e-3	unnamed	PTGS2
Disease Ontology	DOID:3978	extrinsic cardiomyopathy	252	3.730842e-2	1.000000e+0	3.308902e-1	2.680360e+1	3.730842e-2	1	3.730842e-2	1.000000e+0	296	4.059818e-2	1.000000e+0	3.065437e-1	2.437973e+1	4.101768e-2	1	370	5.000000e-1	2.702703e-3	unnamed	PTGS2
Disease Ontology	DOID:0050498	dsDNA virus infectious disease	253	3.739700e-2	1.000000e+0	3.303648e-1	2.674011e+1	3.739700e-2	1	3.739700e-2	1.000000e+0	322	4.753523e-2	1.000000e+0	3.299417e-1	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	PTGS2
Disease Ontology	DOID:731	urologic neoplasm	254	3.752395e-2	1.000000e+0	3.301812e-1	2.664965e+1	3.752395e-2	1	3.752395e-2	1.000000e+0	287	3.657622e-2	1.000000e+0	2.848357e-1	2.708859e+1	3.691591e-2	1	333	5.000000e-1	3.003003e-3	unnamed	PTGS2
Disease Ontology	DOID:2237	hepatitis	255	3.759959e-2	1.000000e+0	3.295493e-1	2.659603e+1	3.759959e-2	1	3.759959e-2	1.000000e+0	320	4.601990e-2	1.000000e+0	3.214202e-1	2.147738e+1	4.656061e-2	1	420	5.000000e-1	2.380952e-3	unnamed	PTGS2
Disease Ontology	DOID:0060040	pervasive developmental disease	256	3.808154e-2	1.000000e+0	3.324697e-1	2.625945e+1	3.808154e-2	1	3.808154e-2	1.000000e+0	241	2.193980e-2	1.000000e+0	2.034666e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	PTGS2
Disease Ontology	DOID:1247	blood coagulation disease	257	3.813833e-2	1.000000e+0	3.316699e-1	2.622034e+1	3.813833e-2	1	3.813833e-2	1.000000e+0	317	4.417824e-2	1.000000e+0	3.114775e-1	2.238337e+1	4.467602e-2	1	403	5.000000e-1	2.481390e-3	unnamed	PTGS2
Disease Ontology	DOID:1176	bronchial disease	258	3.879433e-2	1.000000e+0	3.360672e-1	2.577696e+1	3.879433e-2	1	3.879433e-2	1.000000e+0	8	4.401836e-4	9.838103e-1	1.229763e-1	4.760158e+1	4.201541e-2	2	379	1.000000e+0	5.277045e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:10652	Alzheimer's disease	259	3.889460e-2	1.000000e+0	3.356349e-1	2.571051e+1	3.889460e-2	1	3.889460e-2	1.000000e+0	310	4.276871e-2	1.000000e+0	3.083486e-1	2.312949e+1	4.323485e-2	1	390	5.000000e-1	2.564103e-3	unnamed	PTGS2
Disease Ontology	DOID:2869	arteriopathy	260	3.890202e-2	1.000000e+0	3.344077e-1	2.570561e+1	3.890202e-2	1	3.890202e-2	1.000000e+0	318	4.472009e-2	1.000000e+0	3.143063e-1	2.210907e+1	4.523031e-2	1	408	5.000000e-1	2.450980e-3	unnamed	PTGS2
Disease Ontology	DOID:4451	renal carcinoma	261	3.907764e-2	1.000000e+0	3.346304e-1	2.559008e+1	3.907764e-2	1	3.907764e-2	1.000000e+0	293	3.940334e-2	1.000000e+0	3.005681e-1	2.512674e+1	3.979824e-2	1	359	5.000000e-1	2.785515e-3	unnamed	PTGS2
Disease Ontology	DOID:680	tauopathy	262	3.951549e-2	1.000000e+0	3.370882e-1	2.530653e+1	3.951549e-2	1	3.951549e-2	1.000000e+0	316	4.363624e-2	1.000000e+0	3.086297e-1	2.266457e+1	4.412172e-2	1	398	5.000000e-1	2.512563e-3	unnamed	PTGS2
Disease Ontology	DOID:50	thyroid gland disease	263	4.014086e-2	1.000000e+0	3.411210e-1	2.491227e+1	4.014086e-2	1	4.014086e-2	1.000000e+0	299	4.135815e-2	1.000000e+0	3.091487e-1	2.392706e+1	4.179369e-2	1	377	5.000000e-1	2.652520e-3	unnamed	PTGS2
Disease Ontology	DOID:1112	neck cancer	264	4.017075e-2	1.000000e+0	3.400819e-1	2.489373e+1	4.017075e-2	1	4.017075e-2	1.000000e+0	298	4.124960e-2	1.000000e+0	3.093720e-1	2.399069e+1	4.168283e-2	1	376	5.000000e-1	2.659574e-3	unnamed	PTGS2
Disease Ontology	DOID:4725	neck neoplasm	265	4.031124e-2	1.000000e+0	3.399835e-1	2.480698e+1	4.031124e-2	1	4.031124e-2	1.000000e+0	302	4.168376e-2	1.000000e+0	3.084874e-1	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	PTGS2
Disease Ontology	DOID:0070004	myeloma	266	4.117706e-2	1.000000e+0	3.459802e-1	2.428537e+1	4.117706e-2	1	4.117706e-2	1.000000e+0	296	4.059818e-2	1.000000e+0	3.065437e-1	2.437973e+1	4.101768e-2	1	370	5.000000e-1	2.702703e-3	unnamed	PTGS2
Disease Ontology	DOID:1301	RNA virus infectious disease	267	4.155492e-2	1.000000e+0	3.478474e-1	2.406454e+1	4.155492e-2	1	4.155492e-2	1.000000e+0	335	5.304516e-2	1.000000e+0	3.538983e-1	1.859897e+1	5.376642e-2	1	485	5.000000e-1	2.061856e-3	unnamed	PTGS2
Disease Ontology	DOID:9119	acute myeloid leukemia	268	4.177457e-2	1.000000e+0	3.483812e-1	2.393801e+1	4.177457e-2	1	4.177457e-2	1.000000e+0	299	4.135815e-2	1.000000e+0	3.091487e-1	2.392706e+1	4.179369e-2	1	377	5.000000e-1	2.652520e-3	unnamed	PLA2G4A
Disease Ontology	DOID:4960	bone marrow cancer	269	4.244589e-2	1.000000e+0	3.526638e-1	2.355941e+1	4.244589e-2	1	4.244589e-2	1.000000e+0	306	4.233480e-2	1.000000e+0	3.092101e-1	2.336917e+1	4.279142e-2	1	386	5.000000e-1	2.590674e-3	unnamed	PTGS2
Disease Ontology	DOID:3069	astrocytoma	270	4.313016e-2	1.000000e+0	3.570219e-1	2.318563e+1	4.313016e-2	1	4.313016e-2	1.000000e+0	301	4.157523e-2	1.000000e+0	3.087064e-1	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	PTGS2
Disease Ontology	DOID:2126	primary brain tumor	271	4.334785e-2	1.000000e+0	3.574998e-1	2.306920e+1	4.334785e-2	1	4.334785e-2	1.000000e+0	302	4.168376e-2	1.000000e+0	3.084874e-1	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	PTGS2
Disease Ontology	DOID:911	malignant neoplasm of brain	272	4.364353e-2	1.000000e+0	3.586150e-1	2.291290e+1	4.364353e-2	1	4.364353e-2	1.000000e+0	305	4.222631e-2	1.000000e+0	3.094289e-1	2.342987e+1	4.268056e-2	1	385	5.000000e-1	2.597403e-3	unnamed	PTGS2
Disease Ontology	DOID:3119	gastrointestinal neoplasm	273	4.370194e-2	1.000000e+0	3.577796e-1	2.288228e+1	4.370194e-2	1	4.370194e-2	1.000000e+0	304	4.211781e-2	1.000000e+0	3.096490e-1	2.349089e+1	4.256970e-2	1	384	5.000000e-1	2.604167e-3	unnamed	PTGS2
Disease Ontology	DOID:1307	dementia	274	4.416445e-2	1.000000e+0	3.602465e-1	2.264265e+1	4.416445e-2	1	4.416445e-2	1.000000e+0	326	4.872500e-2	1.000000e+0	3.340502e-1	2.027079e+1	4.933208e-2	1	445	5.000000e-1	2.247191e-3	unnamed	PTGS2
Disease Ontology	DOID:326	ischemia	275	4.429986e-2	1.000000e+0	3.600370e-1	2.257343e+1	4.429986e-2	1	4.429986e-2	1.000000e+0	328	4.969789e-2	1.000000e+0	3.386426e-1	1.986894e+1	5.032980e-2	1	454	5.000000e-1	2.202643e-3	unnamed	PTGS2
Disease Ontology	DOID:8377	digestive system cancer	276	4.455231e-2	1.000000e+0	3.607769e-1	2.244552e+1	4.455231e-2	1	4.455231e-2	1.000000e+0	309	4.255177e-2	1.000000e+0	3.077774e-1	2.324871e+1	4.301314e-2	1	388	5.000000e-1	2.577320e-3	unnamed	PTGS2
Disease Ontology	DOID:3459	breast carcinoma	277	4.496474e-2	1.000000e+0	3.628021e-1	2.223965e+1	4.496474e-2	1	4.496474e-2	1.000000e+0	311	4.287718e-2	1.000000e+0	3.081366e-1	2.307033e+1	4.334571e-2	1	391	5.000000e-1	2.557545e-3	unnamed	PTGS2
Disease Ontology	DOID:368	neoplasm of cerebrum	278	4.511970e-2	1.000000e+0	3.627429e-1	2.216327e+1	4.511970e-2	1	4.511970e-2	1.000000e+0	313	4.298563e-2	1.000000e+0	3.069421e-1	2.301148e+1	4.345657e-2	1	392	5.000000e-1	2.551020e-3	unnamed	PTGS2
Disease Ontology	DOID:1659	supratentorial neoplasm	279	4.529725e-2	1.000000e+0	3.628651e-1	2.207640e+1	4.529725e-2	1	4.529725e-2	1.000000e+0	315	4.320252e-2	1.000000e+0	3.065322e-1	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	PTGS2
Disease Ontology	DOID:2320	obstructive lung disease	280	4.622808e-2	1.000000e+0	3.689991e-1	2.163188e+1	4.622808e-2	1	4.622808e-2	1.000000e+0	18	6.629393e-4	1.000000e+0	8.231496e-2	3.879785e+1	5.154925e-2	2	465	1.000000e+0	4.301075e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:3908	non-small cell lung carcinoma	281	4.635042e-2	1.000000e+0	3.686590e-1	2.157478e+1	4.635042e-2	1	4.635042e-2	1.000000e+0	319	4.504512e-2	1.000000e+0	3.155983e-1	2.194769e+1	4.556288e-2	1	411	5.000000e-1	2.433090e-3	unnamed	PTGS2
Disease Ontology	DOID:7148	rheumatoid arthritis	282	4.706922e-2	1.000000e+0	3.730486e-1	2.124531e+1	4.706922e-2	1	4.706922e-2	1.000000e+0	24	7.302165e-4	1.000000e+0	6.800141e-2	3.696926e+1	5.409900e-2	2	488	1.000000e+0	4.098361e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:5679	retinal disease	283	4.769824e-2	1.000000e+0	3.766981e-1	2.096514e+1	4.769824e-2	1	4.769824e-2	1.000000e+0	324	4.850873e-2	1.000000e+0	3.346204e-1	2.036230e+1	4.911036e-2	1	443	5.000000e-1	2.257336e-3	unnamed	PTGS2
Disease Ontology	DOID:657	adenoma	284	4.777118e-2	1.000000e+0	3.759457e-1	2.093312e+1	4.777118e-2	1	4.777118e-2	1.000000e+0	321	4.656123e-2	1.000000e+0	3.241880e-1	2.122471e+1	4.711490e-2	1	425	5.000000e-1	2.352941e-3	unnamed	PTGS2
Disease Ontology	DOID:4961	bone marrow disease	285	4.784351e-2	1.000000e+0	3.751938e-1	2.090148e+1	4.784351e-2	1	4.784351e-2	1.000000e+0	323	4.818428e-2	1.000000e+0	3.334113e-1	2.050114e+1	4.877778e-2	1	440	5.000000e-1	2.272727e-3	unnamed	PTGS2
Disease Ontology	DOID:1037	lymphoblastic leukemia	286	4.801529e-2	1.000000e+0	3.752244e-1	2.082670e+1	4.801529e-2	1	4.801529e-2	1.000000e+0	311	4.287718e-2	1.000000e+0	3.081366e-1	2.307033e+1	4.334571e-2	1	391	5.000000e-1	2.557545e-3	unnamed	PTGS2
Disease Ontology	DOID:937	DNA virus infectious disease	287	5.023839e-2	1.000000e+0	3.912293e-1	1.990510e+1	5.023839e-2	1	5.023839e-2	1.000000e+0	339	6.187077e-2	1.000000e+0	4.079091e-1	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	PTGS2
Disease Ontology	DOID:449	head neoplasm	288	5.090150e-2	1.000000e+0	3.950168e-1	1.964579e+1	5.090150e-2	1	5.090150e-2	1.000000e+0	330	5.045424e-2	1.000000e+0	3.417128e-1	1.956725e+1	5.110581e-2	1	461	5.000000e-1	2.169197e-3	unnamed	PTGS2
Disease Ontology	DOID:8692	myeloid leukemia	289	5.217081e-2	1.000000e+0	4.034663e-1	1.916781e+1	5.217081e-2	1	5.217081e-2	1.000000e+0	25	7.758443e-4	1.000000e+0	6.936048e-2	3.586680e+1	5.576188e-2	2	503	1.000000e+0	3.976143e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:229	female reproductive system disease	290	5.249388e-2	1.000000e+0	4.045649e-1	1.904984e+1	5.249388e-2	1	5.249388e-2	1.000000e+0	332	5.185810e-2	1.000000e+0	3.491050e-1	1.903059e+1	5.254698e-2	1	474	5.000000e-1	2.109705e-3	unnamed	PTGS2
Disease Ontology	DOID:3905	lung carcinoma	291	5.322895e-2	1.000000e+0	4.088203e-1	1.878677e+1	5.322895e-2	1	5.322895e-2	1.000000e+0	331	5.142625e-2	1.000000e+0	3.472437e-1	1.919255e+1	5.210354e-2	1	470	5.000000e-1	2.127660e-3	unnamed	PTGS2
Disease Ontology	DOID:409	liver disease	292	5.695922e-2	1.000000e+0	4.359721e-1	1.755642e+1	5.695922e-2	1	5.695922e-2	1.000000e+0	343	6.862335e-2	1.000000e+0	4.471521e-1	1.431825e+1	6.984092e-2	1	630	5.000000e-1	1.587302e-3	unnamed	PTGS2
Disease Ontology	DOID:0050177	simple genetic disease	293	5.697693e-2	1.000000e+0	4.346192e-1	1.755096e+1	5.697693e-2	1	5.697693e-2	1.000000e+0	32	1.035397e-3	1.000000e+0	7.231601e-2	3.105164e+1	6.440885e-2	2	581	1.000000e+0	3.442341e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:769	neuroblastoma	294	5.857072e-2	1.000000e+0	4.452570e-1	1.707338e+1	5.857072e-2	1	5.857072e-2	1.000000e+0	325	4.861687e-2	1.000000e+0	3.343345e-1	2.031644e+1	4.922122e-2	1	444	5.000000e-1	2.252252e-3	unnamed	PTGS2
Disease Ontology	DOID:3369	Ewings sarcoma	295	5.884188e-2	1.000000e+0	4.458020e-1	1.699470e+1	5.884188e-2	1	5.884188e-2	1.000000e+0	327	4.883312e-2	1.000000e+0	3.337677e-1	2.022534e+1	4.944294e-2	1	446	5.000000e-1	2.242152e-3	unnamed	PTGS2
Disease Ontology	DOID:2438	tumor of dermis	296	6.071436e-2	1.000000e+0	4.584344e-1	1.647057e+1	6.071436e-2	1	6.071436e-2	1.000000e+0	329	5.002208e-2	1.000000e+0	3.398156e-1	1.973851e+1	5.066238e-2	1	457	5.000000e-1	2.188184e-3	unnamed	PTGS2
Disease Ontology	DOID:440	neuromuscular disease	297	6.093191e-2	1.000000e+0	4.585280e-1	1.641176e+1	6.093191e-2	1	6.093191e-2	1.000000e+0	336	5.724786e-2	1.000000e+0	3.808005e-1	1.721469e+1	5.808991e-2	1	524	5.000000e-1	1.908397e-3	unnamed	PTGS2
Disease Ontology	DOID:4159	skin cancer	298	6.228896e-2	1.000000e+0	4.671672e-1	1.605421e+1	6.228896e-2	1	6.228896e-2	1.000000e+0	334	5.261359e-2	1.000000e+0	3.520700e-1	1.875364e+1	5.332299e-2	1	481	5.000000e-1	2.079002e-3	unnamed	PTGS2
Disease Ontology	DOID:0060037	developmental disease of mental health	299	6.415934e-2	1.000000e+0	4.795857e-1	1.558620e+1	6.415934e-2	1	6.415934e-2	1.000000e+0	308	4.244329e-2	1.000000e+0	3.079895e-1	2.330879e+1	4.290228e-2	1	387	5.000000e-1	2.583979e-3	unnamed	PTGS2
Disease Ontology	DOID:1192	peripheral nervous system neoplasm	300	6.432174e-2	1.000000e+0	4.791970e-1	1.554684e+1	6.432174e-2	1	6.432174e-2	1.000000e+0	333	5.228984e-2	1.000000e+0	3.509543e-1	1.887134e+1	5.299041e-2	1	478	5.000000e-1	2.092050e-3	unnamed	PTGS2
Disease Ontology	DOID:10763	hypertension	301	6.448833e-2	1.000000e+0	4.788419e-1	1.550668e+1	6.448833e-2	1	6.448833e-2	1.000000e+0	340	6.197814e-2	1.000000e+0	4.074151e-1	1.588116e+1	6.296768e-2	1	568	5.000000e-1	1.760563e-3	unnamed	PTGS2
Disease Ontology	DOID:848	arthritis	302	6.457103e-2	1.000000e+0	4.778684e-1	1.548682e+1	6.457103e-2	1	6.457103e-2	1.000000e+0	37	1.233093e-3	1.000000e+0	7.448548e-2	2.845584e+1	7.028435e-2	2	634	1.000000e+0	3.154574e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:630	genetic disease	303	6.499915e-2	1.000000e+0	4.794492e-1	1.538482e+1	6.499915e-2	1	6.499915e-2	1.000000e+0	38	1.240891e-3	1.000000e+0	7.298398e-2	2.836635e+1	7.050607e-2	2	636	1.000000e+0	3.144654e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:3342	bone inflammation disease	304	6.811308e-2	1.000000e+0	5.007656e-1	1.468147e+1	6.811308e-2	1	6.811308e-2	1.000000e+0	43	1.369005e-3	1.000000e+0	7.115642e-2	2.700749e+1	7.405354e-2	2	668	1.000000e+0	2.994012e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:3118	hepatobiliary disease	305	6.824507e-2	1.000000e+0	5.000909e-1	1.465307e+1	6.824507e-2	1	6.824507e-2	1.000000e+0	359	8.109914e-2	1.000000e+0	5.048930e-1	1.207564e+1	8.281137e-2	1	747	5.000000e-1	1.338688e-3	unnamed	PTGS2
Disease Ontology	DOID:5614	eye disease	306	6.845790e-2	1.000000e+0	5.000111e-1	1.460752e+1	6.845790e-2	1	6.845790e-2	1.000000e+0	344	6.883732e-2	1.000000e+0	4.472425e-1	1.427294e+1	7.006264e-2	1	632	5.000000e-1	1.582278e-3	unnamed	PTGS2
Disease Ontology	DOID:168	primitive neuroectodermal tumor	307	6.935969e-2	1.000000e+0	5.049476e-1	1.441760e+1	6.935969e-2	1	6.935969e-2	1.000000e+0	337	5.789360e-2	1.000000e+0	3.839531e-1	1.701981e+1	5.875506e-2	1	530	5.000000e-1	1.886792e-3	unnamed	PTGS2
Disease Ontology	DOID:688	embryonal cancer	308	7.040036e-2	1.000000e+0	5.108598e-1	1.420447e+1	7.040036e-2	1	7.040036e-2	1.000000e+0	338	5.961449e-2	1.000000e+0	3.941964e-1	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	PTGS2
Disease Ontology	DOID:114	heart disease	309	7.093406e-2	1.000000e+0	5.130667e-1	1.409760e+1	7.093406e-2	1	7.093406e-2	1.000000e+0	346	7.012061e-2	1.000000e+0	4.529467e-1	1.400699e+1	7.139294e-2	1	644	5.000000e-1	1.552795e-3	unnamed	PTGS2
Disease Ontology	DOID:870	neuropathy	310	7.105799e-2	1.000000e+0	5.123052e-1	1.407301e+1	7.105799e-2	1	7.105799e-2	1.000000e+0	344	6.883732e-2	1.000000e+0	4.472425e-1	1.427294e+1	7.006264e-2	1	632	5.000000e-1	1.582278e-3	unnamed	PTGS2
Disease Ontology	DOID:1749	squamous cell carcinoma	311	7.192071e-2	1.000000e+0	5.168578e-1	1.390420e+1	7.192071e-2	1	7.192071e-2	1.000000e+0	349	7.652380e-2	1.000000e+0	4.900593e-1	1.281321e+1	7.804445e-2	1	704	5.000000e-1	1.420455e-3	unnamed	PTGS2
Disease Ontology	DOID:2428	epithelioma	312	7.206581e-2	1.000000e+0	5.162407e-1	1.387621e+1	7.206581e-2	1	7.206581e-2	1.000000e+0	350	7.673686e-2	1.000000e+0	4.900197e-1	1.277691e+1	7.826617e-2	1	706	5.000000e-1	1.416431e-3	unnamed	PTGS2
Disease Ontology	DOID:353	lymphoma	313	7.370780e-2	1.000000e+0	5.263161e-1	1.356708e+1	7.370780e-2	1	7.370780e-2	1.000000e+0	352	7.694989e-2	1.000000e+0	4.885881e-1	1.274082e+1	7.848789e-2	1	708	5.000000e-1	1.412429e-3	unnamed	PTGS2
Disease Ontology	DOID:2144	malignant neoplasm of ovary	314	7.395274e-2	1.000000e+0	5.263834e-1	1.352215e+1	7.395274e-2	1	7.395274e-2	1.000000e+0	354	7.737589e-2	1.000000e+0	4.885173e-1	1.266924e+1	7.893132e-2	1	712	5.000000e-1	1.404494e-3	unnamed	PTGS2
Disease Ontology	DOID:417	autoimmune disease	315	7.426329e-2	1.000000e+0	5.269157e-1	1.346560e+1	7.426329e-2	1	7.426329e-2	1.000000e+0	368	8.820552e-2	1.000000e+0	5.357047e-1	1.108170e+1	9.023890e-2	1	814	5.000000e-1	1.228501e-3	unnamed	PTGS2
Disease Ontology	DOID:1244	malignant neoplasm of female genital organ	316	7.450734e-2	1.000000e+0	5.269744e-1	1.342150e+1	7.450734e-2	1	7.450734e-2	1.000000e+0	355	7.812114e-2	1.000000e+0	4.918331e-1	1.254590e+1	7.970733e-2	1	719	5.000000e-1	1.390821e-3	unnamed	PTGS2
Disease Ontology	DOID:1281	female reproductive cancer	317	7.531950e-2	1.000000e+0	5.310381e-1	1.327677e+1	7.531950e-2	1	7.531950e-2	1.000000e+0	357	7.886609e-2	1.000000e+0	4.937415e-1	1.242493e+1	8.048334e-2	1	726	5.000000e-1	1.377410e-3	unnamed	PTGS2
Disease Ontology	DOID:3347	osteosarcoma	318	7.547113e-2	1.000000e+0	5.304339e-1	1.325010e+1	7.547113e-2	1	7.547113e-2	1.000000e+0	341	6.498213e-2	1.000000e+0	4.259093e-1	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	PTGS2
Disease Ontology	DOID:2394	ovarian neoplasm	319	7.564403e-2	1.000000e+0	5.299825e-1	1.321981e+1	7.564403e-2	1	7.564403e-2	1.000000e+0	356	7.875969e-2	1.000000e+0	4.944604e-1	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	PTGS2
Disease Ontology	DOID:183	bone tissue neoplasm	320	7.606199e-2	1.000000e+0	5.312455e-1	1.314717e+1	7.606199e-2	1	7.606199e-2	1.000000e+0	342	6.551805e-2	1.000000e+0	4.281662e-1	1.500915e+1	6.662602e-2	1	601	5.000000e-1	1.663894e-3	unnamed	PTGS2
Disease Ontology	DOID:0050155	sensory system disease	321	7.608032e-2	1.000000e+0	5.297181e-1	1.314400e+1	7.608032e-2	1	7.608032e-2	1.000000e+0	350	7.673686e-2	1.000000e+0	4.900197e-1	1.277691e+1	7.826617e-2	1	706	5.000000e-1	1.416431e-3	unnamed	PTGS2
Disease Ontology	DOID:850	lung disease	322	7.639029e-2	1.000000e+0	5.302245e-1	1.309067e+1	7.639029e-2	1	7.639029e-2	1.000000e+0	49	1.828835e-3	1.000000e+0	8.341727e-2	2.336917e+1	8.558284e-2	2	772	1.000000e+0	2.590674e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:0050161	lower respiratory tract disease	323	7.950492e-2	1.000000e+0	5.501347e-1	1.257784e+1	7.950492e-2	1	7.950492e-2	1.000000e+0	52	1.963992e-3	1.000000e+0	8.441389e-2	2.255125e+1	8.868688e-2	2	800	1.000000e+0	2.500000e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:1909	melanoma	324	8.029886e-2	1.000000e+0	5.539134e-1	1.245348e+1	8.029886e-2	1	8.029886e-2	1.000000e+0	347	7.599104e-2	1.000000e+0	4.894524e-1	1.290486e+1	7.749016e-2	1	699	5.000000e-1	1.430615e-3	unnamed	PTGS2
Disease Ontology	DOID:191	melanocytic neoplasm	325	8.062511e-2	1.000000e+0	5.544527e-1	1.240308e+1	8.062511e-2	1	8.062511e-2	1.000000e+0	348	7.631072e-2	1.000000e+0	4.900990e-1	1.284972e+1	7.782274e-2	1	702	5.000000e-1	1.424501e-3	unnamed	PTGS2
Disease Ontology	DOID:9256	colorectal cancer	326	8.071500e-2	1.000000e+0	5.533682e-1	1.238927e+1	8.071500e-2	1	8.071500e-2	1.000000e+0	45	1.595036e-3	1.000000e+0	7.922012e-2	2.502219e+1	7.992905e-2	2	721	1.000000e+0	2.773925e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:3168	squamous cell neoplasm	327	8.073938e-2	1.000000e+0	5.518426e-1	1.238553e+1	8.073938e-2	1	8.073938e-2	1.000000e+0	365	8.492093e-2	1.000000e+0	5.199953e-1	1.152043e+1	8.680228e-2	1	783	5.000000e-1	1.277139e-3	unnamed	PTGS2
Disease Ontology	DOID:934	viral infectious disease	328	8.111120e-2	1.000000e+0	5.526937e-1	1.232875e+1	8.111120e-2	1	8.111120e-2	1.000000e+0	376	9.991807e-2	1.000000e+0	5.939279e-1	9.751892e+0	1.025442e-1	1	925	5.000000e-1	1.081081e-3	unnamed	PTGS2
Disease Ontology	DOID:120	female genital cancer	329	8.268050e-2	1.000000e+0	5.616745e-1	1.209475e+1	8.268050e-2	1	8.268050e-2	1.000000e+0	366	8.545110e-2	1.000000e+0	5.218120e-1	1.144734e+1	8.735658e-2	1	788	5.000000e-1	1.269036e-3	unnamed	PTGS2
Disease Ontology	DOID:423	myopathy	330	8.319420e-2	1.000000e+0	5.634516e-1	1.202007e+1	8.319420e-2	1	8.319420e-2	1.000000e+0	360	8.152418e-2	1.000000e+0	5.061293e-1	1.201132e+1	8.325481e-2	1	751	5.000000e-1	1.331558e-3	unnamed	PTGS2
Disease Ontology	DOID:0080000	muscular disease	331	8.321398e-2	1.000000e+0	5.618829e-1	1.201721e+1	8.321398e-2	1	8.321398e-2	1.000000e+0	361	8.163042e-2	1.000000e+0	5.053850e-1	1.199535e+1	8.336567e-2	1	752	5.000000e-1	1.329787e-3	unnamed	PTGS2
Disease Ontology	DOID:1579	respiratory system disease	332	8.437815e-2	1.000000e+0	5.680276e-1	1.185141e+1	8.437815e-2	1	8.437815e-2	1.000000e+0	71	2.474980e-3	1.000000e+0	7.790958e-2	2.009020e+1	9.955102e-2	2	898	1.000000e+0	2.227171e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:5419	schizophrenia	333	8.467094e-2	1.000000e+0	5.682869e-1	1.181043e+1	8.467094e-2	1	8.467094e-2	1.000000e+0	39	1.248714e-3	1.000000e+0	7.156092e-2	2.827743e+1	7.072779e-2	2	638	1.000000e+0	3.134796e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:2468	psychotic disease	334	8.473193e-2	1.000000e+0	5.669936e-1	1.180193e+1	8.473193e-2	1	8.473193e-2	1.000000e+0	40	1.256561e-3	1.000000e+0	7.021035e-2	2.818906e+1	7.094950e-2	2	640	1.000000e+0	3.125000e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:0080001	bone disease	335	8.760496e-2	1.000000e+0	5.844689e-1	1.141488e+1	8.760496e-2	1	8.760496e-2	1.000000e+0	56	2.038379e-3	1.000000e+0	8.135316e-2	2.213620e+1	9.034976e-2	2	815	1.000000e+0	2.453988e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:201	connective tissue neoplasm	336	8.800066e-2	1.000000e+0	5.853615e-1	1.136355e+1	8.800066e-2	1	8.800066e-2	1.000000e+0	353	7.716290e-2	1.000000e+0	4.885526e-1	1.270493e+1	7.870961e-2	1	710	5.000000e-1	1.408451e-3	unnamed	PTGS2
Disease Ontology	DOID:1994	large Intestine carcinoma	337	8.851868e-2	1.000000e+0	5.870601e-1	1.129705e+1	8.851868e-2	1	8.851868e-2	1.000000e+0	51	1.924884e-3	1.000000e+0	8.435521e-2	2.277904e+1	8.780001e-2	2	792	1.000000e+0	2.525253e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:15	reproductive system disease	338	8.872162e-2	1.000000e+0	5.866651e-1	1.127121e+1	8.872162e-2	1	8.872162e-2	1.000000e+0	362	8.290487e-2	1.000000e+0	5.118574e-1	1.180694e+1	8.469597e-2	1	764	5.000000e-1	1.308901e-3	unnamed	PTGS2
Disease Ontology	DOID:684	hepatocellular carcinoma	339	9.124792e-2	1.000000e+0	6.015903e-1	1.095915e+1	9.124792e-2	1	9.124792e-2	1.000000e+0	372	9.211812e-2	1.000000e+0	5.534516e-1	1.059988e+1	9.434067e-2	1	851	5.000000e-1	1.175088e-3	unnamed	PTGS2
Disease Ontology	DOID:284	malignant neoplasm of abdomen	340	9.133327e-2	1.000000e+0	6.003819e-1	1.094891e+1	9.133327e-2	1	9.133327e-2	1.000000e+0	370	9.063867e-2	1.000000e+0	5.475066e-1	1.077718e+1	9.278865e-2	1	837	5.000000e-1	1.194743e-3	unnamed	PTGS2
Disease Ontology	DOID:686	liver and intrahepatic biliary tract carcinoma	341	9.251093e-2	1.000000e+0	6.063400e-1	1.080953e+1	9.251093e-2	1	9.251093e-2	1.000000e+0	373	9.338526e-2	1.000000e+0	5.595605e-1	1.045249e+1	9.567097e-2	1	863	5.000000e-1	1.158749e-3	unnamed	PTGS2
Disease Ontology	DOID:1289	neurodegenerative disease	342	9.274080e-2	1.000000e+0	6.060693e-1	1.078274e+1	9.274080e-2	1	9.274080e-2	1.000000e+0	375	9.981289e-2	1.000000e+0	5.948848e-1	9.762446e+0	1.024333e-1	1	924	5.000000e-1	1.082251e-3	unnamed	PTGS2
Disease Ontology	DOID:9351	diabetes mellitus	343	9.310870e-2	1.000000e+0	6.066995e-1	1.074013e+1	9.310870e-2	1	9.310870e-2	1.000000e+0	67	2.349754e-3	1.000000e+0	7.838358e-2	2.061829e+1	9.700127e-2	2	875	1.000000e+0	2.285714e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:1318	malignant neoplasm of central nervous system	344	9.457325e-2	1.000000e+0	6.144512e-1	1.057381e+1	9.457325e-2	1	9.457325e-2	1.000000e+0	363	8.396623e-2	1.000000e+0	5.169822e-1	1.165439e+1	8.580456e-2	1	774	5.000000e-1	1.291990e-3	unnamed	PTGS2
Disease Ontology	DOID:1428	endocrine pancreas disease	345	9.553022e-2	1.000000e+0	6.188697e-1	1.046789e+1	9.553022e-2	1	9.553022e-2	1.000000e+0	70	2.447480e-3	1.000000e+0	7.814454e-2	2.020269e+1	9.899673e-2	2	893	1.000000e+0	2.239642e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:4695	malignant neoplasm of nervous system	346	9.564362e-2	1.000000e+0	6.178136e-1	1.045548e+1	9.564362e-2	1	9.564362e-2	1.000000e+0	364	8.439060e-2	1.000000e+0	5.181676e-1	1.159447e+1	8.624799e-2	1	778	5.000000e-1	1.285347e-3	unnamed	PTGS2
Disease Ontology	DOID:1033	lymphoid cancer	347	9.576498e-2	1.000000e+0	6.168148e-1	1.044223e+1	9.576498e-2	1	9.576498e-2	1.000000e+0	374	9.602230e-2	1.000000e+0	5.738231e-1	1.015822e+1	9.844244e-2	1	888	5.000000e-1	1.126126e-3	unnamed	PTGS2
Disease Ontology	DOID:4194	glucose metabolism disease	348	9.709597e-2	1.000000e+0	6.235905e-1	1.029909e+1	9.709597e-2	1	9.709597e-2	1.000000e+0	72	2.547198e-3	1.000000e+0	7.906927e-2	1.980351e+1	1.009922e-1	2	911	1.000000e+0	2.195390e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:26	pancreas disease	349	9.807021e-2	1.000000e+0	6.280427e-1	1.019678e+1	9.807021e-2	1	9.807021e-2	1.000000e+0	75	2.637507e-3	1.000000e+0	7.859771e-2	1.946170e+1	1.027659e-1	2	927	1.000000e+0	2.157497e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:169	neuroendocrine tumor	350	9.840882e-2	1.000000e+0	6.284106e-1	1.016169e+1	9.840882e-2	1	9.840882e-2	1.000000e+0	369	8.926381e-2	1.000000e+0	5.406629e-1	1.094721e+1	9.134749e-2	1	824	5.000000e-1	1.213592e-3	unnamed	PTGS2
Disease Ontology	DOID:3070	malignant glioma	351	9.870456e-2	1.000000e+0	6.285034e-1	1.013124e+1	9.870456e-2	1	9.870456e-2	1.000000e+0	367	8.714662e-2	1.000000e+0	5.307158e-1	1.121953e+1	8.913031e-2	1	804	5.000000e-1	1.243781e-3	unnamed	PTGS2
Disease Ontology	DOID:619	lymphoproliferative disease	352	9.974272e-2	1.000000e+0	6.333096e-1	1.002579e+1	9.974272e-2	1	9.974272e-2	1.000000e+0	377	1.010747e-1	1.000000e+0	5.992094e-1	9.637286e+0	1.037636e-1	1	936	5.000000e-1	1.068376e-3	unnamed	PTGS2
Disease Ontology	DOID:2916	immunoproliferative disease	353	9.975771e-2	1.000000e+0	6.316104e-1	1.002429e+1	9.975771e-2	1	9.975771e-2	1.000000e+0	378	1.011798e-1	1.000000e+0	5.982456e-1	9.627001e+0	1.038745e-1	1	937	5.000000e-1	1.067236e-3	unnamed	PTGS2
Disease Ontology	DOID:0050013	carbohydrate metabolism disease	354	1.011074e-1	1.000000e+0	6.383476e-1	9.890476e+0	1.011074e-1	1	1.011074e-1	1.000000e+0	77	2.775920e-3	1.000000e+0	8.057378e-2	1.897056e+1	1.054265e-1	2	951	1.000000e+0	2.103049e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:75	lymphatic system disease	355	1.035697e-1	1.000000e+0	6.520515e-1	9.655335e+0	1.035697e-1	1	1.035697e-1	1.000000e+0	379	1.052741e-1	1.000000e+0	6.208116e-1	9.242316e+0	1.081980e-1	1	976	5.000000e-1	1.024590e-3	unnamed	PTGS2
Disease Ontology	DOID:1265	genitourinary cancer	356	1.098597e-1	1.000000e+0	6.897091e-1	9.102521e+0	1.098597e-1	1	1.098597e-1	1.000000e+0	385	1.099868e-1	1.000000e+0	6.384948e-1	8.834966e+0	1.131866e-1	1	1021	5.000000e-1	9.794319e-4	unnamed	PTGS2
Disease Ontology	DOID:1240	leukemia	357	1.114394e-1	1.000000e+0	6.976668e-1	8.973483e+0	1.114394e-1	1	1.114394e-1	1.000000e+0	84	3.358542e-3	1.000000e+0	8.936121e-2	1.724761e+1	1.159581e-1	2	1046	1.000000e+0	1.912046e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:122	abdominal cancer	358	1.132547e-1	1.000000e+0	7.070510e-1	8.829653e+0	1.132547e-1	1	1.132547e-1	1.000000e+0	387	1.128084e-1	1.000000e+0	6.514904e-1	8.607347e+0	1.161798e-1	1	1048	5.000000e-1	9.541985e-4	unnamed	PTGS2
Disease Ontology	DOID:0060035	medical disorder	359	1.146356e-1	1.000000e+0	7.136785e-1	8.723297e+0	1.146356e-1	1	1.146356e-1	1.000000e+0	371	9.148422e-2	1.000000e+0	5.511246e-1	1.067515e+1	9.367552e-2	1	845	5.000000e-1	1.183432e-3	unnamed	PLA2G4A
Disease Ontology	DOID:170	endocrine gland cancer	360	1.163017e-1	1.000000e+0	7.220397e-1	8.598327e+0	1.163017e-1	1	1.163017e-1	1.000000e+0	380	1.061128e-1	1.000000e+0	6.241108e-1	9.167175e+0	1.090849e-1	1	984	5.000000e-1	1.016260e-3	unnamed	PTGS2
Disease Ontology	DOID:3165	skin neoplasm	361	1.200813e-1	1.000000e+0	7.434396e-1	8.327690e+0	1.200813e-1	1	1.200813e-1	1.000000e+0	383	1.090453e-1	1.000000e+0	6.363348e-1	8.913538e+0	1.121889e-1	1	1012	5.000000e-1	9.881423e-4	unnamed	PTGS2
Disease Ontology	DOID:1561	cognitive disease	362	1.201035e-1	1.000000e+0	7.415230e-1	8.326155e+0	1.201035e-1	1	1.201035e-1	1.000000e+0	82	3.218685e-3	1.000000e+0	8.772879e-2	1.761816e+1	1.135192e-1	2	1024	1.000000e+0	1.953125e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:178	vascular disease	363	1.205522e-1	1.000000e+0	7.422429e-1	8.295164e+0	1.205522e-1	1	1.205522e-1	1.000000e+0	392	1.288165e-1	1.000000e+0	7.344512e-1	7.504576e+0	1.332520e-1	1	1202	5.000000e-1	8.319468e-4	unnamed	PTGS2
Disease Ontology	DOID:0050117	disease by infectious agent	364	1.209421e-1	1.000000e+0	7.425978e-1	8.268418e+0	1.209421e-1	1	1.209421e-1	1.000000e+0	121	6.156339e-3	1.000000e+0	1.137142e-1	1.274082e+1	1.569758e-1	2	1416	1.000000e+0	1.412429e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:65	connective tissue disease	365	1.230503e-1	1.000000e+0	7.534724e-1	8.126760e+0	1.230503e-1	1	1.230503e-1	1.000000e+0	390	1.217659e-1	1.000000e+0	6.978123e-1	7.954586e+0	1.257137e-1	1	1134	5.000000e-1	8.818342e-4	unnamed	PTGS2
Disease Ontology	DOID:2627	glioma	366	1.253026e-1	1.000000e+0	7.651675e-1	7.980682e+0	1.253026e-1	1	1.253026e-1	1.000000e+0	382	1.084173e-1	1.000000e+0	6.343263e-1	8.966700e+0	1.115238e-1	1	1006	5.000000e-1	9.940358e-4	unnamed	PTGS2
Disease Ontology	DOID:1319	brain neoplasm	367	1.265868e-1	1.000000e+0	7.709033e-1	7.899721e+0	1.265868e-1	1	1.265868e-1	1.000000e+0	384	1.094638e-1	1.000000e+0	6.371135e-1	8.878445e+0	1.126323e-1	1	1016	5.000000e-1	9.842520e-4	unnamed	PTGS2
Disease Ontology	DOID:3620	central nervous system neoplasm	368	1.271973e-1	1.000000e+0	7.725162e-1	7.861801e+0	1.271973e-1	1	1.271973e-1	1.000000e+0	386	1.101959e-1	1.000000e+0	6.380514e-1	8.817693e+0	1.134083e-1	1	1023	5.000000e-1	9.775171e-4	unnamed	PTGS2
Disease Ontology	DOID:2227	malignant neoplasm of lymphatic and hemopoietic tissue	369	1.308045e-1	1.000000e+0	7.922712e-1	7.644994e+0	1.308045e-1	1	1.308045e-1	1.000000e+0	100	4.774054e-3	1.000000e+0	1.067001e-1	1.446752e+1	1.382407e-1	2	1247	1.000000e+0	1.603849e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:171	neuroectodermal tumor	370	1.311969e-1	1.000000e+0	7.925002e-1	7.622132e+0	1.311969e-1	1	1.311969e-1	1.000000e+0	388	1.187505e-1	1.000000e+0	6.840396e-1	8.163348e+0	1.224988e-1	1	1105	5.000000e-1	9.049774e-4	unnamed	PTGS2
Disease Ontology	DOID:3095	germ cell and embryonal cancer	371	1.321992e-1	1.000000e+0	7.964022e-1	7.564342e+0	1.321992e-1	1	1.321992e-1	1.000000e+0	389	1.204148e-1	1.000000e+0	6.918434e-1	8.046833e+0	1.242725e-1	1	1121	5.000000e-1	8.920607e-4	unnamed	PTGS2
Disease Ontology	DOID:2994	germ cell cancer	372	1.346344e-1	1.000000e+0	8.088922e-1	7.427520e+0	1.346344e-1	1	1.346344e-1	1.000000e+0	391	1.229084e-1	1.000000e+0	7.025582e-1	7.878166e+0	1.269331e-1	1	1145	5.000000e-1	8.733624e-4	unnamed	PTGS2
Disease Ontology	DOID:28	endocrine system disease	373	1.359578e-1	1.000000e+0	8.146533e-1	7.355222e+0	1.359578e-1	1	1.359578e-1	1.000000e+0	108	5.212646e-3	1.000000e+0	1.078728e-1	1.384574e+1	1.444488e-1	2	1303	1.000000e+0	1.534919e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:0014667	disease of metabolism	374	1.387898e-1	1.000000e+0	8.293989e-1	7.205143e+0	1.387898e-1	1	1.387898e-1	1.000000e+0	119	5.983599e-3	1.000000e+0	1.123810e-1	1.292335e+1	1.547586e-1	2	1396	1.000000e+0	1.432665e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:177	soft tissue neoplasm	375	1.450676e-1	1.000000e+0	8.646029e-1	6.893336e+0	1.450676e-1	1	1.450676e-1	1.000000e+0	393	1.364568e-1	1.000000e+0	7.760329e-1	7.069357e+0	1.414556e-1	1	1276	5.000000e-1	7.836991e-4	unnamed	PTGS2
Disease Ontology	DOID:3350	mesenchymal cell neoplasm	376	1.453323e-1	1.000000e+0	8.638768e-1	6.880783e+0	1.453323e-1	1	1.453323e-1	1.000000e+0	394	1.369718e-1	1.000000e+0	7.769847e-1	7.041764e+0	1.420099e-1	1	1281	5.000000e-1	7.806401e-4	unnamed	PTGS2
Disease Ontology	DOID:2531	hematologic cancer	377	1.484252e-1	1.000000e+0	8.799213e-1	6.737401e+0	1.484252e-1	1	1.484252e-1	1.000000e+0	127	6.208641e-3	1.000000e+0	1.092623e-1	1.268706e+1	1.576409e-1	2	1422	1.000000e+0	1.406470e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:1115	sarcoma	378	1.495909e-1	1.000000e+0	8.844859e-1	6.684897e+0	1.495909e-1	1	1.495909e-1	1.000000e+0	395	1.416001e-1	1.000000e+0	8.012056e-1	6.802790e+0	1.469985e-1	1	1326	5.000000e-1	7.541478e-4	unnamed	PTGS2
Disease Ontology	DOID:77	gastrointestinal system disease	379	1.566959e-1	1.000000e+0	9.240510e-1	6.381787e+0	1.566959e-1	1	1.566959e-1	1.000000e+0	150	8.400618e-3	1.000000e+0	1.251692e-1	1.090750e+1	1.833601e-1	2	1654	1.000000e+0	1.209190e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:74	hematopoietic system disease	380	1.634383e-1	1.000000e+0	9.612753e-1	6.118517e+0	1.634383e-1	1	1.634383e-1	1.000000e+0	145	8.168540e-3	1.000000e+0	1.259082e-1	1.106131e+1	1.808104e-1	2	1631	1.000000e+0	1.226242e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:3094	neuroepithelial neoplasm	381	1.687017e-1	1.000000e+0	9.896281e-1	5.927623e+0	1.687017e-1	1	1.687017e-1	1.000000e+0	396	1.534735e-1	1.000000e+0	8.661951e-1	6.255548e+0	1.598581e-1	1	1442	5.000000e-1	6.934813e-4	unnamed	PTGS2
Disease Ontology	DOID:4241	malignant neoplasm of breast	382	1.689834e-1	1.000000e+0	9.886856e-1	5.917740e+0	1.689834e-1	1	1.689834e-1	1.000000e+0	399	1.624258e-1	1.000000e+0	9.098287e-1	5.895752e+0	1.696137e-1	1	1530	5.000000e-1	6.535948e-4	unnamed	PTGS2
Disease Ontology	DOID:3937	malignant neoplasm of thorax	383	1.691008e-1	1.000000e+0	9.867893e-1	5.913634e+0	1.691008e-1	1	1.691008e-1	1.000000e+0	400	1.626287e-1	1.000000e+0	9.086879e-1	5.888055e+0	1.698354e-1	1	1532	5.000000e-1	6.527415e-4	unnamed	PTGS2
Disease Ontology	DOID:3195	neural neoplasm	384	1.692055e-1	1.000000e+0	9.848289e-1	5.909975e+0	1.692055e-1	1	1.692055e-1	1.000000e+0	397	1.541874e-1	1.000000e+0	8.680323e-1	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	PTGS2
Disease Ontology	DOID:5093	thoracic cancer	385	1.702657e-1	1.000000e+0	9.884256e-1	5.873173e+0	1.702657e-1	1	1.702657e-1	1.000000e+0	401	1.639470e-1	1.000000e+0	9.137694e-1	5.838511e+0	1.712765e-1	1	1545	5.000000e-1	6.472492e-4	unnamed	PTGS2
Disease Ontology	DOID:299	adenocarcinoma	386	1.706462e-1	1.000000e+0	9.880680e-1	5.860077e+0	1.706462e-1	1	1.706462e-1	1.000000e+0	143	7.900248e-3	1.000000e+0	1.234759e-1	1.124751e+1	1.778172e-1	2	1604	1.000000e+0	1.246883e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:3093	nervous system cancer	387	1.722624e-1	1.000000e+0	9.948487e-1	5.805099e+0	1.722624e-1	1	1.722624e-1	1.000000e+0	398	1.573451e-1	1.000000e+0	8.835837e-1	6.094932e+0	1.640707e-1	1	1480	5.000000e-1	6.756757e-4	unnamed	PTGS2
Disease Ontology	DOID:150	disease of mental health	388	1.737444e-1	1.000000e+0	1.000000e+0	5.755580e+0	1.737444e-1	1	1.737444e-1	1.000000e+0	128	6.278720e-3	1.000000e+0	1.096323e-1	1.261608e+1	1.585278e-1	2	1430	1.000000e+0	1.398601e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:1612	mammary cancer	389	1.772500e-1	1.000000e+0	1.000000e+0	5.641748e+0	1.772500e-1	1	1.772500e-1	1.000000e+0	402	1.677945e-1	1.000000e+0	9.328873e-1	5.698358e+0	1.754892e-1	1	1583	5.000000e-1	6.317119e-4	unnamed	PTGS2
Disease Ontology	DOID:197	glandular cell epithelial neoplasm	390	1.860840e-1	1.000000e+0	1.000000e+0	5.373918e+0	1.860840e-1	1	1.860840e-1	1.000000e+0	165	9.458223e-3	1.000000e+0	1.281159e-1	1.027977e+1	1.945568e-1	2	1755	1.000000e+0	1.139601e-3	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:936	brain disease	391	1.872681e-1	1.000000e+0	1.000000e+0	5.339937e+0	1.872681e-1	1	1.872681e-1	1.000000e+0	403	1.748588e-1	1.000000e+0	9.697504e-1	5.457048e+0	1.832493e-1	1	1653	5.000000e-1	6.049607e-4	unnamed	PTGS2
Disease Ontology	DOID:225	syndrome	392	2.011593e-1	1.000000e+0	1.000000e+0	4.971185e+0	2.011593e-1	1	2.011593e-1	1.000000e+0	405	1.993468e-1	1.000000e+0	1.000000e+0	4.752634e+0	2.104096e-1	1	1898	5.000000e-1	5.268704e-4	unnamed	PTGS2
Disease Ontology	DOID:193	reproductive system cancer	393	2.095200e-1	1.000000e+0	1.000000e+0	4.772814e+0	2.095200e-1	1	2.095200e-1	1.000000e+0	406	2.033098e-1	1.000000e+0	1.000000e+0	4.654541e+0	2.148440e-1	1	1938	5.000000e-1	5.159959e-4	unnamed	PTGS2
Disease Ontology	DOID:17	musculoskeletal system disease	394	2.136568e-1	1.000000e+0	1.000000e+0	4.680403e+0	2.136568e-1	1	2.136568e-1	1.000000e+0	185	1.286845e-2	1.000000e+0	1.554648e-1	8.813385e+0	2.269276e-1	2	2047	1.000000e+0	9.770396e-4	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:157	epithelial carcinoma	395	2.158701e-1	1.000000e+0	1.000000e+0	4.632416e+0	2.158701e-1	1	2.158701e-1	1.000000e+0	188	1.323574e-2	1.000000e+0	1.573504e-1	8.690270e+0	2.301425e-1	2	2076	1.000000e+0	9.633911e-4	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:155	glandular and epithelial neoplasm	396	2.196335e-1	1.000000e+0	1.000000e+0	4.553039e+0	2.196335e-1	1	2.196335e-1	1.000000e+0	407	2.107139e-1	1.000000e+0	1.000000e+0	4.481123e+0	2.231584e-1	1	2013	5.000000e-1	4.967710e-4	unnamed	PTGS2
Disease Ontology	DOID:331	central nervous system disease	397	2.247960e-1	1.000000e+0	1.000000e+0	4.448477e+0	2.247960e-1	1	2.247960e-1	1.000000e+0	408	2.201408e-1	1.000000e+0	1.000000e+0	4.277146e+0	2.338008e-1	1	2109	5.000000e-1	4.741584e-4	unnamed	PTGS2
Disease Ontology	DOID:1287	cardiovascular system disease	398	2.464292e-1	1.000000e+0	1.000000e+0	4.057961e+0	2.464292e-1	1	2.464292e-1	1.000000e+0	221	1.930360e-2	1.000000e+0	1.952197e-1	7.196250e+0	2.779225e-1	2	2507	1.000000e+0	7.977663e-4	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:863	nervous system disease	399	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	409	2.652858e-1	1.000000e+0	1.000000e+0	3.500388e+0	2.856826e-1	1	2577	5.000000e-1	3.880481e-4	unnamed	PTGS2
Disease Ontology	DOID:2985	chronic rejection of renal transplant	400	2.674662e-1	1.000000e+0	1.000000e+0	3.738791e+0	2.674662e-1	1	2.674662e-1	1.000000e+0	251	2.413204e-2	1.000000e+0	2.148809e-1	6.436318e+0	3.107367e-1	2	2803	1.000000e+0	7.135212e-4	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:2108	transplant-related disease	401	2.674780e-1	1.000000e+0	1.000000e+0	3.738626e+0	2.674780e-1	1	2.674780e-1	1.000000e+0	252	2.414927e-2	1.000000e+0	2.141810e-1	6.434023e+0	3.108475e-1	2	2804	1.000000e+0	7.132668e-4	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:557	kidney disease	402	2.854845e-1	1.000000e+0	1.000000e+0	3.502817e+0	2.854845e-1	1	2.854845e-1	1.000000e+0	263	2.790264e-2	1.000000e+0	2.371194e-1	5.985733e+0	3.341278e-1	2	3014	1.000000e+0	6.635700e-4	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:18	urinary system disease	403	2.923209e-1	1.000000e+0	1.000000e+0	3.420898e+0	2.923209e-1	1	2.923209e-1	1.000000e+0	266	2.911932e-2	1.000000e+0	2.446680e-1	5.859370e+0	3.413336e-1	2	3079	1.000000e+0	6.495615e-4	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:2914	immune system disease	404	3.205063e-1	1.000000e+0	1.000000e+0	3.120063e+0	3.205063e-1	1	3.205063e-1	1.000000e+0	285	3.599066e-2	1.000000e+0	2.822425e-1	5.270523e+0	3.794690e-1	2	3423	1.000000e+0	5.842828e-4	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:305	carcinoma	405	3.218892e-1	1.000000e+0	1.000000e+0	3.106659e+0	3.218892e-1	1	3.218892e-1	1.000000e+0	278	3.190720e-2	1.000000e+0	2.565201e-1	5.597580e+0	3.572973e-1	2	3223	1.000000e+0	6.205399e-4	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:462	cancer by anatomical entity	406	3.485076e-1	1.000000e+0	1.000000e+0	2.869378e+0	3.485076e-1	1	3.485076e-1	1.000000e+0	288	3.675178e-2	1.000000e+0	2.852091e-1	5.215669e+0	3.834599e-1	2	3459	1.000000e+0	5.782018e-4	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:162	cancer	407	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	358	7.990207e-2	1.000000e+0	4.988300e-1	3.537451e+0	5.653789e-1	2	5100	1.000000e+0	3.921569e-4	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:7	disease of anatomical entity	408	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	381	1.068296e-1	1.000000e+0	6.266776e-1	3.059352e+0	6.537332e-1	2	5897	1.000000e+0	3.391555e-4	unnamed	PLA2G4A,PTGS2
Disease Ontology	DOID:4	disease	409	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	404	1.910563e-1	1.000000e+0	1.000000e+0	2.287725e+0	8.742309e-1	2	7886	1.000000e+0	2.536140e-4	unnamed	PLA2G4A,PTGS2
Placenta Disorders	00001	Genes associated with preterm birth from dbPTB	1	6.332664e-2	1.899799e-1	1.899799e-1	1.579114e+1	6.332664e-2	1	6.332664e-2	1.000000e+0	1	1.075009e-3	3.225027e-3	3.225027e-3	3.047466e+1	6.562829e-2	2	592	1.000000e+0	3.378378e-3	unnamed	PLA2G4A,PTGS2
PANTHER Pathway	P00054	Toll receptor signaling pathway	1	3.948194e-3	6.001255e-1	6.001255e-1	2.532804e+2	3.948194e-3	1	3.948194e-3	1.000000e+0	3	5.424845e-3	8.245764e-1	2.748588e-1	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	PTGS2
PANTHER Pathway	P00046	Oxidative stress response	2	5.464214e-3	8.305605e-1	4.152803e-1	1.830089e+2	5.464214e-3	1	5.464214e-3	1.000000e+0	2	5.093135e-3	7.741565e-1	3.870783e-1	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	PLA2G4A
PANTHER Pathway	P00056	VEGF signaling pathway	3	6.798945e-3	1.000000e+0	3.444799e-1	1.470816e+2	6.798945e-3	1	6.798945e-3	1.000000e+0	4	6.530143e-3	9.925817e-1	2.481454e-1	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	PLA2G4A
PANTHER Pathway	P00019	Endothelin signaling pathway	4	1.075455e-2	1.000000e+0	4.086729e-1	9.298389e+1	1.075455e-2	1	1.075455e-2	1.000000e+0	1	1.614947e-5	2.454719e-3	2.454719e-3	2.471370e+2	8.092678e-3	2	73	1.000000e+0	2.739726e-2	unnamed	PLA2G4A,PTGS2
PANTHER Pathway	P00031	Inflammation mediated by chemokine and cytokine signaling pathway	5	1.674738e-2	1.000000e+0	5.091204e-1	5.971083e+1	1.674738e-2	1	1.674738e-2	1.000000e+0	6	2.106249e-2	1.000000e+0	5.335831e-1	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PLA2G4A
PANTHER Pathway	P00005	Angiogenesis	6	1.932399e-2	1.000000e+0	4.895411e-1	5.174915e+1	1.932399e-2	1	1.932399e-2	1.000000e+0	5	1.667005e-2	1.000000e+0	5.067695e-1	5.973841e+1	1.673965e-2	1	151	5.000000e-1	6.622517e-3	unnamed	PLA2G4A
BioCyc Pathway	PWY66-393	aspirin-triggered lipoxin biosynthesis	1	2.205701e-4	7.322927e-2	7.322927e-2	4.533707e+3	2.205701e-4	1	2.205701e-4	1.000000e+0	1	2.217111e-4	7.360809e-2	7.360809e-2	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	PTGS2
BioCyc Pathway	PWY66-395	aspirin triggered resolvin D biosynthesis	1	2.205701e-4	7.322927e-2	7.322927e-2	4.533707e+3	2.205701e-4	1	2.205701e-4	1.000000e+0	1	2.217111e-4	7.360809e-2	7.360809e-2	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	PTGS2
BioCyc Pathway	PWY66-394	aspirin triggered resolvin E biosynthesis	3	2.862789e-4	9.504459e-2	3.168153e-2	3.493097e+3	2.862789e-4	1	2.862789e-4	1.000000e+0	3	3.325574e-4	1.104091e-1	3.680302e-2	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	PTGS2
BioCyc Pathway	PWY66-374	C20 prostanoid biosynthesis	4	5.506832e-4	1.828268e-1	4.570671e-2	1.815926e+3	5.506832e-4	1	5.506832e-4	1.000000e+0	4	9.975062e-4	3.311721e-1	8.279301e-2	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	PTGS2
BioCyc Pathway	LIPASYN-PWY	phospholipases	5	2.928704e-3	9.723297e-1	1.944659e-1	3.414480e+2	2.928704e-3	1	2.928704e-3	1.000000e+0	5	3.876395e-3	1.000000e+0	2.573926e-1	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_ACYL_CHAIN_REMODELLING_OF_PI	Genes involved in Acyl chain remodelling of PI	1	8.747744e-4	1.000000e+0	1.000000e+0	1.143152e+3	8.747744e-4	1	8.747744e-4	1.000000e+0	4	1.662234e-3	1.000000e+0	5.485372e-1	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	PLA2G4A
MSigDB Pathway	KEGG_ALPHA_LINOLENIC_ACID_METABOLISM	alpha-Linolenic acid metabolism	2	9.455459e-4	1.000000e+0	6.240603e-1	1.057590e+3	9.455459e-4	1	9.455459e-4	1.000000e+0	8	1.994515e-3	1.000000e+0	3.290950e-1	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_ACYL_CHAIN_REMODELLING_OF_PS	Genes involved in Acyl chain remodelling of PS	3	9.627776e-4	1.000000e+0	4.236221e-1	1.038661e+3	9.627776e-4	1	9.627776e-4	1.000000e+0	4	1.662234e-3	1.000000e+0	5.485372e-1	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_ACYL_CHAIN_REMODELLING_OF_PG	Genes involved in Acyl chain remodelling of PG	4	9.861397e-4	1.000000e+0	3.254261e-1	1.014055e+3	9.861397e-4	1	9.861397e-4	1.000000e+0	7	1.773000e-3	1.000000e+0	3.343371e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_ACYL_CHAIN_REMODELLING_OF_PC	Genes involved in Acyl chain remodelling of PC	5	1.273527e-3	1.000000e+0	3.362111e-1	7.852208e+2	1.273527e-3	1	1.273527e-3	1.000000e+0	11	2.437470e-3	1.000000e+0	2.924964e-1	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_ACYL_CHAIN_REMODELLING_OF_PE	Genes involved in Acyl chain remodelling of PE	6	1.319349e-3	1.000000e+0	2.902568e-1	7.579496e+2	1.319349e-3	1	1.319349e-3	1.000000e+0	9	2.326740e-3	1.000000e+0	3.412552e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_PLATELET_SENSITIZATION_BY_LDL	Genes involved in Platelet sensitization by LDL	7	1.392469e-3	1.000000e+0	2.625799e-1	7.181488e+2	1.392469e-3	1	1.392469e-3	1.000000e+0	4	1.662234e-3	1.000000e+0	5.485372e-1	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	PLA2G4A
MSigDB Pathway	KEGG_LINOLEIC_ACID_METABOLISM	Linoleic acid metabolism	8	1.410125e-3	1.000000e+0	2.326706e-1	7.091568e+2	1.410125e-3	1	1.410125e-3	1.000000e+0	15	3.101718e-3	1.000000e+0	2.729512e-1	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	PLA2G4A
MSigDB Pathway	PID_S1P_S1P1_PATHWAY	S1P1 pathway	9	2.053799e-3	1.000000e+0	3.012239e-1	4.869027e+2	2.053799e-3	1	2.053799e-3	1.000000e+0	9	2.326740e-3	1.000000e+0	3.412552e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	PTGS2
MSigDB Pathway	REACTOME_ADP_SIGNALLING_THROUGH_P2RY1	Genes involved in ADP signalling through P2Y purinoceptor 1	10	2.116234e-3	1.000000e+0	2.793429e-1	4.725375e+2	2.116234e-3	1	2.116234e-3	1.000000e+0	13	2.769621e-3	1.000000e+0	2.812231e-1	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	PLA2G4A
MSigDB Pathway	KEGG_ETHER_LIPID_METABOLISM	Ether lipid metabolism	11	2.421127e-3	1.000000e+0	2.905352e-1	4.130308e+2	2.421127e-3	1	2.421127e-3	1.000000e+0	19	3.544427e-3	1.000000e+0	2.462444e-1	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_SIGNAL_AMPLIFICATION	Genes involved in Signal amplification	12	2.620306e-3	1.000000e+0	2.882337e-1	3.816348e+2	2.620306e-3	1	2.620306e-3	1.000000e+0	18	3.433759e-3	1.000000e+0	2.518090e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_SYNTHESIS_OF_PA	Genes involved in Synthesis of PA	13	2.766047e-3	1.000000e+0	2.808602e-1	3.615267e+2	2.766047e-3	1	2.766047e-3	1.000000e+0	14	2.991025e-3	1.000000e+0	2.820109e-1	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	PLA2G4A
MSigDB Pathway	KEGG_ARACHIDONIC_ACID_METABOLISM	Arachidonic acid metabolism	14	2.841231e-3	1.000000e+0	2.678875e-1	3.519601e+2	2.841231e-3	1	2.841231e-3	1.000000e+0	2	9.807668e-6	1.294612e-2	6.473061e-3	3.165088e+2	6.318940e-3	2	57	1.000000e+0	3.508772e-2	unnamed	PLA2G4A,PTGS2
MSigDB Pathway	PID_TCRCALCIUMPATHWAY	Calcium signaling in the CD4+ TCR pathway	15	2.947968e-3	1.000000e+0	2.594212e-1	3.392167e+2	2.947968e-3	1	2.947968e-3	1.000000e+0	16	3.212404e-3	1.000000e+0	2.650233e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	PTGS2
MSigDB Pathway	BIOCARTA_SPPA_PATHWAY	Aspirin Blocks Signaling Pathway Involved in Platelet Activation	16	3.304270e-3	1.000000e+0	2.726023e-1	3.026387e+2	3.304270e-3	1	3.304270e-3	1.000000e+0	11	2.437470e-3	1.000000e+0	2.924964e-1	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_CA_DEPENDENT_EVENTS	Genes involved in Ca-dependent events	17	3.943739e-3	1.000000e+0	3.062197e-1	2.535665e+2	3.943739e-3	1	3.943739e-3	1.000000e+0	16	3.212404e-3	1.000000e+0	2.650233e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS	Genes involved in Phase 1 - Functionalization of compounds	18	4.733687e-3	1.000000e+0	3.471370e-1	2.112518e+2	4.733687e-3	1	4.733687e-3	1.000000e+0	27	7.413939e-3	1.000000e+0	3.624592e-1	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	PTGS2
MSigDB Pathway	PID_P38ALPHABETADOWNSTREAMPATHWAY	Signaling mediated by p38-alpha and p38-beta	19	4.914422e-3	1.000000e+0	3.414230e-1	2.034827e+2	4.914422e-3	1	4.914422e-3	1.000000e+0	1	4.320044e-6	5.702458e-3	5.702458e-3	4.747632e+2	4.212627e-3	2	38	1.000000e+0	5.263158e-2	unnamed	PLA2G4A,PTGS2
MSigDB Pathway	BIOCARTA_FCER1_PATHWAY	Fc Epsilon Receptor I Signaling in Mast Cells	20	5.025681e-3	1.000000e+0	3.316949e-1	1.989780e+2	5.025681e-3	1	5.025681e-3	1.000000e+0	20	4.208307e-3	1.000000e+0	2.777483e-1	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	PLA2G4A
MSigDB Pathway	BIOCARTA_P38MAPK_PATHWAY	p38 MAPK Signaling Pathway	21	5.278245e-3	1.000000e+0	3.317754e-1	1.894569e+2	5.278245e-3	1	5.278245e-3	1.000000e+0	21	4.650770e-3	1.000000e+0	2.923341e-1	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_PLC_BETA_MEDIATED_EVENTS	Genes involved in PLC beta mediated events	22	5.449551e-3	1.000000e+0	3.269731e-1	1.835014e+2	5.449551e-3	1	5.449551e-3	1.000000e+0	21	4.650770e-3	1.000000e+0	2.923341e-1	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	PLA2G4A
MSigDB Pathway	KEGG_LEISHMANIA_INFECTION	Leishmania infection	23	5.609334e-3	1.000000e+0	3.219270e-1	1.782743e+2	5.609334e-3	1	5.609334e-3	1.000000e+0	28	7.634827e-3	1.000000e+0	3.599276e-1	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	PTGS2
MSigDB Pathway	KEGG_VEGF_SIGNALING_PATHWAY	VEGF signaling pathway	24	6.293489e-3	1.000000e+0	3.461419e-1	1.588944e+2	6.293489e-3	1	6.293489e-3	1.000000e+0	3	1.751369e-5	2.311807e-2	7.706024e-3	2.373816e+2	8.425254e-3	2	76	1.000000e+0	2.631579e-2	unnamed	PLA2G4A,PTGS2
MSigDB Pathway	PID_NFAT_TFPATHWAY	Calcineurin-regulated NFAT-dependent transcription in lymphocytes	25	6.582325e-3	1.000000e+0	3.475468e-1	1.519220e+2	6.582325e-3	1	6.582325e-3	1.000000e+0	23	5.203711e-3	1.000000e+0	2.986478e-1	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	PTGS2
MSigDB Pathway	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS	Genes involved in Glycerophospholipid biosynthesis	26	6.937794e-3	1.000000e+0	3.522265e-1	1.441380e+2	6.937794e-3	1	6.937794e-3	1.000000e+0	34	9.069997e-3	1.000000e+0	3.521293e-1	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	PLA2G4A
MSigDB Pathway	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	Glycerophospholipid metabolism	27	6.953803e-3	1.000000e+0	3.399637e-1	1.438062e+2	6.953803e-3	1	6.953803e-3	1.000000e+0	31	8.407740e-3	1.000000e+0	3.580070e-1	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	PLA2G4A
MSigDB Pathway	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	Fc epsilon RI signaling pathway	28	7.232590e-3	1.000000e+0	3.409650e-1	1.382631e+2	7.232590e-3	1	7.232590e-3	1.000000e+0	33	8.738896e-3	1.000000e+0	3.495558e-1	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	PLA2G4A
MSigDB Pathway	PID_FCER1PATHWAY	Fc-epsilon receptor I signaling in mast cells	29	7.266974e-3	1.000000e+0	3.307726e-1	1.376089e+2	7.266974e-3	1	7.266974e-3	1.000000e+0	25	6.751129e-3	1.000000e+0	3.564596e-1	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	PLA2G4A
MSigDB Pathway	BIOCARTA_PPARA_PATHWAY	Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)	30	7.367793e-3	1.000000e+0	3.241829e-1	1.357259e+2	7.367793e-3	1	7.367793e-3	1.000000e+0	24	6.419641e-3	1.000000e+0	3.530803e-1	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	PTGS2
MSigDB Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	Genes involved in Biological oxidations	31	8.699493e-3	1.000000e+0	3.704300e-1	1.149492e+2	8.699493e-3	1	8.699493e-3	1.000000e+0	41	1.502036e-2	1.000000e+0	4.835823e-1	6.632721e+1	1.507677e-2	1	136	5.000000e-1	7.352941e-3	unnamed	PTGS2
MSigDB Pathway	PID_ENDOTHELINPATHWAY	Endothelins	32	8.794914e-3	1.000000e+0	3.627902e-1	1.137021e+2	8.794914e-3	1	8.794914e-3	1.000000e+0	26	6.972090e-3	1.000000e+0	3.539676e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_OPIOID_SIGNALLING	Genes involved in Opioid Signalling	33	9.062463e-3	1.000000e+0	3.624985e-1	1.103453e+2	9.062463e-3	1	9.062463e-3	1.000000e+0	32	8.518131e-3	1.000000e+0	3.513729e-1	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_PLATELET_HOMEOSTASIS	Genes involved in Platelet homeostasis	34	9.259648e-3	1.000000e+0	3.594922e-1	1.079955e+2	9.259648e-3	1	9.259648e-3	1.000000e+0	30	8.297342e-3	1.000000e+0	3.650830e-1	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	PLA2G4A
MSigDB Pathway	KEGG_SMALL_CELL_LUNG_CANCER	Small cell lung cancer	35	9.448206e-3	1.000000e+0	3.563323e-1	1.058402e+2	9.448206e-3	1	9.448206e-3	1.000000e+0	36	9.511379e-3	1.000000e+0	3.487506e-1	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	PTGS2
MSigDB Pathway	KEGG_LONG_TERM_DEPRESSION	Long-term depression	36	9.746261e-3	1.000000e+0	3.573629e-1	1.026034e+2	9.746261e-3	1	9.746261e-3	1.000000e+0	28	7.634827e-3	1.000000e+0	3.599276e-1	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	PLA2G4A
MSigDB Pathway	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	Fc gamma R-mediated phagocytosis	37	9.759422e-3	1.000000e+0	3.481740e-1	1.024651e+2	9.759422e-3	1	9.759422e-3	1.000000e+0	37	1.061440e-2	1.000000e+0	3.786759e-1	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	PLA2G4A
MSigDB Pathway	KEGG_GNRH_SIGNALING_PATHWAY	GnRH signaling pathway	38	1.016792e-2	1.000000e+0	3.532014e-1	9.834850e+1	1.016792e-2	1	1.016792e-2	1.000000e+0	38	1.105544e-2	1.000000e+0	3.840311e-1	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	PLA2G4A
MSigDB Pathway	PID_CMYB_PATHWAY	C-MYB transcription factor network	39	1.156677e-2	1.000000e+0	3.914907e-1	8.645458e+1	1.156677e-2	1	1.156677e-2	1.000000e+0	35	9.290700e-3	1.000000e+0	3.503921e-1	1.073869e+2	9.312122e-3	1	84	5.000000e-1	1.190476e-2	unnamed	PTGS2
MSigDB Pathway	PID_PDGFRBPATHWAY	PDGFR-beta signaling pathway	40	1.244375e-2	1.000000e+0	4.106438e-1	8.036166e+1	1.244375e-2	1	1.244375e-2	1.000000e+0	40	1.436009e-2	1.000000e+0	4.738830e-1	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	PLA2G4A
MSigDB Pathway	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	Vascular smooth muscle contraction	41	1.349831e-2	1.000000e+0	4.345797e-1	7.408334e+1	1.349831e-2	1	1.349831e-2	1.000000e+0	39	1.259830e-2	1.000000e+0	4.264040e-1	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_PHOSPHOLIPID_METABOLISM	Genes involved in Phospholipid metabolism	42	1.785088e-2	1.000000e+0	5.610277e-1	5.601966e+1	1.785088e-2	1	1.785088e-2	1.000000e+0	42	2.161085e-2	1.000000e+0	6.791981e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	Genes involved in Platelet activation, signaling and aggregation	43	1.957477e-2	1.000000e+0	6.008999e-1	5.108616e+1	1.957477e-2	1	1.957477e-2	1.000000e+0	43	2.183015e-2	1.000000e+0	6.701348e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PLA2G4A
MSigDB Pathway	KEGG_MAPK_SIGNALING_PATHWAY	MAPK signaling pathway	44	3.047188e-2	1.000000e+0	9.141564e-1	3.281714e+1	3.047188e-2	1	3.047188e-2	1.000000e+0	44	2.916257e-2	1.000000e+0	8.748771e-1	3.403962e+1	2.937753e-2	1	265	5.000000e-1	3.773585e-3	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS	Genes involved in Metabolism of lipids and lipoproteins	45	4.109831e-2	1.000000e+0	1.000000e+0	2.433190e+1	4.109831e-2	1	4.109831e-2	1.000000e+0	47	5.153422e-2	1.000000e+0	1.000000e+0	1.915180e+1	5.221440e-2	1	471	5.000000e-1	2.123142e-3	unnamed	PLA2G4A
MSigDB Pathway	KEGG_PATHWAYS_IN_CANCER	Pathways in cancer	46	4.235254e-2	1.000000e+0	1.000000e+0	2.361133e+1	4.235254e-2	1	4.235254e-2	1.000000e+0	45	3.592322e-2	1.000000e+0	1.000000e+0	2.758563e+1	3.625076e-2	1	327	5.000000e-1	3.058104e-3	unnamed	PTGS2
MSigDB Pathway	REACTOME_HEMOSTASIS	Genes involved in Hemostasis	47	4.242109e-2	1.000000e+0	1.000000e+0	2.357318e+1	4.242109e-2	1	4.242109e-2	1.000000e+0	46	4.948174e-2	1.000000e+0	1.000000e+0	1.995686e+1	5.010809e-2	1	452	5.000000e-1	2.212389e-3	unnamed	PLA2G4A
MSigDB Pathway	REACTOME_SIGNALING_BY_GPCR	Genes involved in Signaling by GPCR	48	7.350402e-2	1.000000e+0	1.000000e+0	1.360470e+1	7.350402e-2	1	7.350402e-2	1.000000e+0	48	9.707604e-2	1.000000e+0	1.000000e+0	1.004510e+1	9.955102e-2	1	898	5.000000e-1	1.113586e-3	unnamed	PLA2G4A
MGI Expression: Detected	8419	TS26_urinary bladder	1	5.143208e-3	1.000000e+0	1.000000e+0	1.944312e+2	5.143208e-3	1	5.143208e-3	1.000000e+0	5	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	PTGS2
MGI Expression: Detected	11202	TS23_4th ventricle lateral recess	2	5.724463e-3	1.000000e+0	1.000000e+0	1.746889e+2	5.724463e-3	1	5.724463e-3	1.000000e+0	6	6.751129e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	PLA2G4A
MGI Expression: Detected	9392	TS23_bladder fundus region	3	8.709923e-3	1.000000e+0	1.000000e+0	1.148116e+2	8.709923e-3	1	8.709923e-3	1.000000e+0	9	9.511379e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	PLA2G4A
MGI Expression: Detected	15023	TS23_smooth muscle	4	1.350363e-2	1.000000e+0	1.000000e+0	7.405416e+1	1.350363e-2	1	1.350363e-2	1.000000e+0	8	9.180352e-3	1.000000e+0	1.000000e+0	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	PLA2G4A
MGI Expression: Detected	8371	TS23_rest of skin epidermis	5	1.434810e-2	1.000000e+0	1.000000e+0	6.969562e+1	1.434810e-2	1	1.434810e-2	1.000000e+0	14	1.656012e-2	1.000000e+0	1.000000e+0	6.013667e+1	1.662879e-2	1	150	5.000000e-1	6.666667e-3	unnamed	PLA2G4A
MGI Expression: Detected	9654	TS23_thyroid cartilage	6	1.440846e-2	1.000000e+0	1.000000e+0	6.940367e+1	1.440846e-2	1	1.440846e-2	1.000000e+0	7	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	PLA2G4A
MGI Expression: Detected	9959	TS23_4th ventricle	7	1.442165e-2	1.000000e+0	1.000000e+0	6.934018e+1	1.442165e-2	1	1.442165e-2	1.000000e+0	12	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	PLA2G4A
MGI Expression: Detected	8611	TS23_respiratory system cartilage	8	1.713765e-2	1.000000e+0	1.000000e+0	5.835106e+1	1.713765e-2	1	1.713765e-2	1.000000e+0	10	1.083493e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	PLA2G4A
MGI Expression: Detected	12014	TS23_lateral ventricle choroid plexus	9	1.996512e-2	1.000000e+0	1.000000e+0	5.008736e+1	1.996512e-2	1	1.996512e-2	1.000000e+0	16	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	PLA2G4A
MGI Expression: Detected	7473	TS23_head mesenchyme	10	2.340099e-2	1.000000e+0	1.000000e+0	4.273323e+1	2.340099e-2	1	2.340099e-2	1.000000e+0	13	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	PLA2G4A
MGI Expression: Detected	10308	TS23_metanephros pelvis	11	2.922481e-2	1.000000e+0	1.000000e+0	3.421751e+1	2.922481e-2	1	2.922481e-2	1.000000e+0	17	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	PLA2G4A
MGI Expression: Detected	9045	TS23_pharyngo-tympanic tube	12	3.024457e-2	1.000000e+0	1.000000e+0	3.306379e+1	3.024457e-2	1	3.024457e-2	1.000000e+0	22	2.544509e-2	1.000000e+0	1.000000e+0	3.904978e+1	2.560834e-2	1	231	5.000000e-1	4.329004e-3	unnamed	PLA2G4A
MGI Expression: Detected	11304	TS23_choroid invagination	13	3.027258e-2	1.000000e+0	1.000000e+0	3.303319e+1	3.027258e-2	1	3.027258e-2	1.000000e+0	30	3.090952e-2	1.000000e+0	1.000000e+0	3.210142e+1	3.115127e-2	1	281	5.000000e-1	3.558719e-3	unnamed	PLA2G4A
MGI Expression: Detected	10813	TS23_metanephros calyx	14	3.134238e-2	1.000000e+0	1.000000e+0	3.190568e+1	3.134238e-2	1	3.134238e-2	1.000000e+0	25	2.992705e-2	1.000000e+0	1.000000e+0	3.316360e+1	3.015354e-2	1	272	5.000000e-1	3.676471e-3	unnamed	PLA2G4A
MGI Expression: Detected	8145	TS23_nasal septum	15	3.178845e-2	1.000000e+0	1.000000e+0	3.145797e+1	3.178845e-2	1	3.178845e-2	1.000000e+0	19	2.500727e-2	1.000000e+0	1.000000e+0	3.973789e+1	2.516490e-2	1	227	5.000000e-1	4.405286e-3	unnamed	PLA2G4A
MGI Expression: Detected	7913	TS23_middle ear	16	3.257587e-2	1.000000e+0	1.000000e+0	3.069757e+1	3.257587e-2	1	3.257587e-2	1.000000e+0	23	2.675795e-2	1.000000e+0	1.000000e+0	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	PLA2G4A
MGI Expression: Detected	8527	TS23_nose turbinate bone	17	3.376376e-2	1.000000e+0	1.000000e+0	2.961756e+1	3.376376e-2	1	3.376376e-2	1.000000e+0	26	3.025460e-2	1.000000e+0	1.000000e+0	3.280182e+1	3.048611e-2	1	275	5.000000e-1	3.636364e-3	unnamed	PLA2G4A
MGI Expression: Detected	3700	TS19_renal-urinary system	18	3.438915e-2	1.000000e+0	1.000000e+0	2.907894e+1	3.438915e-2	1	3.438915e-2	1.000000e+0	18	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	PTGS2
MGI Expression: Detected	7868	TS26_lung	19	3.530301e-2	1.000000e+0	1.000000e+0	2.832620e+1	3.530301e-2	1	3.530301e-2	1.000000e+0	1	2.101090e-4	1.000000e+0	1.000000e+0	6.885878e+1	2.904495e-2	2	262	1.000000e+0	7.633588e-3	unnamed	PLA2G4A,PTGS2
MGI Expression: Detected	7623	TS26_respiratory system	20	3.656856e-2	1.000000e+0	1.000000e+0	2.734589e+1	3.656856e-2	1	3.656856e-2	1.000000e+0	2	2.215083e-4	1.000000e+0	1.000000e+0	6.706691e+1	2.982096e-2	2	269	1.000000e+0	7.434944e-3	unnamed	PLA2G4A,PTGS2
MGI Expression: Detected	10260	TS23_rectum	21	3.722571e-2	1.000000e+0	1.000000e+0	2.686315e+1	3.722571e-2	1	3.722571e-2	1.000000e+0	35	3.853390e-2	1.000000e+0	1.000000e+0	2.569943e+1	3.891137e-2	1	351	5.000000e-1	2.849003e-3	unnamed	PLA2G4A
MGI Expression: Detected	9947	TS23_trachea	22	3.788211e-2	1.000000e+0	1.000000e+0	2.639768e+1	3.788211e-2	1	3.788211e-2	1.000000e+0	26	3.025460e-2	1.000000e+0	1.000000e+0	3.280182e+1	3.048611e-2	1	275	5.000000e-1	3.636364e-3	unnamed	PLA2G4A
MGI Expression: Detected	8804	TS23_lower respiratory tract	23	3.810183e-2	1.000000e+0	1.000000e+0	2.624546e+1	3.810183e-2	1	3.810183e-2	1.000000e+0	28	3.036376e-2	1.000000e+0	1.000000e+0	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	PLA2G4A
MGI Expression: Detected	7869	TS23_respiratory tract	24	3.936191e-2	1.000000e+0	1.000000e+0	2.540527e+1	3.936191e-2	1	3.936191e-2	1.000000e+0	31	3.112777e-2	1.000000e+0	1.000000e+0	3.187456e+1	3.137298e-2	1	283	5.000000e-1	3.533569e-3	unnamed	PLA2G4A
MGI Expression: Detected	9638	TS23_urethra of male	25	4.158767e-2	1.000000e+0	1.000000e+0	2.404559e+1	4.158767e-2	1	4.158767e-2	1.000000e+0	33	3.635858e-2	1.000000e+0	1.000000e+0	2.725227e+1	3.669420e-2	1	331	5.000000e-1	3.021148e-3	unnamed	PLA2G4A
MGI Expression: Detected	7647	TS26_renal-urinary system	26	4.793158e-2	1.000000e+0	1.000000e+0	2.086307e+1	4.793158e-2	1	4.793158e-2	1.000000e+0	34	3.733778e-2	1.000000e+0	1.000000e+0	2.653088e+1	3.769192e-2	1	340	5.000000e-1	2.941176e-3	unnamed	PTGS2
MGI Expression: Detected	6309	TS22_ureter	27	5.326405e-2	1.000000e+0	1.000000e+0	1.877439e+1	5.326405e-2	1	5.326405e-2	1.000000e+0	37	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	PLA2G4A
MGI Expression: Detected	6306	TS22_drainage component	28	5.400047e-2	1.000000e+0	1.000000e+0	1.851836e+1	5.400047e-2	1	5.400047e-2	1.000000e+0	38	4.244329e-2	1.000000e+0	1.000000e+0	2.330879e+1	4.290228e-2	1	387	5.000000e-1	2.583979e-3	unnamed	PLA2G4A
MGI Expression: Detected	7441	TS23_embryo mesenchyme	29	5.699941e-2	1.000000e+0	1.000000e+0	1.754404e+1	5.699941e-2	1	5.699941e-2	1.000000e+0	36	4.135815e-2	1.000000e+0	1.000000e+0	2.392706e+1	4.179369e-2	1	377	5.000000e-1	2.652520e-3	unnamed	PLA2G4A
MGI Expression: Detected	8799	TS23_hindgut	30	6.070389e-2	1.000000e+0	1.000000e+0	1.647341e+1	6.070389e-2	1	6.070389e-2	1.000000e+0	40	5.843155e-2	1.000000e+0	1.000000e+0	1.686075e+1	5.930935e-2	1	535	5.000000e-1	1.869159e-3	unnamed	PLA2G4A
MGI Expression: Detected	6258	TS22_main bronchus	31	6.265526e-2	1.000000e+0	1.000000e+0	1.596035e+1	6.265526e-2	1	6.265526e-2	1.000000e+0	39	5.315304e-2	1.000000e+0	1.000000e+0	1.856070e+1	5.387728e-2	1	486	5.000000e-1	2.057613e-3	unnamed	PLA2G4A
MGI Expression: Detected	6875	TS22_facial bone primordium	32	6.958050e-2	1.000000e+0	1.000000e+0	1.437184e+1	6.958050e-2	1	6.958050e-2	1.000000e+0	41	6.058180e-2	1.000000e+0	1.000000e+0	1.625315e+1	6.152652e-2	1	555	5.000000e-1	1.801802e-3	unnamed	PLA2G4A
MGI Expression: Detected	6873	TS22_viscerocranium	33	6.988708e-2	1.000000e+0	1.000000e+0	1.430880e+1	6.988708e-2	1	6.988708e-2	1.000000e+0	42	6.068925e-2	1.000000e+0	1.000000e+0	1.622392e+1	6.163738e-2	1	556	5.000000e-1	1.798561e-3	unnamed	PLA2G4A
MGI Expression: Detected	14331	TS22_gonad	34	7.009554e-2	1.000000e+0	1.000000e+0	1.426624e+1	7.009554e-2	1	7.009554e-2	1.000000e+0	44	6.573237e-2	1.000000e+0	1.000000e+0	1.495937e+1	6.684774e-2	1	603	5.000000e-1	1.658375e-3	unnamed	PLA2G4A
MGI Expression: Detected	6961	TS28_urinary bladder	35	7.132225e-2	1.000000e+0	1.000000e+0	1.402087e+1	7.132225e-2	1	7.132225e-2	1.000000e+0	45	6.733902e-2	1.000000e+0	1.000000e+0	1.459628e+1	6.851061e-2	1	618	5.000000e-1	1.618123e-3	unnamed	PTGS2
MGI Expression: Detected	15072	TS22_meninges	36	7.865579e-2	1.000000e+0	1.000000e+0	1.271362e+1	7.865579e-2	1	7.865579e-2	1.000000e+0	46	7.076192e-2	1.000000e+0	1.000000e+0	1.387769e+1	7.205809e-2	1	650	5.000000e-1	1.538462e-3	unnamed	PTGS2
MGI Expression: Detected	5956	TS22_middle ear	37	8.347899e-2	1.000000e+0	1.000000e+0	1.197906e+1	8.347899e-2	1	8.347899e-2	1.000000e+0	48	7.428520e-2	1.000000e+0	1.000000e+0	1.320717e+1	7.571642e-2	1	683	5.000000e-1	1.464129e-3	unnamed	PLA2G4A
MGI Expression: Detected	6262	TS22_trachea	38	8.940319e-2	1.000000e+0	1.000000e+0	1.118528e+1	8.940319e-2	1	8.940319e-2	1.000000e+0	47	7.375180e-2	1.000000e+0	1.000000e+0	1.330457e+1	7.516213e-2	1	678	5.000000e-1	1.474926e-3	unnamed	PLA2G4A
MGI Expression: Detected	11365	TS23_submandibular gland primordium	39	9.143420e-2	1.000000e+0	1.000000e+0	1.093683e+1	9.143420e-2	1	9.143420e-2	1.000000e+0	61	9.812917e-2	1.000000e+0	1.000000e+0	9.934471e+0	1.006596e-1	1	908	5.000000e-1	1.101322e-3	unnamed	PLA2G4A
MGI Expression: Detected	8776	TS23_midgut	40	9.403671e-2	1.000000e+0	1.000000e+0	1.063414e+1	9.403671e-2	1	9.403671e-2	1.000000e+0	56	8.502697e-2	1.000000e+0	1.000000e+0	1.150574e+1	8.691314e-2	1	784	5.000000e-1	1.275510e-3	unnamed	PLA2G4A
MGI Expression: Detected	15561	TS22_urethra	41	9.613757e-2	1.000000e+0	1.000000e+0	1.040176e+1	9.613757e-2	1	9.613757e-2	1.000000e+0	53	7.992979e-2	1.000000e+0	1.000000e+0	1.225611e+1	8.159193e-2	1	736	5.000000e-1	1.358696e-3	unnamed	PLA2G4A
MGI Expression: Detected	6274	TS22_larynx	42	9.645471e-2	1.000000e+0	1.000000e+0	1.036756e+1	9.645471e-2	1	9.645471e-2	1.000000e+0	49	7.471181e-2	1.000000e+0	1.000000e+0	1.313028e+1	7.615986e-2	1	687	5.000000e-1	1.455604e-3	unnamed	PLA2G4A
MGI Expression: Detected	7576	TS23_ear	43	9.679940e-2	1.000000e+0	1.000000e+0	1.033064e+1	9.679940e-2	1	9.679940e-2	1.000000e+0	50	7.545814e-2	1.000000e+0	1.000000e+0	1.299784e+1	7.693587e-2	1	694	5.000000e-1	1.440922e-3	unnamed	PLA2G4A
MGI Expression: Detected	10179	TS23_salivary gland	44	9.797890e-2	1.000000e+0	1.000000e+0	1.020628e+1	9.797890e-2	1	9.797890e-2	1.000000e+0	64	1.021254e-1	1.000000e+0	1.000000e+0	9.535412e+0	1.048722e-1	1	946	5.000000e-1	1.057082e-3	unnamed	PLA2G4A
MGI Expression: Detected	6257	TS22_lower respiratory tract	45	9.837091e-2	1.000000e+0	1.000000e+0	1.016561e+1	9.837091e-2	1	9.837091e-2	1.000000e+0	54	8.396623e-2	1.000000e+0	1.000000e+0	1.165439e+1	8.580456e-2	1	774	5.000000e-1	1.291990e-3	unnamed	PLA2G4A
MGI Expression: Detected	6256	TS22_respiratory tract	46	9.841003e-2	1.000000e+0	1.000000e+0	1.016157e+1	9.841003e-2	1	9.841003e-2	1.000000e+0	55	8.417843e-2	1.000000e+0	1.000000e+0	1.162436e+1	8.602627e-2	1	776	5.000000e-1	1.288660e-3	unnamed	PLA2G4A
MGI Expression: Detected	7379	TS22_adrenal gland	47	9.915582e-2	1.000000e+0	1.000000e+0	1.008514e+1	9.915582e-2	1	9.915582e-2	1.000000e+0	57	8.682883e-2	1.000000e+0	1.000000e+0	1.126155e+1	8.879774e-2	1	801	5.000000e-1	1.248439e-3	unnamed	PLA2G4A
MGI Expression: Detected	6858	TS22_cranium	48	1.023757e-1	1.000000e+0	1.000000e+0	9.767946e+0	1.023757e-1	1	1.023757e-1	1.000000e+0	60	9.707604e-2	1.000000e+0	1.000000e+0	1.004510e+1	9.955102e-2	1	898	5.000000e-1	1.113586e-3	unnamed	PLA2G4A
MGI Expression: Detected	5796	TS22_heart atrium	49	1.107744e-1	1.000000e+0	1.000000e+0	9.027353e+0	1.107744e-1	1	1.107744e-1	1.000000e+0	58	9.327970e-2	1.000000e+0	1.000000e+0	1.046462e+1	9.556011e-2	1	862	5.000000e-1	1.160093e-3	unnamed	PLA2G4A
MGI Expression: Detected	14882	TS22_choroid plexus	50	1.113392e-1	1.000000e+0	1.000000e+0	8.981559e+0	1.113392e-1	1	1.113392e-1	1.000000e+0	65	1.025456e-1	1.000000e+0	1.000000e+0	9.495263e+0	1.053157e-1	1	950	5.000000e-1	1.052632e-3	unnamed	PLA2G4A
MGI Expression: Detected	6324	TS22_urinary bladder	51	1.164763e-1	1.000000e+0	1.000000e+0	8.585439e+0	1.164763e-1	1	1.164763e-1	1.000000e+0	3	2.387522e-3	1.000000e+0	1.000000e+0	2.045465e+1	9.777729e-2	2	882	1.000000e+0	2.267574e-3	unnamed	PLA2G4A,PTGS2
MGI Expression: Detected	8522	TS23_thymus primordium	52	1.165455e-1	1.000000e+0	1.000000e+0	8.580336e+0	1.165455e-1	1	1.165455e-1	1.000000e+0	75	1.237388e-1	1.000000e+0	1.000000e+0	7.823504e+0	1.278200e-1	1	1153	5.000000e-1	8.673027e-4	unnamed	PLA2G4A
MGI Expression: Detected	15546	TS22_hair	53	1.175256e-1	1.000000e+0	1.000000e+0	8.508786e+0	1.175256e-1	1	1.175256e-1	1.000000e+0	67	1.057984e-1	1.000000e+0	1.000000e+0	9.195209e+0	1.087523e-1	1	981	5.000000e-1	1.019368e-3	unnamed	PLA2G4A
MGI Expression: Detected	7776	TS23_haemolymphoid system	54	1.177883e-1	1.000000e+0	1.000000e+0	8.489804e+0	1.177883e-1	1	1.177883e-1	1.000000e+0	77	1.252947e-1	1.000000e+0	1.000000e+0	7.723031e+0	1.294828e-1	1	1168	5.000000e-1	8.561644e-4	unnamed	PLA2G4A
MGI Expression: Detected	15544	TS22_haemolymphoid system	55	1.219806e-1	1.000000e+0	1.000000e+0	8.198027e+0	1.219806e-1	1	1.219806e-1	1.000000e+0	71	1.142697e-1	1.000000e+0	1.000000e+0	8.493879e+0	1.177318e-1	1	1062	5.000000e-1	9.416196e-4	unnamed	PLA2G4A
MGI Expression: Detected	6068	TS22_thymus primordium	56	1.222946e-1	1.000000e+0	1.000000e+0	8.176977e+0	1.222946e-1	1	1.222946e-1	1.000000e+0	72	1.213503e-1	1.000000e+0	1.000000e+0	7.982743e+0	1.252702e-1	1	1130	5.000000e-1	8.849558e-4	unnamed	PLA2G4A
MGI Expression: Detected	6090	TS22_oesophagus	57	1.223668e-1	1.000000e+0	1.000000e+0	8.172154e+0	1.223668e-1	1	1.223668e-1	1.000000e+0	62	1.004439e-1	1.000000e+0	1.000000e+0	9.699462e+0	1.030985e-1	1	930	5.000000e-1	1.075269e-3	unnamed	PLA2G4A
MGI Expression: Detected	15548	TS22_vibrissa follicle	58	1.227087e-1	1.000000e+0	1.000000e+0	8.149379e+0	1.227087e-1	1	1.227087e-1	1.000000e+0	68	1.077891e-1	1.000000e+0	1.000000e+0	9.020500e+0	1.108586e-1	1	1000	5.000000e-1	1.000000e-3	unnamed	PLA2G4A
MGI Expression: Detected	3556	TS19_visceral organ	59	1.227154e-1	1.000000e+0	1.000000e+0	8.148934e+0	1.227154e-1	1	1.227154e-1	1.000000e+0	59	9.697070e-2	1.000000e+0	1.000000e+0	1.005630e+1	9.944016e-2	1	897	5.000000e-1	1.114827e-3	unnamed	PTGS2
MGI Expression: Detected	15547	TS22_hair follicle	60	1.240608e-1	1.000000e+0	1.000000e+0	8.060566e+0	1.240608e-1	1	1.240608e-1	1.000000e+0	69	1.096730e-1	1.000000e+0	1.000000e+0	8.861002e+0	1.128541e-1	1	1018	5.000000e-1	9.823183e-4	unnamed	PLA2G4A
MGI Expression: Detected	7492	TS26_visceral organ	61	1.243287e-1	1.000000e+0	1.000000e+0	8.043196e+0	1.243287e-1	1	1.243287e-1	1.000000e+0	4	3.580536e-3	1.000000e+0	1.000000e+0	1.670463e+1	1.197273e-1	2	1080	1.000000e+0	1.851852e-3	unnamed	PLA2G4A,PTGS2
MGI Expression: Detected	5945	TS22_labyrinth	62	1.278308e-1	1.000000e+0	1.000000e+0	7.822840e+0	1.278308e-1	1	1.278308e-1	1.000000e+0	63	1.012849e-1	1.000000e+0	1.000000e+0	9.616738e+0	1.039854e-1	1	938	5.000000e-1	1.066098e-3	unnamed	PLA2G4A
MGI Expression: Detected	8375	TS23_vibrissa	63	1.298650e-1	1.000000e+0	1.000000e+0	7.700301e+0	1.298650e-1	1	1.298650e-1	1.000000e+0	66	1.056935e-1	1.000000e+0	1.000000e+0	9.204592e+0	1.086414e-1	1	980	5.000000e-1	1.020408e-3	unnamed	PLA2G4A
MGI Expression: Detected	6060	TS22_foregut gland	64	1.353133e-1	1.000000e+0	1.000000e+0	7.390259e+0	1.353133e-1	1	1.353133e-1	1.000000e+0	80	1.307814e-1	1.000000e+0	1.000000e+0	7.387797e+0	1.353584e-1	1	1221	5.000000e-1	8.190008e-4	unnamed	PLA2G4A
MGI Expression: Detected	6151	TS22_salivary gland	65	1.368294e-1	1.000000e+0	1.000000e+0	7.308370e+0	1.368294e-1	1	1.368294e-1	1.000000e+0	88	1.352201e-1	1.000000e+0	1.000000e+0	7.136472e+0	1.401253e-1	1	1264	5.000000e-1	7.911392e-4	unnamed	PLA2G4A
MGI Expression: Detected	7736	TS23_rest of skin	66	1.371253e-1	1.000000e+0	1.000000e+0	7.292599e+0	1.371253e-1	1	1.371253e-1	1.000000e+0	70	1.120773e-1	1.000000e+0	1.000000e+0	8.665226e+0	1.154038e-1	1	1041	5.000000e-1	9.606148e-4	unnamed	PLA2G4A
MGI Expression: Detected	14382	TS22_tooth	67	1.399558e-1	1.000000e+0	1.000000e+0	7.145113e+0	1.399558e-1	1	1.399558e-1	1.000000e+0	73	1.214542e-1	1.000000e+0	1.000000e+0	7.975685e+0	1.253811e-1	1	1131	5.000000e-1	8.841733e-4	unnamed	PLA2G4A
MGI Expression: Detected	14381	TS22_jaw	68	1.400172e-1	1.000000e+0	1.000000e+0	7.141978e+0	1.400172e-1	1	1.400172e-1	1.000000e+0	74	1.216620e-1	1.000000e+0	1.000000e+0	7.961606e+0	1.256028e-1	1	1133	5.000000e-1	8.826125e-4	unnamed	PLA2G4A
MGI Expression: Detected	6283	TS22_liver	69	1.413531e-1	1.000000e+0	1.000000e+0	7.074480e+0	1.413531e-1	1	1.413531e-1	1.000000e+0	100	1.539834e-1	1.000000e+0	1.000000e+0	6.233932e+0	1.604124e-1	1	1447	5.000000e-1	6.910850e-4	unnamed	PLA2G4A
MGI Expression: Detected	9169	TS23_drainage component	70	1.457842e-1	1.000000e+0	1.000000e+0	6.859453e+0	1.457842e-1	1	1.457842e-1	1.000000e+0	90	1.384131e-1	1.000000e+0	1.000000e+0	6.965637e+0	1.435619e-1	1	1295	5.000000e-1	7.722008e-4	unnamed	PLA2G4A
MGI Expression: Detected	14126	TS22_skin	71	1.465811e-1	1.000000e+0	1.000000e+0	6.822160e+0	1.465811e-1	1	1.465811e-1	1.000000e+0	82	1.314014e-1	1.000000e+0	1.000000e+0	7.351671e+0	1.360235e-1	1	1227	5.000000e-1	8.149959e-4	unnamed	PLA2G4A
MGI Expression: Detected	6007	TS22_olfactory epithelium	72	1.474473e-1	1.000000e+0	1.000000e+0	6.782086e+0	1.474473e-1	1	1.474473e-1	1.000000e+0	83	1.317114e-1	1.000000e+0	1.000000e+0	7.333740e+0	1.363561e-1	1	1230	5.000000e-1	8.130081e-4	unnamed	PLA2G4A
MGI Expression: Detected	7565	TS23_gland	73	1.482368e-1	1.000000e+0	1.000000e+0	6.745964e+0	1.482368e-1	1	1.482368e-1	1.000000e+0	101	1.544932e-1	1.000000e+0	1.000000e+0	6.212466e+0	1.609667e-1	1	1452	5.000000e-1	6.887052e-4	unnamed	PLA2G4A
MGI Expression: Detected	7620	TS23_respiratory system	74	1.491012e-1	1.000000e+0	1.000000e+0	6.706855e+0	1.491012e-1	1	1.491012e-1	1.000000e+0	79	1.302645e-1	1.000000e+0	1.000000e+0	7.418174e+0	1.348041e-1	1	1216	5.000000e-1	8.223684e-4	unnamed	PLA2G4A
MGI Expression: Detected	6006	TS22_nasal cavity epithelium	75	1.515001e-1	1.000000e+0	1.000000e+0	6.600654e+0	1.515001e-1	1	1.515001e-1	1.000000e+0	85	1.335698e-1	1.000000e+0	1.000000e+0	7.227965e+0	1.383515e-1	1	1248	5.000000e-1	8.012821e-4	unnamed	PLA2G4A
MGI Expression: Detected	6005	TS22_nasal cavity	76	1.531636e-1	1.000000e+0	1.000000e+0	6.528965e+0	1.531636e-1	1	1.531636e-1	1.000000e+0	86	1.348077e-1	1.000000e+0	1.000000e+0	7.159127e+0	1.396818e-1	1	1260	5.000000e-1	7.936508e-4	unnamed	PLA2G4A
MGI Expression: Detected	14294	TS22_intestine	77	1.532463e-1	1.000000e+0	1.000000e+0	6.525444e+0	1.532463e-1	1	1.532463e-1	1.000000e+0	87	1.349108e-1	1.000000e+0	1.000000e+0	7.153450e+0	1.397927e-1	1	1261	5.000000e-1	7.930214e-4	unnamed	PLA2G4A
MGI Expression: Detected	14796	TS22_genital tubercle	78	1.568692e-1	1.000000e+0	1.000000e+0	6.374736e+0	1.568692e-1	1	1.568692e-1	1.000000e+0	76	1.246725e-1	1.000000e+0	1.000000e+0	7.762909e+0	1.288177e-1	1	1162	5.000000e-1	8.605852e-4	unnamed	PLA2G4A
MGI Expression: Detected	6073	TS22_tongue	79	1.571634e-1	1.000000e+0	1.000000e+0	6.362804e+0	1.571634e-1	1	1.571634e-1	1.000000e+0	78	1.260204e-1	1.000000e+0	1.000000e+0	7.677021e+0	1.302589e-1	1	1175	5.000000e-1	8.510638e-4	unnamed	PLA2G4A
MGI Expression: Detected	5786	TS22_heart	80	1.580825e-1	1.000000e+0	1.000000e+0	6.325810e+0	1.580825e-1	1	1.580825e-1	1.000000e+0	81	1.308847e-1	1.000000e+0	1.000000e+0	7.381751e+0	1.354692e-1	1	1222	5.000000e-1	8.183306e-4	unnamed	PLA2G4A
MGI Expression: Detected	6004	TS22_nose	81	1.592731e-1	1.000000e+0	1.000000e+0	6.278524e+0	1.592731e-1	1	1.592731e-1	1.000000e+0	91	1.386189e-1	1.000000e+0	1.000000e+0	6.954896e+0	1.437836e-1	1	1297	5.000000e-1	7.710100e-4	unnamed	PLA2G4A
MGI Expression: Detected	6096	TS22_stomach	82	1.611981e-1	1.000000e+0	1.000000e+0	6.203548e+0	1.611981e-1	1	1.611981e-1	1.000000e+0	93	1.414974e-1	1.000000e+0	1.000000e+0	6.807925e+0	1.468876e-1	1	1325	5.000000e-1	7.547170e-4	unnamed	PLA2G4A
MGI Expression: Detected	6069	TS22_pharynx	83	1.630132e-1	1.000000e+0	1.000000e+0	6.134472e+0	1.630132e-1	1	1.630132e-1	1.000000e+0	84	1.333634e-1	1.000000e+0	1.000000e+0	7.239567e+0	1.381298e-1	1	1246	5.000000e-1	8.025682e-4	unnamed	PLA2G4A
MGI Expression: Detected	7525	TS23_integumental system	84	1.656409e-1	1.000000e+0	1.000000e+0	6.037155e+0	1.656409e-1	1	1.656409e-1	1.000000e+0	92	1.389275e-1	1.000000e+0	1.000000e+0	6.938846e+0	1.441162e-1	1	1300	5.000000e-1	7.692308e-4	unnamed	PLA2G4A
MGI Expression: Detected	6764	TS22_tail	85	1.685274e-1	1.000000e+0	1.000000e+0	5.933752e+0	1.685274e-1	1	1.685274e-1	1.000000e+0	95	1.430375e-1	1.000000e+0	1.000000e+0	6.731716e+0	1.485505e-1	1	1340	5.000000e-1	7.462687e-4	unnamed	PLA2G4A
MGI Expression: Detected	5785	TS22_cardiovascular system	86	1.703620e-1	1.000000e+0	1.000000e+0	5.869853e+0	1.703620e-1	1	1.703620e-1	1.000000e+0	94	1.424216e-1	1.000000e+0	1.000000e+0	6.761994e+0	1.478854e-1	1	1334	5.000000e-1	7.496252e-4	unnamed	PLA2G4A
MGI Expression: Detected	6841	TS22_skeleton	87	1.708206e-1	1.000000e+0	1.000000e+0	5.854096e+0	1.708206e-1	1	1.708206e-1	1.000000e+0	97	1.519428e-1	1.000000e+0	1.000000e+0	6.321303e+0	1.581952e-1	1	1427	5.000000e-1	7.007708e-4	unnamed	PLA2G4A
MGI Expression: Detected	7372	TS22_gland	88	1.711188e-1	1.000000e+0	1.000000e+0	5.843894e+0	1.711188e-1	1	1.711188e-1	1.000000e+0	98	1.530655e-1	1.000000e+0	1.000000e+0	6.272949e+0	1.594147e-1	1	1438	5.000000e-1	6.954103e-4	unnamed	PLA2G4A
MGI Expression: Detected	5911	TS22_inner ear	89	1.714490e-1	1.000000e+0	1.000000e+0	5.832639e+0	1.714490e-1	1	1.714490e-1	1.000000e+0	89	1.364568e-1	1.000000e+0	1.000000e+0	7.069357e+0	1.414556e-1	1	1276	5.000000e-1	7.836991e-4	unnamed	PLA2G4A
MGI Expression: Detected	8416	TS23_urinary bladder	90	1.763697e-1	1.000000e+0	1.000000e+0	5.669908e+0	1.763697e-1	1	1.763697e-1	1.000000e+0	105	1.676934e-1	1.000000e+0	1.000000e+0	5.701960e+0	1.753783e-1	1	1582	5.000000e-1	6.321113e-4	unnamed	PLA2G4A
MGI Expression: Detected	5910	TS22_ear	91	1.803802e-1	1.000000e+0	1.000000e+0	5.543845e+0	1.803802e-1	1	1.803802e-1	1.000000e+0	96	1.475472e-1	1.000000e+0	1.000000e+0	6.517702e+0	1.534283e-1	1	1384	5.000000e-1	7.225434e-4	unnamed	PLA2G4A
MGI Expression: Detected	6568	TS22_integumental system	92	1.850874e-1	1.000000e+0	1.000000e+0	5.402852e+0	1.850874e-1	1	1.850874e-1	1.000000e+0	103	1.626287e-1	1.000000e+0	1.000000e+0	5.888055e+0	1.698354e-1	1	1532	5.000000e-1	6.527415e-4	unnamed	PLA2G4A
MGI Expression: Detected	6304	TS22_metanephros	93	1.870028e-1	1.000000e+0	1.000000e+0	5.347512e+0	1.870028e-1	1	1.870028e-1	1.000000e+0	104	1.654668e-1	1.000000e+0	1.000000e+0	5.782372e+0	1.729394e-1	1	1560	5.000000e-1	6.410256e-4	unnamed	PLA2G4A
MGI Expression: Detected	6585	TS22_forelimb	94	1.870231e-1	1.000000e+0	1.000000e+0	5.346934e+0	1.870231e-1	1	1.870231e-1	1.000000e+0	99	1.532695e-1	1.000000e+0	1.000000e+0	6.264236e+0	1.596364e-1	1	1440	5.000000e-1	6.944444e-4	unnamed	PLA2G4A
MGI Expression: Detected	6673	TS22_hindlimb	95	1.911455e-1	1.000000e+0	1.000000e+0	5.231616e+0	1.911455e-1	1	1.911455e-1	1.000000e+0	102	1.587692e-1	1.000000e+0	1.000000e+0	6.037818e+0	1.656227e-1	1	1494	5.000000e-1	6.693440e-4	unnamed	PLA2G4A
MGI Expression: Detected	6221	TS22_lung	96	1.938574e-1	1.000000e+0	1.000000e+0	5.158431e+0	1.938574e-1	1	1.938574e-1	1.000000e+0	107	1.779777e-1	1.000000e+0	1.000000e+0	5.356591e+0	1.866859e-1	1	1684	5.000000e-1	5.938242e-4	unnamed	PLA2G4A
MGI Expression: Detected	6327	TS22_reproductive system	97	1.969804e-1	1.000000e+0	1.000000e+0	5.076647e+0	1.969804e-1	1	1.969804e-1	1.000000e+0	106	1.692098e-1	1.000000e+0	1.000000e+0	5.648403e+0	1.770412e-1	1	1597	5.000000e-1	6.261741e-4	unnamed	PLA2G4A
MGI Expression: Detected	6220	TS22_respiratory system	98	2.099993e-1	1.000000e+0	1.000000e+0	4.761920e+0	2.099993e-1	1	2.099993e-1	1.000000e+0	110	1.887973e-1	1.000000e+0	1.000000e+0	5.033761e+0	1.986586e-1	1	1792	5.000000e-1	5.580357e-4	unnamed	PLA2G4A
MGI Expression: Detected	6149	TS22_oral region	99	2.100630e-1	1.000000e+0	1.000000e+0	4.760476e+0	2.100630e-1	1	2.100630e-1	1.000000e+0	109	1.851987e-1	1.000000e+0	1.000000e+0	5.136959e+0	1.946677e-1	1	1756	5.000000e-1	5.694761e-4	unnamed	PLA2G4A
MGI Expression: Detected	7612	TS23_nose	100	2.118241e-1	1.000000e+0	1.000000e+0	4.720898e+0	2.118241e-1	1	2.118241e-1	1.000000e+0	111	1.912916e-1	1.000000e+0	1.000000e+0	4.964502e+0	2.014301e-1	1	1817	5.000000e-1	5.503577e-4	unnamed	PLA2G4A
MGI Expression: Detected	6584	TS22_limb	101	2.158969e-1	1.000000e+0	1.000000e+0	4.631841e+0	2.158969e-1	1	2.158969e-1	1.000000e+0	108	1.780782e-1	1.000000e+0	1.000000e+0	5.353412e+0	1.867967e-1	1	1685	5.000000e-1	5.934718e-4	unnamed	PLA2G4A
MGI Expression: Detected	6059	TS22_foregut	102	2.181768e-1	1.000000e+0	1.000000e+0	4.583440e+0	2.181768e-1	1	2.181768e-1	1.000000e+0	112	1.966662e-1	1.000000e+0	1.000000e+0	4.821219e+0	2.074164e-1	1	1871	5.000000e-1	5.344735e-4	unnamed	PLA2G4A
MGI Expression: Detected	8259	TS23_male reproductive system	103	2.246603e-1	1.000000e+0	1.000000e+0	4.451166e+0	2.246603e-1	1	2.246603e-1	1.000000e+0	115	2.139608e-1	1.000000e+0	1.000000e+0	4.408847e+0	2.268167e-1	1	2046	5.000000e-1	4.887586e-4	unnamed	PLA2G4A
MGI Expression: Detected	7821	TS23_gut	104	2.282340e-1	1.000000e+0	1.000000e+0	4.381469e+0	2.282340e-1	1	2.282340e-1	1.000000e+0	113	2.071643e-1	1.000000e+0	1.000000e+0	4.562721e+0	2.191675e-1	1	1977	5.000000e-1	5.058169e-4	unnamed	PLA2G4A
MGI Expression: Detected	7825	TS23_oral region	105	2.306091e-1	1.000000e+0	1.000000e+0	4.336342e+0	2.306091e-1	1	2.306091e-1	1.000000e+0	114	2.102214e-1	1.000000e+0	1.000000e+0	4.492281e+0	2.226041e-1	1	2008	5.000000e-1	4.980080e-4	unnamed	PLA2G4A
MGI Expression: Detected	6301	TS22_renal-urinary system	106	2.309447e-1	1.000000e+0	1.000000e+0	4.330041e+0	2.309447e-1	1	2.309447e-1	1.000000e+0	11	1.146284e-2	1.000000e+0	1.000000e+0	9.337992e+0	2.141788e-1	2	1932	1.000000e+0	1.035197e-3	unnamed	PLA2G4A,PTGS2
MGI Expression: Detected	6960	TS28_kidney	107	2.525264e-1	1.000000e+0	1.000000e+0	3.959982e+0	2.525264e-1	1	2.525264e-1	1.000000e+0	120	2.607175e-1	1.000000e+0	1.000000e+0	3.566825e+0	2.803614e-1	1	2529	5.000000e-1	3.954132e-4	unnamed	PTGS2
MGI Expression: Detected	1016	TS15_embryo	108	2.533670e-1	1.000000e+0	1.000000e+0	3.946844e+0	2.533670e-1	1	2.533670e-1	1.000000e+0	116	2.237590e-1	1.000000e+0	1.000000e+0	4.203402e+0	2.379026e-1	1	2146	5.000000e-1	4.659832e-4	unnamed	PTGS2
MGI Expression: Detected	1015	Theiler_stage_15	109	2.573675e-1	1.000000e+0	1.000000e+0	3.885495e+0	2.573675e-1	1	2.573675e-1	1.000000e+0	117	2.277584e-1	1.000000e+0	1.000000e+0	4.124600e+0	2.424478e-1	1	2187	5.000000e-1	4.572474e-4	unnamed	PTGS2
MGI Expression: Detected	6959	TS28_renal-urinary system	110	2.619747e-1	1.000000e+0	1.000000e+0	3.817163e+0	2.619747e-1	1	2.619747e-1	1.000000e+0	122	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	PTGS2
MGI Expression: Detected	6020	TS22_gut	111	2.671263e-1	1.000000e+0	1.000000e+0	3.743547e+0	2.671263e-1	1	2.671263e-1	1.000000e+0	119	2.480816e-1	1.000000e+0	1.000000e+0	3.763246e+0	2.657281e-1	1	2397	5.000000e-1	4.171882e-4	unnamed	PLA2G4A
MGI Expression: Detected	5909	TS22_sensory organ	112	2.701558e-1	1.000000e+0	1.000000e+0	3.701567e+0	2.701558e-1	1	2.701558e-1	1.000000e+0	118	2.346599e-1	1.000000e+0	1.000000e+0	3.994907e+0	2.503187e-1	1	2258	5.000000e-1	4.428698e-4	unnamed	PLA2G4A
MGI Expression: Detected	7648	TS23_reproductive system	113	2.726454e-1	1.000000e+0	1.000000e+0	3.667768e+0	2.726454e-1	1	2.726454e-1	1.000000e+0	121	2.658558e-1	1.000000e+0	1.000000e+0	3.492257e+0	2.863478e-1	1	2583	5.000000e-1	3.871467e-4	unnamed	PLA2G4A
MGI Expression: Detected	7448	TS26_organ system	114	2.750733e-1	1.000000e+0	1.000000e+0	3.635395e+0	2.750733e-1	1	2.750733e-1	1.000000e+0	15	2.001863e-2	1.000000e+0	1.000000e+0	7.066588e+0	2.830220e-1	2	2553	1.000000e+0	7.833921e-4	unnamed	PLA2G4A,PTGS2
MGI Expression: Detected	6019	TS22_alimentary system	115	2.958102e-1	1.000000e+0	1.000000e+0	3.380547e+0	2.958102e-1	1	2.958102e-1	1.000000e+0	124	2.795646e-1	1.000000e+0	1.000000e+0	3.306635e+0	3.024223e-1	1	2728	5.000000e-1	3.665689e-4	unnamed	PLA2G4A
MGI Expression: Detected	8013	TS23_metanephros	116	2.993178e-1	1.000000e+0	1.000000e+0	3.340931e+0	2.993178e-1	1	2.993178e-1	1.000000e+0	126	2.899716e-1	1.000000e+0	1.000000e+0	3.177351e+0	3.147276e-1	1	2839	5.000000e-1	3.522367e-4	unnamed	PLA2G4A
MGI Expression: Detected	6934	TS26_embryo	117	3.006505e-1	1.000000e+0	1.000000e+0	3.326122e+0	3.006505e-1	1	3.006505e-1	1.000000e+0	20	2.507098e-2	1.000000e+0	1.000000e+0	6.314666e+0	3.167230e-1	2	2857	1.000000e+0	7.000350e-4	unnamed	PLA2G4A,PTGS2
MGI Expression: Detected	6933	Theiler_stage_26	118	3.012560e-1	1.000000e+0	1.000000e+0	3.319436e+0	3.012560e-1	1	3.012560e-1	1.000000e+0	21	2.521161e-2	1.000000e+0	1.000000e+0	6.297033e+0	3.176099e-1	2	2865	1.000000e+0	6.980803e-4	unnamed	PLA2G4A,PTGS2
MGI Expression: Detected	3399	TS19_organ system	119	3.233706e-1	1.000000e+0	1.000000e+0	3.092427e+0	3.233706e-1	1	3.233706e-1	1.000000e+0	123	2.724900e-1	1.000000e+0	1.000000e+0	3.400113e+0	2.941079e-1	1	2653	5.000000e-1	3.769318e-4	unnamed	PTGS2
MGI Expression: Detected	7592	TS23_alimentary system	120	3.288505e-1	1.000000e+0	1.000000e+0	3.040895e+0	3.288505e-1	1	3.288505e-1	1.000000e+0	129	3.081630e-1	1.000000e+0	1.000000e+0	2.972158e+0	3.364559e-1	1	3035	5.000000e-1	3.294893e-4	unnamed	PLA2G4A
MGI Expression: Detected	4000	TS20_embryo	121	3.348154e-1	1.000000e+0	1.000000e+0	2.986720e+0	3.348154e-1	1	3.348154e-1	1.000000e+0	125	2.872599e-1	1.000000e+0	1.000000e+0	3.210142e+0	3.115127e-1	1	2810	5.000000e-1	3.558719e-4	unnamed	PTGS2
MGI Expression: Detected	3999	Theiler_stage_20	122	3.376967e-1	1.000000e+0	1.000000e+0	2.961237e+0	3.376967e-1	1	3.376967e-1	1.000000e+0	127	2.900650e-1	1.000000e+0	1.000000e+0	3.176232e+0	3.148384e-1	1	2840	5.000000e-1	3.521127e-4	unnamed	PTGS2
MGI Expression: Detected	6018	TS22_visceral organ	123	3.446359e-1	1.000000e+0	1.000000e+0	2.901613e+0	3.446359e-1	1	3.446359e-1	1.000000e+0	32	3.338943e-2	1.000000e+0	1.000000e+0	5.471944e+0	3.655008e-1	2	3297	1.000000e+0	6.066121e-4	unnamed	PLA2G4A,PTGS2
MGI Expression: Detected	6365	TS22_brain	124	3.486991e-1	1.000000e+0	1.000000e+0	2.867802e+0	3.486991e-1	1	3.486991e-1	1.000000e+0	128	2.970534e-1	1.000000e+0	1.000000e+0	3.094511e+0	3.231528e-1	1	2915	5.000000e-1	3.430532e-4	unnamed	PLA2G4A
MGI Expression: Detected	7644	TS23_renal-urinary system	125	3.497890e-1	1.000000e+0	1.000000e+0	2.858867e+0	3.497890e-1	1	3.497890e-1	1.000000e+0	136	3.379875e-1	1.000000e+0	1.000000e+0	2.683076e+0	3.727066e-1	1	3362	5.000000e-1	2.974420e-4	unnamed	PLA2G4A
MGI Expression: Detected	2023	TS17_embryo	126	3.504112e-1	1.000000e+0	1.000000e+0	2.853790e+0	3.504112e-1	1	3.504112e-1	1.000000e+0	134	3.281190e-1	1.000000e+0	1.000000e+0	2.772979e+0	3.606230e-1	1	3253	5.000000e-1	3.074085e-4	unnamed	PTGS2
MGI Expression: Detected	2022	Theiler_stage_17	127	3.517739e-1	1.000000e+0	1.000000e+0	2.842735e+0	3.517739e-1	1	3.517739e-1	1.000000e+0	135	3.303888e-1	1.000000e+0	1.000000e+0	2.751830e+0	3.633945e-1	1	3278	5.000000e-1	3.050641e-4	unnamed	PTGS2
MGI Expression: Detected	6351	TS22_central nervous system	128	3.611614e-1	1.000000e+0	1.000000e+0	2.768845e+0	3.611614e-1	1	3.611614e-1	1.000000e+0	24	2.887390e-2	1.000000e+0	1.000000e+0	5.884214e+0	3.398925e-1	2	3066	1.000000e+0	6.523157e-4	unnamed	PLA2G4A,PTGS2
MGI Expression: Detected	6350	TS22_nervous system	129	3.685477e-1	1.000000e+0	1.000000e+0	2.713353e+0	3.685477e-1	1	3.685477e-1	1.000000e+0	29	3.088577e-2	1.000000e+0	1.000000e+0	5.689372e+0	3.515326e-1	2	3171	1.000000e+0	6.307159e-4	unnamed	PLA2G4A,PTGS2
MGI Expression: Detected	3341	TS19_embryo	130	3.699199e-1	1.000000e+0	1.000000e+0	2.703288e+0	3.699199e-1	1	3.699199e-1	1.000000e+0	132	3.257542e-1	1.000000e+0	1.000000e+0	2.795321e+0	3.577407e-1	1	3227	5.000000e-1	3.098853e-4	unnamed	PTGS2
MGI Expression: Detected	3340	Theiler_stage_19	131	3.711587e-1	1.000000e+0	1.000000e+0	2.694265e+0	3.711587e-1	1	3.711587e-1	1.000000e+0	133	3.271190e-1	1.000000e+0	1.000000e+0	2.782387e+0	3.594036e-1	1	3242	5.000000e-1	3.084516e-4	unnamed	PTGS2
MGI Expression: Detected	7485	TS23_sensory organ	132	3.817293e-1	1.000000e+0	1.000000e+0	2.619657e+0	3.817293e-1	1	3.817293e-1	1.000000e+0	137	3.416806e-1	1.000000e+0	1.000000e+0	2.650749e+0	3.772518e-1	1	3403	5.000000e-1	2.938584e-4	unnamed	PLA2G4A
MGI Expression: Detected	8824	TS23_hindbrain	133	3.841897e-1	1.000000e+0	1.000000e+0	2.602881e+0	3.841897e-1	1	3.841897e-1	1.000000e+0	130	3.099139e-1	1.000000e+0	1.000000e+0	2.953667e+0	3.385622e-1	1	3054	5.000000e-1	3.274394e-4	unnamed	PLA2G4A
MGI Expression: Detected	9955	TS23_telencephalon	134	3.981348e-1	1.000000e+0	1.000000e+0	2.511712e+0	3.981348e-1	1	3.981348e-1	1.000000e+0	131	3.219255e-1	1.000000e+0	1.000000e+0	2.832182e+0	3.530846e-1	1	3185	5.000000e-1	3.139717e-4	unnamed	PLA2G4A
MGI Expression: Detected	6945	TS28_visceral organ	135	4.216843e-1	1.000000e+0	1.000000e+0	2.371443e+0	4.216843e-1	1	4.216843e-1	1.000000e+0	140	4.474230e-1	1.000000e+0	1.000000e+0	1.948272e+0	5.132753e-1	1	4630	5.000000e-1	2.159827e-4	unnamed	PTGS2
MGI Expression: Detected	8820	TS23_forebrain	136	4.358269e-1	1.000000e+0	1.000000e+0	2.294489e+0	4.358269e-1	1	4.358269e-1	1.000000e+0	138	3.510021e-1	1.000000e+0	1.000000e+0	2.572141e+0	3.887811e-1	1	3507	5.000000e-1	2.851440e-4	unnamed	PLA2G4A
MGI Expression: Detected	5784	TS22_organ system	137	4.769468e-1	1.000000e+0	1.000000e+0	2.096670e+0	4.769468e-1	1	4.769468e-1	1.000000e+0	43	6.517131e-2	1.000000e+0	1.000000e+0	3.916848e+0	5.106147e-1	2	4606	1.000000e+0	4.342162e-4	unnamed	PLA2G4A,PTGS2
MGI Expression: Detected	7005	TS28_brain	138	4.776274e-1	1.000000e+0	1.000000e+0	2.093682e+0	4.776274e-1	1	4.776274e-1	1.000000e+0	141	4.562057e-1	1.000000e+0	1.000000e+0	1.904264e+0	5.251372e-1	1	4737	5.000000e-1	2.111041e-4	unnamed	PTGS2
MGI Expression: Detected	7003	TS28_central nervous system	139	4.961740e-1	1.000000e+0	1.000000e+0	2.015422e+0	4.961740e-1	1	4.961740e-1	1.000000e+0	144	4.783750e-1	1.000000e+0	1.000000e+0	1.800140e+0	5.555124e-1	1	5011	5.000000e-1	1.995610e-4	unnamed	PTGS2
MGI Expression: Detected	7001	TS28_nervous system	140	4.974351e-1	1.000000e+0	1.000000e+0	2.010313e+0	4.974351e-1	1	4.974351e-1	1.000000e+0	145	4.798952e-1	1.000000e+0	1.000000e+0	1.793340e+0	5.576188e-1	1	5030	5.000000e-1	1.988072e-4	unnamed	PTGS2
MGI Expression: Detected	5741	TS22_embryo	141	5.012384e-1	1.000000e+0	1.000000e+0	1.995059e+0	5.012384e-1	1	5.012384e-1	1.000000e+0	51	7.591070e-2	1.000000e+0	1.000000e+0	3.629250e+0	5.510781e-1	2	4971	1.000000e+0	4.023335e-4	unnamed	PLA2G4A,PTGS2
MGI Expression: Detected	7901	TS23_brain	142	5.025340e-1	1.000000e+0	1.000000e+0	1.989915e+0	5.025340e-1	1	5.025340e-1	1.000000e+0	139	4.293954e-1	1.000000e+0	1.000000e+0	2.044074e+0	4.892190e-1	1	4413	5.000000e-1	2.266032e-4	unnamed	PLA2G4A
MGI Expression: Detected	5740	Theiler_stage_22	143	5.025708e-1	1.000000e+0	1.000000e+0	1.989769e+0	5.025708e-1	1	5.025708e-1	1.000000e+0	52	7.664554e-2	1.000000e+0	1.000000e+0	3.611812e+0	5.537387e-1	2	4995	1.000000e+0	4.004004e-4	unnamed	PLA2G4A,PTGS2
MGI Expression: Detected	7489	TS23_visceral organ	144	5.150818e-1	1.000000e+0	1.000000e+0	1.941439e+0	5.150818e-1	1	5.150818e-1	1.000000e+0	146	5.216365e-1	1.000000e+0	1.000000e+0	1.621517e+0	6.167064e-1	1	5563	5.000000e-1	1.797591e-4	unnamed	PLA2G4A
MGI Expression: Detected	7608	TS23_central nervous system	145	5.265571e-1	1.000000e+0	1.000000e+0	1.899129e+0	5.265571e-1	1	5.265571e-1	1.000000e+0	142	4.610183e-1	1.000000e+0	1.000000e+0	1.880838e+0	5.316778e-1	1	4796	5.000000e-1	2.085071e-4	unnamed	PLA2G4A
MGI Expression: Detected	7501	TS23_nervous system	146	5.331601e-1	1.000000e+0	1.000000e+0	1.875609e+0	5.331601e-1	1	5.331601e-1	1.000000e+0	143	4.686418e-1	1.000000e+0	1.000000e+0	1.844683e+0	5.420986e-1	1	4890	5.000000e-1	2.044990e-4	unnamed	PLA2G4A
MGI Expression: Detected	6944	TS28_organ system	147	6.191523e-1	1.000000e+0	1.000000e+0	1.615112e+0	6.191523e-1	1	6.191523e-1	1.000000e+0	147	6.326325e-1	1.000000e+0	1.000000e+0	1.269420e+0	7.877612e-1	1	7106	5.000000e-1	1.407261e-4	unnamed	PTGS2
MGI Expression: Detected	6937	TS28_postnatal mouse	148	6.225233e-1	1.000000e+0	1.000000e+0	1.606366e+0	6.225233e-1	1	6.225233e-1	1.000000e+0	148	6.373878e-1	1.000000e+0	1.000000e+0	1.256862e+0	7.956322e-1	1	7177	5.000000e-1	1.393340e-4	unnamed	PTGS2
MGI Expression: Detected	7445	TS23_organ system	149	6.921258e-1	1.000000e+0	1.000000e+0	1.444824e+0	6.921258e-1	1	6.921258e-1	1.000000e+0	149	6.938167e-1	1.000000e+0	1.000000e+0	1.119447e+0	8.932986e-1	1	8058	5.000000e-1	1.241003e-4	unnamed	PLA2G4A
MGI Expression: Detected	6925	TS23_embryo	150	7.220129e-1	1.000000e+0	1.000000e+0	1.385017e+0	7.220129e-1	1	7.220129e-1	1.000000e+0	150	7.337668e-1	1.000000e+0	1.000000e+0	1.033039e+0	9.680173e-1	1	8732	5.000000e-1	1.145213e-4	unnamed	PLA2G4A
MGI Expression: Detected	6924	Theiler_stage_23	151	7.220179e-1	1.000000e+0	1.000000e+0	1.385007e+0	7.220179e-1	1	7.220179e-1	1.000000e+0	151	7.339383e-1	1.000000e+0	1.000000e+0	1.032685e+0	9.683499e-1	1	8735	5.000000e-1	1.144820e-4	unnamed	PLA2G4A
MSigDB Perturbation	BIERIE_INFLAMMATORY_RESPONSE_TGFB1	Inflammatory genes down-regulated in mammary carcinoma cells after stimulation with TGFB1 [GeneID=7040] for 1 hr.	1	4.428331e-4	1.000000e+0	1.000000e+0	2.258187e+3	4.428331e-4	1	4.428331e-4	1.000000e+0	10	5.542315e-4	1.000000e+0	1.864435e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	PTGS2
MSigDB Perturbation	LY_AGING_MIDDLE_DN	Genes down-regulated in fibroblasts from middle-age individuals, compared to those from the young donors.	2	6.943343e-4	1.000000e+0	1.000000e+0	1.440228e+3	6.943343e-4	1	6.943343e-4	1.000000e+0	23	1.773000e-3	1.000000e+0	2.593205e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	PTGS2
MSigDB Perturbation	KUWANO_RNA_STABILIZED_BY_NO	Transcripts stabilized by NO [PubChemID=145068] identified as up-regulated by NO [PubChem=145068] in the presence of actinomycin D [PubChemiD=2019] in IMR-90 and NIH 3T3 cells (fibroblast).	3	7.233745e-4	1.000000e+0	8.111439e-1	1.382410e+3	7.233745e-4	1	7.233745e-4	1.000000e+0	13	7.758812e-4	1.000000e+0	2.007742e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	PTGS2
MSigDB Perturbation	SHIN_B_CELL_LYMPHOMA_CLUSTER_6	Cluster 6 of genes distinguishing among different B lymphocyte neoplasms.	4	9.284113e-4	1.000000e+0	7.807939e-1	1.077109e+3	9.284113e-4	1	9.284113e-4	1.000000e+0	19	1.219107e-3	1.000000e+0	2.158461e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	PTGS2
MSigDB Perturbation	AGARWAL_AKT_PATHWAY_TARGETS	Angiogenic and metastatic genes changed in RKO cells (colorectal cancer) upon perturbation of key components of AKT pathway.	5	1.045517e-3	1.000000e+0	7.034238e-1	9.564650e+2	1.045517e-3	1	1.045517e-3	1.000000e+0	17	1.108309e-3	1.000000e+0	2.193148e-1	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	PTGS2
MSigDB Perturbation	ROETH_TERT_TARGETS_UP	Genes up-regulated in T lymphocytes overexpressing TERT [GeneID=7015] off a retrovirus vector.	6	1.393876e-3	1.000000e+0	7.814998e-1	7.174239e+2	1.393876e-3	1	1.393876e-3	1.000000e+0	20	1.551461e-3	1.000000e+0	2.609557e-1	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	PLA2G4A
MSigDB Perturbation	LEE_LIVER_CANCER_HEPATOBLAST	Fig.5, Supplementary Fig.2 Genes overexpressed in human hepatocellular carcinoma with hepatoblast property	7	1.396725e-3	1.000000e+0	6.712261e-1	7.159607e+2	1.396725e-3	1	1.396725e-3	1.000000e+0	23	1.773000e-3	1.000000e+0	2.593205e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	PTGS2
MSigDB Perturbation	MATTHEWS_AP1_TARGETS	Known targets of AP1 that were down-regulated by overexpression of TAM67, a dominant-negative form of JUN [GeneID=3725].	8	1.560668e-3	1.000000e+0	6.562609e-1	6.407513e+2	1.560668e-3	1	1.560668e-3	1.000000e+0	25	1.883760e-3	1.000000e+0	2.534787e-1	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	PTGS2
MSigDB Perturbation	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS	NF-kB-driven pro-inflammatory genes that are  negatively regulated by glucocorticoids.	9	1.794483e-3	1.000000e+0	6.707379e-1	5.572635e+2	1.794483e-3	1	1.794483e-3	1.000000e+0	32	2.658910e-3	1.000000e+0	2.795179e-1	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	PTGS2
MSigDB Perturbation	DAZARD_UV_RESPONSE_CLUSTER_G28	Cluster G28: genes differentially up-regulated in NHEK (normal keratinocyte) compared to SCC12B2 cells (squamous cell carcinoma) by UV-B radiation.	10	1.853124e-3	1.000000e+0	6.233909e-1	5.396293e+2	1.853124e-3	1	1.853124e-3	1.000000e+0	32	2.658910e-3	1.000000e+0	2.795179e-1	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	PTGS2
MSigDB Perturbation	GALIE_TUMOR_ANGIOGENESIS	Angiogenic genes up-regulated in A17 carcinomas (high vascularization) compared to the syngeneic BB1 and spontaneous tumors (little vascularization).	11	1.883884e-3	1.000000e+0	5.761260e-1	5.308181e+2	1.883884e-3	1	1.883884e-3	1.000000e+0	15	8.866967e-4	1.000000e+0	1.988565e-1	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	PTGS2
MSigDB Perturbation	ABE_VEGFA_TARGETS_2HR	Genes up-regulated in HUVEC cells (endothelium) at 2 h after VEGFA [GeneID=7422] stimulation.	12	1.903207e-3	1.000000e+0	5.335324e-1	5.254288e+2	1.903207e-3	1	1.903207e-3	1.000000e+0	47	3.655089e-3	1.000000e+0	2.616111e-1	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	PTGS2
MSigDB Perturbation	ABE_VEGFA_TARGETS	Genes most profoundly induced in HUVEC cells (endothelium) by VEGFA [GeneID=7422].	13	1.986281e-3	1.000000e+0	5.139884e-1	5.034534e+2	1.986281e-3	1	1.986281e-3	1.000000e+0	27	2.105263e-3	1.000000e+0	2.623002e-1	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	PTGS2
MSigDB Perturbation	MATZUK_IMPLANTATION_AND_UTERINE	Genes important for implantation and uterine, based on mouse models with female fertility defects.	14	2.137160e-3	1.000000e+0	5.135290e-1	4.679108e+2	2.137160e-3	1	2.137160e-3	1.000000e+0	30	2.437470e-3	1.000000e+0	2.733216e-1	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	PTGS2
MSigDB Perturbation	SESTO_RESPONSE_TO_UV_C3	Cluster 3: genes changed in primary keratinocytes by UVB irradiation.	15	2.198428e-3	1.000000e+0	4.930341e-1	4.548705e+2	2.198428e-3	1	2.198428e-3	1.000000e+0	28	2.216004e-3	1.000000e+0	2.662371e-1	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	PTGS2
MSigDB Perturbation	LY_AGING_PREMATURE_DN	Genes down-regulated in fibroblasts from patients with Hutchinson-Gilford progeria (premature aging), compared to those from normal young individuals.	16	2.216999e-3	1.000000e+0	4.661240e-1	4.510601e+2	2.216999e-3	1	2.216999e-3	1.000000e+0	43	3.433759e-3	1.000000e+0	2.686318e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	PTGS2
MSigDB Perturbation	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	Genes from the magenta module which are up-regulated in HAEC cells (primary aortic endothelium) after exposure to the oxidized 1-palmitoyl-2-arachidonyl-sn-3-glycerophosphorylcholine (oxPAPC).	17	2.324377e-3	1.000000e+0	4.599532e-1	4.302229e+2	2.324377e-3	1	2.324377e-3	1.000000e+0	35	2.880326e-3	1.000000e+0	2.768405e-1	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	PTGS2
MSigDB Perturbation	WATANABE_COLON_CANCER_MSI_VS_MSS_UP	Up-regulated genes discriminating between MSI (microsatellite instability) and MSS (microsatellite stability) colon cancers.	18	2.634232e-3	1.000000e+0	4.923087e-1	3.796173e+2	2.634232e-3	1	2.634232e-3	1.000000e+0	38	3.101718e-3	1.000000e+0	2.745837e-1	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	PLA2G4A
MSigDB Perturbation	MATZUK_OVULATION	Genes important for ovulation, based on mouse models with female fertility defects.	19	2.741669e-3	1.000000e+0	4.854197e-1	3.647413e+2	2.741669e-3	1	2.741669e-3	1.000000e+0	20	1.551461e-3	1.000000e+0	2.609557e-1	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	PTGS2
MSigDB Perturbation	TIAN_TNF_SIGNALING_VIA_NFKB	Genes modulated in HeLa cells (cervical carcinoma) by TNF [GeneID=7124] via NFKB pathway.	20	2.832930e-3	1.000000e+0	4.764988e-1	3.529914e+2	2.832930e-3	1	2.832930e-3	1.000000e+0	38	3.101718e-3	1.000000e+0	2.745837e-1	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	PTGS2
MSigDB Perturbation	FERRARI_RESPONSE_TO_FENRETINIDE_UP	Genes up-regulated in HUVEC cells (umbilical vein endothelium) by fenretinide [PubChem=1744].	21	3.200252e-3	1.000000e+0	5.126499e-1	3.124754e+2	3.200252e-3	1	3.200252e-3	1.000000e+0	29	2.326740e-3	1.000000e+0	2.699018e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	PTGS2
MSigDB Perturbation	GROSS_ELK3_TARGETS_DN	Genes down-regulated in SEND cells (skin endothelium) at normal oxygen (normoxia) conditions after knockdown of ELK3 [GeneID=2004] by RNAi.	22	3.221125e-3	1.000000e+0	4.925393e-1	3.104505e+2	3.221125e-3	1	3.221125e-3	1.000000e+0	45	3.544427e-3	1.000000e+0	2.649656e-1	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	PTGS2
MSigDB Perturbation	ABE_VEGFA_TARGETS_30MIN	Genes up-regulated in HUVEC cells (endothelium) at 30 min after VEGFA [GeneID=7422] stimulation.	23	3.393733e-3	1.000000e+0	4.963703e-1	2.946608e+2	3.393733e-3	1	3.393733e-3	1.000000e+0	41	3.212404e-3	1.000000e+0	2.635738e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	PTGS2
MSigDB Perturbation	ZHOU_TNF_SIGNALING_30MIN	Genes up-regulated in HeLa cells (cervical carcinoma) at 30 min after stimulation with TNF [GeneID=7124].	24	3.400741e-3	1.000000e+0	4.766705e-1	2.940536e+2	3.400741e-3	1	3.400741e-3	1.000000e+0	60	5.867038e-3	1.000000e+0	3.289453e-1	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	PTGS2
MSigDB Perturbation	CHIN_BREAST_CANCER_COPY_NUMBER_UP	Genes from common regions of gains observed in more than 15% of 148 primary breast cancer tumors.	25	3.555562e-3	1.000000e+0	4.784364e-1	2.812495e+2	3.555562e-3	1	3.555562e-3	1.000000e+0	36	2.991025e-3	1.000000e+0	2.794947e-1	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	PTGS2
MSigDB Perturbation	LIANG_SILENCED_BY_METHYLATION_2	Genes up-regulated in T24 cells (bladder carcinoma) after treatment with decitabine (5-aza-2'-deoxycytidine) [PubChem=451668].	26	3.832561e-3	1.000000e+0	4.958744e-1	2.609221e+2	3.832561e-3	1	3.832561e-3	1.000000e+0	65	6.309133e-3	1.000000e+0	3.265219e-1	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	PTGS2
MSigDB Perturbation	VALK_AML_CLUSTER_2	Top 40 genes from cluster 2 of acute myeloid leukemia (AML) expression profile; 71% of the samples are FAB M4 or M5 subtypes, and 82% bear internal tundem duplications in FLT3 [GeneID=2322].	27	4.191708e-3	1.000000e+0	5.222558e-1	2.385662e+2	4.191708e-3	1	4.191708e-3	1.000000e+0	38	3.101718e-3	1.000000e+0	2.745837e-1	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	PLA2G4A
MSigDB Perturbation	ZHU_CMV_8_HR_UP	Up-regulated at 8 h following infection of primary human foreskin fibroblasts with CMV	28	4.309896e-3	1.000000e+0	5.178032e-1	2.320242e+2	4.309896e-3	1	4.309896e-3	1.000000e+0	2	6.931735e-6	2.331836e-2	1.165918e-2	3.758542e+2	5.321213e-3	2	48	1.000000e+0	4.166667e-2	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	Genes with high levels of histone H3 monomethylation mark at K27 (H3K27me1) in SW48 cells (colon cancer) by ChIP-chip assay on a 12K CpG array (CpG promoters only, HCP=high-CpG-density promoters).	29	4.344359e-3	1.000000e+0	5.039456e-1	2.301836e+2	4.344359e-3	1	4.344359e-3	1.000000e+0	34	2.769621e-3	1.000000e+0	2.740296e-1	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	PLA2G4A
MSigDB Perturbation	SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A	Genes basally silent, with hypermethylated promoters, up-regulated by the combination of TSA and decitabine [PubChem=5562;451668] in RKO cells (colorectal cancer).	30	4.362267e-3	1.000000e+0	4.891555e-1	2.292386e+2	4.362267e-3	1	4.362267e-3	1.000000e+0	31	2.548193e-3	1.000000e+0	2.765200e-1	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	PTGS2
MSigDB Perturbation	PLASARI_TGFB1_TARGETS_1HR_UP	Genes up-regulated in MEF cells (embryonic fibroblast) upon stimulation with TGFB1 [GeneID=7040] for 1 h.	31	4.539080e-3	1.000000e+0	4.925634e-1	2.203089e+2	4.539080e-3	1	4.539080e-3	1.000000e+0	45	3.544427e-3	1.000000e+0	2.649656e-1	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	PTGS2
MSigDB Perturbation	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	Genes down-regulated in NIH3T3 cells (fibroblasts) transfrormed by expression of constitutively active (Q63L) form of RHOA [GeneID=387] off plasmid vector; their expression did NOT reverted completely after treatment with Y27632 [PubChem=123862], an inhibitor of ROCK proteins.	32	4.627598e-3	1.000000e+0	4.864762e-1	2.160948e+2	4.627598e-3	1	4.627598e-3	1.000000e+0	43	3.433759e-3	1.000000e+0	2.686318e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	PTGS2
MSigDB Perturbation	AMIT_EGF_RESPONSE_40_HELA	Genes whose expression peaked at 40 min after stimulation of HeLa cells with EGF [GeneID=1950].	33	5.120468e-3	1.000000e+0	5.219774e-1	1.952946e+2	5.120468e-3	1	5.120468e-3	1.000000e+0	53	4.650770e-3	1.000000e+0	2.951923e-1	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	PTGS2
MSigDB Perturbation	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	Genes up-regulated in quescent CD34+ [GeneID=8842] cells isolated from peripheral blood of CML (chronic myeloblastic leukemia) patients compared to the dividing cells from normal donors.	34	5.265834e-3	1.000000e+0	5.210078e-1	1.899034e+2	5.265834e-3	1	5.265834e-3	1.000000e+0	60	5.867038e-3	1.000000e+0	3.289453e-1	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	PTGS2
MSigDB Perturbation	LY_AGING_OLD_DN	Genes down-regulated in fibroblasts from old individuals, compared to those from young donors.	35	5.480074e-3	1.000000e+0	5.267134e-1	1.824793e+2	5.480074e-3	1	5.480074e-3	1.000000e+0	67	6.419641e-3	1.000000e+0	3.223235e-1	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	PTGS2
MSigDB Perturbation	LI_PROSTATE_CANCER_EPIGENETIC	Genes affected by epigenetic aberrations in prostate cancer.	36	5.488222e-3	1.000000e+0	5.128439e-1	1.822084e+2	5.488222e-3	1	5.488222e-3	1.000000e+0	42	3.323085e-3	1.000000e+0	2.661633e-1	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	PTGS2
MSigDB Perturbation	SCHOEN_NFKB_SIGNALING	Genes down-regulated in A375 cells (melanoma) treated with KINK-1, a small molecule inhibitor of NFKB.	37	5.561698e-3	1.000000e+0	5.056636e-1	1.798012e+2	5.561698e-3	1	5.561698e-3	1.000000e+0	48	3.765745e-3	1.000000e+0	2.639160e-1	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	PTGS2
MSigDB Perturbation	CHANG_IMMORTALIZED_BY_HPV31_DN	Genes down-regulated in normal keratinocytes immortalized by infection with the high risk HPV31 (human papilloma virus) strain.	38	5.573688e-3	1.000000e+0	4.934181e-1	1.794144e+2	5.573688e-3	1	5.573688e-3	1.000000e+0	71	7.082562e-3	1.000000e+0	3.355738e-1	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	PTGS2
MSigDB Perturbation	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	Genes up-regulated in HUVEC cells (primary endothelium) after stimulation with leukotriene LTD4 [PubChem=3908] or thrombin (F2) [GeneID=2147] for 1 h.	39	5.592701e-3	1.000000e+0	4.824063e-1	1.788045e+2	5.592701e-3	1	5.592701e-3	1.000000e+0	50	4.097676e-3	1.000000e+0	2.756916e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	PTGS2
MSigDB Perturbation	SESTO_RESPONSE_TO_UV_C7	Cluster 7: genes changed in primary keratinocytes by UVB irradiation.	40	5.668145e-3	1.000000e+0	4.766910e-1	1.764246e+2	5.668145e-3	1	5.668145e-3	1.000000e+0	75	7.413939e-3	1.000000e+0	3.325399e-1	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	PLA2G4A
MSigDB Perturbation	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	Genes down-regulated in NIH3T3 cells (fibroblasts) transformed by activated KRAS [GeneID=3845] vs those reverted to normal cells upon over-expression of a dominant negative form of CDC25 [GeneID=5923].	41	5.801295e-3	1.000000e+0	4.759892e-1	1.723753e+2	5.801295e-3	1	5.801295e-3	1.000000e+0	56	5.535402e-3	1.000000e+0	3.325195e-1	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	PTGS2
MSigDB Perturbation	WOOD_EBV_EBNA1_TARGETS_DN	Genes down-regulated in the Ad/AH cells (adenocarcinoma) engineered to stably express the Epstein-Barr virus (EBV) gene EBNA1.	42	5.849281e-3	1.000000e+0	4.684996e-1	1.709612e+2	5.849281e-3	1	5.849281e-3	1.000000e+0	55	5.203711e-3	1.000000e+0	3.182779e-1	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	PTGS2
MSigDB Perturbation	ONDER_CDH1_TARGETS_3_DN	Genes down-regulated in HMLE cells (immortalized nontransformed mammary epithelial) cells after loss of function of E-cadhedrin (CDH1) [GeneID=999], which was achieved either by RNAi knockdown or by expression of a dominan-negative form of CDH1.	43	6.051385e-3	1.000000e+0	4.734153e-1	1.652514e+2	6.051385e-3	1	6.051385e-3	1.000000e+0	67	6.419641e-3	1.000000e+0	3.223235e-1	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	PTGS2
MSigDB Perturbation	TSUNODA_CISPLATIN_RESISTANCE_DN	Genes down-regulated in bladder cancer cells resistant to cisplatin [PubChem=2767] compared to the parental cells sensitive to the drug.	44	6.063529e-3	1.000000e+0	4.635844e-1	1.649205e+2	6.063529e-3	1	6.063529e-3	1.000000e+0	56	5.535402e-3	1.000000e+0	3.325195e-1	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	PTGS2
MSigDB Perturbation	BURTON_ADIPOGENESIS_PEAK_AT_2HR	Cluster 2: genes maximally expressed at 2 h time point during differentiation of 3T3-L1 fibroblasts into adipocytes (cluster 2) in response to adipogenic hormones.	45	6.378721e-3	1.000000e+0	4.768448e-1	1.567712e+2	6.378721e-3	1	6.378721e-3	1.000000e+0	56	5.535402e-3	1.000000e+0	3.325195e-1	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	PTGS2
MSigDB Perturbation	SPIRA_SMOKERS_LUNG_CANCER_UP	Up-regulated genes that distinguished smokers with and without lung cancer.	46	6.434379e-3	1.000000e+0	4.705489e-1	1.554151e+2	6.434379e-3	1	6.434379e-3	1.000000e+0	50	4.097676e-3	1.000000e+0	2.756916e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	PLA2G4A
MSigDB Perturbation	AMIT_EGF_RESPONSE_60_MCF10A	Genes whose expression peaked at 60 min after stimulation of MCF10A cells with EGF [GeneID=1950].	47	6.671589e-3	1.000000e+0	4.775154e-1	1.498893e+2	6.671589e-3	1	6.671589e-3	1.000000e+0	49	3.876395e-3	1.000000e+0	2.661264e-1	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	PTGS2
MSigDB Perturbation	JACKSON_DNMT1_TARGETS_UP	Genes up-regulated in MEF cells (embryonic fibroblast) upon Cre-lox knockout of DNMT1 [GeneID=1786].	48	6.796050e-3	1.000000e+0	4.762898e-1	1.471443e+2	6.796050e-3	1	6.796050e-3	1.000000e+0	81	8.407740e-3	1.000000e+0	3.491807e-1	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	PTGS2
MSigDB Perturbation	SMIRNOV_RESPONSE_TO_IR_2HR_DN	Genes down-regulated in B lymphocytes at 2 h after exprosure to 10 Gy dose of ionizing radiation.	49	6.847218e-3	1.000000e+0	4.700825e-1	1.460447e+2	6.847218e-3	1	6.847218e-3	1.000000e+0	63	6.088097e-3	1.000000e+0	3.250851e-1	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	PLA2G4A
MSigDB Perturbation	STOSSI_RESPONSE_TO_ESTRADIOL	Genes up-regulated by estradiol (E2) [PubChem=5757] in U2OS cells (osteosarcoma) expressing ESR1 or ESR2 [GeneID=2099;2100].	50	6.935845e-3	1.000000e+0	4.666437e-1	1.441785e+2	6.935845e-3	1	6.935845e-3	1.000000e+0	1	6.642913e-6	2.234676e-2	2.234676e-2	3.838511e+2	5.210354e-3	2	47	1.000000e+0	4.255319e-2	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	ZHU_CMV_24_HR_UP	Up-regulated at 24 h following infection of primary human foreskin fibroblasts with CMV	51	7.020604e-3	1.000000e+0	4.630845e-1	1.424379e+2	7.020604e-3	1	7.020604e-3	1.000000e+0	89	1.050413e-2	1.000000e+0	3.970325e-1	9.495263e+1	1.053157e-2	1	95	5.000000e-1	1.052632e-2	unnamed	PLA2G4A
MSigDB Perturbation	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	Genes up-regulated in T helper cells (defines as CD4+) isolated from patients with mucosis fungoides compared to those from normal control donors.	52	7.058547e-3	1.000000e+0	4.566337e-1	1.416722e+2	7.058547e-3	1	7.058547e-3	1.000000e+0	70	6.861613e-3	1.000000e+0	3.297495e-1	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	PTGS2
MSigDB Perturbation	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	Genes up-regulated in macrophages by aerolysin-related cytotoxic enterotoxin (Act) from Aeromonas hydrophila.	53	7.121378e-3	1.000000e+0	4.520060e-1	1.404223e+2	7.121378e-3	1	7.121378e-3	1.000000e+0	85	9.401043e-3	1.000000e+0	3.720601e-1	1.061235e+2	9.422981e-3	1	85	5.000000e-1	1.176471e-2	unnamed	PTGS2
MSigDB Perturbation	PETROVA_PROX1_TARGETS_DN	Genes specific to BEC (blood endothelium cells) repressed in BEC by expression of PROX1 [GeneID=5629] off adenovirus vector.	54	7.265389e-3	1.000000e+0	4.526068e-1	1.376389e+2	7.265389e-3	1	7.265389e-3	1.000000e+0	71	7.082562e-3	1.000000e+0	3.355738e-1	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	PLA2G4A
MSigDB Perturbation	BRUNO_HEMATOPOIESIS	Genes that are rapidly down-regulated as multipotential cells of the FDCP-mix hematopoiesis model undergo differentiation and loose their self-renewal and proliferation properties.	55	7.335790e-3	1.000000e+0	4.486836e-1	1.363180e+2	7.335790e-3	1	7.335790e-3	1.000000e+0	78	7.745261e-3	1.000000e+0	3.340392e-1	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	PTGS2
MSigDB Perturbation	WEINMANN_ADAPTATION_TO_HYPOXIA_DN	Genes most down-regulated in hypoxia tolerant NCI H460 cells (lung cancer).	56	7.382339e-3	1.000000e+0	4.434676e-1	1.354584e+2	7.382339e-3	1	7.382339e-3	1.000000e+0	53	4.650770e-3	1.000000e+0	2.951923e-1	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	PLA2G4A
MSigDB Perturbation	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	Genes up-regulated in RAW 264.7 cells (macrophage) 3 hr after stimulation with bacterial lipopolysaccharide (LPS).	57	7.456379e-3	1.000000e+0	4.400572e-1	1.341134e+2	7.456379e-3	1	7.456379e-3	1.000000e+0	88	9.732033e-3	1.000000e+0	3.720291e-1	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	PTGS2
MSigDB Perturbation	TRAYNOR_RETT_SYNDROM_UP	Genes up-regulated in primary fibroblasts from Rett syndrom patients who carry mutations inactivating MECP2 [GeneID=4204].	58	7.596146e-3	1.000000e+0	4.405765e-1	1.316457e+2	7.596146e-3	1	7.596146e-3	1.000000e+0	52	4.540164e-3	1.000000e+0	2.937137e-1	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	PLA2G4A
MSigDB Perturbation	LINDSTEDT_DENDRITIC_CELL_MATURATION_A	Maturation of monocyte-derived dendritic cells (DC) in response to inflammatory stimuli: genes up-regulated only at 8 hr after the stimulation (cluster A).	59	7.603920e-3	1.000000e+0	4.335523e-1	1.315111e+2	7.603920e-3	1	7.603920e-3	1.000000e+0	75	7.413939e-3	1.000000e+0	3.325399e-1	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	PLA2G4A
MSigDB Perturbation	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9	Genes co-regulated in uterus during a time course response to progesterone [PubChem=5994]: SOM cluster 9.	60	7.851859e-3	1.000000e+0	4.402276e-1	1.273584e+2	7.851859e-3	1	7.851859e-3	1.000000e+0	79	8.297342e-3	1.000000e+0	3.533197e-1	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	PLA2G4A
MSigDB Perturbation	MISSIAGLIA_REGULATED_BY_METHYLATION_UP	Genes up-regulated in PaCa44 and CFPAC1 cells (pancreatic cancer) after treatment with decitabine [PubChem=451668], a DNA hypomethylating agent similar to azacitidine [PubChem=9444].	61	8.011843e-3	1.000000e+0	4.418334e-1	1.248152e+2	8.011843e-3	1	8.011843e-3	1.000000e+0	104	1.391979e-2	1.000000e+0	4.502517e-1	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	PTGS2
MSigDB Perturbation	SANSOM_WNT_PATHWAY_REQUIRE_MYC	Wnt target genes up-regulated after Cre-lox knockout of APC [GeneID=324] in the small intestine that require functional MYC [GeneID=4609].	62	8.354193e-3	1.000000e+0	4.532823e-1	1.197004e+2	8.354193e-3	1	8.354193e-3	1.000000e+0	67	6.419641e-3	1.000000e+0	3.223235e-1	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	PTGS2
MSigDB Perturbation	BROWNE_HCMV_INFECTION_4HR_UP	Genes up-regulated in primary fibroblast cell culture point after infection with HCMV (AD169 strain) at 4 h time point that were not up-regulated at the previous time point, 2 h.	63	8.495661e-3	1.000000e+0	4.536413e-1	1.177071e+2	8.495661e-3	1	8.495661e-3	1.000000e+0	62	5.977571e-3	1.000000e+0	3.243314e-1	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	PTGS2
MSigDB Perturbation	HALMOS_CEBPA_TARGETS_UP	Genes up-regulated in H358 cells (lung cancer) by inducible expression of CEBPA [GeneID=1050] off plasmid vector.	64	8.556671e-3	1.000000e+0	4.497600e-1	1.168679e+2	8.556671e-3	1	8.556671e-3	1.000000e+0	59	5.756499e-3	1.000000e+0	3.282180e-1	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	PTGS2
MSigDB Perturbation	HARRIS_HYPOXIA	Genes known to be induced by hypoxia	65	8.557812e-3	1.000000e+0	4.428997e-1	1.168523e+2	8.557812e-3	1	8.557812e-3	1.000000e+0	82	8.959636e-3	1.000000e+0	3.675636e-1	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	PTGS2
MSigDB Perturbation	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	Genes up-regulated in quiescent vs dividing CD34+ [GeneID=8842] cells isolated from peripheral blood of normal donors.	66	8.660737e-3	1.000000e+0	4.414351e-1	1.154636e+2	8.660737e-3	1	8.660737e-3	1.000000e+0	71	7.082562e-3	1.000000e+0	3.355738e-1	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	PTGS2
MSigDB Perturbation	HOQUE_METHYLATED_IN_CANCER	Genes whose DNA was methylated both in primary tumors and across a panel of cancer cell lines.	67	9.030063e-3	1.000000e+0	4.533900e-1	1.107412e+2	9.030063e-3	1	9.030063e-3	1.000000e+0	65	6.309133e-3	1.000000e+0	3.265219e-1	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	PTGS2
MSigDB Perturbation	ZHU_CMV_ALL_UP	Up-regulated at any timepoint following infection of primary human foreskin fibroblasts with CMV	68	9.684409e-3	1.000000e+0	4.790934e-1	1.032588e+2	9.684409e-3	1	9.684409e-3	1.000000e+0	6	4.610710e-5	1.551043e-1	2.585071e-2	1.466748e+2	1.363561e-2	2	123	1.000000e+0	1.626016e-2	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	BROWNE_HCMV_INFECTION_8HR_UP	Genes up-regulated in primary fibroblast cell culture point after infection with HCMV (AD169 strain) at 8 h time point that were not up-regulated at the previous time point, 6 h.	69	9.799072e-3	1.000000e+0	4.777403e-1	1.020505e+2	9.799072e-3	1	9.799072e-3	1.000000e+0	92	1.116569e-2	1.000000e+0	4.082759e-1	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	PLA2G4A
MSigDB Perturbation	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	Genes up-regulated in MMH-RT cells (hepatocytes displaying an invasive, metastatic phenotype) during epithelial to mesenchymal transition (EMT).	70	1.014515e-2	1.000000e+0	4.875469e-1	9.856923e+1	1.014515e-2	1	1.014515e-2	1.000000e+0	77	7.634827e-3	1.000000e+0	3.335527e-1	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	PLA2G4A
MSigDB Perturbation	AMIT_SERUM_RESPONSE_60_MCF10A	Genes whose expression peaked at 60 min after stimulation of MCF10A cells with serum.	71	1.027117e-2	1.000000e+0	4.866509e-1	9.735984e+1	1.027117e-2	1	1.027117e-2	1.000000e+0	64	6.198618e-3	1.000000e+0	3.258149e-1	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	PTGS2
MSigDB Perturbation	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	Genes downregulated in MCF10A cells (breast cancer) co-cultured with cancer-associated fibroblasts (CAF).	72	1.096813e-2	1.000000e+0	5.124554e-1	9.117328e+1	1.096813e-2	1	1.096813e-2	1.000000e+0	94	1.149638e-2	1.000000e+0	4.114236e-1	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	PTGS2
MSigDB Perturbation	GHANDHI_BYSTANDER_IRRADIATION_UP	Genes significantly (FDR &lt; 10%) up-regulated in IMR-90 cells (fibroblast) in response to bystander irradiation.	73	1.105264e-2	1.000000e+0	5.093299e-1	9.047611e+1	1.105264e-2	1	1.105264e-2	1.000000e+0	3	2.040806e-5	6.865271e-2	2.288424e-2	2.200122e+2	9.090405e-3	2	82	1.000000e+0	2.439024e-2	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	Genes up-regulated between two breast carcinoma subtypes: metaplastic (MCB) and ductal (DCB).	74	1.116177e-2	1.000000e+0	5.074080e-1	8.959151e+1	1.116177e-2	1	1.116177e-2	1.000000e+0	84	9.069997e-3	1.000000e+0	3.632318e-1	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	PLA2G4A
MSigDB Perturbation	RICKMAN_HEAD_AND_NECK_CANCER_C	Cluster c: genes identifying an intrinsic group in head and neck squamous cell carcinoma (HNSCC).	75	1.131305e-2	1.000000e+0	5.074280e-1	8.839348e+1	1.131305e-2	1	1.131305e-2	1.000000e+0	101	1.314903e-2	1.000000e+0	4.379538e-1	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	PTGS2
MSigDB Perturbation	TIEN_INTESTINE_PROBIOTICS_2HR_DN	Genes down-regulated in Caco-2 cells (intestinal epithelium) after coculture with the probiotic bacteria L. casei for 2h.	76	1.138529e-2	1.000000e+0	5.039489e-1	8.783263e+1	1.138529e-2	1	1.138529e-2	1.000000e+0	87	9.621709e-3	1.000000e+0	3.720394e-1	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	PTGS2
MSigDB Perturbation	FERNANDEZ_BOUND_BY_MYC	Genes identified by ChIP within the high-affinity group of MYC [GeneID=4609] targets.	77	1.164859e-2	1.000000e+0	5.089072e-1	8.584729e+1	1.164859e-2	1	1.164859e-2	1.000000e+0	116	1.985555e-2	1.000000e+0	5.758109e-1	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	PLA2G4A
MSigDB Perturbation	BURTON_ADIPOGENESIS_9	Strongly down-regulated at 8-96 h during differentiation of 3T3-L1 cells (fibroblast) into adipocytes.	78	1.178968e-2	1.000000e+0	5.084677e-1	8.481993e+1	1.178968e-2	1	1.178968e-2	1.000000e+0	4	2.461135e-5	8.279258e-2	2.069815e-2	2.004556e+2	9.977274e-3	2	90	1.000000e+0	2.222222e-2	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	AKL_HTLV1_INFECTION_DN	Genes down-regulated in WE17/10 cells (CD4+ [GeneID=920] T lymphocytes) infected by HTLV1 (and thus displaying low CD7 [GeneID=924]) compared to the uninfected (i.e., CD7+) cells.	79	1.184945e-2	1.000000e+0	5.045766e-1	8.439210e+1	1.184945e-2	1	1.184945e-2	1.000000e+0	74	7.193027e-3	1.000000e+0	3.269911e-1	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	PTGS2
MSigDB Perturbation	DAZARD_RESPONSE_TO_UV_SCC_UP	Genes up-regulated in SCC12B2 cells (squamous cell carcinoma) by UV-B irradiation.	80	1.236768e-2	1.000000e+0	5.200609e-1	8.085592e+1	1.236768e-2	1	1.236768e-2	1.000000e+0	102	1.325916e-2	1.000000e+0	4.372923e-1	7.517083e+1	1.330303e-2	1	120	5.000000e-1	8.333333e-3	unnamed	PTGS2
MSigDB Perturbation	LAIHO_COLORECTAL_CANCER_SERRATED_UP	Genes up-regulated in serrated vs conventional colorectal carcinoma (CRC) samples.	81	1.251101e-2	1.000000e+0	5.195931e-1	7.992959e+1	1.251101e-2	1	1.251101e-2	1.000000e+0	98	1.226779e-2	1.000000e+0	4.211107e-1	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	PLA2G4A
MSigDB Perturbation	NGUYEN_NOTCH1_TARGETS_DN	Genes down-regulated in primary keratinocytes by expression of constantly active NOTCH1 [GeneID=4851].	82	1.257156e-2	1.000000e+0	5.157406e-1	7.954460e+1	1.257156e-2	1	1.257156e-2	1.000000e+0	86	9.511379e-3	1.000000e+0	3.720498e-1	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	PTGS2
MSigDB Perturbation	GHANDHI_DIRECT_IRRADIATION_UP	Genes significantly (FDR &lt; 10%) up-regulated in IMR-90 cells (fibroblast) in response to direct irradiation.	83	1.308288e-2	1.000000e+0	5.302507e-1	7.643574e+1	1.308288e-2	1	1.308288e-2	1.000000e+0	95	1.160660e-2	1.000000e+0	4.109958e-1	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	PTGS2
MSigDB Perturbation	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP	Top up-regulated genes from principal component 3 (PCA3) which captures variation among different plasma cell tumors arising from overexpression of BCL2L1 and MYC [GeneID=598;4609].	84	1.341821e-2	1.000000e+0	5.373674e-1	7.452558e+1	1.341821e-2	1	1.341821e-2	1.000000e+0	79	8.297342e-3	1.000000e+0	3.533197e-1	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	PLA2G4A
MSigDB Perturbation	RICKMAN_METASTASIS_DN	Genes down-regulated in metastatic vs non-metastatic HNSCC (head and neck squamous cell carcinoma) samples.	85	1.357986e-2	1.000000e+0	5.374429e-1	7.363844e+1	1.357986e-2	1	1.357986e-2	1.000000e+0	130	2.719538e-2	1.000000e+0	7.037328e-1	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	PTGS2
MSigDB Perturbation	LABBE_TGFB1_TARGETS_UP	Up-regulated genes in NMuMG cells (mammary epithelium) after stimulation with TGFB1 [GeneID=7040].	86	1.372604e-2	1.000000e+0	5.369116e-1	7.285423e+1	1.372604e-2	1	1.372604e-2	1.000000e+0	92	1.116569e-2	1.000000e+0	4.082759e-1	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	PTGS2
MSigDB Perturbation	BENPORATH_MYC_TARGETS_WITH_EBOX	Set 'Myc targets1': targets of c-Myc [GeneID=4609] identified by ChIP on chip in cultured cell lines, focusing on E-box-containing genes; high affinity bound subset	87	1.387680e-2	1.000000e+0	5.365696e-1	7.206271e+1	1.387680e-2	1	1.387680e-2	1.000000e+0	128	2.610163e-2	1.000000e+0	6.859835e-1	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	PLA2G4A
MSigDB Perturbation	TAVAZOIE_METASTASIS	Putative metastasis genes: up-regulated in metastatic cell lines LM2 (lung) and BoM2 (bone) relative to the parental MDA-MB-231 line (breast adenocarcinoma).	88	1.424979e-2	1.000000e+0	5.447306e-1	7.017649e+1	1.424979e-2	1	1.424979e-2	1.000000e+0	90	1.083493e-2	1.000000e+0	4.049856e-1	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	PTGS2
MSigDB Perturbation	SUNG_METASTASIS_STROMA_UP	Genes up-regulated in metastatic vs non-metastatic stromal cells originated from either bone or prostate tissues.	89	1.513193e-2	1.000000e+0	5.719529e-1	6.608542e+1	1.513193e-2	1	1.513193e-2	1.000000e+0	96	1.193722e-2	1.000000e+0	4.183001e-1	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	PTGS2
MSigDB Perturbation	WILCOX_PRESPONSE_TO_ROGESTERONE_UP	Genes up-regulated in primary cultures of ovarian surface epithlium cells exposed to progesterone [PubChem=5994] for 5 days.	90	1.526570e-2	1.000000e+0	5.705979e-1	6.550634e+1	1.526570e-2	1	1.526570e-2	1.000000e+0	107	1.634023e-2	1.000000e+0	5.137246e-1	6.094932e+1	1.640707e-2	1	148	5.000000e-1	6.756757e-3	unnamed	PLA2G4A
MSigDB Perturbation	LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP	Up-regulated genes in NMuMG cells (mammary epithelium) after stimulation with both TGFB1 and WNT3A [GeneID=7040;89780].	91	1.542180e-2	1.000000e+0	5.700982e-1	6.484326e+1	1.542180e-2	1	1.542180e-2	1.000000e+0	5	3.751617e-5	1.262044e-1	2.524088e-2	1.625315e+2	1.230530e-2	2	111	1.000000e+0	1.801802e-2	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	Genes up-regulated in A549 cells (lung cancer) expressing MIRLET7A3 [GeneID=406883] microRNA off a plasmid vector.	92	1.571449e-2	1.000000e+0	5.746037e-1	6.363552e+1	1.571449e-2	1	1.571449e-2	1.000000e+0	97	1.215761e-2	1.000000e+0	4.216309e-1	8.200455e+1	1.219445e-2	1	110	5.000000e-1	9.090909e-3	unnamed	PLA2G4A
MSigDB Perturbation	SMITH_TERT_TARGETS_UP	Genes consistently up-regulated in HMEC cells (primary mammary epithelium) upon expression of TERT [GeneID=7015] off a retroviral vector.	93	1.607734e-2	1.000000e+0	5.815502e-1	6.219934e+1	1.607734e-2	1	1.607734e-2	1.000000e+0	106	1.601034e-2	1.000000e+0	5.081017e-1	6.221034e+1	1.607450e-2	1	145	5.000000e-1	6.896552e-3	unnamed	PTGS2
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	Genes up-rgulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 6h.	94	1.609703e-2	1.000000e+0	5.760682e-1	6.212328e+1	1.609703e-2	1	1.609703e-2	1.000000e+0	82	8.959636e-3	1.000000e+0	3.675636e-1	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	PLA2G4A
MSigDB Perturbation	WINZEN_DEGRADED_VIA_KHSRP	Transcripts (mRNA molecules) rapidly degraded upon interaction with KHSRP [GeneID=8570].	95	1.616108e-2	1.000000e+0	5.722723e-1	6.187705e+1	1.616108e-2	1	1.616108e-2	1.000000e+0	90	1.083493e-2	1.000000e+0	4.049856e-1	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	PTGS2
MSigDB Perturbation	SERVITJA_LIVER_HNF1A_TARGETS_DN	Genes down-regulated in liver tissue upon knockout of HNF1A [GeneID=6927].	96	1.712039e-2	1.000000e+0	5.999270e-1	5.840990e+1	1.712039e-2	1	1.712039e-2	1.000000e+0	109	1.710974e-2	1.000000e+0	5.280474e-1	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	PLA2G4A
MSigDB Perturbation	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	Genes down-regulated in OV-90 cells (ovarian cancer) exposed to ascites which inhibited invasion.	97	1.751752e-2	1.000000e+0	6.075148e-1	5.708571e+1	1.751752e-2	1	1.751752e-2	1.000000e+0	105	1.590037e-2	1.000000e+0	5.094176e-1	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	PTGS2
MSigDB Perturbation	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN	Genes down-regulated in RWPE-1 cells (prostate cancer) upon expression of constitutively active form of STAT3 [GeneID=6774].	98	1.813081e-2	1.000000e+0	6.223678e-1	5.515473e+1	1.813081e-2	1	1.813081e-2	1.000000e+0	100	1.303889e-2	1.000000e+0	4.386283e-1	7.644492e+1	1.308131e-2	1	118	5.000000e-1	8.474576e-3	unnamed	PTGS2
MSigDB Perturbation	ONDER_CDH1_TARGETS_1_DN	Genes down-regulated in HMLE cells (mmortalized nontransformed mammary epithelial) by expression of a dominant-negative form of E-cadhedrin (CDH1) [GeneID=999].	99	1.889397e-2	1.000000e+0	6.420133e-1	5.292695e+1	1.889397e-2	1	1.889397e-2	1.000000e+0	116	1.985555e-2	1.000000e+0	5.758109e-1	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	PTGS2
MSigDB Perturbation	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	Genes up-regulated in BEC (blood endothelial cells) compared to LEC (lymphatic endothelial cells).	100	1.889531e-2	1.000000e+0	6.356382e-1	5.292319e+1	1.889531e-2	1	1.889531e-2	1.000000e+0	112	1.787895e-2	1.000000e+0	5.370070e-1	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	PLA2G4A
MSigDB Perturbation	VERHAAK_AML_WITH_NPM1_MUTATED_UP	Genes up-regulated in acute myeloid leukemia (AML) patients with mutated NPM1 [GeneID=4869].	101	1.941447e-2	1.000000e+0	6.466364e-1	5.150798e+1	1.941447e-2	1	1.941447e-2	1.000000e+0	120	2.139152e-2	1.000000e+0	5.996756e-1	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	PLA2G4A
MSigDB Perturbation	DAZARD_RESPONSE_TO_UV_NHEK_UP	Genes up-regulated in NHEK cells (normal keratinocytes) by UV-B irradiation.	102	1.991262e-2	1.000000e+0	6.567260e-1	5.021941e+1	1.991262e-2	1	1.991262e-2	1.000000e+0	131	2.730472e-2	1.000000e+0	7.011685e-1	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	PTGS2
MSigDB Perturbation	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	Angiogenic markers up-regulated in lymph endothelial cells upon infection with KSHV (Kaposi's sarcoma herpes virus).	103	2.004915e-2	1.000000e+0	6.548091e-1	4.987741e+1	2.004915e-2	1	2.004915e-2	1.000000e+0	113	1.798882e-2	1.000000e+0	5.355256e-1	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	PTGS2
MSigDB Perturbation	MCLACHLAN_DENTAL_CARIES_UP	Genes up-regulated in pulpal tissue extracted from carious teeth.	104	2.021270e-2	1.000000e+0	6.538031e-1	4.947385e+1	2.021270e-2	1	2.021270e-2	1.000000e+0	127	2.577339e-2	1.000000e+0	6.826904e-1	3.854915e+1	2.594091e-2	1	234	5.000000e-1	4.273504e-3	unnamed	PTGS2
MSigDB Perturbation	GROSS_HYPOXIA_VIA_ELK3_DN	Genes down-regulated in SEND cells (skin endothelium) at hypoxia with ELK3 [GeneID=2004] knockdown by RNAi.	105	2.042624e-2	1.000000e+0	6.544178e-1	4.895663e+1	2.042624e-2	1	2.042624e-2	1.000000e+0	109	1.710974e-2	1.000000e+0	5.280474e-1	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	PTGS2
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 8 days after transduction.	106	2.091328e-2	1.000000e+0	6.637007e-1	4.781650e+1	2.091328e-2	1	2.091328e-2	1.000000e+0	108	1.645017e-2	1.000000e+0	5.123923e-1	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	PTGS2
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 16 days after transduction.	107	2.140041e-2	1.000000e+0	6.728129e-1	4.672808e+1	2.140041e-2	1	2.140041e-2	1.000000e+0	111	1.765921e-2	1.000000e+0	5.351854e-1	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	PTGS2
MSigDB Perturbation	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	Genes up-regulated in the urogenital sinus (UGS) of day E16 females exposed to the androgen dihydrotestosterone [PubChem=10635] for 12 h.	108	2.182813e-2	1.000000e+0	6.799058e-1	4.581244e+1	2.182813e-2	1	2.182813e-2	1.000000e+0	99	1.270846e-2	1.000000e+0	4.318309e-1	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	PLA2G4A
MSigDB Perturbation	WU_CELL_MIGRATION	Genes associated with migration rate of 40 human bladder cancer cells.	109	2.190490e-2	1.000000e+0	6.760375e-1	4.565190e+1	2.190490e-2	1	2.190490e-2	1.000000e+0	118	2.007505e-2	1.000000e+0	5.723091e-1	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	PTGS2
MSigDB Perturbation	CHEBOTAEV_GR_TARGETS_DN	Genes down-regulated in follicular epithelial stem cells after transgenic expression of GR [GeneID=2908] under control of the keratin5 (K5) [GeneID=3852] promoter.	110	2.213472e-2	1.000000e+0	6.769200e-1	4.517790e+1	2.213472e-2	1	2.213472e-2	1.000000e+0	102	1.325916e-2	1.000000e+0	4.372923e-1	7.517083e+1	1.330303e-2	1	120	5.000000e-1	8.333333e-3	unnamed	PLA2G4A
MSigDB Perturbation	MCLACHLAN_DENTAL_CARIES_DN	Genes down-regulated in pulpal tissue extracted from carious teeth.	111	2.237122e-2	1.000000e+0	6.779890e-1	4.470029e+1	2.237122e-2	1	2.237122e-2	1.000000e+0	125	2.511674e-2	1.000000e+0	6.759417e-1	3.956360e+1	2.527576e-2	1	228	5.000000e-1	4.385965e-3	unnamed	PTGS2
MSigDB Perturbation	PLASARI_TGFB1_TARGETS_10HR_UP	Genes up-regulated in MEF cells (embryonic fibroblast) upon stimulation with TGFB1 [GeneID=7040] for 10 h.	112	2.300849e-2	1.000000e+0	6.910764e-1	4.346222e+1	2.300849e-2	1	2.300849e-2	1.000000e+0	121	2.150119e-2	1.000000e+0	5.977686e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PTGS2
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 3 days after transduction.	113	2.318581e-2	1.000000e+0	6.902395e-1	4.312983e+1	2.318581e-2	1	2.318581e-2	1.000000e+0	7	8.931983e-5	3.004719e-1	4.292456e-2	1.055029e+2	1.895682e-2	2	171	1.000000e+0	1.169591e-2	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	WINTER_HYPOXIA_METAGENE	Genes regulated by hypoxia, based on literature searches.	114	2.362064e-2	1.000000e+0	6.970161e-1	4.233586e+1	2.362064e-2	1	2.362064e-2	1.000000e+0	128	2.610163e-2	1.000000e+0	6.859835e-1	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	PTGS2
MSigDB Perturbation	CHEN_HOXA5_TARGETS_9HR_UP	Genes up-regulated 9 h after induction of HoxA5 [GeneID=3205] expression in a breast cancer cell line.	115	2.368734e-2	1.000000e+0	6.929062e-1	4.221664e+1	2.368734e-2	1	2.368734e-2	1.000000e+0	123	2.358369e-2	1.000000e+0	6.450043e-1	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	PTGS2
MSigDB Perturbation	RAO_BOUND_BY_SALL4_ISOFORM_A	Loci bound exclusively by SALL4 [GeneID=57167] isoform a in ES cells (embryonic stem).	116	2.491626e-2	1.000000e+0	7.225715e-1	4.013444e+1	2.491626e-2	1	2.491626e-2	1.000000e+0	119	2.084310e-2	1.000000e+0	5.892117e-1	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	PTGS2
MSigDB Perturbation	MULLIGHAN_MLL_SIGNATURE_2_UP	The 'MLL signature 2': genes up-regulated in pediatric AML (acute myeloid leukemia) with rearranged MLL [GeneID=4297] compared to the AML cases with intact MLL and NPM1 [GeneID=4869].	117	2.570756e-2	1.000000e+0	7.391473e-1	3.889906e+1	2.570756e-2	1	2.570756e-2	1.000000e+0	146	4.450337e-2	1.000000e+0	1.000000e+0	2.221798e+1	4.500859e-2	1	406	5.000000e-1	2.463054e-3	unnamed	PLA2G4A
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 10 days after transduction.	118	2.741763e-2	1.000000e+0	7.816348e-1	3.647288e+1	2.741763e-2	1	2.741763e-2	1.000000e+0	115	1.974579e-2	1.000000e+0	5.776073e-1	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	PTGS2
MSigDB Perturbation	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	Genes up-regulated in hematopoietic stem cells (HSC, CD34+ [GeneID=947]) cultured in a three-dimentional collagen gel compared to the cells grown in suspension.	119	2.860847e-2	1.000000e+0	8.087302e-1	3.495468e+1	2.860847e-2	1	2.860847e-2	1.000000e+0	125	2.511674e-2	1.000000e+0	6.759417e-1	3.956360e+1	2.527576e-2	1	228	5.000000e-1	4.385965e-3	unnamed	PTGS2
MSigDB Perturbation	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	Genes whose expression changes in Calu-6 cells (lung cancer) by TNF [GeneID=7124] were blocked completely by p38 inhibitor LY479754.	120	2.964625e-2	1.000000e+0	8.310832e-1	3.373108e+1	2.964625e-2	1	2.964625e-2	1.000000e+0	124	2.445986e-2	1.000000e+0	6.635723e-1	4.063288e+1	2.461061e-2	1	222	5.000000e-1	4.504505e-3	unnamed	PTGS2
MSigDB Perturbation	BILD_HRAS_ONCOGENIC_SIGNATURE	Genes selected in supervised analyses to discriminate cells expressing activated HRAS [GeneID=3265] oncogene from control cells expressing GFP.	121	3.045925e-2	1.000000e+0	8.468175e-1	3.283075e+1	3.045925e-2	1	3.045925e-2	1.000000e+0	131	2.730472e-2	1.000000e+0	7.011685e-1	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	PTGS2
MSigDB Perturbation	SERVITJA_ISLET_HNF1A_TARGETS_UP	Genes up-regulated in pancreatic islets upon knockout of HNF1A [GeneID=6927].	122	3.243849e-2	1.000000e+0	8.944515e-1	3.082758e+1	3.243849e-2	1	3.243849e-2	1.000000e+0	113	1.798882e-2	1.000000e+0	5.355256e-1	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	PLA2G4A
MSigDB Perturbation	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF	Class III of genes transiently induced by EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	123	3.298466e-2	1.000000e+0	9.021170e-1	3.031712e+1	3.298466e-2	1	3.298466e-2	1.000000e+0	122	2.325502e-2	1.000000e+0	6.412286e-1	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	PTGS2
MSigDB Perturbation	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	Genes down-regulated in bone relapse of breast cancer.	124	3.400917e-2	1.000000e+0	9.226359e-1	2.940383e+1	3.400917e-2	1	3.400917e-2	1.000000e+0	8	2.719416e-4	9.148115e-1	1.143514e-1	6.054027e+1	3.303586e-2	2	298	1.000000e+0	6.711409e-3	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	GRUETZMANN_PANCREATIC_CANCER_UP	Genes up-regulated in pancreatic ductal adenocarcinoma (PDAC) identified in a meta analysis across four independent studies.	125	3.406127e-2	1.000000e+0	9.166569e-1	2.935886e+1	3.406127e-2	1	3.406127e-2	1.000000e+0	139	3.962064e-2	1.000000e+0	9.588765e-1	2.498753e+1	4.001995e-2	1	361	5.000000e-1	2.770083e-3	unnamed	PTGS2
MSigDB Perturbation	DURCHDEWALD_SKIN_CARCINOGENESIS_DN	Genes down-regulated upon skin specific knockout of FOS [GeneID=2353] by cre-lox in the K5-SOS-F mice (express a constitutively active form of SOS1 [GeneID=6654] in the skin).	126	3.494641e-2	1.000000e+0	9.330137e-1	2.861524e+1	3.494641e-2	1	3.494641e-2	1.000000e+0	134	2.850706e-2	1.000000e+0	7.156548e-1	3.482819e+1	2.871238e-2	1	259	5.000000e-1	3.861004e-3	unnamed	PTGS2
MSigDB Perturbation	MULLIGHAN_NPM1_SIGNATURE_3_UP	The 'NPM1 signature 3': genes up-regulated in pediatric AML (acute myeloid leukemia) with mutated NPM1 [GeneID=4869] compared to the AML cases with intact NPM1 and MLL [GeneID=4297].	127	3.521189e-2	1.000000e+0	9.326992e-1	2.839949e+1	3.521189e-2	1	3.521189e-2	1.000000e+0	138	3.875130e-2	1.000000e+0	9.446331e-1	2.555382e+1	3.913309e-2	1	353	5.000000e-1	2.832861e-3	unnamed	PLA2G4A
MSigDB Perturbation	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	Genes up-regulated in nsopharyngeal carcinoma relative to the normal tissue.	128	3.539566e-2	1.000000e+0	9.302422e-1	2.825205e+1	3.539566e-2	1	3.539566e-2	1.000000e+0	135	3.101865e-2	1.000000e+0	7.729388e-1	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	PTGS2
MSigDB Perturbation	CHANDRAN_METASTASIS_DN	Genes down-regulated in metastatic tumors from the whole panel of patients with prostate cancer.	129	3.983857e-2	1.000000e+0	1.000000e+0	2.510130e+1	3.983857e-2	1	3.983857e-2	1.000000e+0	137	3.243680e-2	1.000000e+0	7.964773e-1	3.057797e+1	3.270329e-2	1	295	5.000000e-1	3.389831e-3	unnamed	PTGS2
MSigDB Perturbation	KUMAR_TARGETS_OF_MLL_AF9_FUSION	Myeloid leukemia model in mice with germ-line MLL-AF9 fusion knock-in [GeneID=4297;4300]: genes changed in comparison among the leukemic, preleukemic and wild-type animals.	130	4.113256e-2	1.000000e+0	1.000000e+0	2.431164e+1	4.113256e-2	1	4.113256e-2	1.000000e+0	144	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	PLA2G4A
MSigDB Perturbation	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	Genes up-regulated in macrophages by P.gingivalis LPS (lipopolysaccharide).	131	4.318233e-2	1.000000e+0	1.000000e+0	2.315762e+1	4.318233e-2	1	4.318233e-2	1.000000e+0	140	4.146669e-2	1.000000e+0	9.963853e-1	2.386376e+1	4.190455e-2	1	378	5.000000e-1	2.645503e-3	unnamed	PTGS2
MSigDB Perturbation	BOQUEST_STEM_CELL_UP	Genes up-regulated in freshly isolated CD31- [GeneID=5175] (stromal stem cells from adipose tissue) versus the CD31+ (non-stem) counterparts.	132	4.418718e-2	1.000000e+0	1.000000e+0	2.263100e+1	4.418718e-2	1	4.418718e-2	1.000000e+0	133	2.806993e-2	1.000000e+0	7.099793e-1	3.537451e+1	2.826894e-2	1	255	5.000000e-1	3.921569e-3	unnamed	PLA2G4A
MSigDB Perturbation	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP	Genes up-regulated in CD133+ [GeneID=8842] cells (hematopoietic stem cells, HSC) compared to the CD133- cells.	133	4.458995e-2	1.000000e+0	1.000000e+0	2.242658e+1	4.458995e-2	1	4.458995e-2	1.000000e+0	136	3.210963e-2	1.000000e+0	7.942411e-1	3.089212e+1	3.237071e-2	1	292	5.000000e-1	3.424658e-3	unnamed	PLA2G4A
MSigDB Perturbation	PEDRIOLI_MIR31_TARGETS_DN	Genes down-regulated in primary LEC cells (lymphatic endothelum) upon overexpression of MIR31 [GeneID=407035].	134	4.478233e-2	1.000000e+0	1.000000e+0	2.233023e+1	4.478233e-2	1	4.478233e-2	1.000000e+0	142	4.276871e-2	1.000000e+0	1.000000e+0	2.312949e+1	4.323485e-2	1	390	5.000000e-1	2.564103e-3	unnamed	PLA2G4A
MSigDB Perturbation	OSMAN_BLADDER_CANCER_UP	Genes up-regulated in blood samples from bladder cancer patients.	135	4.618577e-2	1.000000e+0	1.000000e+0	2.165169e+1	4.618577e-2	1	4.618577e-2	1.000000e+0	142	4.276871e-2	1.000000e+0	1.000000e+0	2.312949e+1	4.323485e-2	1	390	5.000000e-1	2.564103e-3	unnamed	PLA2G4A
MSigDB Perturbation	KIM_WT1_TARGETS_DN	Genes down-regulated in UB27 cells (osteosarcoma) at any time point after inducing the expression of a mutant form of WT1 [GeneID=7490].	136	4.691887e-2	1.000000e+0	1.000000e+0	2.131339e+1	4.691887e-2	1	4.691887e-2	1.000000e+0	151	4.894124e-2	1.000000e+0	1.000000e+0	2.018009e+1	4.955379e-2	1	447	5.000000e-1	2.237136e-3	unnamed	PLA2G4A
MSigDB Perturbation	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B	Category B genes: p53-dependent genes whose expression in the absence of S389 phosphorylation is dissimilar to loss of TP53 [GeneID=7157] in MEF (embryonic fibroblast) cells in response to UV-C irradiation.	137	4.740517e-2	1.000000e+0	1.000000e+0	2.109475e+1	4.740517e-2	1	4.740517e-2	1.000000e+0	157	5.778599e-2	1.000000e+0	1.000000e+0	1.705198e+1	5.864420e-2	1	529	5.000000e-1	1.890359e-3	unnamed	PTGS2
MSigDB Perturbation	THUM_SYSTOLIC_HEART_FAILURE_UP	Genes up-regulated in samples with systolic heart failure compared to normal hearts.	138	4.930256e-2	1.000000e+0	1.000000e+0	2.028292e+1	4.930256e-2	1	4.930256e-2	1.000000e+0	145	4.417824e-2	1.000000e+0	1.000000e+0	2.238337e+1	4.467602e-2	1	403	5.000000e-1	2.481390e-3	unnamed	PLA2G4A
MSigDB Perturbation	BERENJENO_TRANSFORMED_BY_RHOA_UP	Genes up-regulated in NIH3T3 cells (fibroblasts) transformed by  expression of contitutively active (Q63L) form of RHOA [GeneID=387] off plasmid vector.	139	5.123973e-2	1.000000e+0	1.000000e+0	1.951611e+1	5.123973e-2	1	5.123973e-2	1.000000e+0	14	8.647155e-4	1.000000e+0	2.077788e-1	3.397552e+1	5.886592e-2	2	531	1.000000e+0	3.766478e-3	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	FOSTER_TOLERANT_MACROPHAGE_DN	Class NT (non-tolerizeable) genes: induced during the first LPS stimulation and induced at equal or greater degree in tolerant macrophages.	140	5.132241e-2	1.000000e+0	1.000000e+0	1.948467e+1	5.132241e-2	1	5.132241e-2	1.000000e+0	9	5.027351e-4	1.000000e+0	1.879112e-1	4.454568e+1	4.489773e-2	2	405	1.000000e+0	4.938272e-3	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	HAN_SATB1_TARGETS_DN	Genes down-regulated in MDA-MB-231 cells (breast cancer) after knockdown of SATB1 [GeneID=6304] by RNAi.	141	5.266731e-2	1.000000e+0	1.000000e+0	1.898711e+1	5.266731e-2	1	5.266731e-2	1.000000e+0	149	4.688595e-2	1.000000e+0	1.000000e+0	2.107593e+1	4.744748e-2	1	428	5.000000e-1	2.336449e-3	unnamed	PTGS2
MSigDB Perturbation	MATSUDA_NATURAL_KILLER_DIFFERENTIATION	Genes changed between developmental stages of Valpha14i  natural killer T lymphocyte cells (NKT).	142	5.281432e-2	1.000000e+0	1.000000e+0	1.893426e+1	5.281432e-2	1	5.281432e-2	1.000000e+0	152	5.077830e-2	1.000000e+0	1.000000e+0	1.944073e+1	5.143839e-2	1	464	5.000000e-1	2.155172e-3	unnamed	PTGS2
MSigDB Perturbation	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	Genes up-regulated in macrophage by live P.gingivalis.	143	5.350410e-2	1.000000e+0	1.000000e+0	1.869016e+1	5.350410e-2	1	5.350410e-2	1.000000e+0	147	4.591162e-2	1.000000e+0	1.000000e+0	2.152864e+1	4.644975e-2	1	419	5.000000e-1	2.386635e-3	unnamed	PTGS2
MSigDB Perturbation	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	Genes down-regulated in APL (acute promyeolocytic leukemia) blasts expressing PML-RARA fusion [GeneID=5371;5914] compared to normal promyeloblasts.	144	5.446063e-2	1.000000e+0	1.000000e+0	1.836189e+1	5.446063e-2	1	5.446063e-2	1.000000e+0	164	7.086879e-2	1.000000e+0	1.000000e+0	1.385637e+1	7.216895e-2	1	651	5.000000e-1	1.536098e-3	unnamed	PLA2G4A
MSigDB Perturbation	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	Genes down-regulated in luminal-like breast cancer cell lines compared to the basal-like ones.	145	5.472836e-2	1.000000e+0	1.000000e+0	1.827206e+1	5.472836e-2	1	5.472836e-2	1.000000e+0	11	5.854244e-4	1.000000e+0	1.790334e-1	4.128375e+1	4.844521e-2	2	437	1.000000e+0	4.576659e-3	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	FEVR_CTNNB1_TARGETS_DN	Genes down-regulated in intestinal crypt cells upon deletion of CTNNB1 [GeneID=1499].	146	5.544406e-2	1.000000e+0	1.000000e+0	1.803620e+1	5.544406e-2	1	5.544406e-2	1.000000e+0	160	5.950698e-2	1.000000e+0	1.000000e+0	1.655138e+1	6.041794e-2	1	545	5.000000e-1	1.834862e-3	unnamed	PLA2G4A
MSigDB Perturbation	ONDER_CDH1_TARGETS_2_DN	Genes down-regulated in HMLE cells (immortalized nontransformed mammary epithelium) after E-cadhedrin (CDH1) [GeneID=999] knockdown by RNAi.	147	5.631047e-2	1.000000e+0	1.000000e+0	1.775869e+1	5.631047e-2	1	5.631047e-2	1.000000e+0	12	6.431089e-4	1.000000e+0	1.802849e-1	3.939083e+1	5.077324e-2	2	458	1.000000e+0	4.366812e-3	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	MARTINEZ_RB1_AND_TP53_TARGETS_UP	Genes up-regulated in mice with skin specific double knockout of both RB1 and TP53 [GeneID=5925;7157] by Cre-lox.	148	5.663788e-2	1.000000e+0	1.000000e+0	1.765603e+1	5.663788e-2	1	5.663788e-2	1.000000e+0	162	6.390983e-2	1.000000e+0	1.000000e+0	1.539334e+1	6.496314e-2	1	586	5.000000e-1	1.706485e-3	unnamed	PTGS2
MSigDB Perturbation	MARTINEZ_TP53_TARGETS_UP	Genes up-regulated in mice with skin specific knockout of TP53 [GeneID=7157].	149	5.702439e-2	1.000000e+0	1.000000e+0	1.753636e+1	5.702439e-2	1	5.702439e-2	1.000000e+0	161	6.380257e-2	1.000000e+0	1.000000e+0	1.541966e+1	6.485228e-2	1	585	5.000000e-1	1.709402e-3	unnamed	PTGS2
MSigDB Perturbation	CHICAS_RB1_TARGETS_SENESCENT	Genes up-regulated in senescent IMR90 cells (fibroblast) after knockdown of RB1 [GeneID=5925] by RNAi.	150	5.829074e-2	1.000000e+0	1.000000e+0	1.715538e+1	5.829074e-2	1	5.829074e-2	1.000000e+0	159	5.907688e-2	1.000000e+0	1.000000e+0	1.667375e+1	5.997450e-2	1	541	5.000000e-1	1.848429e-3	unnamed	PTGS2
MSigDB Perturbation	WEST_ADRENOCORTICAL_TUMOR_DN	Down-regulated genes in pediatric adrenocortical tumors (ACT) compared to the normal tissue.	151	5.877938e-2	1.000000e+0	1.000000e+0	1.701277e+1	5.877938e-2	1	5.877938e-2	1.000000e+0	158	5.864668e-2	1.000000e+0	1.000000e+0	1.679795e+1	5.953107e-2	1	537	5.000000e-1	1.862197e-3	unnamed	PLA2G4A
MSigDB Perturbation	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	Genes up-regulated in nasopharyngeal carcinoma (NPC) positive for LMP1 [GeneID=9260], a latent gene of Epstein-Barr virus (EBV).	152	5.992122e-2	1.000000e+0	1.000000e+0	1.668858e+1	5.992122e-2	1	5.992122e-2	1.000000e+0	141	4.190080e-2	1.000000e+0	9.996758e-1	2.361387e+1	4.234799e-2	1	382	5.000000e-1	2.617801e-3	unnamed	PTGS2
MSigDB Perturbation	SMID_BREAST_CANCER_LUMINAL_B_DN	Genes down-regulated in the luminal B subtype of breast cancer.	153	6.137749e-2	1.000000e+0	1.000000e+0	1.629262e+1	6.137749e-2	1	6.137749e-2	1.000000e+0	16	9.009473e-4	1.000000e+0	1.894242e-1	3.328598e+1	6.008536e-2	2	542	1.000000e+0	3.690037e-3	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	Genes up-regulated in macrophages by P.gingivalis FimA pathogen.	154	6.196591e-2	1.000000e+0	1.000000e+0	1.613791e+1	6.196591e-2	1	6.196591e-2	1.000000e+0	154	5.218192e-2	1.000000e+0	1.000000e+0	1.891090e+1	5.287955e-2	1	477	5.000000e-1	2.096436e-3	unnamed	PTGS2
MSigDB Perturbation	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	Down-regulated genes in peripheral zone of human pancreatic cancer growing in the pancreas of nude mice compared to that of the tumor from the central zone.	155	6.253641e-2	1.000000e+0	1.000000e+0	1.599068e+1	6.253641e-2	1	6.253641e-2	1.000000e+0	163	6.508932e-2	1.000000e+0	1.000000e+0	1.510972e+1	6.618258e-2	1	597	5.000000e-1	1.675042e-3	unnamed	PTGS2
MSigDB Perturbation	ENK_UV_RESPONSE_EPIDERMIS_DN	Genes down-regulated in epidermis after to UVB irradiation.	156	6.268049e-2	1.000000e+0	1.000000e+0	1.595393e+1	6.268049e-2	1	6.268049e-2	1.000000e+0	156	5.530932e-2	1.000000e+0	1.000000e+0	1.782708e+1	5.609445e-2	1	506	5.000000e-1	1.976285e-3	unnamed	PTGS2
MSigDB Perturbation	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	Genes up-regulated in the urogenital sinus (UGS) of day E16 females exposed to the androgen dihydrotestosterone [PubChem=10635] for 48 h.	157	6.278376e-2	1.000000e+0	1.000000e+0	1.592768e+1	6.278376e-2	1	6.278376e-2	1.000000e+0	153	5.164219e-2	1.000000e+0	1.000000e+0	1.911123e+1	5.232526e-2	1	472	5.000000e-1	2.118644e-3	unnamed	PLA2G4A
MSigDB Perturbation	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	Genes down-regulated in luminal-like breast cancer cell lines compared to the mesenchymal-like ones.	158	6.453439e-2	1.000000e+0	1.000000e+0	1.549561e+1	6.453439e-2	1	6.453439e-2	1.000000e+0	150	4.883312e-2	1.000000e+0	1.000000e+0	2.022534e+1	4.944294e-2	1	446	5.000000e-1	2.242152e-3	unnamed	PTGS2
MSigDB Perturbation	MARTINEZ_RB1_TARGETS_UP	Genes up-regulated in mice with skin specific knockout of RB1 [GeneID=5925] by Cre-lox.	159	6.518802e-2	1.000000e+0	1.000000e+0	1.534024e+1	6.518802e-2	1	6.518802e-2	1.000000e+0	165	7.150984e-2	1.000000e+0	1.000000e+0	1.372983e+1	7.283410e-2	1	657	5.000000e-1	1.522070e-3	unnamed	PTGS2
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 6 h.	160	6.654607e-2	1.000000e+0	1.000000e+0	1.502718e+1	6.654607e-2	1	6.654607e-2	1.000000e+0	170	9.285739e-2	1.000000e+0	1.000000e+0	1.051340e+1	9.511668e-2	1	858	5.000000e-1	1.165501e-3	unnamed	PLA2G4A
MSigDB Perturbation	SMID_BREAST_CANCER_BASAL_UP	Genes up-regulated in basal subtype of breast cancer samles.	161	7.093597e-2	1.000000e+0	1.000000e+0	1.409722e+1	7.093597e-2	1	7.093597e-2	1.000000e+0	18	1.209846e-3	1.000000e+0	2.261068e-1	2.872771e+1	6.961920e-2	2	628	1.000000e+0	3.184713e-3	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	RIGGI_EWING_SARCOMA_PROGENITOR_UP	Genes up-regulated in mesenchymal stem cells (MSC) engineered to express EWS-FLI1 [GeneID=2130;2321] fusion protein.	162	7.155100e-2	1.000000e+0	1.000000e+0	1.397605e+1	7.155100e-2	1	7.155100e-2	1.000000e+0	148	4.656123e-2	1.000000e+0	1.000000e+0	2.122471e+1	4.711490e-2	1	425	5.000000e-1	2.352941e-3	unnamed	PTGS2
MSigDB Perturbation	SCHLOSSER_SERUM_RESPONSE_DN	Cluster 4: genes down-regulated in B493-6 cells (B lymphocytes) upon serum stimulation but not affected by MYC [GeneID=4609].	163	7.399847e-2	1.000000e+0	1.000000e+0	1.351379e+1	7.399847e-2	1	7.399847e-2	1.000000e+0	166	7.524493e-2	1.000000e+0	1.000000e+0	1.303540e+1	7.671415e-2	1	692	5.000000e-1	1.445087e-3	unnamed	PLA2G4A
MSigDB Perturbation	LIM_MAMMARY_STEM_CELL_UP	Genes consistently up-regulated in mammary stem cells both in mouse and human species.	164	7.541254e-2	1.000000e+0	1.000000e+0	1.326039e+1	7.541254e-2	1	7.541254e-2	1.000000e+0	155	5.326091e-2	1.000000e+0	1.000000e+0	1.852259e+1	5.398814e-2	1	487	5.000000e-1	2.053388e-3	unnamed	PTGS2
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 24 h.	165	7.774937e-2	1.000000e+0	1.000000e+0	1.286184e+1	7.774937e-2	1	7.774937e-2	1.000000e+0	171	1.027556e-1	1.000000e+0	1.000000e+0	9.475315e+0	1.055374e-1	1	952	5.000000e-1	1.050420e-3	unnamed	PLA2G4A
MSigDB Perturbation	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	Genes up-regulated in T24 (bladder cancer) cells in response to the photodynamic therapy (PDT) stress.	166	7.787022e-2	1.000000e+0	1.000000e+0	1.284188e+1	7.787022e-2	1	7.787022e-2	1.000000e+0	26	1.910320e-3	1.000000e+0	2.471660e-1	2.286565e+1	8.746744e-2	2	789	1.000000e+0	2.534854e-3	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	DANG_BOUND_BY_MYC	Genes whose promoters are bound by MYC [GeneID=4609], according to MYC Target Gene Database.	167	7.799204e-2	1.000000e+0	1.000000e+0	1.282182e+1	7.799204e-2	1	7.799204e-2	1.000000e+0	172	1.188545e-1	1.000000e+0	1.000000e+0	8.155967e+0	1.226096e-1	1	1106	5.000000e-1	9.041591e-4	unnamed	PLA2G4A
MSigDB Perturbation	LEE_BMP2_TARGETS_DN	Genes down-regulated in uterus upon knockout of BMP2 [GeneID=650].	168	8.052857e-2	1.000000e+0	1.000000e+0	1.241795e+1	8.052857e-2	1	8.052857e-2	1.000000e+0	169	9.264620e-2	1.000000e+0	1.000000e+0	1.053797e+1	9.489496e-2	1	856	5.000000e-1	1.168224e-3	unnamed	PTGS2
MSigDB Perturbation	NUYTTEN_NIPP1_TARGETS_UP	Genes up-regulated in PC3 cells (prostate cancer) after knockdown of NIPP1 [GeneID=5511] by RNAi.	169	8.459132e-2	1.000000e+0	1.000000e+0	1.182154e+1	8.459132e-2	1	8.459132e-2	1.000000e+0	22	1.671193e-3	1.000000e+0	2.555406e-1	2.444580e+1	8.181365e-2	2	738	1.000000e+0	2.710027e-3	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A	Category A genes: p53-dependent genes whose expression in the absence of S389 phosphorylation is similar to loss of TP53 [GeneID=7157] in MEF (embryonic fibroblast) cells in response to UV-C irradiation.	170	9.103755e-2	1.000000e+0	1.000000e+0	1.098448e+1	9.103755e-2	1	9.103755e-2	1.000000e+0	168	9.211812e-2	1.000000e+0	1.000000e+0	1.059988e+1	9.434067e-2	1	851	5.000000e-1	1.175088e-3	unnamed	PLA2G4A
MSigDB Perturbation	WONG_ADULT_TISSUE_STEM_MODULE	The 'adult tissue stem' module: genes coordinately up-regulated in a compendium of adult tissue stem cells.	171	1.017240e-1	1.000000e+0	1.000000e+0	9.830524e+0	1.017240e-1	1	1.017240e-1	1.000000e+0	167	7.716290e-2	1.000000e+0	1.000000e+0	1.270493e+1	7.870961e-2	1	710	5.000000e-1	1.408451e-3	unnamed	PTGS2
MSigDB Perturbation	CHEN_METABOLIC_SYNDROM_NETWORK	Genes forming the macrophage-enriched metabolic network (MEMN) claimed to have a causal relationship with the metabolic syndrom traits.	172	1.026637e-1	1.000000e+0	1.000000e+0	9.740537e+0	1.026637e-1	1	1.026637e-1	1.000000e+0	173	1.250874e-1	1.000000e+0	1.000000e+0	7.736278e+0	1.292611e-1	1	1166	5.000000e-1	8.576329e-4	unnamed	PLA2G4A
MSigDB Perturbation	NUYTTEN_EZH2_TARGETS_UP	Genes up-regulated in PC3 cells (prostate cancer) after knockdown of EZH2 [GeneID=2146] by RNAi.	173	1.213858e-1	1.000000e+0	1.000000e+0	8.238198e+0	1.213858e-1	1	1.213858e-1	1.000000e+0	37	3.075650e-3	1.000000e+0	2.796348e-1	1.802298e+1	1.109695e-1	2	1001	1.000000e+0	1.998002e-3	unnamed	PLA2G4A,PTGS2
MSigDB Perturbation	DODD_NASOPHARYNGEAL_CARCINOMA_DN	Genes down-regulated in nasopharyngeal carcinoma (NPC) compared to the normal tissue.	174	1.258050e-1	1.000000e+0	1.000000e+0	7.948812e+0	1.258050e-1	1	1.258050e-1	1.000000e+0	174	1.382073e-1	1.000000e+0	1.000000e+0	6.976411e+0	1.433402e-1	1	1293	5.000000e-1	7.733952e-4	unnamed	PTGS2
MSigDB Perturbation	PILON_KLF1_TARGETS_DN	Genes down-regulated in erythroid progenitor cells from fetal livers of E13.5 embryos with KLF1 [GeneID=10661] knockout compared to those from the wild type embryos.	175	1.766774e-1	1.000000e+0	1.000000e+0	5.660033e+0	1.766774e-1	1	1.766774e-1	1.000000e+0	175	2.003385e-1	1.000000e+0	1.000000e+0	4.727725e+0	2.115182e-1	1	1908	5.000000e-1	5.241090e-4	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	V$MYC_Q2	Motif CACGTGS matches MYC: v-myc myelocytomatosis viral oncogene homolog (avian)	1	1.125728e-2	1.000000e+0	1.000000e+0	8.883141e+1	1.125728e-2	1	1.125728e-2	1.000000e+0	3	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	V$USF2_Q6	Motif CASGYG (no known TF)	2	1.739327e-2	1.000000e+0	1.000000e+0	5.749349e+1	1.739327e-2	1	1.739327e-2	1.000000e+0	10	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	V$LEF1_Q2	Motif TCAAAG matches LEF1: lymphoid enhancer-binding factor 1&lt;br&gt; TCF1: transcription factor 1, hepatic; LF-B1, hepatic nuclear factor (HNF1), albumin proximal factor	3	2.343570e-2	1.000000e+0	1.000000e+0	4.266994e+1	2.343570e-2	1	2.343570e-2	1.000000e+0	5	2.325502e-2	1.000000e+0	1.000000e+0	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	V$NFKB_C	Motif NGGGACTTTCCA (no known TF)	4	2.613382e-2	1.000000e+0	1.000000e+0	3.826459e+1	2.613382e-2	1	2.613382e-2	1.000000e+0	14	2.806993e-2	1.000000e+0	1.000000e+0	3.537451e+1	2.826894e-2	1	255	5.000000e-1	3.921569e-3	unnamed	PTGS2
MSigDB Predicted Promoter Motifs	V$USF_C	Motif NCACGTGN (no known TF)	5	2.667910e-2	1.000000e+0	1.000000e+0	3.748252e+1	2.667910e-2	1	2.667910e-2	1.000000e+0	18	2.927180e-2	1.000000e+0	1.000000e+0	3.391165e+1	2.948839e-2	1	266	5.000000e-1	3.759398e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	V$NMYC_01	Motif NNCCACGTGNNN matches MYCN: v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)	6	2.675365e-2	1.000000e+0	1.000000e+0	3.737808e+1	2.675365e-2	1	2.675365e-2	1.000000e+0	15	2.828851e-2	1.000000e+0	1.000000e+0	3.509922e+1	2.849066e-2	1	257	5.000000e-1	3.891051e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	V$CDP_02	Motif NWNATCGATTANYNN matches CUTL1: cut-like 1, CCAAT displacement protein (Drosophila)	7	2.704347e-2	1.000000e+0	1.000000e+0	3.697750e+1	2.704347e-2	1	2.704347e-2	1.000000e+0	2	1.138616e-2	1.000000e+0	1.000000e+0	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	PTGS2
MSigDB Predicted Promoter Motifs	V$NFKB_Q6	Motif NGGGGAMTTTCCNN (no known TF)	8	2.730950e-2	1.000000e+0	1.000000e+0	3.661729e+1	2.730950e-2	1	2.730950e-2	1.000000e+0	11	2.719538e-2	1.000000e+0	1.000000e+0	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	PTGS2
MSigDB Predicted Promoter Motifs	V$CEBP_C	Motif NGWVTKNKGYAAKNSAYA matches CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha	9	3.209764e-2	1.000000e+0	1.000000e+0	3.115494e+1	3.209764e-2	1	3.209764e-2	1.000000e+0	4	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	V$HNF1_01	Motif GGTTAATNWTTAMCN matches TCF1: transcription factor 1, hepatic; LF-B1, hepatic nuclear factor (HNF1), albumin proximal factor	10	3.406183e-2	1.000000e+0	1.000000e+0	2.935837e+1	3.406183e-2	1	3.406183e-2	1.000000e+0	9	2.599222e-2	1.000000e+0	1.000000e+0	3.822246e+1	2.616263e-2	1	236	5.000000e-1	4.237288e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	V$CEBP_Q2	Motif NNATTGCNNAANNN matches CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha	11	3.529750e-2	1.000000e+0	1.000000e+0	2.833062e+1	3.529750e-2	1	3.529750e-2	1.000000e+0	6	2.424086e-2	1.000000e+0	1.000000e+0	4.100227e+1	2.438889e-2	1	220	5.000000e-1	4.545455e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	V$CEBPDELTA_Q6	Motif MATTKCNTMAYY matches CEBPD: CCAAT/enhancer binding protein (C/EBP), delta	12	3.553141e-2	1.000000e+0	1.000000e+0	2.814411e+1	3.553141e-2	1	3.553141e-2	1.000000e+0	7	2.533565e-2	1.000000e+0	1.000000e+0	3.921957e+1	2.549748e-2	1	230	5.000000e-1	4.347826e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	V$CEBPB_01	Motif RNRTKDNGMAAKNN matches CEBPB: CCAAT/enhancer binding protein (C/EBP), beta	13	3.597141e-2	1.000000e+0	1.000000e+0	2.779986e+1	3.597141e-2	1	3.597141e-2	1.000000e+0	16	2.872559e-2	1.000000e+0	1.000000e+0	3.456130e+1	2.893409e-2	1	261	5.000000e-1	3.831418e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	V$HNF1_C	Motif DGTTAATKAWTNACCAM matches TCF1: transcription factor 1, hepatic; LF-B1, hepatic nuclear factor (HNF1), albumin proximal factor	14	3.766180e-2	1.000000e+0	1.000000e+0	2.655211e+1	3.766180e-2	1	3.766180e-2	1.000000e+0	1	1.618327e-4	9.952711e-2	9.952711e-2	7.843913e+1	2.549748e-2	2	230	1.000000e+0	8.695652e-3	unnamed	PLA2G4A,PTGS2
MSigDB Predicted Promoter Motifs	V$CEBPB_02	Motif NKNTTGCNYAAYNN matches CEBPB: CCAAT/enhancer binding protein (C/EBP), beta	15	3.796622e-2	1.000000e+0	1.000000e+0	2.633920e+1	3.796622e-2	1	3.796622e-2	1.000000e+0	13	2.741405e-2	1.000000e+0	1.000000e+0	3.622691e+1	2.760379e-2	1	249	5.000000e-1	4.016064e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	V$CEBP_Q3	Motif NNNTKNNGNAAN matches CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha	16	4.116827e-2	1.000000e+0	1.000000e+0	2.429055e+1	4.116827e-2	1	4.116827e-2	1.000000e+0	12	2.730472e-2	1.000000e+0	1.000000e+0	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	V$CEBPA_01	Motif NNATTRCNNAANNN matches CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha	17	4.127006e-2	1.000000e+0	1.000000e+0	2.423064e+1	4.127006e-2	1	4.127006e-2	1.000000e+0	8	2.588281e-2	1.000000e+0	1.000000e+0	3.838511e+1	2.605177e-2	1	235	5.000000e-1	4.255319e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	V$CEBP_Q2_01	Motif NTTRCNNAANNN matches CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha	18	4.214096e-2	1.000000e+0	1.000000e+0	2.372988e+1	4.214096e-2	1	4.214096e-2	1.000000e+0	17	2.916257e-2	1.000000e+0	1.000000e+0	3.403962e+1	2.937753e-2	1	265	5.000000e-1	3.773585e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	RGAGGAARY_V$PU1_Q6	Motif RGAGGAARY matches SPI1: spleen focus forming virus (SFFV) proviral integration oncogene spi1	19	5.221701e-2	1.000000e+0	1.000000e+0	1.915085e+1	5.221701e-2	1	5.221701e-2	1.000000e+0	19	5.228984e-2	1.000000e+0	1.000000e+0	1.887134e+1	5.299041e-2	1	478	5.000000e-1	2.092050e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	CACGTG_V$MYC_Q2	Motif CACGTG matches MYC: v-myc myelocytomatosis viral oncogene homolog (avian)	20	9.316007e-2	1.000000e+0	1.000000e+0	1.073421e+1	9.316007e-2	1	9.316007e-2	1.000000e+0	22	1.063225e-1	1.000000e+0	1.000000e+0	9.148580e+0	1.093066e-1	1	986	5.000000e-1	1.014199e-3	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	WTGAAAT_UNKNOWN	Motif WTGAAAT (no known TF)	21	9.506027e-2	1.000000e+0	1.000000e+0	1.051964e+1	9.506027e-2	1	9.506027e-2	1.000000e+0	20	6.358802e-2	1.000000e+0	1.000000e+0	1.547256e+1	6.463056e-2	1	583	5.000000e-1	1.715266e-3	unnamed	PTGS2
MSigDB Predicted Promoter Motifs	TTANTCA_UNKNOWN	Motif TTANTCA (no known TF)	22	1.354023e-1	1.000000e+0	1.000000e+0	7.385397e+0	1.354023e-1	1	1.354023e-1	1.000000e+0	21	9.802388e-2	1.000000e+0	1.000000e+0	9.945424e+0	1.005488e-1	1	907	5.000000e-1	1.102536e-3	unnamed	PTGS2
MSigDB Predicted Promoter Motifs	CTTTGA_V$LEF1_Q2	Motif CTTTGA matches LEF1: lymphoid enhancer-binding factor 1	23	1.653166e-1	1.000000e+0	1.000000e+0	6.049001e+0	1.653166e-1	1	1.653166e-1	1.000000e+0	23	1.247763e-1	1.000000e+0	1.000000e+0	7.756234e+0	1.289286e-1	1	1163	5.000000e-1	8.598452e-4	unnamed	PLA2G4A
MSigDB Predicted Promoter Motifs	AACTTT_UNKNOWN	Motif AACTTT (no known TF)	24	2.964325e-1	1.000000e+0	1.000000e+0	3.373449e+0	2.964325e-1	1	2.964325e-1	1.000000e+0	24	1.917900e-1	1.000000e+0	1.000000e+0	4.950878e+0	2.019844e-1	1	1822	5.000000e-1	5.488474e-4	unnamed	PTGS2
MSigDB miRNA Motifs	GAGACTG,MIR-452	Targets of MicroRNA GAGACTG,MIR-452	1	1.356102e-2	1.000000e+0	1.000000e+0	7.374079e+1	1.356102e-2	1	1.356102e-2	1.000000e+0	1	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	PLA2G4A
MSigDB miRNA Motifs	GTACTGT,MIR-101	Targets of MicroRNA GTACTGT,MIR-101	2	4.071928e-2	1.000000e+0	1.000000e+0	2.455839e+1	4.071928e-2	1	4.071928e-2	1.000000e+0	2	2.719538e-2	1.000000e+0	1.000000e+0	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	PTGS2
MSigDB miRNA Motifs	TACTTGA,MIR-26A,MIR-26B	Targets of MicroRNA TACTTGA,MIR-26A,MIR-26B	3	4.708394e-2	1.000000e+0	1.000000e+0	2.123867e+1	4.708394e-2	1	4.708394e-2	1.000000e+0	3	3.178240e-2	1.000000e+0	1.000000e+0	3.121280e+1	3.203814e-2	1	289	5.000000e-1	3.460208e-3	unnamed	PTGS2
InterPro	IPR002642	Lysophospholipase, catalytic domain	1	5.617822e-4	1.000000e+0	1.000000e+0	1.780049e+3	5.617822e-4	1	5.617822e-4	1.000000e+0	1	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	PLA2G4A
InterPro	IPR016035	Acyl transferase/acyl hydrolase/lysophospholipase	2	9.631876e-4	1.000000e+0	1.000000e+0	1.038219e+3	9.631876e-4	1	9.631876e-4	1.000000e+0	3	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	PLA2G4A
InterPro	IPR019791	Haem peroxidase, animal, subgroup	3	1.174504e-3	1.000000e+0	1.000000e+0	8.514235e+2	1.174504e-3	1	1.174504e-3	1.000000e+0	2	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	PTGS2
InterPro	IPR000008	C2 domain	4	2.190168e-2	1.000000e+0	1.000000e+0	4.565859e+1	2.190168e-2	1	2.190168e-2	1.000000e+0	4	1.612031e-2	1.000000e+0	1.000000e+0	6.178425e+1	1.618536e-2	1	146	5.000000e-1	6.849315e-3	unnamed	PLA2G4A
InterPro	IPR000742	Epidermal growth factor-like domain	5	3.630027e-2	1.000000e+0	1.000000e+0	2.754800e+1	3.630027e-2	1	3.630027e-2	1.000000e+0	5	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	PTGS2
TreeFam	TF329675	PTGS1, PTGS2	1	1.974408e-4	1.000000e+0	1.000000e+0	5.064810e+3	1.974408e-4	1	1.974408e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	PTGS2
TreeFam	TF325228	PLA2G4A, PLA2G4B, PLA2G4C, PLA2G4D, PLA2G4E, ...	2	5.617822e-4	1.000000e+0	1.000000e+0	1.780049e+3	5.617822e-4	1	5.617822e-4	1.000000e+0	2	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	PLA2G4A
Ensembl Genes	1661	PTGS2	1	1.250564e-4	1.000000e+0	1.000000e+0	7.996393e+3	1.250564e-4	1	1.250564e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	PTGS2
Ensembl Genes	1662	PLA2G4A	2	3.996454e-4	1.000000e+0	1.000000e+0	2.502218e+3	3.996454e-4	1	3.996454e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	PLA2G4A
MSigDB Oncogenic Signatures	EIF4E_DN	Genes down-regulated in HMEC cells (primary mammary epithelium) upon over-expression of EIF4E [Gene ID=1977] gene.	1	1.175075e-2	1.000000e+0	1.000000e+0	8.510093e+1	1.175075e-2	1	1.175075e-2	1.000000e+0	4	1.050413e-2	1.000000e+0	4.910681e-1	9.495263e+1	1.053157e-2	1	95	5.000000e-1	1.052632e-2	unnamed	PTGS2
MSigDB Oncogenic Signatures	MYC_UP.V1_UP	Genes up-regulated in primary epithelial breast cancer cell culture over-expressing MYC [Gene ID=4609] gene.	2	1.182324e-2	1.000000e+0	1.000000e+0	8.457919e+1	1.182324e-2	1	1.182324e-2	1.000000e+0	9	1.831837e-2	1.000000e+0	3.806150e-1	5.434036e+1	1.840253e-2	1	166	5.000000e-1	6.024096e-3	unnamed	PLA2G4A
MSigDB Oncogenic Signatures	WNT_UP.V1_DN	Genes down-regulated in C57MG cells (mammary epithelium) by over-expression of WNT1 [Gene ID=7471] gene.	3	1.542902e-2	1.000000e+0	9.617422e-1	6.481292e+1	1.542902e-2	1	1.542902e-2	1.000000e+0	11	1.886750e-2	1.000000e+0	3.207475e-1	5.275146e+1	1.895682e-2	1	171	5.000000e-1	5.847953e-3	unnamed	PTGS2
MSigDB Oncogenic Signatures	PTEN_DN.V2_UP	Genes up-regulated in HCT116 cells (colon carcinoma) upon knockdown of PTEN [Gene ID=5728] by RNAi.	4	1.584049e-2	1.000000e+0	7.405429e-1	6.312934e+1	1.584049e-2	1	1.584049e-2	1.000000e+0	5	1.425002e-2	1.000000e+0	5.329507e-1	6.992636e+1	1.430076e-2	1	129	5.000000e-1	7.751938e-3	unnamed	PTGS2
MSigDB Oncogenic Signatures	RELA_DN.V1_UP	Genes up-regulated in HEK293 cells (kidney fibroblasts) upon knockdown of RELA [Gene ID=5970] gene by RNAi.	5	1.677068e-2	1.000000e+0	6.272234e-1	5.962789e+1	1.677068e-2	1	1.677068e-2	1.000000e+0	7	1.623027e-2	1.000000e+0	4.335801e-1	6.136395e+1	1.629621e-2	1	147	5.000000e-1	6.802721e-3	unnamed	PTGS2
MSigDB Oncogenic Signatures	CSR_EARLY_UP.V1_UP	Genes up-regulated in early serum response of CRL 2091 cells (foreskin fibroblasts).	6	1.694885e-2	1.000000e+0	5.282392e-1	5.900105e+1	1.694885e-2	1	1.694885e-2	1.000000e+0	8	1.765921e-2	1.000000e+0	4.127840e-1	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	PTGS2
MSigDB Oncogenic Signatures	AKT_UP_MTOR_DN.V1_DN	Genes down-regulated by everolimus [PubChem = 6442177] in mouse prostate tissue transgenically expressing human AKT1 gene [Gene ID=207]  vs untreated controls.	7	1.726837e-2	1.000000e+0	4.613122e-1	5.790934e+1	1.726837e-2	1	1.726837e-2	1.000000e+0	13	1.963603e-2	1.000000e+0	2.824567e-1	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	PLA2G4A
MSigDB Oncogenic Signatures	KRAS.LUNG.BREAST_UP.V1_UP	Genes up-regulated in epithelial lung and breast cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	8	1.793933e-2	1.000000e+0	4.193318e-1	5.574346e+1	1.793933e-2	1	1.793933e-2	1.000000e+0	6	1.491033e-2	1.000000e+0	4.647053e-1	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	PTGS2
MSigDB Oncogenic Signatures	GCNP_SHH_UP_EARLY.V1_DN	Genes down-regulated in granule cell neuron precursors (GCNPs) after stimulation with Shh for 3h.	9	1.849399e-2	1.000000e+0	3.842640e-1	5.407163e+1	1.849399e-2	1	1.849399e-2	1.000000e+0	10	1.842821e-2	1.000000e+0	3.446075e-1	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	PLA2G4A
MSigDB Oncogenic Signatures	AKT_UP.V1_DN	Genes down-regulated in mouse prostate by transgenic expression of human AKT1 gene [Gene ID=207]  vs controls.	10	1.925821e-2	1.000000e+0	3.601285e-1	5.192590e+1	1.925821e-2	1	1.925821e-2	1.000000e+0	14	1.996530e-2	1.000000e+0	2.666794e-1	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	PLA2G4A
MSigDB Oncogenic Signatures	KRAS.DF.V1_DN	Genes down-regulated in epithelial lung cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	11	2.057707e-2	1.000000e+0	3.498102e-1	4.859778e+1	2.057707e-2	1	2.057707e-2	1.000000e+0	16	2.084310e-2	1.000000e+0	2.436037e-1	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	PTGS2
MSigDB Oncogenic Signatures	E2F1_UP.V1_DN	Genes down-regulated in mouse fibroblasts over-expressing E2F1 [Gene ID=1869] gene.	12	2.216589e-2	1.000000e+0	3.454185e-1	4.511436e+1	2.216589e-2	1	2.216589e-2	1.000000e+0	3	1.091748e-4	2.041569e-2	6.805229e-3	9.545503e+1	2.095228e-2	2	189	1.000000e+0	1.058201e-2	unnamed	PLA2G4A,PTGS2
MSigDB Oncogenic Signatures	ATF2_S_UP.V1_DN	Genes down-regulated in myometrial cells over-expressing a shortened splice form of ATF2 [Gene ID=1386] gene.	13	2.304423e-2	1.000000e+0	3.314824e-1	4.339481e+1	2.304423e-2	1	2.304423e-2	1.000000e+0	12	1.952626e-2	1.000000e+0	3.042842e-1	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	PTGS2
MSigDB Oncogenic Signatures	PIGF_UP.V1_UP	Genes up-regulated in HUVEC cells (endothelium) by treatment with PIGF [Gene ID=5281].	14	2.376115e-2	1.000000e+0	3.173811e-1	4.208551e+1	2.376115e-2	1	2.376115e-2	1.000000e+0	2	1.045905e-4	1.955842e-2	9.779212e-3	9.751892e+1	2.050884e-2	2	185	1.000000e+0	1.081081e-2	unnamed	PLA2G4A,PTGS2
MSigDB Oncogenic Signatures	P53_DN.V1_DN	Genes down-regulated in NCI-60 panel of cell lines with mutated TP53 [Gene ID=7157].	15	2.437345e-2	1.000000e+0	3.038557e-1	4.102825e+1	2.437345e-2	1	2.437345e-2	1.000000e+0	15	2.062369e-2	1.000000e+0	2.571087e-1	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	PLA2G4A
MSigDB Oncogenic Signatures	ATF2_UP.V1_DN	Genes down-regulated in myometrial cells over-expressing ATF2 [Gene ID=1386] gene.	16	2.462208e-2	1.000000e+0	2.877706e-1	4.061395e+1	2.462208e-2	1	2.462208e-2	1.000000e+0	1	1.001046e-4	1.871956e-2	1.871956e-2	9.967403e+1	2.006541e-2	2	181	1.000000e+0	1.104972e-2	unnamed	PLA2G4A,PTGS2
MSigDB Oncogenic Signatures	KRAS.600.LUNG.BREAST_UP.V1_UP	Genes up-regulated in epithelial lung and breast cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	17	3.169326e-2	1.000000e+0	3.486259e-1	3.155245e+1	3.169326e-2	1	3.169326e-2	1.000000e+0	18	2.949024e-2	1.000000e+0	3.063708e-1	3.365858e+1	2.971010e-2	1	268	5.000000e-1	3.731343e-3	unnamed	PTGS2
MSigDB Oncogenic Signatures	KRAS.600_UP.V1_UP	Genes up-regulated in four lineages of epithelial cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	18	4.035466e-2	1.000000e+0	4.192401e-1	2.478028e+1	4.035466e-2	1	4.035466e-2	1.000000e+0	17	2.916257e-2	1.000000e+0	3.207883e-1	3.403962e+1	2.937753e-2	1	265	5.000000e-1	3.773585e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN	Genes down-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 3 h versus PMN treated with F. tularensis vaccine at 3 h.	1	1.265905e-2	1.000000e+0	1.000000e+0	7.899487e+1	1.265905e-2	1	1.265905e-2	1.000000e+0	35	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 8 h.	2	1.317515e-2	1.000000e+0	1.000000e+0	7.590045e+1	1.317515e-2	1	1.317515e-2	1.000000e+0	35	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN	Genes down-regulated in comparison of control RAW264.7 cells (macrophages) versus those infected with B. abortus.	3	1.333530e-2	1.000000e+0	1.000000e+0	7.498894e+1	1.333530e-2	1	1.333530e-2	1.000000e+0	91	2.172051e-2	1.000000e+0	4.558920e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 10 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.	4	1.370657e-2	1.000000e+0	1.000000e+0	7.295771e+1	1.370657e-2	1	1.370657e-2	1.000000e+0	29	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with TGFB1 [GeneID=7040] and IL6 [GeneID=3569] versus those treated with TGFB1 [GeneID=7040], IL6 [GeneID=3569] and IL23A [GeneID=51561].	5	1.396963e-2	1.000000e+0	1.000000e+0	7.158388e+1	1.396963e-2	1	1.396963e-2	1.000000e+0	63	2.128185e-2	1.000000e+0	6.452116e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN	Genes down-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458].	6	1.414998e-2	1.000000e+0	1.000000e+0	7.067147e+1	1.414998e-2	1	1.414998e-2	1.000000e+0	46	2.062369e-2	1.000000e+0	8.563315e-1	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN	Genes down-regulated in comparison of naive B cells versus unstimulated neutrophils.	7	1.417805e-2	1.000000e+0	1.000000e+0	7.053155e+1	1.417805e-2	1	1.417805e-2	1.000000e+0	75	2.150119e-2	1.000000e+0	5.475636e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN	Genes down-regulated in comparison of B cells from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	8	1.428072e-2	1.000000e+0	1.000000e+0	7.002449e+1	1.428072e-2	1	1.428072e-2	1.000000e+0	59	2.117217e-2	1.000000e+0	6.854041e-1	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 18 h versus cDCs infected with Newcastle disease virus (NDV) at 18 h.	9	1.482446e-2	1.000000e+0	1.000000e+0	6.745610e+1	1.482446e-2	1	1.482446e-2	1.000000e+0	15	1.930669e-2	1.000000e+0	1.000000e+0	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE3982_NEUTROPHIL_VS_TH2_DN	Genes down-regulated in comparison of neutrophils versus Th2 cells.	10	1.484098e-2	1.000000e+0	1.000000e+0	6.738102e+1	1.484098e-2	1	1.484098e-2	1.000000e+0	63	2.128185e-2	1.000000e+0	6.452116e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_24H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 24 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 24 h.	11	1.492432e-2	1.000000e+0	1.000000e+0	6.700472e+1	1.492432e-2	1	1.492432e-2	1.000000e+0	75	2.150119e-2	1.000000e+0	5.475636e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE3982_BASOPHIL_VS_TH2_DN	Genes down-regulated in comparison of basophils versus Th2 cells.	12	1.531831e-2	1.000000e+0	1.000000e+0	6.528134e+1	1.531831e-2	1	1.531831e-2	1.000000e+0	63	2.128185e-2	1.000000e+0	6.452116e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN	Genes down-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458] versus macrophages cultured with M-CSF [GeneID=1435] and Pam3Cyc.	13	1.552217e-2	1.000000e+0	1.000000e+0	6.442399e+1	1.552217e-2	1	1.552217e-2	1.000000e+0	40	2.029452e-2	1.000000e+0	9.690633e-1	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE20715_0H_VS_48H_OZONE_LUNG_DN	Genes down-regulated in comparison of lung tissue from wild type mice subjected to ozone for 0 h versus that from wild type mice subjected to ozone for 48 h.	14	1.563208e-2	1.000000e+0	1.000000e+0	6.397102e+1	1.563208e-2	1	1.563208e-2	1.000000e+0	91	2.172051e-2	1.000000e+0	4.558920e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 1 h.	15	1.581142e-2	1.000000e+0	1.000000e+0	6.324544e+1	1.581142e-2	1	1.581142e-2	1.000000e+0	10	1.875769e-2	1.000000e+0	1.000000e+0	5.306176e+1	1.884596e-2	1	170	5.000000e-1	5.882353e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN	Genes down-regulated in comparison of microglia cells 1 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.	16	1.607561e-2	1.000000e+0	1.000000e+0	6.220605e+1	1.607561e-2	1	1.607561e-2	1.000000e+0	91	2.172051e-2	1.000000e+0	4.558920e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th2 cells.	17	1.608243e-2	1.000000e+0	1.000000e+0	6.217967e+1	1.608243e-2	1	1.608243e-2	1.000000e+0	4	1.387453e-4	2.650035e-1	6.625088e-2	8.469953e+1	2.361288e-2	2	213	1.000000e+0	9.389671e-3	unnamed	PLA2G4A,PTGS2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.	18	1.631268e-2	1.000000e+0	1.000000e+0	6.130202e+1	1.631268e-2	1	1.631268e-2	1.000000e+0	33	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE3982_MAC_VS_NEUTROPHIL_UP	Genes up-regulated in comparison of macrophages versus neutrophils.	19	1.658722e-2	1.000000e+0	1.000000e+0	6.028739e+1	1.658722e-2	1	1.658722e-2	1.000000e+0	63	2.128185e-2	1.000000e+0	6.452116e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN	Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus Th2 cells.	20	1.661847e-2	1.000000e+0	1.000000e+0	6.017402e+1	1.661847e-2	1	1.661847e-2	1.000000e+0	2	1.222886e-4	2.335712e-1	1.167856e-1	9.020500e+1	2.217172e-2	2	200	1.000000e+0	1.000000e-2	unnamed	PLA2G4A,PTGS2
MSigDB Immunologic Signatures	GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN	Genes down-regulated in comparison of control microglia cells versus those 24 h after stimulation with IFNG [GeneID=3458].	21	1.663662e-2	1.000000e+0	1.000000e+0	6.010836e+1	1.663662e-2	1	1.663662e-2	1.000000e+0	109	2.193980e-2	1.000000e+0	3.844497e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 18 h.	22	1.664334e-2	1.000000e+0	1.000000e+0	6.008408e+1	1.664334e-2	1	1.664334e-2	1.000000e+0	8	1.820853e-2	1.000000e+0	1.000000e+0	5.466970e+1	1.829167e-2	1	165	5.000000e-1	6.060606e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE14000_UNSTIM_VS_4H_LPS_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) before and 4 h after LPS (TLR4 agonist) stimulation.	23	1.668957e-2	1.000000e+0	1.000000e+0	5.991765e+1	1.668957e-2	1	1.668957e-2	1.000000e+0	46	2.062369e-2	1.000000e+0	8.563315e-1	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE2706_R848_VS_LPS_2H_STIM_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) for 2 h.	24	1.673982e-2	1.000000e+0	1.000000e+0	5.973780e+1	1.673982e-2	1	1.673982e-2	1.000000e+0	5	1.688991e-2	1.000000e+0	1.000000e+0	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN	Genes down-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to 5 worms/well B. malayi.	25	1.685134e-2	1.000000e+0	1.000000e+0	5.934248e+1	1.685134e-2	1	1.685134e-2	1.000000e+0	99	2.183015e-2	1.000000e+0	4.211675e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 1 diabetes at the time of diagnosis.	26	1.686420e-2	1.000000e+0	1.000000e+0	5.929720e+1	1.686420e-2	1	1.686420e-2	1.000000e+0	42	2.040425e-2	1.000000e+0	9.279076e-1	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN	Genes down-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to M. tuberculosis.	27	1.698760e-2	1.000000e+0	1.000000e+0	5.886647e+1	1.698760e-2	1	1.698760e-2	1.000000e+0	91	2.172051e-2	1.000000e+0	4.558920e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_1H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 1 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 1 h.	28	1.703274e-2	1.000000e+0	1.000000e+0	5.871045e+1	1.703274e-2	1	1.703274e-2	1.000000e+0	63	2.128185e-2	1.000000e+0	6.452116e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 1 h.	29	1.713227e-2	1.000000e+0	1.000000e+0	5.836938e+1	1.713227e-2	1	1.713227e-2	1.000000e+0	29	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE3982_NKCELL_VS_TH2_DN	Genes down-regulated in comparison of NK cells versus Th2 cells.	30	1.720574e-2	1.000000e+0	1.000000e+0	5.812015e+1	1.720574e-2	1	1.720574e-2	1.000000e+0	3	1.310209e-4	2.502499e-1	8.341664e-2	8.715459e+1	2.294773e-2	2	207	1.000000e+0	9.661836e-3	unnamed	PLA2G4A,PTGS2
MSigDB Immunologic Signatures	GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN	Genes down-regulated in comparison of CD25- T cells treated with IL4 [GeneID=3565] at day 10 versus untreated CD25- T cells at day 10.	31	1.727840e-2	1.000000e+0	1.000000e+0	5.787574e+1	1.727840e-2	1	1.727840e-2	1.000000e+0	83	2.161085e-2	1.000000e+0	4.973099e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE2706_UNSTIM_VS_2H_R848_DC_DN	Genes down-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with R848 for 2 h.	32	1.740663e-2	1.000000e+0	1.000000e+0	5.744938e+1	1.740663e-2	1	1.740663e-2	1.000000e+0	22	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 16 h.	33	1.756268e-2	1.000000e+0	1.000000e+0	5.693893e+1	1.756268e-2	1	1.756268e-2	1.000000e+0	13	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN	Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to M. tuberculosis.	34	1.791043e-2	1.000000e+0	1.000000e+0	5.583338e+1	1.791043e-2	1	1.791043e-2	1.000000e+0	69	2.139152e-2	1.000000e+0	5.921421e-1	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_MAC_UP	Genes up-regulated in comparison of mast cells versus macrophages.	35	1.792320e-2	1.000000e+0	9.780946e-1	5.579362e+1	1.792320e-2	1	1.792320e-2	1.000000e+0	49	2.073340e-2	1.000000e+0	8.081795e-1	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 12 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 12 h.	36	1.795528e-2	1.000000e+0	9.526274e-1	5.569392e+1	1.795528e-2	1	1.795528e-2	1.000000e+0	69	2.139152e-2	1.000000e+0	5.921421e-1	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 72 h versus the untreated cells at 72 h.	37	1.797168e-2	1.000000e+0	9.277273e-1	5.564309e+1	1.797168e-2	1	1.797168e-2	1.000000e+0	7	1.776908e-2	1.000000e+0	1.000000e+0	5.602795e+1	1.784823e-2	1	161	5.000000e-1	6.211180e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP	Genes up-regulated in comparison of virus specific (gp33) exhausted CD8 T cells versus the virus specific (gp276) cells.	38	1.799985e-2	1.000000e+0	9.047293e-1	5.555601e+1	1.799985e-2	1	1.799985e-2	1.000000e+0	99	2.183015e-2	1.000000e+0	4.211675e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated neutrophils.	39	1.813086e-2	1.000000e+0	8.879472e-1	5.515460e+1	1.813086e-2	1	1.813086e-2	1.000000e+0	125	2.369323e-2	1.000000e+0	3.620326e-1	4.195581e+1	2.383460e-2	1	215	5.000000e-1	4.651163e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_CPG_0.5H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 0.5 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 0.5 h.	40	1.818883e-2	1.000000e+0	8.685166e-1	5.497881e+1	1.818883e-2	1	1.818883e-2	1.000000e+0	109	2.193980e-2	1.000000e+0	3.844497e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 2 h.	41	1.831277e-2	1.000000e+0	8.531071e-1	5.460669e+1	1.831277e-2	1	1.831277e-2	1.000000e+0	9	1.842821e-2	1.000000e+0	1.000000e+0	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	Genes down-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435], IFNG [GeneID=3458] and Pam3Cys (TLR2 agonist).	42	1.842864e-2	1.000000e+0	8.380643e-1	5.426335e+1	1.842864e-2	1	1.842864e-2	1.000000e+0	46	2.062369e-2	1.000000e+0	8.563315e-1	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP	Genes up-regulated in comparison of macrophages versus effector memory CD4 [GeneID=920] T cells.	43	1.849790e-2	1.000000e+0	8.216509e-1	5.406018e+1	1.849790e-2	1	1.849790e-2	1.000000e+0	59	2.117217e-2	1.000000e+0	6.854041e-1	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE360_L_MAJOR_VS_T_GONDII_MAC_UP	Genes up-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to M. tuberculosis.	44	1.862523e-2	1.000000e+0	8.085043e-1	5.369061e+1	1.862523e-2	1	1.862523e-2	1.000000e+0	54	2.106249e-2	1.000000e+0	7.449881e-1	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN	Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist).	45	1.862794e-2	1.000000e+0	7.906526e-1	5.368279e+1	1.862794e-2	1	1.862794e-2	1.000000e+0	13	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_12H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 12 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 12 h.	46	1.865290e-2	1.000000e+0	7.745008e-1	5.361096e+1	1.865290e-2	1	1.865290e-2	1.000000e+0	99	2.183015e-2	1.000000e+0	4.211675e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated wth vehicle.	47	1.871033e-2	1.000000e+0	7.603560e-1	5.344641e+1	1.871033e-2	1	1.871033e-2	1.000000e+0	31	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN	Genes down-regulated in comparison of naive CD8 T cells versus unstimulated neutrophils.	48	1.876123e-2	1.000000e+0	7.465406e-1	5.330142e+1	1.876123e-2	1	1.876123e-2	1.000000e+0	109	2.193980e-2	1.000000e+0	3.844497e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_MAC_UP	Genes up-regulated in comparison of eosinophils versus macrophages.	49	1.885392e-2	1.000000e+0	7.349181e-1	5.303937e+1	1.885392e-2	1	1.885392e-2	1.000000e+0	35	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP	Genes up-regulated in comparison of ex vivo CD4- [GeneID=920] CD8- dendritic cells (DC) versus cultured CD4- [GeneID=920] CD8- DCs.	50	1.895237e-2	1.000000e+0	7.239805e-1	5.276384e+1	1.895237e-2	1	1.895237e-2	1.000000e+0	83	2.161085e-2	1.000000e+0	4.973099e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN	Genes down-regulated in comparison of macrophages exposed to 50 worms/well B. malayi versus macrophages exposed to M. tuberculosis.	51	1.902103e-2	1.000000e+0	7.123562e-1	5.257339e+1	1.902103e-2	1	1.902103e-2	1.000000e+0	124	2.314545e-2	1.000000e+0	3.565146e-1	4.295476e+1	2.328031e-2	1	210	5.000000e-1	4.761905e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE339_CD4POS_VS_CD8POS_DC_UP	Genes up-regulated in comparison of CD4 [GeneID=920] dendritic cells (DC) versus CD8 DCs.	52	1.911371e-2	1.000000e+0	7.020613e-1	5.231846e+1	1.911371e-2	1	1.911371e-2	1.000000e+0	99	2.183015e-2	1.000000e+0	4.211675e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h versus PBMC cultured for 12 h with YF17D vaccine.	53	1.926059e-2	1.000000e+0	6.941081e-1	5.191950e+1	1.926059e-2	1	1.926059e-2	1.000000e+0	118	2.237830e-2	1.000000e+0	3.622250e-1	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulated with LPS (TLR4 agonist) at 8 h.	54	1.928850e-2	1.000000e+0	6.822414e-1	5.184436e+1	1.928850e-2	1	1.928850e-2	1.000000e+0	44	2.051397e-2	1.000000e+0	8.904928e-1	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP	Genes up-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus monocytes treated with vehicle.	55	1.933753e-2	1.000000e+0	6.715397e-1	5.171291e+1	1.933753e-2	1	1.933753e-2	1.000000e+0	27	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE3982_DC_VS_TH2_DN	Genes down-regulated in comparison of dendritic cells (DC) versus Th2 cells.	56	1.934066e-2	1.000000e+0	6.596547e-1	5.170453e+1	1.934066e-2	1	1.934066e-2	1.000000e+0	69	2.139152e-2	1.000000e+0	5.921421e-1	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_24H_CPG_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 0.5 h versus those stimulated with CpG DNA (TLR9 agonist) at 24 h.	57	1.937638e-2	1.000000e+0	6.492787e-1	5.160922e+1	1.937638e-2	1	1.937638e-2	1.000000e+0	114	2.204943e-2	1.000000e+0	3.694247e-1	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN	Genes down-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 2 h.	58	1.939602e-2	1.000000e+0	6.387310e-1	5.155696e+1	1.939602e-2	1	1.939602e-2	1.000000e+0	19	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_12H_CPG_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 0.5 h versus those stimulated with CpG DNA (TLR9 agonist) at 12 h.	59	1.940816e-2	1.000000e+0	6.282981e-1	5.152472e+1	1.940816e-2	1	1.940816e-2	1.000000e+0	91	2.172051e-2	1.000000e+0	4.558920e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP	Genes up-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	60	1.944144e-2	1.000000e+0	6.188858e-1	5.143651e+1	1.944144e-2	1	1.944144e-2	1.000000e+0	28	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN	Genes down-regulated in comparison of CD8 T cells with progressing HIV infection versus those with controlled HIV infection.	61	1.955331e-2	1.000000e+0	6.122430e-1	5.114223e+1	1.955331e-2	1	1.955331e-2	1.000000e+0	1	1.012169e-4	1.933243e-1	1.933243e-1	9.912637e+1	2.017627e-2	2	182	1.000000e+0	1.098901e-2	unnamed	PLA2G4A,PTGS2
MSigDB Immunologic Signatures	GSE3982_MAC_VS_BASOPHIL_UP	Genes up-regulated in comparison of macrophages versus basophils.	62	1.961962e-2	1.000000e+0	6.044109e-1	5.096939e+1	1.961962e-2	1	1.961962e-2	1.000000e+0	75	2.150119e-2	1.000000e+0	5.475636e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with vehicle (control).	63	1.971112e-2	1.000000e+0	5.975911e-1	5.073277e+1	1.971112e-2	1	1.971112e-2	1.000000e+0	22	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_4H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 4 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 4 h.	64	1.982967e-2	1.000000e+0	5.917917e-1	5.042947e+1	1.982967e-2	1	1.982967e-2	1.000000e+0	75	2.150119e-2	1.000000e+0	5.475636e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE8515_IL1_VS_IL6_4H_STIM_)MAC_UP	Genes up-regulated in comparison of untreated macrophages versus those treated with IL1 and IL6 [GeneID=3569].	65	1.983242e-2	1.000000e+0	5.827680e-1	5.042250e+1	1.983242e-2	1	1.983242e-2	1.000000e+0	109	2.193980e-2	1.000000e+0	3.844497e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN	Genes down-regulated in comparison of lung tissue from wild type mice subjected to ozone for 0 h versus that from TLR4 [GeneID=7099] deficient mice subjected to ozone for 6 h.	66	1.992545e-2	1.000000e+0	5.766304e-1	5.018708e+1	1.992545e-2	1	1.992545e-2	1.000000e+0	59	2.117217e-2	1.000000e+0	6.854041e-1	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_POLYIC_4H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 4 h versus those stimulated with poly(I:C) (TLR3 agonist) at 4 h.	67	1.992883e-2	1.000000e+0	5.681204e-1	5.017856e+1	1.992883e-2	1	1.992883e-2	1.000000e+0	83	2.161085e-2	1.000000e+0	4.973099e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP	Genes up-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	68	1.998272e-2	1.000000e+0	5.612793e-1	5.004325e+1	1.998272e-2	1	1.998272e-2	1.000000e+0	22	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP	Genes up-regulated in comparison of untreated wild type macrophages at 1 h versus those from IRAK4 [GeneID=51135] deficient mice treated with LPS (TLR4 agonist) at 1 h.	69	2.007240e-2	1.000000e+0	5.556273e-1	4.981964e+1	2.007240e-2	1	2.007240e-2	1.000000e+0	54	2.106249e-2	1.000000e+0	7.449881e-1	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) treated with immunosuppressive DNA versus the untreated cells.	70	2.007932e-2	1.000000e+0	5.478786e-1	4.980248e+1	2.007932e-2	1	2.007932e-2	1.000000e+0	91	2.172051e-2	1.000000e+0	4.558920e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP	Genes up-regulated in comparison of monocytes treated with 1 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	71	2.008849e-2	1.000000e+0	5.404087e-1	4.977976e+1	2.008849e-2	1	2.008849e-2	1.000000e+0	31	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN	Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with 1 ng/ml LPS (TLR4 agonist).	72	2.009729e-2	1.000000e+0	5.331364e-1	4.975795e+1	2.009729e-2	1	2.009729e-2	1.000000e+0	35	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN	Genes down-regulated in comparison of control macrophages versus macrophages treated with interferon alpha.	73	2.023911e-2	1.000000e+0	5.295438e-1	4.940928e+1	2.023911e-2	1	2.023911e-2	1.000000e+0	42	2.040425e-2	1.000000e+0	9.279076e-1	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE14000_4H_VS_16H_LPS_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.	74	2.032426e-2	1.000000e+0	5.245856e-1	4.920229e+1	2.032426e-2	1	2.032426e-2	1.000000e+0	51	2.084310e-2	1.000000e+0	7.805945e-1	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_DC_UP	Genes up-regulated in comparison of mast cells versus dendritic cells (DC).	75	2.034979e-2	1.000000e+0	5.182413e-1	4.914056e+1	2.034979e-2	1	2.034979e-2	1.000000e+0	122	2.303588e-2	1.000000e+0	3.606437e-1	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE29618_BCELL_VS_MDC_DN	Genes down-regulated in comparison of B cells versus myeloid dendritic cells (mDC).	76	2.038664e-2	1.000000e+0	5.123485e-1	4.905174e+1	2.038664e-2	1	2.038664e-2	1.000000e+0	116	2.215906e-2	1.000000e+0	3.648604e-1	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP	Genes up-regulated in comparison of untreated eosinophils versus eosinophils treated with PMA [PubChem=4792] at 2 h.	77	2.049593e-2	1.000000e+0	5.084055e-1	4.879017e+1	2.049593e-2	1	2.049593e-2	1.000000e+0	122	2.303588e-2	1.000000e+0	3.606437e-1	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE29618_PDC_VS_MDC_DN	Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) versus myeloid DCs.	78	2.054977e-2	1.000000e+0	5.032059e-1	4.866234e+1	2.054977e-2	1	2.054977e-2	1.000000e+0	75	2.150119e-2	1.000000e+0	5.475636e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP	Genes up-regulated in comparison of thymic progenitors versus DN3 thymocytes.	79	2.065567e-2	1.000000e+0	4.993966e-1	4.841285e+1	2.065567e-2	1	2.065567e-2	1.000000e+0	91	2.172051e-2	1.000000e+0	4.558920e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE17721_LPS_VS_CPG_4H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 4 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 4 h.	80	2.068521e-2	1.000000e+0	4.938594e-1	4.834372e+1	2.068521e-2	1	2.068521e-2	1.000000e+0	99	2.183015e-2	1.000000e+0	4.211675e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h versus the untreated cells at 24 h.	81	2.088410e-2	1.000000e+0	4.924522e-1	4.788331e+1	2.088410e-2	1	2.088410e-2	1.000000e+0	6	1.699983e-2	1.000000e+0	1.000000e+0	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 3 h versus PBMC cultured for 3 h with YF17D vaccine.	82	2.092132e-2	1.000000e+0	4.873137e-1	4.779813e+1	2.092132e-2	1	2.092132e-2	1.000000e+0	75	2.150119e-2	1.000000e+0	5.475636e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with control IgG.	83	2.092453e-2	1.000000e+0	4.815163e-1	4.779080e+1	2.092453e-2	1	2.092453e-2	1.000000e+0	53	2.095280e-2	1.000000e+0	7.550915e-1	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP	Genes up-regulated in comparison of polysome bound (translated) mRNA in dendritic cells (DC) at 4 h after LPS (TLR4 agonist) stimulation versus those at 16 h after the stimulation.	84	2.094484e-2	1.000000e+0	4.762458e-1	4.774447e+1	2.094484e-2	1	2.094484e-2	1.000000e+0	44	2.051397e-2	1.000000e+0	8.904928e-1	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_1H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 1 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 1 h.	85	2.099153e-2	1.000000e+0	4.716920e-1	4.763826e+1	2.099153e-2	1	2.099153e-2	1.000000e+0	63	2.128185e-2	1.000000e+0	6.452116e-1	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	86	2.100856e-2	1.000000e+0	4.665855e-1	4.759964e+1	2.100856e-2	1	2.100856e-2	1.000000e+0	33	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE339_CD8POS_VS_CD4CD8DN_DC_DN	Genes down-regulated in comparison of CD8 dendritic cells (DC) versus CD4- [GeneID=920] CD8- DCs.	87	2.103694e-2	1.000000e+0	4.618455e-1	4.753542e+1	2.103694e-2	1	2.103694e-2	1.000000e+0	114	2.204943e-2	1.000000e+0	3.694247e-1	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN	Genes down-regulated in comparison of monocytes cultured for 0 days versus those cultured for 1 day.	88	2.104557e-2	1.000000e+0	4.567845e-1	4.751593e+1	2.104557e-2	1	2.104557e-2	1.000000e+0	83	2.161085e-2	1.000000e+0	4.973099e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN	Genes down-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] versus monocytes treated with 5000 ng/ml LPS (TLR4 agonist).	89	2.114013e-2	1.000000e+0	4.536814e-1	4.730339e+1	2.114013e-2	1	2.114013e-2	1.000000e+0	40	2.029452e-2	1.000000e+0	9.690633e-1	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE22886_TH1_VS_TH2_48H_ACT_DN	Genes down-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 48 h versus stimulated CD4 [GeneID=920] Th2 cells at 48 h.	90	2.129336e-2	1.000000e+0	4.518924e-1	4.696301e+1	2.129336e-2	1	2.129336e-2	1.000000e+0	116	2.215906e-2	1.000000e+0	3.648604e-1	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP	Genes up-regulated in comparison of monocytes cultured for 1 day versus those cultured for 7 days.	91	2.135447e-2	1.000000e+0	4.482092e-1	4.682861e+1	2.135447e-2	1	2.135447e-2	1.000000e+0	54	2.106249e-2	1.000000e+0	7.449881e-1	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN	Genes down-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus unstimulated neutrophils.	92	2.136985e-2	1.000000e+0	4.436567e-1	4.679490e+1	2.136985e-2	1	2.136985e-2	1.000000e+0	120	2.259752e-2	1.000000e+0	3.596772e-1	4.400244e+1	2.272601e-2	1	205	5.000000e-1	4.878049e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from patients with type 2 diabetes at the time of diagnosis.	93	2.145680e-2	1.000000e+0	4.406719e-1	4.660528e+1	2.145680e-2	1	2.145680e-2	1.000000e+0	83	2.161085e-2	1.000000e+0	4.973099e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE22886_NEUTROPHIL_VS_DC_UP	Genes up-regulated in comparison of neutrophils versus dendritic cells (DC).	94	2.157904e-2	1.000000e+0	4.384677e-1	4.634126e+1	2.157904e-2	1	2.157904e-2	1.000000e+0	121	2.270712e-2	1.000000e+0	3.584347e-1	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP	Genes up-regulated in comparison of myeloid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.	95	2.170493e-2	1.000000e+0	4.363833e-1	4.607249e+1	2.170493e-2	1	2.170493e-2	1.000000e+0	119	2.248791e-2	1.000000e+0	3.609404e-1	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE29618_BCELL_VS_MONOCYTE_DN	Genes down-regulated in comparison of B cells versus monocytes.	96	2.186627e-2	1.000000e+0	4.350477e-1	4.573254e+1	2.186627e-2	1	2.186627e-2	1.000000e+0	91	2.172051e-2	1.000000e+0	4.558920e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	97	2.213425e-2	1.000000e+0	4.358394e-1	4.517885e+1	2.213425e-2	1	2.213425e-2	1.000000e+0	22	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP	Genes up-regulated in comparison of thymic progenitors versus fetal DN3 thymocytes.	98	2.224626e-2	1.000000e+0	4.335751e-1	4.495138e+1	2.224626e-2	1	2.224626e-2	1.000000e+0	99	2.183015e-2	1.000000e+0	4.211675e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE17721_LPS_VS_CPG_6H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 6 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 6 h.	99	2.225685e-2	1.000000e+0	4.293998e-1	4.492999e+1	2.225685e-2	1	2.225685e-2	1.000000e+0	99	2.183015e-2	1.000000e+0	4.211675e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE2706_2H_VS_8H_R848_STIM_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with R848 at 2 h versus DCs stimulatd with R848 for 8 h.	100	2.226501e-2	1.000000e+0	4.252617e-1	4.491352e+1	2.226501e-2	1	2.226501e-2	1.000000e+0	12	1.897731e-2	1.000000e+0	1.000000e+0	5.244477e+1	1.906768e-2	1	172	5.000000e-1	5.813953e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE11057_PBMC_VS_MEM_CD4_TCELL_UP	Genes up-regulated in comparison of peripheral mononuclear blood cells (PBMC) versus memory T cells.	101	2.230354e-2	1.000000e+0	4.217798e-1	4.483593e+1	2.230354e-2	1	2.230354e-2	1.000000e+0	49	2.073340e-2	1.000000e+0	8.081795e-1	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP	Genes up-regulated in comparison of naive CD8 T cells versus effector CD8 T cells.	102	2.257884e-2	1.000000e+0	4.227998e-1	4.428925e+1	2.257884e-2	1	2.257884e-2	1.000000e+0	35	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP	Genes up-regulated in comparison of thymic progenitors versus fetal DN2 thymocytes.	103	2.274011e-2	1.000000e+0	4.216855e-1	4.397516e+1	2.274011e-2	1	2.274011e-2	1.000000e+0	99	2.183015e-2	1.000000e+0	4.211675e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP	Genes up-regulated in comparison of CD4 [GeneID=920] dendritic cells (DC) versus CD8 DCs.	104	2.286824e-2	1.000000e+0	4.199840e-1	4.372877e+1	2.286824e-2	1	2.286824e-2	1.000000e+0	99	2.183015e-2	1.000000e+0	4.211675e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 48 h versus the untreated cells at 48 h.	105	2.299035e-2	1.000000e+0	4.182054e-1	4.349651e+1	2.299035e-2	1	2.299035e-2	1.000000e+0	10	1.875769e-2	1.000000e+0	1.000000e+0	5.306176e+1	1.884596e-2	1	170	5.000000e-1	5.882353e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 6 h.	106	2.318055e-2	1.000000e+0	4.176873e-1	4.313961e+1	2.318055e-2	1	2.318055e-2	1.000000e+0	19	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE20715_WT_VS_TLR4_KO_LUNG_UP	Genes up-regulated in comparison of lung tissue from wild type mice versus that from TLR4 [GeneID=7099] deficient animals.	107	2.342447e-2	1.000000e+0	4.181377e-1	4.269041e+1	2.342447e-2	1	2.342447e-2	1.000000e+0	75	2.150119e-2	1.000000e+0	5.475636e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE22886_TH1_VS_TH2_12H_ACT_DN	Genes down-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 12 h versus stimulated CD4 [GeneID=920] Th2 cells at 12 h.	108	2.354448e-2	1.000000e+0	4.163885e-1	4.247281e+1	2.354448e-2	1	2.354448e-2	1.000000e+0	109	2.193980e-2	1.000000e+0	3.844497e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 1 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 1 h.	109	2.375137e-2	1.000000e+0	4.161937e-1	4.210284e+1	2.375137e-2	1	2.375137e-2	1.000000e+0	83	2.161085e-2	1.000000e+0	4.973099e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE17721_12H_VS_24H_POLYIC_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 12 h versus those stimulated at 24 h.	110	2.387296e-2	1.000000e+0	4.145214e-1	4.188839e+1	2.387296e-2	1	2.387296e-2	1.000000e+0	69	2.139152e-2	1.000000e+0	5.921421e-1	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN	Genes down-regulated in comparison of unstimulated macrophage cells versus macrophage cells stimulated with LPS (TLR4 agonist) for 40 min.	111	2.410066e-2	1.000000e+0	4.147051e-1	4.149264e+1	2.410066e-2	1	2.410066e-2	1.000000e+0	69	2.139152e-2	1.000000e+0	5.921421e-1	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN	Genes down-regulated in comparison of unstimulated macrophage cells versus macrophage cells stimulated with LPS (TLR4 agonist) for 60 min.	112	2.414016e-2	1.000000e+0	4.116759e-1	4.142474e+1	2.414016e-2	1	2.414016e-2	1.000000e+0	59	2.117217e-2	1.000000e+0	6.854041e-1	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 6 h versus the untreated cells at 6 h.	113	2.421729e-2	1.000000e+0	4.093365e-1	4.129281e+1	2.421729e-2	1	2.421729e-2	1.000000e+0	15	1.930669e-2	1.000000e+0	1.000000e+0	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP	Genes up-regulated in comparison of CD4 [GeneID=920] dendritic cells (DC) versus CD4- [GeneID=920] CD8- DCs.	114	2.443376e-2	1.000000e+0	4.093726e-1	4.092697e+1	2.443376e-2	1	2.443376e-2	1.000000e+0	54	2.106249e-2	1.000000e+0	7.449881e-1	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 48 h.	115	2.453797e-2	1.000000e+0	4.075437e-1	4.075317e+1	2.453797e-2	1	2.453797e-2	1.000000e+0	19	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE9037_WT_VS_IRAK4_KO_BMDM_UP	Genes up-regulated in comparison of untreated wild type macrophages at 4 h versus those from IRAK4 [GeneID=51135] deficient mice at 4 h.	116	2.460623e-2	1.000000e+0	4.051543e-1	4.064012e+1	2.460623e-2	1	2.460623e-2	1.000000e+0	69	2.139152e-2	1.000000e+0	5.921421e-1	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 4 h.	117	2.484765e-2	1.000000e+0	4.056326e-1	4.024525e+1	2.484765e-2	1	2.484765e-2	1.000000e+0	22	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP	Genes up-regulated in comparison of type 2 myeloid (T2M) cells treated with IL25 [GeneID=64806] versus macrophages treated with IL25 [GeneID=64806].	118	2.505265e-2	1.000000e+0	4.055132e-1	3.991594e+1	2.505265e-2	1	2.505265e-2	1.000000e+0	51	2.084310e-2	1.000000e+0	7.805945e-1	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 2 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 2 h.	119	2.521429e-2	1.000000e+0	4.046999e-1	3.966005e+1	2.521429e-2	1	2.521429e-2	1.000000e+0	83	2.161085e-2	1.000000e+0	4.973099e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP	Genes up-regulated in comparison of ActCD4TGF versus WTActCD4TGF (see Fig. 1 in the paper for details).	120	2.543665e-2	1.000000e+0	4.048667e-1	3.931335e+1	2.543665e-2	1	2.543665e-2	1.000000e+0	54	2.106249e-2	1.000000e+0	7.449881e-1	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_2H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 2 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 2 h.	121	2.546058e-2	1.000000e+0	4.018984e-1	3.927640e+1	2.546058e-2	1	2.546058e-2	1.000000e+0	83	2.161085e-2	1.000000e+0	4.973099e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h.	122	2.548746e-2	1.000000e+0	3.990250e-1	3.923497e+1	2.548746e-2	1	2.548746e-2	1.000000e+0	15	1.930669e-2	1.000000e+0	1.000000e+0	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	PTGS2
MSigDB Immunologic Signatures	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP	Genes up-regulated in comparison of thymic progenitors versus DN2 thymocytes.	123	2.548845e-2	1.000000e+0	3.957963e-1	3.923346e+1	2.548845e-2	1	2.548845e-2	1.000000e+0	75	2.150119e-2	1.000000e+0	5.475636e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_NKCELL_UP	Genes up-regulated in comparison of mast cells versus NK cells.	124	2.574760e-2	1.000000e+0	3.965961e-1	3.883858e+1	2.574760e-2	1	2.574760e-2	1.000000e+0	99	2.183015e-2	1.000000e+0	4.211675e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	PLA2G4A
MSigDB Immunologic Signatures	GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 6 h.	125	2.588933e-2	1.000000e+0	3.955890e-1	3.862596e+1	2.588933e-2	1	2.588933e-2	1.000000e+0	15	1.930669e-2	1.000000e+0	1.000000e+0	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	PTGS2
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
